Background  ||| S:24 E:43 ||| NN
The  ||| S:43 E:47 ||| DT
overuse  ||| S:47 E:55 ||| NN
of  ||| S:55 E:58 ||| IN
antibiotics  ||| S:58 E:70 ||| NN
in  ||| S:70 E:73 ||| IN
the  ||| S:73 E:77 ||| DT
clinic  ||| S:77 E:84 ||| NN
and  ||| S:84 E:88 ||| CC
for  ||| S:88 E:100 ||| IN
agricultural  ||| S:100 E:113 ||| JJ
uses  ||| S:113 E:118 ||| NNS
has  ||| S:118 E:122 ||| VBZ
resulted  ||| S:122 E:131 ||| VBN
in  ||| S:131 E:134 ||| IN
a  ||| S:134 E:136 ||| DT
tremendous  ||| S:136 E:147 ||| JJ
selective  ||| S:147 E:165 ||| JJ
pressure  ||| S:165 E:174 ||| NN
for  ||| S:174 E:178 ||| IN
antibiotic  ||| S:178 E:189 ||| JJ
resistant  ||| S:189 E:199 ||| JJ
bacteria ||| S:199 E:207 ||| NNS
.  ||| S:207 E:209 ||| .
These  ||| S:209 E:215 ||| DT
bacteria  ||| S:215 E:232 ||| NNS
become  ||| S:232 E:239 ||| VBP
resistant  ||| S:239 E:249 ||| VBN
by  ||| S:249 E:252 ||| IN
a  ||| S:252 E:254 ||| DT
number  ||| S:254 E:261 ||| NN
of  ||| S:261 E:264 ||| IN
mechanisms ||| S:264 E:274 ||| NNS
,  ||| S:274 E:276 ||| ,
such  ||| S:276 E:281 ||| JJ
as  ||| S:281 E:292 ||| IN
producing  ||| S:292 E:302 ||| VBG
enzymes  ||| S:302 E:310 ||| NN
that  ||| S:310 E:315 ||| IN
hydrolyze  ||| S:315 E:325 ||| NN
or  ||| S:325 E:328 ||| CC
inactivate  ||| S:328 E:339 ||| VBG
the  ||| S:339 E:351 ||| DT
antibiotics ||| S:351 E:362 ||| NN
,  ||| S:362 E:364 ||| ,
producing  ||| S:364 E:374 ||| VBG
efflux  ||| S:374 E:381 ||| JJ
pumps  ||| S:381 E:387 ||| NNS
that  ||| S:387 E:392 ||| WDT
transport  ||| S:392 E:402 ||| VBZ
the  ||| S:402 E:414 ||| DT
antibiotic  ||| S:414 E:425 ||| NN
out  ||| S:425 E:429 ||| RP
of  ||| S:429 E:432 ||| IN
the  ||| S:432 E:436 ||| DT
cell ||| S:436 E:440 ||| NN
,  ||| S:440 E:442 ||| ,
or  ||| S:442 E:445 ||| CC
modifying  ||| S:445 E:455 ||| VB
their  ||| S:455 E:461 ||| PRP$
cell  ||| S:461 E:466 ||| NN
wall  ||| S:466 E:479 ||| NN
components  ||| S:479 E:490 ||| NNS
so  ||| S:490 E:493 ||| IN
they  ||| S:493 E:498 ||| PRP
no  ||| S:498 E:501 ||| RB
longer  ||| S:501 E:508 ||| JJR
bind  ||| S:508 E:513 ||| NN
effectively  ||| S:513 E:525 ||| RB
to  ||| S:525 E:528 ||| TO
the  ||| S:528 E:540 ||| DT
antibiotics  ||| S:540 E:552 ||| NN
[  ||| S:552 E:554 ||| -LRB-
1  ||| S:554 E:556 ||| CD
2  ||| S:556 E:558 ||| CD
3  ||| S:558 E:560 ||| CD
]  ||| S:560 E:562 ||| -RRB-
.  ||| S:562 E:564 ||| .
The  ||| S:564 E:568 ||| DT
most  ||| S:568 E:573 ||| RBS
common ||| S:573 E:579 ||| JJ
,  ||| S:579 E:581 ||| ,
least  ||| S:581 E:587 ||| JJS
expensive ||| S:587 E:596 ||| JJ
,  ||| S:596 E:606 ||| ,
and  ||| S:606 E:610 ||| CC
effective  ||| S:610 E:620 ||| JJ
antibiotics  ||| S:620 E:632 ||| NNS
are  ||| S:632 E:636 ||| VBP
the  ||| S:636 E:640 ||| DT
β-lactam  ||| S:640 E:649 ||| JJ
containing  ||| S:649 E:668 ||| JJ
antibiotics ||| S:668 E:679 ||| NN
,  ||| S:679 E:681 ||| ,
such  ||| S:681 E:686 ||| JJ
as  ||| S:686 E:689 ||| IN
the  ||| S:689 E:693 ||| DT
penicillins ||| S:693 E:704 ||| NN
,  ||| S:704 E:706 ||| ,
cephalosporins ||| S:706 E:720 ||| NN
,  ||| S:720 E:722 ||| ,
and  ||| S:722 E:734 ||| CC
carbapenems  ||| S:734 E:746 ||| NNS
[  ||| S:746 E:748 ||| -LRB-
2  ||| S:748 E:750 ||| CD
4  ||| S:750 E:752 ||| CD
5  ||| S:752 E:754 ||| CD
]  ||| S:754 E:756 ||| -RRB-
.  ||| S:756 E:758 ||| .
These  ||| S:758 E:764 ||| DT
antibiotics  ||| S:764 E:776 ||| NNS
are  ||| S:776 E:788 ||| VBP
mechanism-based  ||| S:788 E:804 ||| JJ
inhibitors  ||| S:804 E:815 ||| NN
of  ||| S:815 E:818 ||| IN
transpeptidase ||| S:818 E:832 ||| NN
,  ||| S:832 E:834 ||| ,
a  ||| S:834 E:836 ||| DT
bacterial  ||| S:836 E:854 ||| JJ
enzyme  ||| S:854 E:861 ||| NNS
required  ||| S:861 E:870 ||| VBN
for  ||| S:870 E:874 ||| IN
the  ||| S:874 E:878 ||| DT
production  ||| S:878 E:889 ||| NN
of  ||| S:889 E:892 ||| IN
a  ||| S:892 E:894 ||| DT
strong  ||| S:894 E:901 ||| JJ
viable  ||| S:901 E:908 ||| JJ
cell  ||| S:908 E:921 ||| NN
wall  ||| S:921 E:926 ||| NN
[  ||| S:926 E:928 ||| -LRB-
6  ||| S:928 E:930 ||| CD
7  ||| S:930 E:932 ||| CD
]  ||| S:932 E:934 ||| -RRB-
.  ||| S:934 E:936 ||| .
In  ||| S:936 E:939 ||| IN
response  ||| S:939 E:948 ||| NN
to  ||| S:948 E:951 ||| TO
the  ||| S:951 E:955 ||| DT
widespread  ||| S:955 E:966 ||| JJ
use  ||| S:966 E:970 ||| NN
of  ||| S:970 E:981 ||| IN
β-lactam  ||| S:981 E:990 ||| JJ
containing  ||| S:990 E:1001 ||| JJ
antibiotics ||| S:1001 E:1012 ||| NN
,  ||| S:1012 E:1014 ||| ,
bacteria  ||| S:1014 E:1023 ||| NNS
have  ||| S:1023 E:1028 ||| VBP
acquired  ||| S:1028 E:1037 ||| VBN
the  ||| S:1037 E:1049 ||| DT
ability  ||| S:1049 E:1057 ||| NN
to  ||| S:1057 E:1060 ||| TO
produce  ||| S:1060 E:1068 ||| VB
β-lactamases ||| S:1068 E:1080 ||| JJ
,  ||| S:1080 E:1082 ||| ,
which  ||| S:1082 E:1088 ||| WDT
are  ||| S:1088 E:1092 ||| VBP
enzymes  ||| S:1092 E:1100 ||| VBN
that  ||| S:1100 E:1113 ||| IN
hydrolyze  ||| S:1113 E:1123 ||| NN
and  ||| S:1123 E:1127 ||| CC
inactivate  ||| S:1127 E:1138 ||| JJ
β-lactam  ||| S:1138 E:1147 ||| JJ
containing  ||| S:1147 E:1158 ||| JJ
antibiotics ||| S:1158 E:1169 ||| NN
.  ||| S:1169 E:1179 ||| .
There  ||| S:1179 E:1185 ||| EX
are  ||| S:1185 E:1189 ||| VBP
over  ||| S:1189 E:1194 ||| IN
300  ||| S:1194 E:1198 ||| CD
distinct  ||| S:1198 E:1207 ||| JJ
β-lactamases  ||| S:1207 E:1220 ||| NN
known ||| S:1220 E:1225 ||| VBN
,  ||| S:1225 E:1227 ||| ,
and  ||| S:1227 E:1231 ||| CC
these  ||| S:1231 E:1245 ||| DT
enzymes  ||| S:1245 E:1253 ||| NNS
have  ||| S:1253 E:1258 ||| VBP
been  ||| S:1258 E:1263 ||| VBN
grouped  ||| S:1263 E:1271 ||| VBN
by  ||| S:1271 E:1274 ||| IN
a  ||| S:1274 E:1276 ||| DT
number  ||| S:1276 E:1283 ||| NN
of  ||| S:1283 E:1286 ||| IN
classification  ||| S:1286 E:1309 ||| JJ
schemes  ||| S:1309 E:1317 ||| NNS
[  ||| S:1317 E:1319 ||| -LRB-
8  ||| S:1319 E:1321 ||| CD
9  ||| S:1321 E:1323 ||| CD
10  ||| S:1323 E:1326 ||| CD
11  ||| S:1326 E:1329 ||| CD
12  ||| S:1329 E:1332 ||| CD
13  ||| S:1332 E:1335 ||| CD
14  ||| S:1335 E:1338 ||| CD
15  ||| S:1338 E:1341 ||| CD
]  ||| S:1341 E:1343 ||| -RRB-
.  ||| S:1343 E:1345 ||| .
For  ||| S:1345 E:1349 ||| IN
example ||| S:1349 E:1356 ||| NN
,  ||| S:1356 E:1358 ||| ,
Bush  ||| S:1358 E:1363 ||| NNP
has  ||| S:1363 E:1375 ||| VBZ
developed  ||| S:1375 E:1385 ||| VBN
a  ||| S:1385 E:1387 ||| DT
scheme ||| S:1387 E:1393 ||| NN
,  ||| S:1393 E:1395 ||| ,
based  ||| S:1395 E:1401 ||| VBN
on  ||| S:1401 E:1404 ||| IN
the  ||| S:1404 E:1408 ||| DT
enzymes ||| S:1408 E:1415 ||| NN
'  ||| S:1415 E:1417 ||| POS
molecular  ||| S:1417 E:1435 ||| JJ
properties ||| S:1435 E:1445 ||| NNS
,  ||| S:1445 E:1447 ||| ,
that  ||| S:1447 E:1452 ||| WDT
has  ||| S:1452 E:1456 ||| VBZ
four  ||| S:1456 E:1461 ||| CD
distinct  ||| S:1461 E:1470 ||| JJ
β-lactamase  ||| S:1470 E:1482 ||| JJ
groups  ||| S:1482 E:1489 ||| NNS
[  ||| S:1489 E:1491 ||| -LRB-
10  ||| S:1491 E:1502 ||| CD
15  ||| S:1502 E:1505 ||| CD
]  ||| S:1505 E:1507 ||| -RRB-
.  ||| S:1507 E:1509 ||| .
One  ||| S:1509 E:1513 ||| CD
of  ||| S:1513 E:1516 ||| IN
the  ||| S:1516 E:1520 ||| DT
more  ||| S:1520 E:1525 ||| RBR
alarming  ||| S:1525 E:1534 ||| JJ
groups  ||| S:1534 E:1541 ||| NNS
are  ||| S:1541 E:1545 ||| VBP
the  ||| S:1545 E:1549 ||| DT
Bush  ||| S:1549 E:1554 ||| NNP
group  ||| S:1554 E:1560 ||| NN
3  ||| S:1560 E:1570 ||| CD
enzymes ||| S:1570 E:1577 ||| NN
,  ||| S:1577 E:1579 ||| ,
which  ||| S:1579 E:1585 ||| WDT
are  ||| S:1585 E:1589 ||| VBP
Zn ||| S:1589 E:1591 ||| NNP
( ||| S:1591 E:1592 ||| -LRB-
II ||| S:1592 E:1594 ||| NNP
)  ||| S:1594 E:1596 ||| -RRB-
dependent  ||| S:1596 E:1606 ||| JJ
enzymes  ||| S:1606 E:1614 ||| NN
that  ||| S:1614 E:1619 ||| WDT
hydrolyze  ||| S:1619 E:1637 ||| VBP
nearly  ||| S:1637 E:1644 ||| RB
all  ||| S:1644 E:1648 ||| RB
known  ||| S:1648 E:1654 ||| VBN
β-lactam  ||| S:1654 E:1663 ||| JJ
containing  ||| S:1663 E:1674 ||| VBG
antibiotics  ||| S:1674 E:1686 ||| NNS
and  ||| S:1686 E:1690 ||| CC
for  ||| S:1690 E:1702 ||| IN
which  ||| S:1702 E:1708 ||| WDT
there  ||| S:1708 E:1714 ||| EX
are  ||| S:1714 E:1718 ||| VBP
no  ||| S:1718 E:1721 ||| RB
or  ||| S:1721 E:1724 ||| CC
very  ||| S:1724 E:1729 ||| RB
few  ||| S:1729 E:1733 ||| JJ
known  ||| S:1733 E:1739 ||| JJ
clinical  ||| S:1739 E:1748 ||| JJ
inhibitors  ||| S:1748 E:1759 ||| NNS
[  ||| S:1759 E:1769 ||| -LRB-
9  ||| S:1769 E:1771 ||| CD
14  ||| S:1771 E:1774 ||| CD
16  ||| S:1774 E:1777 ||| CD
17  ||| S:1777 E:1780 ||| CD
18  ||| S:1780 E:1783 ||| CD
19  ||| S:1783 E:1786 ||| CD
]  ||| S:1786 E:1788 ||| -RRB-
.  ||| S:1788 E:1790 ||| .
The  ||| S:1790 E:1794 ||| DT
metallo-β-lactamases  ||| S:1794 E:1815 ||| NNS
have  ||| S:1815 E:1820 ||| VBP
been  ||| S:1820 E:1833 ||| VBN
further  ||| S:1833 E:1841 ||| RB
divided  ||| S:1841 E:1849 ||| VBN
by  ||| S:1849 E:1852 ||| IN
Bush  ||| S:1852 E:1857 ||| NNP
into  ||| S:1857 E:1862 ||| IN
subgroups  ||| S:1862 E:1872 ||| NNS
based  ||| S:1872 E:1878 ||| VBN
on  ||| S:1878 E:1881 ||| IN
amino  ||| S:1881 E:1887 ||| JJ
acid  ||| S:1887 E:1900 ||| NN
sequence  ||| S:1900 E:1909 ||| NN
identity ||| S:1909 E:1917 ||| NN
:  ||| S:1917 E:1919 ||| :
the  ||| S:1919 E:1923 ||| DT
Ba  ||| S:1923 E:1926 ||| JJ
enzymes  ||| S:1926 E:1934 ||| JJ
share  ||| S:1934 E:1940 ||| NN
a  ||| S:1940 E:1942 ||| DT
> ||| S:1942 E:1943 ||| CD
23 ||| S:1943 E:1945 ||| CD
%  ||| S:1945 E:1947 ||| NN
sequence  ||| S:1947 E:1964 ||| NN
identity ||| S:1964 E:1972 ||| NN
,  ||| S:1972 E:1974 ||| ,
require  ||| S:1974 E:1982 ||| VB
2  ||| S:1982 E:1984 ||| CD
Zn ||| S:1984 E:1986 ||| NNP
( ||| S:1986 E:1987 ||| -LRB-
II ||| S:1987 E:1989 ||| NNP
)  ||| S:1989 E:1991 ||| -RRB-
ions  ||| S:1991 E:1996 ||| NN
for  ||| S:1996 E:2000 ||| IN
full  ||| S:2000 E:2005 ||| JJ
activity ||| S:2005 E:2013 ||| NN
,  ||| S:2013 E:2015 ||| ,
prefer  ||| S:2015 E:2030 ||| VBP
penicillins  ||| S:2030 E:2042 ||| VBN
and  ||| S:2042 E:2046 ||| CC
cephalosporins  ||| S:2046 E:2061 ||| NN
as  ||| S:2061 E:2064 ||| IN
substrates ||| S:2064 E:2074 ||| NN
,  ||| S:2074 E:2076 ||| ,
and  ||| S:2076 E:2080 ||| CC
are  ||| S:2080 E:2092 ||| VBP
represented  ||| S:2092 E:2104 ||| VBN
by  ||| S:2104 E:2107 ||| IN
metallo-β-lactamase  ||| S:2107 E:2127 ||| JJ
CcrA  ||| S:2127 E:2132 ||| NN
from  ||| S:2132 E:2146 ||| IN
Bacteroides  ||| S:2146 E:2158 ||| NNP
fragilis ||| S:2158 E:2166 ||| NN
,  ||| S:2166 E:2168 ||| ,
the  ||| S:2168 E:2172 ||| DT
Bb  ||| S:2172 E:2175 ||| JJ
enzymes  ||| S:2175 E:2191 ||| JJ
share  ||| S:2191 E:2197 ||| NN
a  ||| S:2197 E:2199 ||| DT
11 ||| S:2199 E:2201 ||| CD
%  ||| S:2201 E:2203 ||| NN
sequence  ||| S:2203 E:2212 ||| NN
identity  ||| S:2212 E:2221 ||| NN
with  ||| S:2221 E:2226 ||| IN
the  ||| S:2226 E:2230 ||| DT
Ba  ||| S:2230 E:2233 ||| JJ
enzymes ||| S:2233 E:2240 ||| NN
,  ||| S:2240 E:2242 ||| ,
require  ||| S:2242 E:2258 ||| VBP
only  ||| S:2258 E:2263 ||| RB
1  ||| S:2263 E:2265 ||| CD
Zn ||| S:2265 E:2267 ||| NNP
( ||| S:2267 E:2268 ||| -LRB-
II ||| S:2268 E:2270 ||| NNP
)  ||| S:2270 E:2272 ||| -RRB-
ion  ||| S:2272 E:2276 ||| NN
for  ||| S:2276 E:2280 ||| IN
full  ||| S:2280 E:2285 ||| JJ
activity ||| S:2285 E:2293 ||| NN
,  ||| S:2293 E:2295 ||| ,
prefer  ||| S:2295 E:2302 ||| VBP
carbapenems  ||| S:2302 E:2314 ||| VBN
as  ||| S:2314 E:2325 ||| IN
substrates ||| S:2325 E:2335 ||| NN
,  ||| S:2335 E:2337 ||| ,
and  ||| S:2337 E:2341 ||| CC
are  ||| S:2341 E:2345 ||| VBP
represented  ||| S:2345 E:2357 ||| VBN
by  ||| S:2357 E:2360 ||| IN
the  ||| S:2360 E:2364 ||| DT
metallo-β-lactamase  ||| S:2364 E:2392 ||| JJ
imiS  ||| S:2392 E:2397 ||| NN
from  ||| S:2397 E:2411 ||| IN
Aeromonas  ||| S:2411 E:2421 ||| NNP
sobria ||| S:2421 E:2427 ||| NN
,  ||| S:2427 E:2429 ||| ,
and  ||| S:2429 E:2433 ||| CC
the  ||| S:2433 E:2437 ||| DT
Bc  ||| S:2437 E:2440 ||| JJ
enzymes  ||| S:2440 E:2456 ||| NNS
have  ||| S:2456 E:2461 ||| VBP
only  ||| S:2461 E:2466 ||| RB
9  ||| S:2466 E:2468 ||| CD
conserved  ||| S:2468 E:2478 ||| CD
residues  ||| S:2478 E:2487 ||| NNS
with  ||| S:2487 E:2492 ||| IN
the  ||| S:2492 E:2496 ||| DT
other  ||| S:2496 E:2510 ||| JJ
metallo-β-lactamases ||| S:2510 E:2530 ||| NN
,  ||| S:2530 E:2532 ||| ,
require  ||| S:2532 E:2540 ||| VB
2  ||| S:2540 E:2542 ||| CD
Zn ||| S:2542 E:2544 ||| NNP
( ||| S:2544 E:2545 ||| -LRB-
II ||| S:2545 E:2547 ||| NNP
)  ||| S:2547 E:2549 ||| -RRB-
ions  ||| S:2549 E:2554 ||| NN
for  ||| S:2554 E:2558 ||| IN
activity ||| S:2558 E:2566 ||| NN
,  ||| S:2566 E:2576 ||| ,
contain  ||| S:2576 E:2584 ||| VBP
a  ||| S:2584 E:2586 ||| DT
different  ||| S:2586 E:2596 ||| JJ
metal  ||| S:2596 E:2602 ||| NN
binding  ||| S:2602 E:2610 ||| JJ
motif  ||| S:2610 E:2616 ||| NN
than  ||| S:2616 E:2621 ||| IN
the  ||| S:2621 E:2625 ||| DT
other  ||| S:2625 E:2639 ||| JJ
metallo-β-lactamases ||| S:2639 E:2659 ||| NN
,  ||| S:2659 E:2661 ||| ,
prefer  ||| S:2661 E:2668 ||| VBP
penicillins  ||| S:2668 E:2680 ||| VBN
as  ||| S:2680 E:2683 ||| IN
substrates ||| S:2683 E:2693 ||| NN
,  ||| S:2693 E:2695 ||| ,
and  ||| S:2695 E:2707 ||| CC
are  ||| S:2707 E:2711 ||| VBP
represented  ||| S:2711 E:2723 ||| VBN
by  ||| S:2723 E:2726 ||| IN
the  ||| S:2726 E:2730 ||| DT
metallo-β-lactamase  ||| S:2730 E:2750 ||| JJ
L1  ||| S:2750 E:2753 ||| NN
from  ||| S:2753 E:2767 ||| IN
Stenotrophomonas  ||| S:2767 E:2784 ||| NNP
maltophilia  ||| S:2784 E:2796 ||| NNS
[  ||| S:2796 E:2798 ||| -LRB-
9  ||| S:2798 E:2800 ||| CD
]  ||| S:2800 E:2802 ||| -RRB-
.  ||| S:2802 E:2812 ||| .
A  ||| S:2812 E:2814 ||| DT
similar  ||| S:2814 E:2822 ||| JJ
grouping  ||| S:2822 E:2831 ||| JJ
scheme  ||| S:2831 E:2838 ||| NN
( ||| S:2838 E:2839 ||| -LRB-
B1 ||| S:2839 E:2841 ||| NNP
,  ||| S:2841 E:2843 ||| ,
B2 ||| S:2843 E:2845 ||| NN
,  ||| S:2845 E:2847 ||| ,
and  ||| S:2847 E:2851 ||| CC
B3 ||| S:2851 E:2853 ||| CD
)  ||| S:2853 E:2855 ||| -RRB-
based  ||| S:2855 E:2861 ||| VBN
on  ||| S:2861 E:2872 ||| IN
structural  ||| S:2872 E:2883 ||| JJ
properties  ||| S:2883 E:2894 ||| NNS
of  ||| S:2894 E:2897 ||| IN
the  ||| S:2897 E:2901 ||| DT
metallo-β-lactamases  ||| S:2901 E:2922 ||| NN
has  ||| S:2922 E:2934 ||| VBZ
recently  ||| S:2934 E:2943 ||| RB
been  ||| S:2943 E:2948 ||| VBN
offered  ||| S:2948 E:2956 ||| VBN
[  ||| S:2956 E:2958 ||| -LRB-
41  ||| S:2958 E:2961 ||| CD
]  ||| S:2961 E:2963 ||| -RRB-
.  ||| S:2963 E:2965 ||| .
The  ||| S:2965 E:2969 ||| DT
diversity  ||| S:2969 E:2979 ||| NN
of  ||| S:2979 E:2982 ||| IN
the  ||| S:2982 E:2986 ||| DT
group  ||| S:2986 E:2992 ||| NN
3  ||| S:2992 E:3002 ||| CD
β-lactamases  ||| S:3002 E:3015 ||| NN
is  ||| S:3015 E:3018 ||| VBZ
best  ||| S:3018 E:3023 ||| JJS
exemplified  ||| S:3023 E:3035 ||| NN
by  ||| S:3035 E:3038 ||| IN
the  ||| S:3038 E:3042 ||| DT
enzymes ||| S:3042 E:3049 ||| NN
'  ||| S:3049 E:3051 ||| POS
vastly  ||| S:3051 E:3066 ||| FW
differing  ||| S:3066 E:3076 ||| FW
efficacies  ||| S:3076 E:3087 ||| FW
towards  ||| S:3087 E:3095 ||| FW
non-clinical  ||| S:3095 E:3108 ||| FW
inhibitors ||| S:3108 E:3118 ||| FW
;  ||| S:3118 E:3120 ||| :
these  ||| S:3120 E:3134 ||| DT
differences  ||| S:3134 E:3146 ||| NNS
predict  ||| S:3146 E:3154 ||| VBP
that  ||| S:3154 E:3159 ||| IN
one  ||| S:3159 E:3163 ||| CD
inhibitor  ||| S:3163 E:3173 ||| NNS
may  ||| S:3173 E:3177 ||| MD
not  ||| S:3177 E:3181 ||| RB
inhibit  ||| S:3181 E:3189 ||| VB
all  ||| S:3189 E:3201 ||| DT
metallo-β-lactamases  ||| S:3201 E:3222 ||| JJ
[  ||| S:3222 E:3224 ||| -LRB-
18  ||| S:3224 E:3227 ||| CD
20  ||| S:3227 E:3230 ||| CD
21  ||| S:3230 E:3233 ||| CD
22  ||| S:3233 E:3236 ||| CD
23  ||| S:3236 E:3239 ||| CD
24  ||| S:3239 E:3242 ||| CD
25  ||| S:3242 E:3245 ||| CD
26  ||| S:3245 E:3248 ||| CD
27  ||| S:3248 E:3251 ||| CD
28  ||| S:3251 E:3254 ||| CD
29  ||| S:3254 E:3257 ||| CD
]  ||| S:3257 E:3259 ||| -RRB-
.  ||| S:3259 E:3269 ||| .
To  ||| S:3269 E:3272 ||| TO
combat  ||| S:3272 E:3279 ||| VB
this  ||| S:3279 E:3284 ||| DT
problem ||| S:3284 E:3291 ||| NN
,  ||| S:3291 E:3293 ||| ,
we  ||| S:3293 E:3296 ||| PRP
are  ||| S:3296 E:3300 ||| VBP
characterizing  ||| S:3300 E:3315 ||| VBG
a  ||| S:3315 E:3325 ||| DT
metallo-β-lactamase  ||| S:3325 E:3345 ||| JJ
from  ||| S:3345 E:3350 ||| IN
each  ||| S:3350 E:3355 ||| DT
of  ||| S:3355 E:3358 ||| IN
the  ||| S:3358 E:3362 ||| DT
subgroups  ||| S:3362 E:3372 ||| NNS
in  ||| S:3372 E:3375 ||| IN
an  ||| S:3375 E:3378 ||| DT
effort  ||| S:3378 E:3393 ||| NN
to  ||| S:3393 E:3396 ||| TO
identify  ||| S:3396 E:3405 ||| VB
a  ||| S:3405 E:3407 ||| DT
common  ||| S:3407 E:3414 ||| JJ
structural  ||| S:3414 E:3425 ||| JJ
or  ||| S:3425 E:3428 ||| CC
mechanistic  ||| S:3428 E:3440 ||| JJ
aspect  ||| S:3440 E:3447 ||| NN
of  ||| S:3447 E:3458 ||| IN
the  ||| S:3458 E:3462 ||| DT
enzymes  ||| S:3462 E:3470 ||| NN
that  ||| S:3470 E:3475 ||| WDT
can  ||| S:3475 E:3479 ||| MD
be  ||| S:3479 E:3482 ||| VB
targeted  ||| S:3482 E:3491 ||| VBN
for  ||| S:3491 E:3495 ||| IN
the  ||| S:3495 E:3499 ||| DT
generation  ||| S:3499 E:3510 ||| NN
of  ||| S:3510 E:3513 ||| IN
an  ||| S:3513 E:3524 ||| DT
inhibitor ||| S:3524 E:3533 ||| NN
.  ||| S:3533 E:3535 ||| .
It  ||| S:3535 E:3538 ||| PRP
is  ||| S:3538 E:3541 ||| VBZ
hoped  ||| S:3541 E:3547 ||| VBN
that  ||| S:3547 E:3552 ||| IN
this  ||| S:3552 E:3557 ||| DT
inhibitor ||| S:3557 E:3566 ||| NN
,  ||| S:3566 E:3568 ||| ,
when  ||| S:3568 E:3573 ||| WRB
given  ||| S:3573 E:3579 ||| VBN
in  ||| S:3579 E:3590 ||| IN
combination  ||| S:3590 E:3602 ||| NN
with  ||| S:3602 E:3607 ||| IN
an  ||| S:3607 E:3610 ||| DT
existing  ||| S:3610 E:3619 ||| JJ
antibiotic ||| S:3619 E:3629 ||| NN
,  ||| S:3629 E:3631 ||| ,
will  ||| S:3631 E:3636 ||| MD
prove  ||| S:3636 E:3642 ||| VB
to  ||| S:3642 E:3645 ||| TO
be  ||| S:3645 E:3656 ||| VB
an  ||| S:3656 E:3659 ||| DT
effective  ||| S:3659 E:3669 ||| JJ
therapy  ||| S:3669 E:3677 ||| NN
against  ||| S:3677 E:3685 ||| IN
bacteria  ||| S:3685 E:3694 ||| NNS
that  ||| S:3694 E:3699 ||| WDT
produce  ||| S:3699 E:3707 ||| VBP
a  ||| S:3707 E:3717 ||| DT
metallo-β-lactamase ||| S:3717 E:3736 ||| JJ
.  ||| S:3736 E:3738 ||| .
This  ||| S:3738 E:3743 ||| DT
work  ||| S:3743 E:3748 ||| NN
describes  ||| S:3748 E:3758 ||| VBZ
our  ||| S:3758 E:3762 ||| PRP$
efforts  ||| S:3762 E:3770 ||| NNS
on  ||| S:3770 E:3781 ||| IN
metallo-β-lactamase  ||| S:3781 E:3801 ||| JJ
L1  ||| S:3801 E:3804 ||| NN
from  ||| S:3804 E:3818 ||| IN
S.  ||| S:3818 E:3821 ||| NNP
maltophilia ||| S:3821 E:3832 ||| NN
.  ||| S:3832 E:3852 ||| .
S.  ||| S:3852 E:3855 ||| NNP
maltophilia  ||| S:3855 E:3867 ||| NN
is  ||| S:3867 E:3870 ||| VBZ
an  ||| S:3870 E:3873 ||| DT
important  ||| S:3873 E:3891 ||| JJ
pathogen  ||| S:3891 E:3900 ||| NN
in  ||| S:3900 E:3903 ||| IN
nosocomial  ||| S:3903 E:3914 ||| JJ
infections  ||| S:3914 E:3925 ||| NNS
of  ||| S:3925 E:3928 ||| IN
immunocompromised  ||| S:3928 E:3954 ||| JJ
patients  ||| S:3954 E:3963 ||| NNS
suffering  ||| S:3963 E:3973 ||| VBG
from  ||| S:3973 E:3978 ||| IN
cancer ||| S:3978 E:3984 ||| NN
,  ||| S:3984 E:3986 ||| ,
cystic  ||| S:3986 E:3993 ||| JJ
fibrosis ||| S:3993 E:4001 ||| NN
,  ||| S:4001 E:4003 ||| ,
drug  ||| S:4003 E:4016 ||| NN
addition ||| S:4016 E:4024 ||| NN
,  ||| S:4024 E:4026 ||| ,
AIDS  ||| S:4026 E:4031 ||| NNP
and  ||| S:4031 E:4035 ||| CC
in  ||| S:4035 E:4038 ||| IN
patients  ||| S:4038 E:4047 ||| NNS
with  ||| S:4047 E:4052 ||| IN
organ  ||| S:4052 E:4058 ||| JJ
transplants  ||| S:4058 E:4070 ||| NNS
and  ||| S:4070 E:4082 ||| CC
on  ||| S:4082 E:4085 ||| IN
dialysis  ||| S:4085 E:4094 ||| NN
[  ||| S:4094 E:4096 ||| -LRB-
30  ||| S:4096 E:4099 ||| CD
31  ||| S:4099 E:4102 ||| CD
32  ||| S:4102 E:4105 ||| CD
]  ||| S:4105 E:4107 ||| -RRB-
.  ||| S:4107 E:4109 ||| .
This  ||| S:4109 E:4114 ||| DT
organism  ||| S:4114 E:4123 ||| NN
is  ||| S:4123 E:4126 ||| VBZ
inherently  ||| S:4126 E:4145 ||| RB
resistant  ||| S:4145 E:4155 ||| JJ
to  ||| S:4155 E:4158 ||| TO
most  ||| S:4158 E:4163 ||| RBS
antibiotics  ||| S:4163 E:4175 ||| JJ
due  ||| S:4175 E:4179 ||| JJ
to  ||| S:4179 E:4182 ||| TO
its  ||| S:4182 E:4186 ||| PRP$
low  ||| S:4186 E:4190 ||| JJ
outer  ||| S:4190 E:4196 ||| JJ
membrane  ||| S:4196 E:4213 ||| JJ
permeability  ||| S:4213 E:4226 ||| NNS
[  ||| S:4226 E:4228 ||| -LRB-
33  ||| S:4228 E:4231 ||| CD
]  ||| S:4231 E:4233 ||| -RRB-
and  ||| S:4233 E:4237 ||| CC
to  ||| S:4237 E:4240 ||| TO
β-lactam  ||| S:4240 E:4249 ||| JJ
containing  ||| S:4249 E:4260 ||| VBG
antibiotics  ||| S:4260 E:4280 ||| JJ
due  ||| S:4280 E:4284 ||| JJ
to  ||| S:4284 E:4287 ||| TO
the  ||| S:4287 E:4291 ||| DT
production  ||| S:4291 E:4302 ||| NN
of  ||| S:4302 E:4305 ||| IN
a  ||| S:4305 E:4307 ||| DT
chromosomally  ||| S:4307 E:4321 ||| NN
expressed  ||| S:4321 E:4331 ||| VBD
group  ||| S:4331 E:4337 ||| NN
2e  ||| S:4337 E:4348 ||| NNP
β-lactamase  ||| S:4348 E:4360 ||| NNP
( ||| S:4360 E:4361 ||| -LRB-
L2 ||| S:4361 E:4363 ||| NNP
)  ||| S:4363 E:4365 ||| -RRB-
and  ||| S:4365 E:4369 ||| CC
a  ||| S:4369 E:4371 ||| DT
group  ||| S:4371 E:4377 ||| NN
3c  ||| S:4377 E:4380 ||| NNP
β-lactamase  ||| S:4380 E:4392 ||| NNP
( ||| S:4392 E:4393 ||| -LRB-
L1 ||| S:4393 E:4395 ||| NNP
)  ||| S:4395 E:4397 ||| -RRB-
[  ||| S:4397 E:4399 ||| -LRB-
34  ||| S:4399 E:4402 ||| CD
35  ||| S:4402 E:4405 ||| CD
]  ||| S:4405 E:4415 ||| -RRB-
.  ||| S:4415 E:4417 ||| .
L1  ||| S:4417 E:4420 ||| NNP
has  ||| S:4420 E:4424 ||| VBZ
been  ||| S:4424 E:4429 ||| VBN
cloned ||| S:4429 E:4435 ||| VBN
,  ||| S:4435 E:4437 ||| ,
over-expressed ||| S:4437 E:4451 ||| NNP
,  ||| S:4451 E:4453 ||| ,
and  ||| S:4453 E:4457 ||| CC
partially  ||| S:4457 E:4475 ||| RB
characterized  ||| S:4475 E:4489 ||| VBN
by  ||| S:4489 E:4492 ||| IN
kinetic  ||| S:4492 E:4500 ||| NN
and  ||| S:4500 E:4504 ||| CC
crystallographic  ||| S:4504 E:4521 ||| JJ
studies  ||| S:4521 E:4529 ||| NNS
[  ||| S:4529 E:4531 ||| -LRB-
36  ||| S:4531 E:4542 ||| CD
37  ||| S:4542 E:4545 ||| CD
]  ||| S:4545 E:4547 ||| -RRB-
.  ||| S:4547 E:4549 ||| .
The  ||| S:4549 E:4553 ||| DT
enzyme  ||| S:4553 E:4560 ||| NN
exists  ||| S:4560 E:4567 ||| VBZ
as  ||| S:4567 E:4570 ||| IN
a  ||| S:4570 E:4572 ||| DT
homotetramer  ||| S:4572 E:4585 ||| NN
of  ||| S:4585 E:4597 ||| IN
ca.  ||| S:4597 E:4601 ||| CD
118  ||| S:4601 E:4605 ||| CD
kDa  ||| S:4605 E:4609 ||| NN
in  ||| S:4609 E:4612 ||| IN
solution  ||| S:4612 E:4621 ||| NN
and  ||| S:4621 E:4625 ||| CC
in  ||| S:4625 E:4628 ||| IN
the  ||| S:4628 E:4640 ||| DT
crystalline  ||| S:4640 E:4652 ||| JJ
state ||| S:4652 E:4657 ||| NN
.  ||| S:4657 E:4659 ||| .
The  ||| S:4659 E:4663 ||| DT
enzyme  ||| S:4663 E:4670 ||| NN
tightly  ||| S:4670 E:4678 ||| RB
binds  ||| S:4678 E:4684 ||| CD
two  ||| S:4684 E:4688 ||| CD
Zn ||| S:4688 E:4690 ||| NNP
( ||| S:4690 E:4691 ||| -LRB-
II ||| S:4691 E:4693 ||| NNP
)  ||| S:4693 E:4695 ||| -RRB-
ions  ||| S:4695 E:4708 ||| FW
per  ||| S:4708 E:4712 ||| FW
subunit  ||| S:4712 E:4720 ||| FW
and  ||| S:4720 E:4724 ||| CC
requires  ||| S:4724 E:4733 ||| VBZ
both  ||| S:4733 E:4738 ||| DT
Zn ||| S:4738 E:4740 ||| NNP
( ||| S:4740 E:4741 ||| -LRB-
II ||| S:4741 E:4743 ||| NNP
)  ||| S:4743 E:4745 ||| -RRB-
ions  ||| S:4745 E:4750 ||| NN
for  ||| S:4750 E:4754 ||| IN
full  ||| S:4754 E:4767 ||| JJ
catalytic  ||| S:4767 E:4777 ||| JJ
activity ||| S:4777 E:4785 ||| NN
.  ||| S:4785 E:4787 ||| .
The  ||| S:4787 E:4791 ||| DT
Zn  ||| S:4791 E:4803 ||| NNP
1  ||| S:4803 E:4805 ||| CD
site  ||| S:4805 E:4810 ||| NN
has  ||| S:4810 E:4814 ||| VBZ
3  ||| S:4814 E:4816 ||| CD
histidine  ||| S:4816 E:4826 ||| CD
residues  ||| S:4826 E:4835 ||| NNS
and  ||| S:4835 E:4839 ||| CC
1  ||| S:4839 E:4849 ||| CD
bridging  ||| S:4849 E:4858 ||| JJ
hydroxide  ||| S:4858 E:4868 ||| NN
as  ||| S:4868 E:4871 ||| IN
ligands ||| S:4871 E:4878 ||| NN
,  ||| S:4878 E:4880 ||| ,
and  ||| S:4880 E:4884 ||| CC
the  ||| S:4884 E:4888 ||| DT
Zn  ||| S:4888 E:4900 ||| NNP
2  ||| S:4900 E:4902 ||| CD
site  ||| S:4902 E:4907 ||| NN
has  ||| S:4907 E:4911 ||| VBZ
2  ||| S:4911 E:4913 ||| CD
histidines ||| S:4913 E:4923 ||| NN
,  ||| S:4923 E:4925 ||| ,
1  ||| S:4925 E:4927 ||| CD
aspartic  ||| S:4927 E:4944 ||| JJ
acid ||| S:4944 E:4948 ||| NN
,  ||| S:4948 E:4950 ||| ,
1  ||| S:4950 E:4952 ||| CD
terminally-bound  ||| S:4952 E:4969 ||| JJ
water ||| S:4969 E:4974 ||| NN
,  ||| S:4974 E:4976 ||| ,
and  ||| S:4976 E:4980 ||| CC
the  ||| S:4980 E:4984 ||| DT
bridging  ||| S:4984 E:4993 ||| JJ
hydroxide  ||| S:4993 E:5011 ||| NN
as  ||| S:5011 E:5014 ||| IN
ligands ||| S:5014 E:5021 ||| NN
.  ||| S:5021 E:5023 ||| .
Spencer  ||| S:5023 E:5031 ||| NNP
and  ||| S:5031 E:5035 ||| CC
coworkers  ||| S:5035 E:5045 ||| VB
used  ||| S:5045 E:5050 ||| VBN
the  ||| S:5050 E:5054 ||| DT
crystal  ||| S:5054 E:5070 ||| NN
structure  ||| S:5070 E:5080 ||| NN
and  ||| S:5080 E:5084 ||| CC
modeling  ||| S:5084 E:5093 ||| JJ
studies  ||| S:5093 E:5101 ||| NNS
to  ||| S:5101 E:5104 ||| TO
propose  ||| S:5104 E:5112 ||| VB
a  ||| S:5112 E:5114 ||| DT
substrate  ||| S:5114 E:5132 ||| JJ
binding  ||| S:5132 E:5140 ||| JJ
model  ||| S:5140 E:5146 ||| NN
and  ||| S:5146 E:5150 ||| CC
identified  ||| S:5150 E:5161 ||| VBN
several  ||| S:5161 E:5169 ||| JJ
active  ||| S:5169 E:5176 ||| JJ
site  ||| S:5176 E:5181 ||| NN
residues  ||| S:5181 E:5198 ||| NNS
that  ||| S:5198 E:5203 ||| WDT
were  ||| S:5203 E:5208 ||| VBD
involved  ||| S:5208 E:5217 ||| VBN
in  ||| S:5217 E:5220 ||| IN
substrate  ||| S:5220 E:5230 ||| JJ
binding  ||| S:5230 E:5238 ||| NNS
( ||| S:5238 E:5239 ||| -LRB-
Figure  ||| S:5239 E:5246 ||| NNP
1 ||| S:5246 E:5247 ||| CD
)  ||| S:5247 E:5249 ||| -RRB-
[  ||| S:5249 E:5251 ||| -LRB-
37  ||| S:5251 E:5254 ||| CD
]  ||| S:5254 E:5256 ||| -RRB-
.  ||| S:5256 E:5266 ||| .
However ||| S:5266 E:5273 ||| RB
,  ||| S:5273 E:5275 ||| ,
this  ||| S:5275 E:5280 ||| DT
model  ||| S:5280 E:5286 ||| NN
has  ||| S:5286 E:5290 ||| VBZ
not  ||| S:5290 E:5294 ||| RB
been  ||| S:5294 E:5299 ||| VBN
tested  ||| S:5299 E:5306 ||| VBN
experimentally ||| S:5306 E:5320 ||| RB
.  ||| S:5320 E:5322 ||| .
In  ||| S:5322 E:5333 ||| IN
order  ||| S:5333 E:5339 ||| NN
to  ||| S:5339 E:5342 ||| TO
prepare  ||| S:5342 E:5350 ||| VB
tight  ||| S:5350 E:5356 ||| JJ
binding  ||| S:5356 E:5364 ||| JJ
inhibitors  ||| S:5364 E:5375 ||| NN
of  ||| S:5375 E:5378 ||| IN
the  ||| S:5378 E:5390 ||| DT
metallo-β-lactamases ||| S:5390 E:5410 ||| JJ
,  ||| S:5410 E:5412 ||| ,
knowledge  ||| S:5412 E:5422 ||| NN
about  ||| S:5422 E:5428 ||| IN
how  ||| S:5428 E:5432 ||| WRB
substrate  ||| S:5432 E:5442 ||| JJ
binds  ||| S:5442 E:5456 ||| NN
to  ||| S:5456 E:5459 ||| TO
the  ||| S:5459 E:5463 ||| DT
enzymes  ||| S:5463 E:5471 ||| NN
is  ||| S:5471 E:5474 ||| VBZ
needed  ||| S:5474 E:5481 ||| VBN
so  ||| S:5481 E:5484 ||| RB
that  ||| S:5484 E:5489 ||| IN
all  ||| S:5489 E:5493 ||| DT
substrate-enzyme  ||| S:5493 E:5518 ||| JJ
binding  ||| S:5518 E:5526 ||| JJ
contacts  ||| S:5526 E:5535 ||| NNS
can  ||| S:5535 E:5539 ||| MD
be  ||| S:5539 E:5542 ||| VB
maintained  ||| S:5542 E:5553 ||| VBN
in  ||| S:5553 E:5556 ||| IN
any  ||| S:5556 E:5560 ||| DT
proposed  ||| S:5560 E:5577 ||| JJ
inhibitor ||| S:5577 E:5586 ||| NN
.  ||| S:5586 E:5588 ||| .
This  ||| S:5588 E:5593 ||| DT
work  ||| S:5593 E:5598 ||| NN
describes  ||| S:5598 E:5608 ||| VBZ
our  ||| S:5608 E:5612 ||| PRP$
efforts  ||| S:5612 E:5620 ||| NNS
at  ||| S:5620 E:5623 ||| IN
understanding  ||| S:5623 E:5645 ||| NN
how  ||| S:5645 E:5649 ||| WRB
substrates  ||| S:5649 E:5660 ||| JJ
bind  ||| S:5660 E:5665 ||| NN
to  ||| S:5665 E:5668 ||| TO
metallo-β-lactamase  ||| S:5668 E:5688 ||| JJ
L1 ||| S:5688 E:5690 ||| NN
.  ||| S:5690 E:5692 ||| .
Several  ||| S:5692 E:5708 ||| JJ
site-directed  ||| S:5708 E:5722 ||| JJ
mutants  ||| S:5722 E:5730 ||| NN
of  ||| S:5730 E:5733 ||| IN
L1  ||| S:5733 E:5736 ||| NNP
were  ||| S:5736 E:5741 ||| VBD
generated  ||| S:5741 E:5751 ||| VBN
and  ||| S:5751 E:5763 ||| CC
characterized ||| S:5763 E:5776 ||| VBN
,  ||| S:5776 E:5778 ||| ,
and  ||| S:5778 E:5782 ||| CC
the  ||| S:5782 E:5786 ||| DT
results  ||| S:5786 E:5794 ||| NNS
from  ||| S:5794 E:5799 ||| IN
these  ||| S:5799 E:5805 ||| DT
studies  ||| S:5805 E:5813 ||| NNS
reveal  ||| S:5813 E:5828 ||| VBP
that  ||| S:5828 E:5833 ||| DT
none  ||| S:5833 E:5838 ||| NN
of  ||| S:5838 E:5841 ||| IN
the  ||| S:5841 E:5845 ||| DT
active  ||| S:5845 E:5852 ||| JJ
site  ||| S:5852 E:5857 ||| NN
residues  ||| S:5857 E:5866 ||| NNS
predicted  ||| S:5866 E:5876 ||| VBD
from  ||| S:5876 E:5889 ||| IN
earlier  ||| S:5889 E:5897 ||| RBR
computational  ||| S:5897 E:5911 ||| JJ
studies  ||| S:5911 E:5919 ||| NNS
[  ||| S:5919 E:5921 ||| -LRB-
37  ||| S:5921 E:5924 ||| CD
]  ||| S:5924 E:5926 ||| -RRB-
are  ||| S:5926 E:5930 ||| VBP
essential  ||| S:5930 E:5940 ||| JJ
for  ||| S:5940 E:5952 ||| IN
tight  ||| S:5952 E:5958 ||| JJ
substrate  ||| S:5958 E:5968 ||| JJ
binding ||| S:5968 E:5975 ||| NN
.  ||| S:5975 E:5999 ||| .
Results  ||| S:5999 E:6026 ||| NNP
Wild  ||| S:6026 E:6031 ||| NNP
type  ||| S:6031 E:6036 ||| NN
L1  ||| S:6036 E:6049 ||| NNP
Wild-type  ||| S:6049 E:6059 ||| NNP
L1  ||| S:6059 E:6062 ||| NNP
was  ||| S:6062 E:6066 ||| VBD
over-expressed  ||| S:6066 E:6081 ||| JJ
in  ||| S:6081 E:6095 ||| IN
Escherichia  ||| S:6095 E:6107 ||| NNP
coli  ||| S:6107 E:6112 ||| NNS
and  ||| S:6112 E:6116 ||| CC
purified  ||| S:6116 E:6125 ||| NN
as  ||| S:6125 E:6138 ||| IN
previously  ||| S:6138 E:6149 ||| RB
described  ||| S:6149 E:6159 ||| VBN
[  ||| S:6159 E:6161 ||| -LRB-
36  ||| S:6161 E:6164 ||| CD
]  ||| S:6164 E:6166 ||| -RRB-
.  ||| S:6166 E:6168 ||| .
This  ||| S:6168 E:6173 ||| DT
procedure  ||| S:6173 E:6183 ||| NN
produced  ||| S:6183 E:6192 ||| VBD
an  ||| S:6192 E:6205 ||| DT
average  ||| S:6205 E:6213 ||| NN
of  ||| S:6213 E:6216 ||| IN
50-60  ||| S:6216 E:6222 ||| CD
mg  ||| S:6222 E:6225 ||| NN
of  ||| S:6225 E:6228 ||| IN
> ||| S:6228 E:6229 ||| CD
90 ||| S:6229 E:6231 ||| CD
%  ||| S:6231 E:6233 ||| NN
pure ||| S:6233 E:6237 ||| NN
,  ||| S:6237 E:6239 ||| ,
active  ||| S:6239 E:6246 ||| JJ
protein  ||| S:6246 E:6254 ||| NN
per  ||| S:6254 E:6258 ||| IN
4  ||| S:6258 E:6270 ||| CD
L  ||| S:6270 E:6272 ||| NNP
of  ||| S:6272 E:6275 ||| IN
growth  ||| S:6275 E:6282 ||| NN
culture ||| S:6282 E:6289 ||| NN
.  ||| S:6289 E:6291 ||| .
Circular  ||| S:6291 E:6300 ||| JJ
dichroism  ||| S:6300 E:6310 ||| JJ
spectra  ||| S:6310 E:6318 ||| NN
were  ||| S:6318 E:6333 ||| VBD
collected  ||| S:6333 E:6343 ||| VBN
on  ||| S:6343 E:6346 ||| IN
wild-type  ||| S:6346 E:6356 ||| JJ
samples  ||| S:6356 E:6364 ||| NNS
to  ||| S:6364 E:6367 ||| TO
ensure  ||| S:6367 E:6374 ||| VB
L1  ||| S:6374 E:6377 ||| NNP
expressed  ||| S:6377 E:6397 ||| VBD
using  ||| S:6397 E:6403 ||| VBG
the  ||| S:6403 E:6407 ||| DT
pET26b  ||| S:6407 E:6414 ||| JJ
expression  ||| S:6414 E:6425 ||| NN
system  ||| S:6425 E:6432 ||| NN
had  ||| S:6432 E:6436 ||| VBD
the  ||| S:6436 E:6440 ||| DT
correct  ||| S:6440 E:6458 ||| JJ
secondary  ||| S:6458 E:6468 ||| JJ
structure ||| S:6468 E:6477 ||| NN
.  ||| S:6477 E:6479 ||| .
The  ||| S:6479 E:6483 ||| DT
CD  ||| S:6483 E:6486 ||| NN
spectrum  ||| S:6486 E:6495 ||| NN
of  ||| S:6495 E:6498 ||| IN
wild  ||| S:6498 E:6503 ||| JJ
type  ||| S:6503 E:6508 ||| NN
L1  ||| S:6508 E:6521 ||| NN
showed  ||| S:6521 E:6528 ||| VBD
an  ||| S:6528 E:6531 ||| DT
intense ||| S:6531 E:6538 ||| JJ
,  ||| S:6538 E:6540 ||| ,
broad  ||| S:6540 E:6546 ||| JJ
feature  ||| S:6546 E:6554 ||| NN
at  ||| S:6554 E:6557 ||| IN
190  ||| S:6557 E:6561 ||| CD
nm  ||| S:6561 E:6564 ||| NNS
and  ||| S:6564 E:6568 ||| CC
a  ||| S:6568 E:6570 ||| DT
smaller  ||| S:6570 E:6588 ||| JJR
feature  ||| S:6588 E:6596 ||| NN
at  ||| S:6596 E:6599 ||| IN
215  ||| S:6599 E:6603 ||| CD
nm  ||| S:6603 E:6606 ||| NNS
( ||| S:6606 E:6607 ||| -LRB-
see  ||| S:6607 E:6611 ||| VB
Additional  ||| S:6611 E:6622 ||| JJ
file  ||| S:6622 E:6627 ||| NN
1 ||| S:6627 E:6628 ||| CD
:  ||| S:6628 E:6630 ||| :
CD  ||| S:6630 E:6633 ||| NNP
spectra ||| S:6633 E:6640 ||| CD
) ||| S:6640 E:6641 ||| -RRB-
.  ||| S:6641 E:6653 ||| .
These  ||| S:6653 E:6659 ||| DT
features  ||| S:6659 E:6668 ||| NNS
are  ||| S:6668 E:6672 ||| VBP
consistent  ||| S:6672 E:6683 ||| JJ
with  ||| S:6683 E:6688 ||| IN
a  ||| S:6688 E:6690 ||| DT
sample  ||| S:6690 E:6697 ||| NN
with  ||| S:6697 E:6712 ||| IN
significant  ||| S:6712 E:6724 ||| JJ
α ||| S:6724 E:6725 ||| FW
/ ||| S:6725 E:6726 ||| FW
β  ||| S:6726 E:6728 ||| FW
content ||| S:6728 E:6735 ||| FW
.  ||| S:6735 E:6737 ||| .
The  ||| S:6737 E:6741 ||| DT
Compton  ||| S:6741 E:6749 ||| NNP
and  ||| S:6749 E:6753 ||| CC
Johnson  ||| S:6753 E:6771 ||| NNP
algorithm  ||| S:6771 E:6781 ||| NNS
[  ||| S:6781 E:6783 ||| -LRB-
38  ||| S:6783 E:6786 ||| CD
]  ||| S:6786 E:6788 ||| -RRB-
was  ||| S:6788 E:6792 ||| VBD
used  ||| S:6792 E:6797 ||| VBN
to  ||| S:6797 E:6800 ||| TO
estimate  ||| S:6800 E:6809 ||| VB
secondary  ||| S:6809 E:6819 ||| JJ
structure  ||| S:6819 E:6839 ||| NN
in  ||| S:6839 E:6842 ||| IN
the  ||| S:6842 E:6846 ||| DT
samples ||| S:6846 E:6853 ||| NNS
;  ||| S:6853 E:6855 ||| :
wild-type  ||| S:6855 E:6865 ||| NNP
L1  ||| S:6865 E:6868 ||| NNP
was  ||| S:6868 E:6872 ||| VBD
estimated  ||| S:6872 E:6882 ||| VBN
to  ||| S:6882 E:6885 ||| TO
have  ||| S:6885 E:6890 ||| VB
38.3 ||| S:6890 E:6894 ||| CD
%  ||| S:6894 E:6906 ||| NN
α-helix ||| S:6906 E:6913 ||| NN
,  ||| S:6913 E:6915 ||| ,
26.7 ||| S:6915 E:6919 ||| CD
%  ||| S:6919 E:6921 ||| NN
β-structure  ||| S:6921 E:6933 ||| NNS
( ||| S:6933 E:6934 ||| -LRB-
9.3 ||| S:6934 E:6937 ||| CD
%  ||| S:6937 E:6939 ||| NN
antiparallel  ||| S:6939 E:6952 ||| NN
β-sheet ||| S:6952 E:6959 ||| NN
,  ||| S:6959 E:6971 ||| ,
2.1 ||| S:6971 E:6974 ||| CD
%  ||| S:6974 E:6976 ||| NN
parallel  ||| S:6976 E:6985 ||| NN
β-sheet ||| S:6985 E:6992 ||| NN
,  ||| S:6992 E:6994 ||| ,
and  ||| S:6994 E:6998 ||| CC
15.3 ||| S:6998 E:7002 ||| CD
%  ||| S:7002 E:7004 ||| NN
β-turn ||| S:7004 E:7010 ||| NN
) ||| S:7010 E:7011 ||| -RRB-
,  ||| S:7011 E:7013 ||| ,
and  ||| S:7013 E:7017 ||| CC
34.9 ||| S:7017 E:7021 ||| CD
%  ||| S:7021 E:7023 ||| NN
other  ||| S:7023 E:7039 ||| JJ
structure ||| S:7039 E:7048 ||| NN
.  ||| S:7048 E:7050 ||| .
These  ||| S:7050 E:7056 ||| DT
estimates  ||| S:7056 E:7066 ||| NNS
are  ||| S:7066 E:7070 ||| VBP
in  ||| S:7070 E:7073 ||| IN
excellent  ||| S:7073 E:7083 ||| JJ
agreement  ||| S:7083 E:7103 ||| NN
with  ||| S:7103 E:7108 ||| IN
the  ||| S:7108 E:7112 ||| DT
crystallographically  ||| S:7112 E:7133 ||| NN
determined  ||| S:7133 E:7144 ||| VBN
secondary  ||| S:7144 E:7164 ||| JJ
structure  ||| S:7164 E:7174 ||| NN
of  ||| S:7174 E:7177 ||| IN
~40 ||| S:7177 E:7180 ||| CD
%  ||| S:7180 E:7182 ||| NN
α-helix  ||| S:7182 E:7190 ||| NN
and  ||| S:7190 E:7194 ||| CC
30 ||| S:7194 E:7196 ||| CD
%  ||| S:7196 E:7198 ||| NN
β-structure  ||| S:7198 E:7210 ||| NNS
[  ||| S:7210 E:7212 ||| -LRB-
37  ||| S:7212 E:7215 ||| CD
]  ||| S:7215 E:7217 ||| -RRB-
.  ||| S:7217 E:7229 ||| .
Metal  ||| S:7229 E:7235 ||| NN
analyses  ||| S:7235 E:7244 ||| NNS
on  ||| S:7244 E:7247 ||| IN
multiple  ||| S:7247 E:7256 ||| JJ
preparations  ||| S:7256 E:7269 ||| NNS
of  ||| S:7269 E:7272 ||| IN
wild-type  ||| S:7272 E:7282 ||| NNP
L1  ||| S:7282 E:7295 ||| NNP
demonstrated  ||| S:7295 E:7308 ||| VBD
that  ||| S:7308 E:7313 ||| IN
the  ||| S:7313 E:7317 ||| DT
enzyme  ||| S:7317 E:7324 ||| JJ
binds  ||| S:7324 E:7330 ||| NN
1.9  ||| S:7330 E:7334 ||| CD
±  ||| S:7334 E:7336 ||| CD
0.2  ||| S:7336 E:7340 ||| CD
Zn ||| S:7340 E:7342 ||| NNP
( ||| S:7342 E:7343 ||| -LRB-
II ||| S:7343 E:7345 ||| NNP
)  ||| S:7345 E:7347 ||| -RRB-
ions  ||| S:7347 E:7362 ||| FW
per  ||| S:7362 E:7366 ||| FW
monomer  ||| S:7366 E:7374 ||| FW
( ||| S:7374 E:7375 ||| -LRB-
Table  ||| S:7375 E:7381 ||| NNP
2 ||| S:7381 E:7382 ||| CD
) ||| S:7382 E:7383 ||| -RRB-
,  ||| S:7383 E:7385 ||| ,
in  ||| S:7385 E:7388 ||| IN
agreement  ||| S:7388 E:7398 ||| NN
with  ||| S:7398 E:7403 ||| IN
previous  ||| S:7403 E:7412 ||| JJ
results  ||| S:7412 E:7430 ||| NNS
[  ||| S:7430 E:7432 ||| -LRB-
36  ||| S:7432 E:7435 ||| CD
]  ||| S:7435 E:7437 ||| -RRB-
.  ||| S:7437 E:7449 ||| .
Steady  ||| S:7449 E:7456 ||| JJ
state  ||| S:7456 E:7462 ||| NN
kinetic  ||| S:7462 E:7470 ||| NN
studies  ||| S:7470 E:7478 ||| NNS
were  ||| S:7478 E:7483 ||| VBD
performed  ||| S:7483 E:7493 ||| VBN
on  ||| S:7493 E:7506 ||| IN
multiple  ||| S:7506 E:7515 ||| JJ
preparations  ||| S:7515 E:7528 ||| NNS
of  ||| S:7528 E:7531 ||| IN
wild  ||| S:7531 E:7536 ||| JJ
type  ||| S:7536 E:7541 ||| NN
L1 ||| S:7541 E:7543 ||| NN
,  ||| S:7543 E:7545 ||| ,
and  ||| S:7545 E:7549 ||| CC
the  ||| S:7549 E:7553 ||| DT
resulting  ||| S:7553 E:7573 ||| VBG
kinetic  ||| S:7573 E:7581 ||| JJ
data  ||| S:7581 E:7586 ||| NNS
are  ||| S:7586 E:7590 ||| VBP
shown  ||| S:7590 E:7596 ||| VBN
in  ||| S:7596 E:7599 ||| IN
Tables  ||| S:7599 E:7606 ||| NNP
3 ||| S:7606 E:7607 ||| CD
,  ||| S:7607 E:7609 ||| ,
4 ||| S:7609 E:7610 ||| CD
,  ||| S:7610 E:7612 ||| ,
5 ||| S:7612 E:7613 ||| CD
.  ||| S:7613 E:7615 ||| .
When  ||| S:7615 E:7620 ||| WRB
using  ||| S:7620 E:7636 ||| VBG
nitrocefin  ||| S:7636 E:7647 ||| NN
as  ||| S:7647 E:7650 ||| IN
substrate  ||| S:7650 E:7660 ||| NN
and  ||| S:7660 E:7664 ||| CC
50  ||| S:7664 E:7667 ||| CD
mM  ||| S:7667 E:7670 ||| JJ
cacodylate ||| S:7670 E:7680 ||| NN
,  ||| S:7680 E:7682 ||| ,
pH  ||| S:7682 E:7685 ||| JJ
7.0 ||| S:7685 E:7688 ||| CD
,  ||| S:7688 E:7690 ||| ,
as  ||| S:7690 E:7703 ||| IN
buffer ||| S:7703 E:7709 ||| NN
,  ||| S:7709 E:7711 ||| ,
wild-type  ||| S:7711 E:7721 ||| FW
L1  ||| S:7721 E:7724 ||| FW
exhibited  ||| S:7724 E:7734 ||| FW
a  ||| S:7734 E:7747 ||| FW
k  ||| S:7747 E:7760 ||| FW
cat  ||| S:7760 E:7764 ||| FW
value  ||| S:7764 E:7770 ||| NN
of  ||| S:7770 E:7773 ||| IN
38  ||| S:7773 E:7776 ||| CD
±  ||| S:7776 E:7778 ||| CD
1  ||| S:7778 E:7780 ||| CD
s  ||| S:7780 E:7782 ||| CD
-1and  ||| S:7782 E:7788 ||| CD
a  ||| S:7788 E:7790 ||| DT
K  ||| S:7790 E:7803 ||| NNP
m  ||| S:7803 E:7805 ||| JJ
value  ||| S:7805 E:7811 ||| NN
of  ||| S:7811 E:7814 ||| IN
12  ||| S:7814 E:7817 ||| CD
±  ||| S:7817 E:7819 ||| CD
1  ||| S:7819 E:7821 ||| CD
μM ||| S:7821 E:7823 ||| NN
.  ||| S:7823 E:7825 ||| .
The  ||| S:7825 E:7829 ||| DT
inclusion  ||| S:7829 E:7839 ||| NN
of  ||| S:7839 E:7852 ||| IN
100  ||| S:7852 E:7856 ||| CD
μM  ||| S:7856 E:7859 ||| JJ
ZnCl  ||| S:7859 E:7875 ||| JJ
2  ||| S:7875 E:7877 ||| CD
in  ||| S:7877 E:7880 ||| IN
the  ||| S:7880 E:7884 ||| DT
assay  ||| S:7884 E:7890 ||| JJ
buffer  ||| S:7890 E:7897 ||| NN
resulted  ||| S:7897 E:7906 ||| VBD
in  ||| S:7906 E:7919 ||| IN
slightly  ||| S:7919 E:7928 ||| RB
lower  ||| S:7928 E:7934 ||| JJR
values  ||| S:7934 E:7941 ||| NNS
of  ||| S:7941 E:7944 ||| IN
K  ||| S:7944 E:7957 ||| NNP
m  ||| S:7957 E:7959 ||| NN
and  ||| S:7959 E:7963 ||| CC
higher  ||| S:7963 E:7970 ||| JJR
values  ||| S:7970 E:7977 ||| NNS
for  ||| S:7977 E:7992 ||| IN
k  ||| S:7992 E:8005 ||| JJ
cat  ||| S:8005 E:8009 ||| NNS
[  ||| S:8009 E:8011 ||| -LRB-
36  ||| S:8011 E:8014 ||| CD
]  ||| S:8014 E:8016 ||| -RRB-
.  ||| S:8016 E:8018 ||| .
The  ||| S:8018 E:8022 ||| DT
inclusion  ||| S:8022 E:8032 ||| NN
of  ||| S:8032 E:8035 ||| IN
higher  ||| S:8035 E:8052 ||| JJR
concentrations  ||| S:8052 E:8067 ||| NNS
of  ||| S:8067 E:8070 ||| IN
Zn ||| S:8070 E:8072 ||| NNP
( ||| S:8072 E:8073 ||| -LRB-
II ||| S:8073 E:8075 ||| NNP
)  ||| S:8075 E:8077 ||| -RRB-
did  ||| S:8077 E:8081 ||| VBD
not  ||| S:8081 E:8085 ||| RB
further  ||| S:8085 E:8093 ||| RB
affect  ||| S:8093 E:8100 ||| VB
the  ||| S:8100 E:8114 ||| DT
steady-state  ||| S:8114 E:8127 ||| JJ
kinetic  ||| S:8127 E:8135 ||| JJ
constants ||| S:8135 E:8144 ||| NN
.  ||| S:8144 E:8146 ||| .
Apparently ||| S:8146 E:8156 ||| RB
,  ||| S:8156 E:8158 ||| ,
the  ||| S:8158 E:8162 ||| DT
purified ||| S:8162 E:8170 ||| NN
,  ||| S:8170 E:8182 ||| ,
recombinant  ||| S:8182 E:8194 ||| JJ
enzyme  ||| S:8194 E:8201 ||| NN
does  ||| S:8201 E:8206 ||| VBZ
not  ||| S:8206 E:8210 ||| RB
bind  ||| S:8210 E:8215 ||| VB
its  ||| S:8215 E:8219 ||| PRP$
full  ||| S:8219 E:8224 ||| JJ
complement  ||| S:8224 E:8235 ||| NN
of  ||| S:8235 E:8248 ||| IN
Zn ||| S:8248 E:8250 ||| NNP
( ||| S:8250 E:8251 ||| -LRB-
II ||| S:8251 E:8253 ||| NNP
) ||| S:8253 E:8254 ||| -RRB-
;  ||| S:8254 E:8256 ||| :
therefore ||| S:8256 E:8265 ||| RB
,  ||| S:8265 E:8267 ||| ,
100  ||| S:8267 E:8271 ||| CD
μM  ||| S:8271 E:8274 ||| JJ
Zn ||| S:8274 E:8276 ||| NNP
( ||| S:8276 E:8277 ||| -LRB-
II ||| S:8277 E:8279 ||| NNP
)  ||| S:8279 E:8281 ||| -RRB-
was  ||| S:8281 E:8285 ||| VBD
included  ||| S:8285 E:8294 ||| VBN
in  ||| S:8294 E:8297 ||| IN
all  ||| S:8297 E:8311 ||| DT
subsequent  ||| S:8311 E:8322 ||| JJ
kinetic  ||| S:8322 E:8330 ||| JJ
studies ||| S:8330 E:8337 ||| NNS
.  ||| S:8337 E:8349 ||| .
Wild-type  ||| S:8349 E:8359 ||| FW
L1  ||| S:8359 E:8362 ||| FW
exhibited  ||| S:8362 E:8383 ||| FW
k  ||| S:8383 E:8396 ||| FW
cat  ||| S:8396 E:8400 ||| FW
values  ||| S:8400 E:8407 ||| NNS
of  ||| S:8407 E:8410 ||| IN
41  ||| S:8410 E:8413 ||| CD
±  ||| S:8413 E:8415 ||| CD
1  ||| S:8415 E:8417 ||| CD
s  ||| S:8417 E:8419 ||| CD
-1 ||| S:8419 E:8421 ||| CD
,  ||| S:8421 E:8423 ||| ,
1.9  ||| S:8423 E:8427 ||| CD
±  ||| S:8427 E:8429 ||| CD
0.1  ||| S:8429 E:8433 ||| CD
s  ||| S:8433 E:8445 ||| CD
-1 ||| S:8445 E:8447 ||| CD
,  ||| S:8447 E:8449 ||| ,
42  ||| S:8449 E:8452 ||| CD
±  ||| S:8452 E:8454 ||| CD
1  ||| S:8454 E:8456 ||| CD
s  ||| S:8456 E:8458 ||| CD
-1 ||| S:8458 E:8460 ||| CD
,  ||| S:8460 E:8462 ||| ,
and  ||| S:8462 E:8466 ||| CC
82  ||| S:8466 E:8469 ||| CD
±  ||| S:8469 E:8471 ||| CD
5  ||| S:8471 E:8473 ||| CD
s  ||| S:8473 E:8475 ||| CD
-1for  ||| S:8475 E:8481 ||| CD
the  ||| S:8481 E:8485 ||| DT
cephalosporins ||| S:8485 E:8499 ||| NN
,  ||| S:8499 E:8511 ||| ,
nitrocefin ||| S:8511 E:8521 ||| NN
,  ||| S:8521 E:8523 ||| ,
cefoxitin ||| S:8523 E:8532 ||| NN
,  ||| S:8532 E:8534 ||| ,
cefaclor ||| S:8534 E:8542 ||| NN
,  ||| S:8542 E:8544 ||| ,
and  ||| S:8544 E:8548 ||| CC
cephalothin ||| S:8548 E:8559 ||| NN
.  ||| S:8559 E:8561 ||| .
For  ||| S:8561 E:8575 ||| IN
these  ||| S:8575 E:8581 ||| DT
same  ||| S:8581 E:8586 ||| JJ
substrates ||| S:8586 E:8596 ||| NN
,  ||| S:8596 E:8598 ||| ,
the  ||| S:8598 E:8602 ||| DT
K  ||| S:8602 E:8615 ||| NNP
m  ||| S:8615 E:8617 ||| NN
values  ||| S:8617 E:8624 ||| NNS
were  ||| S:8624 E:8629 ||| VBD
4  ||| S:8629 E:8631 ||| CD
±  ||| S:8631 E:8633 ||| CD
1  ||| S:8633 E:8635 ||| CD
μM ||| S:8635 E:8637 ||| NN
,  ||| S:8637 E:8639 ||| ,
1.1  ||| S:8639 E:8643 ||| CD
±  ||| S:8643 E:8645 ||| CD
0.1  ||| S:8645 E:8649 ||| CD
μM ||| S:8649 E:8651 ||| NN
,  ||| S:8651 E:8663 ||| ,
13  ||| S:8663 E:8666 ||| CD
±  ||| S:8666 E:8668 ||| CD
1  ||| S:8668 E:8670 ||| CD
μM ||| S:8670 E:8672 ||| NN
,  ||| S:8672 E:8674 ||| ,
and  ||| S:8674 E:8678 ||| CC
8.9  ||| S:8678 E:8682 ||| CD
±  ||| S:8682 E:8684 ||| CD
1.5  ||| S:8684 E:8688 ||| CD
μM ||| S:8688 E:8690 ||| NN
,  ||| S:8690 E:8692 ||| ,
respectively ||| S:8692 E:8704 ||| RB
.  ||| S:8704 E:8706 ||| .
Two  ||| S:8706 E:8720 ||| CD
penicillins  ||| S:8720 E:8732 ||| NNS
were  ||| S:8732 E:8737 ||| VBD
tested  ||| S:8737 E:8744 ||| VBN
as  ||| S:8744 E:8747 ||| IN
substrates ||| S:8747 E:8757 ||| NN
,  ||| S:8757 E:8759 ||| ,
and  ||| S:8759 E:8763 ||| CC
penicillin  ||| S:8763 E:8774 ||| JJ
G  ||| S:8774 E:8786 ||| NNP
and  ||| S:8786 E:8790 ||| CC
ampicillin  ||| S:8790 E:8801 ||| JJ
exhibited  ||| S:8801 E:8811 ||| JJ
K  ||| S:8811 E:8824 ||| NNP
m  ||| S:8824 E:8826 ||| NN
values  ||| S:8826 E:8833 ||| NNS
of  ||| S:8833 E:8836 ||| IN
38  ||| S:8836 E:8839 ||| CD
±  ||| S:8839 E:8841 ||| CD
12  ||| S:8841 E:8844 ||| CD
μM  ||| S:8844 E:8847 ||| JJ
and  ||| S:8847 E:8851 ||| CC
55  ||| S:8851 E:8854 ||| CD
±  ||| S:8854 E:8856 ||| CD
5  ||| S:8856 E:8858 ||| CD
μM  ||| S:8858 E:8871 ||| JJ
and  ||| S:8871 E:8886 ||| CC
k  ||| S:8886 E:8899 ||| JJ
cat  ||| S:8899 E:8903 ||| NN
values  ||| S:8903 E:8910 ||| NNS
of  ||| S:8910 E:8913 ||| IN
600  ||| S:8913 E:8917 ||| CD
±  ||| S:8917 E:8919 ||| CD
100  ||| S:8919 E:8923 ||| CD
s  ||| S:8923 E:8925 ||| CD
-1and  ||| S:8925 E:8931 ||| CD
520  ||| S:8931 E:8935 ||| CD
±  ||| S:8935 E:8947 ||| CD
10  ||| S:8947 E:8950 ||| CD
s  ||| S:8950 E:8952 ||| CD
-1 ||| S:8952 E:8954 ||| CD
,  ||| S:8954 E:8956 ||| ,
respectively  ||| S:8956 E:8969 ||| RB
( ||| S:8969 E:8970 ||| -LRB-
Table  ||| S:8970 E:8976 ||| NNP
4 ||| S:8976 E:8977 ||| CD
) ||| S:8977 E:8978 ||| -RRB-
.  ||| S:8978 E:8980 ||| .
Three  ||| S:8980 E:8986 ||| CD
carbapenems  ||| S:8986 E:8998 ||| NNS
were  ||| S:8998 E:9013 ||| VBD
also  ||| S:9013 E:9018 ||| RB
used  ||| S:9018 E:9023 ||| VBN
as  ||| S:9023 E:9026 ||| IN
substrates  ||| S:9026 E:9037 ||| NN
for  ||| S:9037 E:9041 ||| IN
L1 ||| S:9041 E:9043 ||| NNP
,  ||| S:9043 E:9045 ||| ,
and  ||| S:9045 E:9049 ||| CC
biapenem ||| S:9049 E:9057 ||| NN
,  ||| S:9057 E:9059 ||| ,
imipenem ||| S:9059 E:9067 ||| NN
,  ||| S:9067 E:9079 ||| ,
and  ||| S:9079 E:9083 ||| CC
meropenem  ||| S:9083 E:9093 ||| JJ
exhibited  ||| S:9093 E:9103 ||| JJ
K  ||| S:9103 E:9116 ||| NNP
m  ||| S:9116 E:9118 ||| NN
values  ||| S:9118 E:9125 ||| NNS
of  ||| S:9125 E:9128 ||| IN
32  ||| S:9128 E:9131 ||| CD
±  ||| S:9131 E:9133 ||| CD
1  ||| S:9133 E:9135 ||| CD
μM ||| S:9135 E:9137 ||| NN
,  ||| S:9137 E:9139 ||| ,
57  ||| S:9139 E:9142 ||| CD
±  ||| S:9142 E:9144 ||| CD
7  ||| S:9144 E:9146 ||| CD
μM ||| S:9146 E:9148 ||| NN
,  ||| S:9148 E:9150 ||| ,
and  ||| S:9150 E:9164 ||| CC
15  ||| S:9164 E:9167 ||| CD
±  ||| S:9167 E:9169 ||| CD
4  ||| S:9169 E:9171 ||| CD
μM  ||| S:9171 E:9174 ||| JJ
and  ||| S:9174 E:9189 ||| CC
k  ||| S:9189 E:9202 ||| JJ
cat  ||| S:9202 E:9206 ||| NN
values  ||| S:9206 E:9213 ||| NNS
of  ||| S:9213 E:9216 ||| IN
134  ||| S:9216 E:9220 ||| CD
±  ||| S:9220 E:9222 ||| CD
4  ||| S:9222 E:9224 ||| CD
s  ||| S:9224 E:9226 ||| CD
-1 ||| S:9226 E:9228 ||| CD
,  ||| S:9228 E:9230 ||| ,
370  ||| S:9230 E:9234 ||| CD
±  ||| S:9234 E:9236 ||| CD
5  ||| S:9236 E:9238 ||| CD
s  ||| S:9238 E:9250 ||| CD
-1 ||| S:9250 E:9252 ||| CD
,  ||| S:9252 E:9254 ||| ,
and  ||| S:9254 E:9258 ||| CC
157  ||| S:9258 E:9262 ||| CD
±  ||| S:9262 E:9264 ||| CD
9  ||| S:9264 E:9266 ||| CD
s  ||| S:9266 E:9268 ||| CD
-1 ||| S:9268 E:9270 ||| CD
,  ||| S:9270 E:9272 ||| ,
respectively  ||| S:9272 E:9285 ||| RB
( ||| S:9285 E:9286 ||| -LRB-
Table  ||| S:9286 E:9292 ||| NNP
5 ||| S:9292 E:9293 ||| CD
) ||| S:9293 E:9294 ||| -RRB-
.  ||| S:9294 E:9296 ||| .
L1 ||| S:9296 E:9298 ||| NNP
's  ||| S:9298 E:9311 ||| POS
preference  ||| S:9311 E:9322 ||| NN
for  ||| S:9322 E:9326 ||| IN
penicillins  ||| S:9326 E:9338 ||| NN
and  ||| S:9338 E:9342 ||| CC
carbapenems  ||| S:9342 E:9354 ||| NN
over  ||| S:9354 E:9369 ||| IN
cephalosporins ||| S:9369 E:9383 ||| NN
,  ||| S:9383 E:9385 ||| ,
as  ||| S:9385 E:9388 ||| IN
exemplified  ||| S:9388 E:9400 ||| NN
by  ||| S:9400 E:9403 ||| IN
the  ||| S:9403 E:9418 ||| DT
k  ||| S:9418 E:9431 ||| JJ
cat  ||| S:9431 E:9435 ||| NN
values ||| S:9435 E:9441 ||| NNS
,  ||| S:9441 E:9443 ||| ,
is  ||| S:9443 E:9446 ||| VBZ
in  ||| S:9446 E:9449 ||| IN
agreement  ||| S:9449 E:9459 ||| NN
with  ||| S:9459 E:9474 ||| IN
previous  ||| S:9474 E:9483 ||| JJ
studies  ||| S:9483 E:9491 ||| NNS
and  ||| S:9491 E:9495 ||| CC
supports  ||| S:9495 E:9504 ||| VBZ
L1 ||| S:9504 E:9506 ||| NNP
's  ||| S:9506 E:9509 ||| POS
placement  ||| S:9509 E:9519 ||| NN
in  ||| S:9519 E:9522 ||| IN
the  ||| S:9522 E:9536 ||| DT
β-lactamase  ||| S:9536 E:9548 ||| JJ
3c  ||| S:9548 E:9551 ||| CD
family  ||| S:9551 E:9558 ||| NN
[  ||| S:9558 E:9560 ||| -LRB-
9  ||| S:9560 E:9562 ||| CD
]  ||| S:9562 E:9564 ||| -RRB-
.  ||| S:9564 E:9576 ||| .
Rapid-scanning  ||| S:9576 E:9591 ||| JJ
visible  ||| S:9591 E:9599 ||| JJ
spectra  ||| S:9599 E:9607 ||| NN
of  ||| S:9607 E:9610 ||| IN
25  ||| S:9610 E:9613 ||| CD
μM  ||| S:9613 E:9616 ||| JJ
wild-type  ||| S:9616 E:9626 ||| JJ
L1  ||| S:9626 E:9639 ||| NN
with  ||| S:9639 E:9644 ||| IN
5  ||| S:9644 E:9646 ||| CD
μM  ||| S:9646 E:9649 ||| JJ
nitrocefin  ||| S:9649 E:9660 ||| NN
demonstrated  ||| S:9660 E:9673 ||| VBD
a  ||| S:9673 E:9675 ||| DT
decrease  ||| S:9675 E:9684 ||| NN
in  ||| S:9684 E:9697 ||| IN
absorbance  ||| S:9697 E:9708 ||| NN
at  ||| S:9708 E:9711 ||| IN
390  ||| S:9711 E:9715 ||| CD
nm ||| S:9715 E:9717 ||| NN
,  ||| S:9717 E:9719 ||| ,
an  ||| S:9719 E:9722 ||| DT
increase  ||| S:9722 E:9731 ||| NN
at  ||| S:9731 E:9734 ||| IN
485  ||| S:9734 E:9738 ||| CD
nm ||| S:9738 E:9740 ||| NN
,  ||| S:9740 E:9742 ||| ,
and  ||| S:9742 E:9746 ||| CC
a  ||| S:9746 E:9748 ||| DT
rapid  ||| S:9748 E:9764 ||| JJ
increase  ||| S:9764 E:9773 ||| NN
and  ||| S:9773 E:9777 ||| CC
slower  ||| S:9777 E:9784 ||| JJR
decrease  ||| S:9784 E:9793 ||| NN
in  ||| S:9793 E:9796 ||| IN
absorbance  ||| S:9796 E:9807 ||| NN
at  ||| S:9807 E:9810 ||| IN
665  ||| S:9810 E:9814 ||| CD
nm ||| S:9814 E:9816 ||| NNS
.  ||| S:9816 E:9828 ||| .
These  ||| S:9828 E:9834 ||| DT
spectra  ||| S:9834 E:9842 ||| NNS
are  ||| S:9842 E:9846 ||| VBP
similar  ||| S:9846 E:9854 ||| JJ
to  ||| S:9854 E:9857 ||| TO
those  ||| S:9857 E:9863 ||| DT
previously  ||| S:9863 E:9874 ||| RB
reported  ||| S:9874 E:9893 ||| VBN
for  ||| S:9893 E:9897 ||| IN
wild-type  ||| S:9897 E:9907 ||| NNP
L1  ||| S:9907 E:9910 ||| NNP
and  ||| S:9910 E:9914 ||| CC
nitrocefin  ||| S:9914 E:9925 ||| NNS
[  ||| S:9925 E:9927 ||| -LRB-
39  ||| S:9927 E:9930 ||| CD
]  ||| S:9930 E:9932 ||| -RRB-
,  ||| S:9932 E:9934 ||| ,
and  ||| S:9934 E:9938 ||| CC
the  ||| S:9938 E:9942 ||| DT
features  ||| S:9942 E:9961 ||| NNS
can  ||| S:9961 E:9965 ||| MD
be  ||| S:9965 E:9968 ||| VB
attributed  ||| S:9968 E:9979 ||| VBN
to  ||| S:9979 E:9982 ||| TO
substrate  ||| S:9982 E:9992 ||| VB
decay ||| S:9992 E:9997 ||| NN
,  ||| S:9997 E:9999 ||| ,
product  ||| S:9999 E:10007 ||| NN
formation ||| S:10007 E:10016 ||| NN
,  ||| S:10016 E:10028 ||| ,
and  ||| S:10028 E:10032 ||| CC
intermediate  ||| S:10032 E:10045 ||| JJ
formation  ||| S:10045 E:10055 ||| NN
and  ||| S:10055 E:10059 ||| CC
decay ||| S:10059 E:10064 ||| NN
,  ||| S:10064 E:10066 ||| ,
respectively ||| S:10066 E:10078 ||| RB
.  ||| S:10078 E:10080 ||| .
Under  ||| S:10080 E:10096 ||| IN
these  ||| S:10096 E:10102 ||| DT
conditions ||| S:10102 E:10112 ||| NNS
,  ||| S:10112 E:10114 ||| ,
2.2  ||| S:10114 E:10118 ||| CD
μM  ||| S:10118 E:10121 ||| JJ
intermediate  ||| S:10121 E:10134 ||| NN
was  ||| S:10134 E:10138 ||| VBD
formed  ||| S:10138 E:10145 ||| VBN
during  ||| S:10145 E:10162 ||| IN
the  ||| S:10162 E:10166 ||| DT
first  ||| S:10166 E:10172 ||| JJ
10  ||| S:10172 E:10175 ||| CD
milliseconds  ||| S:10175 E:10188 ||| NN
of  ||| S:10188 E:10191 ||| IN
the  ||| S:10191 E:10195 ||| DT
reaction  ||| S:10195 E:10204 ||| NN
( ||| S:10204 E:10205 ||| -LRB-
Figure  ||| S:10205 E:10212 ||| NNP
2 ||| S:10212 E:10213 ||| CD
) ||| S:10213 E:10214 ||| -RRB-
,  ||| S:10214 E:10216 ||| ,
and  ||| S:10216 E:10230 ||| CC
the  ||| S:10230 E:10234 ||| DT
rate  ||| S:10234 E:10239 ||| NN
of  ||| S:10239 E:10242 ||| IN
decay  ||| S:10242 E:10248 ||| NN
of  ||| S:10248 E:10251 ||| IN
this  ||| S:10251 E:10256 ||| DT
intermediate  ||| S:10256 E:10269 ||| JJ
corresponds  ||| S:10269 E:10281 ||| NN
to  ||| S:10281 E:10284 ||| TO
the  ||| S:10284 E:10298 ||| DT
steady-state  ||| S:10298 E:10322 ||| JJ
k  ||| S:10322 E:10335 ||| NN
cat  ||| S:10335 E:10339 ||| NNS
( ||| S:10339 E:10340 ||| -LRB-
Table  ||| S:10340 E:10346 ||| NNP
3 ||| S:10346 E:10347 ||| CD
) ||| S:10347 E:10348 ||| -RRB-
.  ||| S:10348 E:10350 ||| .
To  ||| S:10350 E:10353 ||| TO
probe  ||| S:10353 E:10359 ||| VB
further  ||| S:10359 E:10367 ||| RBR
the  ||| S:10367 E:10381 ||| DT
binding  ||| S:10381 E:10389 ||| NN
of  ||| S:10389 E:10392 ||| IN
nitrocefin  ||| S:10392 E:10403 ||| VBG
to  ||| S:10403 E:10406 ||| TO
wild-type  ||| S:10406 E:10416 ||| NNP
L1 ||| S:10416 E:10418 ||| NNP
,  ||| S:10418 E:10420 ||| ,
stopped-flow  ||| S:10420 E:10443 ||| JJ
fluorescence  ||| S:10443 E:10456 ||| JJ
studies  ||| S:10456 E:10464 ||| NNS
were  ||| S:10464 E:10469 ||| VBD
conducted  ||| S:10469 E:10479 ||| VBN
as  ||| S:10479 E:10482 ||| IN
previously  ||| S:10482 E:10503 ||| RB
described  ||| S:10503 E:10513 ||| VBN
[  ||| S:10513 E:10515 ||| -LRB-
40  ||| S:10515 E:10518 ||| CD
]  ||| S:10518 E:10520 ||| -RRB-
( ||| S:10520 E:10521 ||| -LRB-
Figure  ||| S:10521 E:10528 ||| NNP
3 ||| S:10528 E:10529 ||| CD
) ||| S:10529 E:10530 ||| -RRB-
.  ||| S:10530 E:10532 ||| .
The  ||| S:10532 E:10536 ||| DT
reaction  ||| S:10536 E:10545 ||| NN
of  ||| S:10545 E:10548 ||| IN
wild-type  ||| S:10548 E:10558 ||| JJ
L1  ||| S:10558 E:10571 ||| NN
with  ||| S:10571 E:10576 ||| IN
nitrocefin  ||| S:10576 E:10587 ||| NN
under  ||| S:10587 E:10593 ||| IN
steady-state  ||| S:10593 E:10606 ||| JJ
conditions  ||| S:10606 E:10617 ||| NNS
at  ||| S:10617 E:10620 ||| IN
10°C  ||| S:10620 E:10635 ||| NNP
resulted  ||| S:10635 E:10644 ||| VBD
in  ||| S:10644 E:10647 ||| IN
a  ||| S:10647 E:10649 ||| DT
rapid  ||| S:10649 E:10655 ||| JJ
decrease  ||| S:10655 E:10664 ||| NN
in  ||| S:10664 E:10667 ||| IN
fluorescence  ||| S:10667 E:10680 ||| VBG
followed  ||| S:10680 E:10689 ||| VBN
by  ||| S:10689 E:10702 ||| IN
a  ||| S:10702 E:10704 ||| DT
rate-limiting  ||| S:10704 E:10718 ||| JJ
return  ||| S:10718 E:10725 ||| NN
of  ||| S:10725 E:10728 ||| IN
fluorescence  ||| S:10728 E:10741 ||| NNS
( ||| S:10741 E:10742 ||| -LRB-
Figure  ||| S:10742 E:10749 ||| NNP
3A ||| S:10749 E:10751 ||| NNP
) ||| S:10751 E:10752 ||| -RRB-
.  ||| S:10752 E:10764 ||| .
Fitting  ||| S:10764 E:10772 ||| JJ
of  ||| S:10772 E:10775 ||| IN
the  ||| S:10775 E:10779 ||| DT
data ||| S:10779 E:10783 ||| NNS
,  ||| S:10783 E:10785 ||| ,
as  ||| S:10785 E:10788 ||| RB
described  ||| S:10788 E:10798 ||| VBN
by  ||| S:10798 E:10801 ||| IN
Spencer  ||| S:10801 E:10820 ||| NNP
et  ||| S:10820 E:10823 ||| FW
al.  ||| S:10823 E:10827 ||| FW
[  ||| S:10827 E:10829 ||| -LRB-
40  ||| S:10829 E:10832 ||| CD
]  ||| S:10832 E:10834 ||| -RRB-
,  ||| S:10834 E:10836 ||| ,
resulted  ||| S:10836 E:10845 ||| VBD
in  ||| S:10845 E:10848 ||| IN
a  ||| S:10848 E:10850 ||| DT
K  ||| S:10850 E:10863 ||| NNP
S  ||| S:10863 E:10865 ||| NNP
value  ||| S:10865 E:10871 ||| NN
for  ||| S:10871 E:10875 ||| IN
wild-type  ||| S:10875 E:10885 ||| JJ
L1  ||| S:10885 E:10888 ||| NN
of  ||| S:10888 E:10891 ||| IN
38  ||| S:10891 E:10894 ||| CD
±  ||| S:10894 E:10896 ||| CD
5  ||| S:10896 E:10898 ||| CD
μM  ||| S:10898 E:10911 ||| NNS
( ||| S:10911 E:10912 ||| -LRB-
Figure  ||| S:10912 E:10919 ||| NNP
3B ||| S:10919 E:10921 ||| NNP
) ||| S:10921 E:10922 ||| -RRB-
.  ||| S:10922 E:10952 ||| .
Ser224  ||| S:10952 E:10959 ||| NNP
mutants  ||| S:10959 E:10977 ||| NNS
( ||| S:10977 E:10978 ||| -LRB-
the  ||| S:10978 E:10982 ||| DT
BBL  ||| S:10982 E:10986 ||| NNP
numbering  ||| S:10986 E:10996 ||| JJ
scheme  ||| S:10996 E:11003 ||| NN
proposed  ||| S:11003 E:11012 ||| VBN
in  ||| S:11012 E:11015 ||| IN
reference  ||| S:11015 E:11025 ||| CD
41  ||| S:11025 E:11028 ||| CD
was  ||| S:11028 E:11042 ||| VBD
used  ||| S:11042 E:11047 ||| VBN
throughout  ||| S:11047 E:11058 ||| IN
this  ||| S:11058 E:11063 ||| DT
manuscript ||| S:11063 E:11073 ||| NN
) ||| S:11073 E:11074 ||| -RRB-
.  ||| S:11074 E:11076 ||| .
All  ||| S:11076 E:11080 ||| DT
sequenced  ||| S:11080 E:11090 ||| JJ
subclass  ||| S:11090 E:11109 ||| JJ
Ba  ||| S:11109 E:11112 ||| NNP
and  ||| S:11112 E:11116 ||| CC
Bb  ||| S:11116 E:11119 ||| NNP
metallo-β-lactamases  ||| S:11119 E:11140 ||| NNP
( ||| S:11140 E:11141 ||| -LRB-
except  ||| S:11141 E:11148 ||| IN
VIM-1 ||| S:11148 E:11153 ||| CD
)  ||| S:11153 E:11155 ||| -RRB-
have  ||| S:11155 E:11160 ||| VBP
a  ||| S:11160 E:11172 ||| DT
lysine  ||| S:11172 E:11179 ||| JJ
residue  ||| S:11179 E:11187 ||| NN
at  ||| S:11187 E:11190 ||| IN
position  ||| S:11190 E:11199 ||| NN
224  ||| S:11199 E:11203 ||| CD
[  ||| S:11203 E:11205 ||| -LRB-
41  ||| S:11205 E:11208 ||| CD
]  ||| S:11208 E:11210 ||| -RRB-
,  ||| S:11210 E:11212 ||| ,
and  ||| S:11212 E:11216 ||| CC
all  ||| S:11216 E:11230 ||| DT
computational  ||| S:11230 E:11244 ||| JJ
models  ||| S:11244 E:11251 ||| NNS
for  ||| S:11251 E:11255 ||| IN
substrate  ||| S:11255 E:11265 ||| JJ
binding  ||| S:11265 E:11273 ||| NN
to  ||| S:11273 E:11276 ||| TO
the  ||| S:11276 E:11290 ||| DT
metallo-β-lactamases  ||| S:11290 E:11311 ||| JJ
assume  ||| S:11311 E:11318 ||| NN
that  ||| S:11318 E:11323 ||| IN
the  ||| S:11323 E:11327 ||| DT
invariant  ||| S:11327 E:11347 ||| JJ
carboxylate  ||| S:11347 E:11359 ||| NN
on  ||| S:11359 E:11362 ||| IN
substrates  ||| S:11362 E:11373 ||| JJ
forms  ||| S:11373 E:11379 ||| NNS
an  ||| S:11379 E:11382 ||| DT
electrostatic  ||| S:11382 E:11406 ||| JJ
interaction  ||| S:11406 E:11418 ||| NN
with  ||| S:11418 E:11423 ||| IN
this  ||| S:11423 E:11428 ||| DT
lysine ||| S:11428 E:11434 ||| NN
.  ||| S:11434 E:11436 ||| .
In  ||| S:11436 E:11439 ||| IN
L1 ||| S:11439 E:11441 ||| NNP
,  ||| S:11441 E:11443 ||| ,
the  ||| S:11443 E:11447 ||| DT
residue  ||| S:11447 E:11455 ||| NN
at  ||| S:11455 E:11468 ||| IN
position  ||| S:11468 E:11477 ||| NN
224  ||| S:11477 E:11481 ||| CD
is  ||| S:11481 E:11484 ||| VBZ
a  ||| S:11484 E:11486 ||| DT
serine  ||| S:11486 E:11493 ||| NN
[  ||| S:11493 E:11495 ||| -LRB-
35  ||| S:11495 E:11498 ||| CD
]  ||| S:11498 E:11500 ||| -RRB-
,  ||| S:11500 E:11502 ||| ,
and  ||| S:11502 E:11506 ||| CC
the  ||| S:11506 E:11520 ||| DT
substrate-binding  ||| S:11520 E:11538 ||| JJ
model  ||| S:11538 E:11544 ||| NN
for  ||| S:11544 E:11548 ||| IN
L1  ||| S:11548 E:11551 ||| NNP
predicts  ||| S:11551 E:11560 ||| VBZ
that  ||| S:11560 E:11565 ||| IN
this  ||| S:11565 E:11570 ||| DT
serine  ||| S:11570 E:11587 ||| JJ
residue  ||| S:11587 E:11595 ||| JJ
interacts  ||| S:11595 E:11605 ||| NN
with  ||| S:11605 E:11610 ||| IN
the  ||| S:11610 E:11614 ||| DT
carboxylate  ||| S:11614 E:11626 ||| NN
on  ||| S:11626 E:11629 ||| IN
substrate  ||| S:11629 E:11639 ||| NN
via  ||| S:11639 E:11643 ||| IN
a  ||| S:11643 E:11655 ||| DT
water  ||| S:11655 E:11661 ||| NN
molecule  ||| S:11661 E:11670 ||| NN
[  ||| S:11670 E:11672 ||| -LRB-
37  ||| S:11672 E:11675 ||| CD
]  ||| S:11675 E:11677 ||| -RRB-
.  ||| S:11677 E:11679 ||| .
To  ||| S:11679 E:11682 ||| TO
test  ||| S:11682 E:11687 ||| VB
the  ||| S:11687 E:11691 ||| DT
proposed  ||| S:11691 E:11700 ||| JJ
role  ||| S:11700 E:11705 ||| NN
of  ||| S:11705 E:11718 ||| IN
Ser224  ||| S:11718 E:11725 ||| CD
in  ||| S:11725 E:11728 ||| IN
L1 ||| S:11728 E:11730 ||| NNP
,  ||| S:11730 E:11732 ||| ,
serine  ||| S:11732 E:11739 ||| NN
was  ||| S:11739 E:11743 ||| VBD
changed  ||| S:11743 E:11751 ||| VBN
to  ||| S:11751 E:11754 ||| TO
an  ||| S:11754 E:11757 ||| DT
alanine  ||| S:11757 E:11765 ||| NN
( ||| S:11765 E:11766 ||| -LRB-
S224A ||| S:11766 E:11771 ||| NNP
) ||| S:11771 E:11772 ||| -RRB-
,  ||| S:11772 E:11784 ||| ,
aspartic  ||| S:11784 E:11793 ||| JJ
acid  ||| S:11793 E:11798 ||| NN
( ||| S:11798 E:11799 ||| -LRB-
S224D ||| S:11799 E:11804 ||| NNP
) ||| S:11804 E:11805 ||| -RRB-
,  ||| S:11805 E:11807 ||| ,
and  ||| S:11807 E:11811 ||| CC
lysine  ||| S:11811 E:11818 ||| NNS
( ||| S:11818 E:11819 ||| -LRB-
S224K ||| S:11819 E:11824 ||| NNP
) ||| S:11824 E:11825 ||| -RRB-
,  ||| S:11825 E:11827 ||| ,
and  ||| S:11827 E:11831 ||| CC
these  ||| S:11831 E:11847 ||| DT
mutants  ||| S:11847 E:11855 ||| NN
were  ||| S:11855 E:11860 ||| VBD
characterized  ||| S:11860 E:11874 ||| VBN
using  ||| S:11874 E:11880 ||| VBG
metal  ||| S:11880 E:11886 ||| NN
analyses ||| S:11886 E:11894 ||| NNS
,  ||| S:11894 E:11896 ||| ,
CD  ||| S:11896 E:11909 ||| NNP
spectroscopy ||| S:11909 E:11921 ||| NN
,  ||| S:11921 E:11923 ||| ,
steady-state  ||| S:11923 E:11936 ||| JJ
kinetics ||| S:11936 E:11944 ||| NN
,  ||| S:11944 E:11946 ||| ,
and  ||| S:11946 E:11950 ||| CC
pre-steady  ||| S:11950 E:11961 ||| JJ
state  ||| S:11961 E:11977 ||| NN
kinetic  ||| S:11977 E:11985 ||| NN
studies ||| S:11985 E:11992 ||| NNS
.  ||| S:11992 E:12004 ||| .
Small-scale  ||| S:12004 E:12016 ||| JJ
growth  ||| S:12016 E:12023 ||| NN
cultures  ||| S:12023 E:12032 ||| NNS
showed  ||| S:12032 E:12039 ||| VBD
that  ||| S:12039 E:12044 ||| IN
all  ||| S:12044 E:12048 ||| DT
three  ||| S:12048 E:12064 ||| CD
mutants  ||| S:12064 E:12072 ||| NNS
were  ||| S:12072 E:12077 ||| VBD
over-expressed  ||| S:12077 E:12092 ||| JJ
at  ||| S:12092 E:12095 ||| IN
levels  ||| S:12095 E:12102 ||| NNS
comparable  ||| S:12102 E:12113 ||| JJ
to  ||| S:12113 E:12116 ||| TO
those  ||| S:12116 E:12132 ||| DT
of  ||| S:12132 E:12135 ||| IN
wild-type  ||| S:12135 E:12145 ||| JJ
L1 ||| S:12145 E:12147 ||| NN
.  ||| S:12147 E:12149 ||| .
Large-scale  ||| S:12149 E:12161 ||| JJ
over-expression  ||| S:12161 E:12177 ||| JJ
and  ||| S:12177 E:12191 ||| CC
purification  ||| S:12191 E:12204 ||| NN
of  ||| S:12204 E:12207 ||| IN
the  ||| S:12207 E:12211 ||| DT
mutants  ||| S:12211 E:12219 ||| NN
showed  ||| S:12219 E:12226 ||| VBD
that  ||| S:12226 E:12231 ||| IN
all  ||| S:12231 E:12235 ||| DT
three  ||| S:12235 E:12241 ||| CD
mutants  ||| S:12241 E:12259 ||| NNS
were  ||| S:12259 E:12264 ||| VBD
isolatable  ||| S:12264 E:12275 ||| VBN
at  ||| S:12275 E:12278 ||| IN
levels  ||| S:12278 E:12285 ||| NNS
comparable  ||| S:12285 E:12296 ||| JJ
to  ||| S:12296 E:12299 ||| TO
those  ||| S:12299 E:12305 ||| DT
of  ||| S:12305 E:12318 ||| IN
wild-type  ||| S:12318 E:12328 ||| JJ
L1 ||| S:12328 E:12330 ||| NN
.  ||| S:12330 E:12332 ||| .
Metal  ||| S:12332 E:12338 ||| NN
analyses  ||| S:12338 E:12347 ||| NNS
of  ||| S:12347 E:12350 ||| IN
the  ||| S:12350 E:12354 ||| DT
S224A  ||| S:12354 E:12360 ||| NNP
and  ||| S:12360 E:12364 ||| CC
S224D  ||| S:12364 E:12380 ||| CD
mutants  ||| S:12380 E:12388 ||| NNS
showed  ||| S:12388 E:12395 ||| VBD
that  ||| S:12395 E:12400 ||| IN
both  ||| S:12400 E:12405 ||| DT
mutants  ||| S:12405 E:12413 ||| JJ
bind  ||| S:12413 E:12418 ||| NN
nearly  ||| S:12418 E:12425 ||| RB
two  ||| S:12425 E:12429 ||| CD
Zn ||| S:12429 E:12431 ||| NNP
( ||| S:12431 E:12432 ||| -LRB-
II ||| S:12432 E:12434 ||| NNP
)  ||| S:12434 E:12446 ||| -RRB-
ions  ||| S:12446 E:12451 ||| NNS
( ||| S:12451 E:12452 ||| -LRB-
Table  ||| S:12452 E:12458 ||| NNP
2 ||| S:12458 E:12459 ||| CD
) ||| S:12459 E:12460 ||| -RRB-
,  ||| S:12460 E:12462 ||| ,
like  ||| S:12462 E:12467 ||| IN
wild-type  ||| S:12467 E:12477 ||| NNP
L1  ||| S:12477 E:12480 ||| NNP
[  ||| S:12480 E:12482 ||| -LRB-
36  ||| S:12482 E:12485 ||| CD
]  ||| S:12485 E:12487 ||| -RRB-
;  ||| S:12487 E:12489 ||| :
however ||| S:12489 E:12496 ||| RB
,  ||| S:12496 E:12498 ||| ,
the  ||| S:12498 E:12512 ||| DT
S224K  ||| S:12512 E:12518 ||| CD
mutant  ||| S:12518 E:12525 ||| NNS
binds  ||| S:12525 E:12531 ||| VBP
only  ||| S:12531 E:12536 ||| RB
1.0  ||| S:12536 E:12540 ||| CD
Zn ||| S:12540 E:12542 ||| NNP
( ||| S:12542 E:12543 ||| -LRB-
II ||| S:12543 E:12545 ||| NNP
)  ||| S:12545 E:12547 ||| -RRB-
per  ||| S:12547 E:12551 ||| IN
protein ||| S:12551 E:12558 ||| NN
.  ||| S:12558 E:12560 ||| .
CD  ||| S:12560 E:12573 ||| NNP
spectra  ||| S:12573 E:12581 ||| NN
of  ||| S:12581 E:12584 ||| IN
the  ||| S:12584 E:12588 ||| DT
mutants  ||| S:12588 E:12596 ||| NN
were  ||| S:12596 E:12601 ||| VBD
similar  ||| S:12601 E:12609 ||| JJ
to  ||| S:12609 E:12612 ||| TO
those  ||| S:12612 E:12618 ||| DT
of  ||| S:12618 E:12621 ||| IN
wild-type  ||| S:12621 E:12641 ||| NNP
L1  ||| S:12641 E:12644 ||| NNP
( ||| S:12644 E:12645 ||| -LRB-
see  ||| S:12645 E:12649 ||| VB
Figure  ||| S:12649 E:12656 ||| NN
in  ||| S:12656 E:12659 ||| IN
Additional  ||| S:12659 E:12670 ||| JJ
materials ||| S:12670 E:12679 ||| NNS
) ||| S:12679 E:12680 ||| -RRB-
.  ||| S:12680 E:12682 ||| .
Steady-state  ||| S:12682 E:12705 ||| JJ
kinetic  ||| S:12705 E:12713 ||| JJ
studies  ||| S:12713 E:12721 ||| NNS
were  ||| S:12721 E:12726 ||| VBD
conducted  ||| S:12726 E:12736 ||| VBN
with  ||| S:12736 E:12741 ||| IN
all  ||| S:12741 E:12745 ||| DT
three  ||| S:12745 E:12751 ||| CD
mutants  ||| S:12751 E:12759 ||| NN
in  ||| S:12759 E:12772 ||| IN
buffer  ||| S:12772 E:12779 ||| NN
containing  ||| S:12779 E:12790 ||| VBG
100  ||| S:12790 E:12794 ||| CD
μM  ||| S:12794 E:12797 ||| JJ
ZnCl  ||| S:12797 E:12813 ||| JJ
2  ||| S:12813 E:12815 ||| CD
to  ||| S:12815 E:12818 ||| TO
ensure  ||| S:12818 E:12825 ||| VB
that  ||| S:12825 E:12830 ||| IN
both  ||| S:12830 E:12835 ||| DT
Zn ||| S:12835 E:12837 ||| NNP
( ||| S:12837 E:12838 ||| -LRB-
II ||| S:12838 E:12840 ||| NNP
)  ||| S:12840 E:12842 ||| -RRB-
binding  ||| S:12842 E:12860 ||| JJ
sites  ||| S:12860 E:12866 ||| NNS
were  ||| S:12866 E:12871 ||| VBD
saturated  ||| S:12871 E:12881 ||| VBN
in  ||| S:12881 E:12884 ||| IN
these  ||| S:12884 E:12890 ||| DT
studies ||| S:12890 E:12897 ||| NNS
.  ||| S:12897 E:12899 ||| .
Addition  ||| S:12899 E:12908 ||| NN
of  ||| S:12908 E:12911 ||| IN
higher  ||| S:12911 E:12928 ||| JJR
concentrations  ||| S:12928 E:12943 ||| NNS
of  ||| S:12943 E:12946 ||| IN
Zn ||| S:12946 E:12948 ||| NNP
( ||| S:12948 E:12949 ||| -LRB-
II ||| S:12949 E:12951 ||| NNP
)  ||| S:12951 E:12953 ||| -RRB-
did  ||| S:12953 E:12957 ||| VBD
not  ||| S:12957 E:12961 ||| RB
result  ||| S:12961 E:12968 ||| VB
in  ||| S:12968 E:12971 ||| IN
different  ||| S:12971 E:12991 ||| JJ
values  ||| S:12991 E:12998 ||| NNS
for  ||| S:12998 E:13002 ||| IN
the  ||| S:13002 E:13006 ||| DT
steady-state  ||| S:13006 E:13019 ||| JJ
kinetic  ||| S:13019 E:13027 ||| JJ
constants  ||| S:13027 E:13037 ||| NN
in  ||| S:13037 E:13040 ||| IN
Tables  ||| S:13040 E:13057 ||| NNP
3 ||| S:13057 E:13058 ||| CD
,  ||| S:13058 E:13060 ||| ,
4 ||| S:13060 E:13061 ||| CD
,  ||| S:13061 E:13063 ||| ,
5 ||| S:13063 E:13064 ||| CD
.  ||| S:13064 E:13076 ||| .
When  ||| S:13076 E:13081 ||| WRB
the  ||| S:13081 E:13085 ||| DT
cephalosporins  ||| S:13085 E:13100 ||| NN
were  ||| S:13100 E:13105 ||| VBD
used  ||| S:13105 E:13110 ||| VBN
as  ||| S:13110 E:13113 ||| IN
substrates ||| S:13113 E:13123 ||| NN
,  ||| S:13123 E:13125 ||| ,
the  ||| S:13125 E:13139 ||| DT
S224A  ||| S:13139 E:13145 ||| NNP
and  ||| S:13145 E:13149 ||| CC
S224K  ||| S:13149 E:13155 ||| CD
mutants  ||| S:13155 E:13163 ||| CD
exhibited  ||| S:13163 E:13173 ||| CD
2-  ||| S:13173 E:13176 ||| CD
to  ||| S:13176 E:13179 ||| TO
4-fold  ||| S:13179 E:13186 ||| CD
changes  ||| S:13186 E:13194 ||| NNS
in  ||| S:13194 E:13207 ||| IN
K  ||| S:13207 E:13220 ||| NNP
m  ||| S:13220 E:13222 ||| NN
values  ||| S:13222 E:13229 ||| NNS
( ||| S:13229 E:13230 ||| -LRB-
Table  ||| S:13230 E:13236 ||| NNP
3 ||| S:13236 E:13237 ||| CD
) ||| S:13237 E:13238 ||| -RRB-
.  ||| S:13238 E:13240 ||| .
In  ||| S:13240 E:13243 ||| IN
studies  ||| S:13243 E:13251 ||| NNS
with  ||| S:13251 E:13266 ||| IN
cefoxitin ||| S:13266 E:13275 ||| NN
,  ||| S:13275 E:13277 ||| ,
cefaclor ||| S:13277 E:13285 ||| NN
,  ||| S:13285 E:13287 ||| ,
and  ||| S:13287 E:13291 ||| CC
cephalothin  ||| S:13291 E:13303 ||| NN
as  ||| S:13303 E:13306 ||| IN
substrate ||| S:13306 E:13315 ||| NN
,  ||| S:13315 E:13317 ||| ,
the  ||| S:13317 E:13331 ||| DT
observed  ||| S:13331 E:13351 ||| JJ
k  ||| S:13351 E:13364 ||| JJ
cat  ||| S:13364 E:13368 ||| NN
values  ||| S:13368 E:13375 ||| NNS
for  ||| S:13375 E:13379 ||| IN
the  ||| S:13379 E:13383 ||| DT
S224A  ||| S:13383 E:13389 ||| NNP
and  ||| S:13389 E:13393 ||| CC
S224K  ||| S:13393 E:13409 ||| CD
mutants  ||| S:13409 E:13417 ||| NNS
were  ||| S:13417 E:13422 ||| VBD
2-  ||| S:13422 E:13425 ||| CD
to  ||| S:13425 E:13428 ||| TO
7-fold  ||| S:13428 E:13435 ||| CD
lower ||| S:13435 E:13440 ||| JJR
;  ||| S:13440 E:13442 ||| :
however ||| S:13442 E:13449 ||| RB
,  ||| S:13449 E:13451 ||| ,
the  ||| S:13451 E:13466 ||| DT
k  ||| S:13466 E:13479 ||| JJ
cat  ||| S:13479 E:13483 ||| NN
values  ||| S:13483 E:13490 ||| NNS
when  ||| S:13490 E:13495 ||| WRB
using  ||| S:13495 E:13501 ||| VBG
nitrocefin  ||| S:13501 E:13512 ||| NN
as  ||| S:13512 E:13525 ||| IN
substrate  ||| S:13525 E:13535 ||| NN
were  ||| S:13535 E:13540 ||| VBD
slightly  ||| S:13540 E:13549 ||| RB
higher  ||| S:13549 E:13556 ||| JJR
(  ||| S:13556 E:13557 ||| -LRB-
< ||| S:13557 E:13559 ||| SYM
2-fold ||| S:13559 E:13565 ||| NNP
) ||| S:13565 E:13566 ||| -RRB-
.  ||| S:13566 E:13568 ||| .
On  ||| S:13568 E:13571 ||| IN
the  ||| S:13571 E:13585 ||| DT
other  ||| S:13585 E:13591 ||| JJ
hand ||| S:13591 E:13595 ||| NN
,  ||| S:13595 E:13597 ||| ,
the  ||| S:13597 E:13601 ||| DT
S224D  ||| S:13601 E:13607 ||| FW
mutant  ||| S:13607 E:13614 ||| FW
exhibited  ||| S:13614 E:13624 ||| FW
3-  ||| S:13624 E:13627 ||| FW
to  ||| S:13627 E:13630 ||| TO
50-fold  ||| S:13630 E:13648 ||| CD
higher  ||| S:13648 E:13655 ||| JJR
K  ||| S:13655 E:13668 ||| NNP
m  ||| S:13668 E:13670 ||| NN
values  ||| S:13670 E:13677 ||| NNS
and  ||| S:13677 E:13681 ||| CC
2-  ||| S:13681 E:13684 ||| CD
to  ||| S:13684 E:13687 ||| TO
20-fold  ||| S:13687 E:13695 ||| CD
lower  ||| S:13695 E:13712 ||| JJR
k  ||| S:13712 E:13725 ||| JJ
cat  ||| S:13725 E:13729 ||| NN
values  ||| S:13729 E:13736 ||| NNS
for  ||| S:13736 E:13740 ||| IN
the  ||| S:13740 E:13744 ||| DT
cephalosporins  ||| S:13744 E:13769 ||| NN
tested ||| S:13769 E:13775 ||| VBD
.  ||| S:13775 E:13777 ||| .
A  ||| S:13777 E:13779 ||| DT
similar  ||| S:13779 E:13787 ||| JJ
trend  ||| S:13787 E:13793 ||| NN
was  ||| S:13793 E:13797 ||| VBD
observed  ||| S:13797 E:13806 ||| VBN
in  ||| S:13806 E:13809 ||| IN
kinetic  ||| S:13809 E:13817 ||| JJ
studies  ||| S:13817 E:13835 ||| NNS
when  ||| S:13835 E:13840 ||| WRB
using  ||| S:13840 E:13846 ||| VBG
penicillins  ||| S:13846 E:13858 ||| NN
as  ||| S:13858 E:13861 ||| IN
substrates  ||| S:13861 E:13872 ||| NNS
( ||| S:13872 E:13873 ||| -LRB-
Table  ||| S:13873 E:13879 ||| NNP
4 ||| S:13879 E:13880 ||| CD
) ||| S:13880 E:13881 ||| -RRB-
.  ||| S:13881 E:13893 ||| .
Generally ||| S:13893 E:13902 ||| RB
,  ||| S:13902 E:13904 ||| ,
the  ||| S:13904 E:13908 ||| DT
S224A  ||| S:13908 E:13914 ||| NNP
and  ||| S:13914 E:13918 ||| CC
S224K  ||| S:13918 E:13924 ||| NNP
mutants  ||| S:13924 E:13932 ||| VBD
exhibited  ||| S:13932 E:13942 ||| VBN
small  ||| S:13942 E:13958 ||| JJ
changes  ||| S:13958 E:13966 ||| NNS
in  ||| S:13966 E:13969 ||| IN
K  ||| S:13969 E:13982 ||| NNP
m  ||| S:13982 E:13984 ||| NN
and  ||| S:13984 E:13999 ||| CC
k  ||| S:13999 E:14012 ||| JJ
cat  ||| S:14012 E:14016 ||| NN
,  ||| S:14016 E:14018 ||| ,
while  ||| S:14018 E:14024 ||| IN
the  ||| S:14024 E:14028 ||| DT
S224D  ||| S:14028 E:14034 ||| CD
mutant  ||| S:14034 E:14041 ||| NNS
yielded  ||| S:14041 E:14059 ||| VBD
20-  ||| S:14059 E:14063 ||| CD
to  ||| S:14063 E:14066 ||| TO
40-fold  ||| S:14066 E:14074 ||| CD
increased  ||| S:14074 E:14084 ||| JJ
values  ||| S:14084 E:14091 ||| NNS
for  ||| S:14091 E:14095 ||| IN
K  ||| S:14095 E:14108 ||| NNP
m  ||| S:14108 E:14110 ||| NN
and  ||| S:14110 E:14114 ||| CC
> ||| S:14114 E:14115 ||| CD
10-fold  ||| S:14115 E:14123 ||| CD
decreases  ||| S:14123 E:14133 ||| NNS
in  ||| S:14133 E:14147 ||| IN
k  ||| S:14147 E:14160 ||| JJ
cat  ||| S:14160 E:14164 ||| NN
when  ||| S:14164 E:14169 ||| WRB
using  ||| S:14169 E:14175 ||| VBG
the  ||| S:14175 E:14179 ||| DT
penicillins  ||| S:14179 E:14191 ||| NN
as  ||| S:14191 E:14204 ||| IN
substrates ||| S:14204 E:14214 ||| NN
.  ||| S:14214 E:14216 ||| .
When  ||| S:14216 E:14221 ||| WRB
the  ||| S:14221 E:14225 ||| DT
carbapenems  ||| S:14225 E:14237 ||| NN
were  ||| S:14237 E:14242 ||| VBD
used  ||| S:14242 E:14247 ||| VBN
as  ||| S:14247 E:14250 ||| IN
substrates  ||| S:14250 E:14271 ||| VBG
however ||| S:14271 E:14278 ||| RB
,  ||| S:14278 E:14280 ||| ,
the  ||| S:14280 E:14284 ||| DT
changes  ||| S:14284 E:14292 ||| NNS
in  ||| S:14292 E:14295 ||| IN
K  ||| S:14295 E:14308 ||| NNP
m  ||| S:14308 E:14310 ||| NN
values  ||| S:14310 E:14317 ||| NNS
were  ||| S:14317 E:14322 ||| VBD
relatively  ||| S:14322 E:14333 ||| RB
smaller  ||| S:14333 E:14341 ||| JJR
than  ||| S:14341 E:14356 ||| IN
with  ||| S:14356 E:14361 ||| IN
the  ||| S:14361 E:14365 ||| DT
other  ||| S:14365 E:14371 ||| JJ
substrates ||| S:14371 E:14381 ||| NN
,  ||| S:14381 E:14383 ||| ,
and  ||| S:14383 E:14387 ||| CC
2-  ||| S:14387 E:14390 ||| CD
to  ||| S:14390 E:14393 ||| TO
37-fold  ||| S:14393 E:14401 ||| CD
changes  ||| S:14401 E:14409 ||| NNS
in  ||| S:14409 E:14423 ||| IN
k  ||| S:14423 E:14436 ||| JJ
cat  ||| S:14436 E:14440 ||| NN
were  ||| S:14440 E:14445 ||| VBD
observed  ||| S:14445 E:14454 ||| VBN
( ||| S:14454 E:14455 ||| -LRB-
Table  ||| S:14455 E:14461 ||| NNP
5 ||| S:14461 E:14462 ||| CD
) ||| S:14462 E:14463 ||| -RRB-
.  ||| S:14463 E:14475 ||| .
Rapid-scanning  ||| S:14475 E:14490 ||| NNP
Vis  ||| S:14490 E:14494 ||| NNP
studies  ||| S:14494 E:14502 ||| NNS
of  ||| S:14502 E:14505 ||| IN
the  ||| S:14505 E:14509 ||| DT
S224X  ||| S:14509 E:14515 ||| CD
mutants  ||| S:14515 E:14523 ||| NNS
were  ||| S:14523 E:14538 ||| VBD
conducted  ||| S:14538 E:14548 ||| VBN
to  ||| S:14548 E:14551 ||| TO
probe  ||| S:14551 E:14557 ||| VB
whether  ||| S:14557 E:14565 ||| IN
the  ||| S:14565 E:14569 ||| DT
mutations  ||| S:14569 E:14579 ||| NN
caused  ||| S:14579 E:14586 ||| VBD
changes  ||| S:14586 E:14604 ||| NNS
in  ||| S:14604 E:14607 ||| IN
the  ||| S:14607 E:14611 ||| DT
amount  ||| S:14611 E:14618 ||| NN
of  ||| S:14618 E:14621 ||| IN
intermediate  ||| S:14621 E:14634 ||| JJ
that  ||| S:14634 E:14639 ||| IN
accumulates  ||| S:14639 E:14651 ||| NN
during  ||| S:14651 E:14668 ||| IN
catalysis ||| S:14668 E:14677 ||| NN
.  ||| S:14677 E:14679 ||| .
When  ||| S:14679 E:14684 ||| WRB
50  ||| S:14684 E:14687 ||| CD
μM  ||| S:14687 E:14690 ||| JJ
S224A  ||| S:14690 E:14696 ||| NN
was  ||| S:14696 E:14700 ||| VBD
reacted  ||| S:14700 E:14708 ||| VBN
with  ||| S:14708 E:14713 ||| IN
5  ||| S:14713 E:14715 ||| CD
μM  ||| S:14715 E:14728 ||| JJ
nitrocefin ||| S:14728 E:14738 ||| NN
,  ||| S:14738 E:14740 ||| ,
1.7  ||| S:14740 E:14744 ||| CD
μM  ||| S:14744 E:14747 ||| JJ
intermediate  ||| S:14747 E:14760 ||| NNS
formed  ||| S:14760 E:14767 ||| VBN
during  ||| S:14767 E:14774 ||| IN
the  ||| S:14774 E:14778 ||| DT
first  ||| S:14778 E:14794 ||| JJ
10  ||| S:14794 E:14797 ||| CD
milliseconds  ||| S:14797 E:14810 ||| NN
of  ||| S:14810 E:14813 ||| IN
the  ||| S:14813 E:14817 ||| DT
reaction  ||| S:14817 E:14826 ||| NN
( ||| S:14826 E:14827 ||| -LRB-
Figure  ||| S:14827 E:14834 ||| NNP
2 ||| S:14834 E:14835 ||| CD
) ||| S:14835 E:14836 ||| -RRB-
,  ||| S:14836 E:14838 ||| ,
and  ||| S:14838 E:14842 ||| CC
rate  ||| S:14842 E:14847 ||| NN
of  ||| S:14847 E:14860 ||| IN
decay  ||| S:14860 E:14866 ||| NN
of  ||| S:14866 E:14869 ||| IN
this  ||| S:14869 E:14874 ||| DT
intermediate  ||| S:14874 E:14887 ||| NN
was  ||| S:14887 E:14891 ||| VBD
equal  ||| S:14891 E:14897 ||| JJ
to  ||| S:14897 E:14900 ||| TO
the  ||| S:14900 E:14904 ||| DT
steady-state  ||| S:14904 E:14928 ||| JJ
k  ||| S:14928 E:14941 ||| NN
cat  ||| S:14941 E:14945 ||| NNS
( ||| S:14945 E:14946 ||| -LRB-
Table  ||| S:14946 E:14952 ||| NNP
3 ||| S:14952 E:14953 ||| CD
) ||| S:14953 E:14954 ||| -RRB-
.  ||| S:14954 E:14956 ||| .
In  ||| S:14956 E:14959 ||| IN
spite  ||| S:14959 E:14965 ||| NN
of  ||| S:14965 E:14968 ||| IN
utilizing  ||| S:14968 E:14978 ||| VBG
a  ||| S:14978 E:14990 ||| DT
number  ||| S:14990 E:14997 ||| NN
of  ||| S:14997 E:15000 ||| IN
reaction  ||| S:15000 E:15009 ||| NN
conditions ||| S:15009 E:15019 ||| NNS
,  ||| S:15019 E:15021 ||| ,
the  ||| S:15021 E:15025 ||| DT
S224K  ||| S:15025 E:15031 ||| NNP
and  ||| S:15031 E:15035 ||| CC
S224D  ||| S:15035 E:15051 ||| CD
mutants  ||| S:15051 E:15059 ||| NNS
yielded  ||| S:15059 E:15067 ||| VBD
rapid-scan  ||| S:15067 E:15078 ||| JJ
spectra  ||| S:15078 E:15086 ||| NN
with  ||| S:15086 E:15091 ||| IN
no  ||| S:15091 E:15094 ||| DT
detectable  ||| S:15094 E:15115 ||| JJ
absorbances  ||| S:15115 E:15127 ||| NN
at  ||| S:15127 E:15130 ||| IN
665  ||| S:15130 E:15134 ||| CD
nm  ||| S:15134 E:15137 ||| NNS
( ||| S:15137 E:15138 ||| -LRB-
Figure  ||| S:15138 E:15145 ||| NNP
2 ||| S:15145 E:15146 ||| CD
) ||| S:15146 E:15147 ||| -RRB-
,  ||| S:15147 E:15149 ||| ,
indicating  ||| S:15149 E:15160 ||| VBG
that  ||| S:15160 E:15165 ||| IN
the  ||| S:15165 E:15179 ||| DT
intermediate  ||| S:15179 E:15192 ||| NN
is  ||| S:15192 E:15195 ||| VBZ
not  ||| S:15195 E:15199 ||| RB
stabilized  ||| S:15199 E:15210 ||| VBN
as  ||| S:15210 E:15213 ||| IN
well  ||| S:15213 E:15218 ||| RB
in  ||| S:15218 E:15221 ||| IN
these  ||| S:15221 E:15227 ||| DT
mutants  ||| S:15227 E:15245 ||| NN
as  ||| S:15245 E:15248 ||| IN
in  ||| S:15248 E:15251 ||| IN
wild-type  ||| S:15251 E:15261 ||| JJ
L1 ||| S:15261 E:15263 ||| NN
.  ||| S:15263 E:15265 ||| .
Stopped-flow  ||| S:15265 E:15278 ||| JJ
fluorescence  ||| S:15278 E:15291 ||| JJ
studies  ||| S:15291 E:15299 ||| NNS
at  ||| S:15299 E:15312 ||| IN
10°C  ||| S:15312 E:15317 ||| CD
with  ||| S:15317 E:15322 ||| IN
the  ||| S:15322 E:15326 ||| DT
S224A ||| S:15326 E:15331 ||| NNP
,  ||| S:15331 E:15333 ||| ,
S224D ||| S:15333 E:15338 ||| NNP
,  ||| S:15338 E:15340 ||| ,
and  ||| S:15340 E:15344 ||| CC
S224K  ||| S:15344 E:15350 ||| CD
mutants  ||| S:15350 E:15358 ||| NNS
and  ||| S:15358 E:15372 ||| CC
nitrocefin  ||| S:15372 E:15383 ||| NN
as  ||| S:15383 E:15386 ||| IN
the  ||| S:15386 E:15390 ||| DT
substrate  ||| S:15390 E:15400 ||| NN
resulted  ||| S:15400 E:15409 ||| VBD
in  ||| S:15409 E:15412 ||| IN
K  ||| S:15412 E:15425 ||| NNP
S  ||| S:15425 E:15427 ||| NNP
values  ||| S:15427 E:15434 ||| NNS
of  ||| S:15434 E:15437 ||| IN
39  ||| S:15437 E:15440 ||| CD
±  ||| S:15440 E:15442 ||| CD
10 ||| S:15442 E:15444 ||| CD
,  ||| S:15444 E:15446 ||| ,
213  ||| S:15446 E:15450 ||| CD
±  ||| S:15450 E:15452 ||| CD
63 ||| S:15452 E:15454 ||| CD
,  ||| S:15454 E:15456 ||| ,
and  ||| S:15456 E:15460 ||| CC
33  ||| S:15460 E:15473 ||| CD
±  ||| S:15473 E:15475 ||| CD
5  ||| S:15475 E:15477 ||| CD
μM ||| S:15477 E:15479 ||| NN
,  ||| S:15479 E:15481 ||| ,
respectively ||| S:15481 E:15493 ||| RB
.  ||| S:15493 E:15523 ||| .
Asn233  ||| S:15523 E:15530 ||| NNP
mutants  ||| S:15530 E:15548 ||| NN
Two-thirds  ||| S:15548 E:15559 ||| NNS
of  ||| S:15559 E:15562 ||| IN
all  ||| S:15562 E:15566 ||| DT
sequenced  ||| S:15566 E:15576 ||| JJ
metallo-β-lactamases  ||| S:15576 E:15597 ||| NNS
have  ||| S:15597 E:15612 ||| VBP
an  ||| S:15612 E:15615 ||| DT
Asn  ||| S:15615 E:15619 ||| NNP
at  ||| S:15619 E:15622 ||| IN
position  ||| S:15622 E:15631 ||| NN
233  ||| S:15631 E:15635 ||| CD
[  ||| S:15635 E:15637 ||| -LRB-
41  ||| S:15637 E:15640 ||| CD
]  ||| S:15640 E:15642 ||| -RRB-
,  ||| S:15642 E:15644 ||| ,
and  ||| S:15644 E:15648 ||| CC
this  ||| S:15648 E:15653 ||| DT
residue  ||| S:15653 E:15661 ||| NN
was  ||| S:15661 E:15675 ||| VBD
predicted  ||| S:15675 E:15685 ||| VBN
[  ||| S:15685 E:15687 ||| -LRB-
42  ||| S:15687 E:15690 ||| CD
]  ||| S:15690 E:15692 ||| -RRB-
and  ||| S:15692 E:15696 ||| CC
shown  ||| S:15696 E:15702 ||| VBN
[  ||| S:15702 E:15704 ||| -LRB-
43  ||| S:15704 E:15707 ||| CD
]  ||| S:15707 E:15709 ||| -RRB-
to  ||| S:15709 E:15712 ||| TO
be  ||| S:15712 E:15715 ||| VB
involved  ||| S:15715 E:15724 ||| VBN
with  ||| S:15724 E:15739 ||| IN
substrate  ||| S:15739 E:15749 ||| JJ
binding  ||| S:15749 E:15757 ||| NN
and  ||| S:15757 E:15761 ||| CC
activation  ||| S:15761 E:15772 ||| NN
by  ||| S:15772 E:15775 ||| IN
interacting  ||| S:15775 E:15797 ||| JJ
electrostatically  ||| S:15797 E:15815 ||| NN
with  ||| S:15815 E:15820 ||| IN
the  ||| S:15820 E:15824 ||| DT
substrate  ||| S:15824 E:15834 ||| JJ
β-lactam  ||| S:15834 E:15843 ||| JJ
carbonyl ||| S:15843 E:15851 ||| NN
.  ||| S:15851 E:15863 ||| .
However ||| S:15863 E:15870 ||| RB
,  ||| S:15870 E:15872 ||| ,
in  ||| S:15872 E:15875 ||| IN
L1 ||| S:15875 E:15877 ||| NNP
,  ||| S:15877 E:15879 ||| ,
Asn233  ||| S:15879 E:15886 ||| NNP
is  ||| S:15886 E:15889 ||| VBZ
14  ||| S:15889 E:15892 ||| CD
Å  ||| S:15892 E:15894 ||| NNS
away  ||| S:15894 E:15899 ||| RB
from  ||| S:15899 E:15904 ||| IN
the  ||| S:15904 E:15908 ||| DT
modeled  ||| S:15908 E:15926 ||| JJ
position  ||| S:15926 E:15935 ||| NN
of  ||| S:15935 E:15938 ||| IN
the  ||| S:15938 E:15942 ||| DT
substrate  ||| S:15942 E:15952 ||| JJ
β-lactam  ||| S:15952 E:15961 ||| JJ
carbonyl  ||| S:15961 E:15970 ||| NNS
[  ||| S:15970 E:15972 ||| -LRB-
37  ||| S:15972 E:15975 ||| CD
]  ||| S:15975 E:15977 ||| -RRB-
.  ||| S:15977 E:15979 ||| .
To  ||| S:15979 E:15992 ||| TO
test  ||| S:15992 E:15997 ||| VB
the  ||| S:15997 E:16001 ||| DT
role  ||| S:16001 E:16006 ||| NN
of  ||| S:16006 E:16009 ||| IN
Asn233  ||| S:16009 E:16016 ||| CD
in  ||| S:16016 E:16019 ||| IN
substrate  ||| S:16019 E:16029 ||| JJ
binding ||| S:16029 E:16036 ||| NN
,  ||| S:16036 E:16038 ||| ,
the  ||| S:16038 E:16042 ||| DT
Asn  ||| S:16042 E:16046 ||| NNP
was  ||| S:16046 E:16060 ||| VBD
changed  ||| S:16060 E:16068 ||| VBN
to  ||| S:16068 E:16071 ||| TO
a  ||| S:16071 E:16073 ||| DT
leucine  ||| S:16073 E:16081 ||| NN
( ||| S:16081 E:16082 ||| -LRB-
N233L ||| S:16082 E:16087 ||| NNP
)  ||| S:16087 E:16089 ||| -RRB-
and  ||| S:16089 E:16093 ||| CC
to  ||| S:16093 E:16096 ||| TO
an  ||| S:16096 E:16099 ||| DT
aspartic  ||| S:16099 E:16108 ||| JJ
acid  ||| S:16108 E:16123 ||| NN
( ||| S:16123 E:16124 ||| -LRB-
N233D ||| S:16124 E:16129 ||| NNP
) ||| S:16129 E:16130 ||| -RRB-
,  ||| S:16130 E:16132 ||| ,
and  ||| S:16132 E:16136 ||| CC
these  ||| S:16136 E:16142 ||| DT
mutants  ||| S:16142 E:16150 ||| NN
were  ||| S:16150 E:16155 ||| VBD
characterized  ||| S:16155 E:16169 ||| VBN
by  ||| S:16169 E:16172 ||| IN
using  ||| S:16172 E:16188 ||| VBG
metal  ||| S:16188 E:16194 ||| NN
analyses ||| S:16194 E:16202 ||| NNS
,  ||| S:16202 E:16204 ||| ,
CD  ||| S:16204 E:16207 ||| NNP
spectroscopy ||| S:16207 E:16219 ||| NN
,  ||| S:16219 E:16221 ||| ,
steady-state  ||| S:16221 E:16234 ||| JJ
kinetics ||| S:16234 E:16242 ||| NN
,  ||| S:16242 E:16254 ||| ,
and  ||| S:16254 E:16258 ||| CC
pre-steady  ||| S:16258 E:16269 ||| JJ
state  ||| S:16269 E:16275 ||| NN
kinetic  ||| S:16275 E:16283 ||| NN
studies ||| S:16283 E:16290 ||| NNS
.  ||| S:16290 E:16302 ||| .
Small-scale  ||| S:16302 E:16314 ||| JJ
growth  ||| S:16314 E:16321 ||| NN
cultures  ||| S:16321 E:16330 ||| NNS
showed  ||| S:16330 E:16337 ||| VBD
that  ||| S:16337 E:16342 ||| IN
both  ||| S:16342 E:16347 ||| DT
mutants  ||| S:16347 E:16365 ||| NN
were  ||| S:16365 E:16370 ||| VBD
over-expressed  ||| S:16370 E:16385 ||| JJ
at  ||| S:16385 E:16388 ||| IN
levels  ||| S:16388 E:16395 ||| NNS
comparable  ||| S:16395 E:16406 ||| JJ
to  ||| S:16406 E:16409 ||| TO
that  ||| S:16409 E:16414 ||| DT
of  ||| S:16414 E:16427 ||| IN
wild-type  ||| S:16427 E:16437 ||| JJ
L1 ||| S:16437 E:16439 ||| NN
.  ||| S:16439 E:16441 ||| .
Large-scale  ||| S:16441 E:16453 ||| JJ
over-expression  ||| S:16453 E:16469 ||| JJ
and  ||| S:16469 E:16483 ||| CC
purification  ||| S:16483 E:16496 ||| NN
of  ||| S:16496 E:16499 ||| IN
the  ||| S:16499 E:16503 ||| DT
mutants  ||| S:16503 E:16511 ||| NN
showed  ||| S:16511 E:16518 ||| VBD
that  ||| S:16518 E:16523 ||| IN
both  ||| S:16523 E:16528 ||| DT
mutants  ||| S:16528 E:16536 ||| NN
were  ||| S:16536 E:16551 ||| VBD
isolatable  ||| S:16551 E:16562 ||| VBN
at  ||| S:16562 E:16565 ||| IN
levels  ||| S:16565 E:16572 ||| NNS
comparable  ||| S:16572 E:16583 ||| JJ
to  ||| S:16583 E:16586 ||| TO
that  ||| S:16586 E:16591 ||| DT
of  ||| S:16591 E:16594 ||| IN
wild-type  ||| S:16594 E:16604 ||| JJ
L1 ||| S:16604 E:16606 ||| NN
.  ||| S:16606 E:16618 ||| .
Metal  ||| S:16618 E:16624 ||| NN
analyses  ||| S:16624 E:16633 ||| NNS
of  ||| S:16633 E:16636 ||| IN
the  ||| S:16636 E:16640 ||| DT
N233L  ||| S:16640 E:16646 ||| NNP
and  ||| S:16646 E:16650 ||| CC
N233D  ||| S:16650 E:16656 ||| CD
mutants  ||| S:16656 E:16664 ||| NNS
showed  ||| S:16664 E:16671 ||| VBD
that  ||| S:16671 E:16686 ||| IN
both  ||| S:16686 E:16691 ||| DT
bind  ||| S:16691 E:16696 ||| NN
nearly  ||| S:16696 E:16703 ||| RB
two  ||| S:16703 E:16707 ||| CD
Zn ||| S:16707 E:16709 ||| NNP
( ||| S:16709 E:16710 ||| -LRB-
II ||| S:16710 E:16712 ||| NNP
)  ||| S:16712 E:16714 ||| -RRB-
ions  ||| S:16714 E:16719 ||| NNS
( ||| S:16719 E:16720 ||| -LRB-
Table  ||| S:16720 E:16726 ||| NNP
2 ||| S:16726 E:16727 ||| CD
) ||| S:16727 E:16728 ||| -RRB-
,  ||| S:16728 E:16730 ||| ,
like  ||| S:16730 E:16745 ||| IN
wild-type  ||| S:16745 E:16755 ||| NNP
L1  ||| S:16755 E:16758 ||| NNP
[  ||| S:16758 E:16760 ||| -LRB-
36  ||| S:16760 E:16763 ||| CD
]  ||| S:16763 E:16765 ||| -RRB-
.  ||| S:16765 E:16767 ||| .
CD  ||| S:16767 E:16770 ||| NNP
spectra  ||| S:16770 E:16778 ||| NN
of  ||| S:16778 E:16781 ||| IN
the  ||| S:16781 E:16785 ||| DT
mutants  ||| S:16785 E:16793 ||| NN
were  ||| S:16793 E:16808 ||| VBD
similar  ||| S:16808 E:16816 ||| JJ
to  ||| S:16816 E:16819 ||| TO
those  ||| S:16819 E:16825 ||| DT
of  ||| S:16825 E:16828 ||| IN
wild-type  ||| S:16828 E:16838 ||| JJ
L1 ||| S:16838 E:16840 ||| NN
.  ||| S:16840 E:16842 ||| .
Steady-state  ||| S:16842 E:16855 ||| JJ
kinetic  ||| S:16855 E:16873 ||| JJ
studies  ||| S:16873 E:16881 ||| NNS
were  ||| S:16881 E:16886 ||| VBD
conducted  ||| S:16886 E:16896 ||| VBN
with  ||| S:16896 E:16901 ||| IN
both  ||| S:16901 E:16906 ||| DT
mutants  ||| S:16906 E:16914 ||| NN
in  ||| S:16914 E:16917 ||| IN
buffer  ||| S:16917 E:16934 ||| NN
containing  ||| S:16934 E:16945 ||| VBG
100  ||| S:16945 E:16949 ||| CD
μM  ||| S:16949 E:16952 ||| JJ
ZnCl  ||| S:16952 E:16968 ||| JJ
2  ||| S:16968 E:16970 ||| CD
to  ||| S:16970 E:16973 ||| TO
ensure  ||| S:16973 E:16980 ||| VB
that  ||| S:16980 E:16985 ||| IN
both  ||| S:16985 E:16990 ||| DT
Zn ||| S:16990 E:16992 ||| NNP
( ||| S:16992 E:16993 ||| -LRB-
II ||| S:16993 E:16995 ||| NNP
)  ||| S:16995 E:16997 ||| -RRB-
binding  ||| S:16997 E:17015 ||| JJ
sites  ||| S:17015 E:17021 ||| NNS
were  ||| S:17021 E:17026 ||| VBD
saturated  ||| S:17026 E:17036 ||| VBN
in  ||| S:17036 E:17039 ||| IN
these  ||| S:17039 E:17045 ||| DT
studies ||| S:17045 E:17052 ||| NNS
.  ||| S:17052 E:17054 ||| .
Addition  ||| S:17054 E:17063 ||| NN
of  ||| S:17063 E:17066 ||| IN
higher  ||| S:17066 E:17083 ||| JJR
concentrations  ||| S:17083 E:17098 ||| NNS
of  ||| S:17098 E:17101 ||| IN
Zn ||| S:17101 E:17103 ||| NNP
( ||| S:17103 E:17104 ||| -LRB-
II ||| S:17104 E:17106 ||| NNP
)  ||| S:17106 E:17108 ||| -RRB-
did  ||| S:17108 E:17112 ||| VBD
not  ||| S:17112 E:17116 ||| RB
result  ||| S:17116 E:17123 ||| VB
in  ||| S:17123 E:17126 ||| IN
different  ||| S:17126 E:17146 ||| JJ
values  ||| S:17146 E:17153 ||| NNS
for  ||| S:17153 E:17157 ||| IN
the  ||| S:17157 E:17161 ||| DT
steady-state  ||| S:17161 E:17174 ||| JJ
kinetic  ||| S:17174 E:17182 ||| JJ
constants  ||| S:17182 E:17192 ||| NN
in  ||| S:17192 E:17195 ||| IN
Tables  ||| S:17195 E:17212 ||| NNP
3 ||| S:17212 E:17213 ||| CD
,  ||| S:17213 E:17215 ||| ,
4 ||| S:17215 E:17216 ||| CD
,  ||| S:17216 E:17218 ||| ,
5 ||| S:17218 E:17219 ||| CD
.  ||| S:17219 E:17231 ||| .
With  ||| S:17231 E:17236 ||| IN
all  ||| S:17236 E:17240 ||| DT
substrates  ||| S:17240 E:17251 ||| JJ
tested ||| S:17251 E:17257 ||| NN
,  ||| S:17257 E:17259 ||| ,
the  ||| S:17259 E:17263 ||| DT
N233L  ||| S:17263 E:17269 ||| NNP
and  ||| S:17269 E:17273 ||| CC
N233D  ||| S:17273 E:17289 ||| FW
mutants  ||| S:17289 E:17297 ||| FW
exhibited  ||| S:17297 E:17307 ||| FW
K  ||| S:17307 E:17320 ||| NNP
m  ||| S:17320 E:17322 ||| NN
values  ||| S:17322 E:17329 ||| NNS
that  ||| S:17329 E:17334 ||| WDT
differed  ||| S:17334 E:17343 ||| VBZ
less  ||| S:17343 E:17348 ||| JJR
than  ||| S:17348 E:17353 ||| IN
a  ||| S:17353 E:17365 ||| DT
factor  ||| S:17365 E:17372 ||| NN
of  ||| S:17372 E:17375 ||| IN
4  ||| S:17375 E:17377 ||| CD
than  ||| S:17377 E:17382 ||| IN
that  ||| S:17382 E:17387 ||| WDT
observed  ||| S:17387 E:17396 ||| VBD
for  ||| S:17396 E:17400 ||| IN
wild-type  ||| S:17400 E:17410 ||| NNP
L1  ||| S:17410 E:17413 ||| NNP
( ||| S:17413 E:17414 ||| -LRB-
Tables  ||| S:17414 E:17431 ||| NNP
3 ||| S:17431 E:17432 ||| CD
,  ||| S:17432 E:17434 ||| ,
4 ||| S:17434 E:17435 ||| CD
,  ||| S:17435 E:17437 ||| ,
5 ||| S:17437 E:17438 ||| CD
) ||| S:17438 E:17439 ||| -RRB-
.  ||| S:17439 E:17441 ||| .
The  ||| S:17441 E:17456 ||| DT
k  ||| S:17456 E:17469 ||| JJ
cat  ||| S:17469 E:17473 ||| NN
values  ||| S:17473 E:17480 ||| VBZ
exhibited  ||| S:17480 E:17490 ||| VBN
by  ||| S:17490 E:17493 ||| IN
these  ||| S:17493 E:17499 ||| DT
mutants  ||| S:17499 E:17517 ||| NN
for  ||| S:17517 E:17521 ||| IN
all  ||| S:17521 E:17525 ||| DT
substrates  ||| S:17525 E:17536 ||| NN
also  ||| S:17536 E:17541 ||| RB
differed  ||| S:17541 E:17550 ||| VBN
by  ||| S:17550 E:17553 ||| IN
less  ||| S:17553 E:17558 ||| JJR
than  ||| S:17558 E:17563 ||| IN
a  ||| S:17563 E:17565 ||| DT
factor  ||| S:17565 E:17572 ||| NN
of  ||| S:17572 E:17585 ||| IN
4 ||| S:17585 E:17586 ||| CD
,  ||| S:17586 E:17588 ||| ,
except  ||| S:17588 E:17595 ||| IN
when  ||| S:17595 E:17600 ||| WRB
biapenem  ||| S:17600 E:17609 ||| NNS
and  ||| S:17609 E:17613 ||| CC
meropenem  ||| S:17613 E:17623 ||| NNS
were  ||| S:17623 E:17628 ||| VBD
used  ||| S:17628 E:17633 ||| VBN
as  ||| S:17633 E:17646 ||| IN
substrates  ||| S:17646 E:17657 ||| NN
for  ||| S:17657 E:17661 ||| IN
the  ||| S:17661 E:17665 ||| DT
N233D  ||| S:17665 E:17671 ||| JJ
mutant ||| S:17671 E:17677 ||| NN
.  ||| S:17677 E:17679 ||| .
With  ||| S:17679 E:17684 ||| IN
these  ||| S:17684 E:17690 ||| DT
two  ||| S:17690 E:17704 ||| CD
substrates ||| S:17704 E:17714 ||| NN
,  ||| S:17714 E:17716 ||| ,
there  ||| S:17716 E:17722 ||| EX
was  ||| S:17722 E:17726 ||| VBD
a  ||| S:17726 E:17728 ||| DT
19-fold  ||| S:17728 E:17736 ||| NNP
and  ||| S:17736 E:17740 ||| CC
45-fold  ||| S:17740 E:17748 ||| CD
decrease  ||| S:17748 E:17757 ||| NN
in  ||| S:17757 E:17770 ||| IN
the  ||| S:17770 E:17785 ||| DT
k  ||| S:17785 E:17798 ||| JJ
cat  ||| S:17798 E:17802 ||| NN
values  ||| S:17802 E:17809 ||| NNS
when  ||| S:17809 E:17814 ||| WRB
using  ||| S:17814 E:17820 ||| VBG
biapenem  ||| S:17820 E:17829 ||| NNS
and  ||| S:17829 E:17843 ||| CC
meropenem ||| S:17843 E:17852 ||| NN
,  ||| S:17852 E:17854 ||| ,
respectively  ||| S:17854 E:17867 ||| RB
( ||| S:17867 E:17868 ||| -LRB-
Table  ||| S:17868 E:17874 ||| NNP
5 ||| S:17874 E:17875 ||| CD
) ||| S:17875 E:17876 ||| -RRB-
.  ||| S:17876 E:17878 ||| .
The  ||| S:17878 E:17882 ||| DT
steady-state  ||| S:17882 E:17905 ||| JJ
kinetic  ||| S:17905 E:17913 ||| JJ
data  ||| S:17913 E:17918 ||| NNS
generally  ||| S:17918 E:17928 ||| RB
support  ||| S:17928 E:17936 ||| VB
the  ||| S:17936 E:17940 ||| DT
prediction  ||| S:17940 E:17951 ||| NN
that  ||| S:17951 E:17956 ||| IN
Asn233  ||| S:17956 E:17973 ||| NNP
does  ||| S:17973 E:17978 ||| VBZ
not  ||| S:17978 E:17982 ||| RB
play  ||| S:17982 E:17987 ||| VB
a  ||| S:17987 E:17989 ||| DT
large  ||| S:17989 E:17995 ||| JJ
role  ||| S:17995 E:18000 ||| NN
in  ||| S:18000 E:18003 ||| IN
binding  ||| S:18003 E:18011 ||| JJ
or  ||| S:18011 E:18014 ||| CC
catalysis ||| S:18014 E:18023 ||| NN
.  ||| S:18023 E:18035 ||| .
However ||| S:18035 E:18042 ||| RB
,  ||| S:18042 E:18044 ||| ,
rapid-scanning  ||| S:18044 E:18059 ||| NNP
Vis  ||| S:18059 E:18063 ||| NNP
studies  ||| S:18063 E:18071 ||| NNS
of  ||| S:18071 E:18074 ||| IN
N233L  ||| S:18074 E:18080 ||| NNP
and  ||| S:18080 E:18084 ||| CC
N233D  ||| S:18084 E:18100 ||| CD
with  ||| S:18100 E:18105 ||| IN
nitrocefin  ||| S:18105 E:18116 ||| JJ
demonstrate  ||| S:18116 E:18128 ||| NN
that  ||| S:18128 E:18133 ||| IN
no  ||| S:18133 E:18136 ||| DT
detectable  ||| S:18136 E:18147 ||| JJ
amounts  ||| S:18147 E:18155 ||| NNS
of  ||| S:18155 E:18168 ||| IN
intermediate  ||| S:18168 E:18181 ||| NNS
are  ||| S:18181 E:18185 ||| VBP
formed  ||| S:18185 E:18192 ||| VBN
during  ||| S:18192 E:18199 ||| IN
the  ||| S:18199 E:18203 ||| DT
reaction ||| S:18203 E:18211 ||| NN
,  ||| S:18211 E:18213 ||| ,
even  ||| S:18213 E:18218 ||| RB
when  ||| S:18218 E:18233 ||| WRB
using  ||| S:18233 E:18239 ||| VBG
a  ||| S:18239 E:18241 ||| DT
wide  ||| S:18241 E:18246 ||| JJ
number  ||| S:18246 E:18253 ||| NN
of  ||| S:18253 E:18256 ||| IN
reaction  ||| S:18256 E:18265 ||| NN
conditions  ||| S:18265 E:18276 ||| NNS
( ||| S:18276 E:18277 ||| -LRB-
Figure  ||| S:18277 E:18284 ||| NNP
2 ||| S:18284 E:18285 ||| CD
) ||| S:18285 E:18286 ||| -RRB-
.  ||| S:18286 E:18298 ||| .
Stopped-flow  ||| S:18298 E:18311 ||| JJ
fluorescence  ||| S:18311 E:18324 ||| JJ
studies  ||| S:18324 E:18332 ||| NNS
at  ||| S:18332 E:18335 ||| IN
10°C  ||| S:18335 E:18340 ||| CD
with  ||| S:18340 E:18345 ||| IN
the  ||| S:18345 E:18349 ||| DT
N233L  ||| S:18349 E:18365 ||| NNP
and  ||| S:18365 E:18369 ||| CC
N233D  ||| S:18369 E:18375 ||| CD
mutants  ||| S:18375 E:18383 ||| NNS
and  ||| S:18383 E:18387 ||| CC
nitrocefin  ||| S:18387 E:18398 ||| NN
as  ||| S:18398 E:18401 ||| IN
substrate  ||| S:18401 E:18411 ||| NN
resulted  ||| S:18411 E:18420 ||| VBD
in  ||| S:18420 E:18433 ||| IN
K  ||| S:18433 E:18446 ||| NNP
S  ||| S:18446 E:18448 ||| NNP
values  ||| S:18448 E:18455 ||| NNS
of  ||| S:18455 E:18458 ||| IN
26  ||| S:18458 E:18461 ||| CD
±  ||| S:18461 E:18463 ||| CD
9  ||| S:18463 E:18465 ||| CD
and  ||| S:18465 E:18469 ||| CC
25  ||| S:18469 E:18472 ||| CD
±  ||| S:18472 E:18474 ||| CD
8  ||| S:18474 E:18476 ||| CD
μM ||| S:18476 E:18478 ||| NN
,  ||| S:18478 E:18490 ||| ,
respectively ||| S:18490 E:18502 ||| RB
.  ||| S:18502 E:18532 ||| .
Tyr228  ||| S:18532 E:18539 ||| NNP
mutants  ||| S:18539 E:18557 ||| VBD
The  ||| S:18557 E:18561 ||| DT
substrate-binding  ||| S:18561 E:18579 ||| JJ
model  ||| S:18579 E:18585 ||| NN
showed  ||| S:18585 E:18592 ||| VBD
that  ||| S:18592 E:18597 ||| IN
Tyr228  ||| S:18597 E:18604 ||| CD
in  ||| S:18604 E:18607 ||| IN
L1  ||| S:18607 E:18620 ||| NNP
was  ||| S:18620 E:18624 ||| VBD
position-conserved  ||| S:18624 E:18643 ||| JJ
with  ||| S:18643 E:18648 ||| IN
Asn233  ||| S:18648 E:18655 ||| CD
in  ||| S:18655 E:18658 ||| IN
the  ||| S:18658 E:18662 ||| DT
other  ||| S:18662 E:18678 ||| JJ
crystallographically  ||| S:18678 E:18699 ||| NN
characterized  ||| S:18699 E:18713 ||| VBD
metallo-β-lactamases  ||| S:18713 E:18734 ||| JJ
[  ||| S:18734 E:18746 ||| -LRB-
37  ||| S:18746 E:18749 ||| CD
42  ||| S:18749 E:18752 ||| CD
44  ||| S:18752 E:18755 ||| CD
45  ||| S:18755 E:18758 ||| CD
46  ||| S:18758 E:18761 ||| CD
]  ||| S:18761 E:18763 ||| -RRB-
.  ||| S:18763 E:18765 ||| .
Spencer  ||| S:18765 E:18773 ||| NNP
and  ||| S:18773 E:18777 ||| CC
coworkers  ||| S:18777 E:18787 ||| JJ
postulated  ||| S:18787 E:18798 ||| NN
that  ||| S:18798 E:18813 ||| IN
Tyr228  ||| S:18813 E:18820 ||| NNP
is  ||| S:18820 E:18823 ||| VBZ
part  ||| S:18823 E:18828 ||| NN
of  ||| S:18828 E:18831 ||| IN
an  ||| S:18831 E:18834 ||| DT
oxyanion  ||| S:18834 E:18843 ||| JJ
hole  ||| S:18843 E:18848 ||| NN
that  ||| S:18848 E:18853 ||| IN
interacts  ||| S:18853 E:18863 ||| NN
with  ||| S:18863 E:18878 ||| IN
the  ||| S:18878 E:18882 ||| DT
β-lactam  ||| S:18882 E:18891 ||| JJ
carbonyl  ||| S:18891 E:18900 ||| NN
on  ||| S:18900 E:18903 ||| IN
substrate  ||| S:18903 E:18913 ||| NN
and  ||| S:18913 E:18917 ||| CC
helps  ||| S:18917 E:18923 ||| VBZ
to  ||| S:18923 E:18926 ||| TO
stabilize  ||| S:18926 E:18946 ||| VB
the  ||| S:18946 E:18950 ||| DT
putative  ||| S:18950 E:18959 ||| JJ
tetrahedral  ||| S:18959 E:18971 ||| NNS
intermediate  ||| S:18971 E:18984 ||| VBP
formed  ||| S:18984 E:18991 ||| VBN
during  ||| S:18991 E:19008 ||| IN
substrate  ||| S:19008 E:19018 ||| JJ
turnover  ||| S:19018 E:19027 ||| NN
[  ||| S:19027 E:19029 ||| -LRB-
37  ||| S:19029 E:19032 ||| CD
]  ||| S:19032 E:19034 ||| -RRB-
.  ||| S:19034 E:19036 ||| .
To  ||| S:19036 E:19039 ||| TO
test  ||| S:19039 E:19044 ||| VB
this  ||| S:19044 E:19049 ||| DT
hypothesis ||| S:19049 E:19059 ||| NN
,  ||| S:19059 E:19071 ||| ,
Tyr228  ||| S:19071 E:19078 ||| NNP
was  ||| S:19078 E:19082 ||| VBD
changed  ||| S:19082 E:19090 ||| VBN
to  ||| S:19090 E:19093 ||| TO
an  ||| S:19093 E:19096 ||| DT
alanine  ||| S:19096 E:19104 ||| NN
and  ||| S:19104 E:19108 ||| CC
to  ||| S:19108 E:19111 ||| TO
a  ||| S:19111 E:19113 ||| DT
phenylalanine  ||| S:19113 E:19137 ||| NN
to  ||| S:19137 E:19140 ||| TO
afford  ||| S:19140 E:19147 ||| VB
the  ||| S:19147 E:19151 ||| DT
Y228A  ||| S:19151 E:19157 ||| NNP
and  ||| S:19157 E:19161 ||| CC
Y228F  ||| S:19161 E:19167 ||| CD
mutants ||| S:19167 E:19174 ||| NN
,  ||| S:19174 E:19176 ||| ,
respectively ||| S:19176 E:19188 ||| RB
.  ||| S:19188 E:19200 ||| .
Small-scale  ||| S:19200 E:19212 ||| JJ
growth  ||| S:19212 E:19219 ||| NN
cultures  ||| S:19219 E:19228 ||| NNS
showed  ||| S:19228 E:19235 ||| VBD
that  ||| S:19235 E:19240 ||| IN
both  ||| S:19240 E:19245 ||| DT
mutants  ||| S:19245 E:19263 ||| NN
were  ||| S:19263 E:19268 ||| VBD
over-expressed  ||| S:19268 E:19283 ||| JJ
at  ||| S:19283 E:19286 ||| IN
levels  ||| S:19286 E:19293 ||| NNS
comparable  ||| S:19293 E:19304 ||| JJ
to  ||| S:19304 E:19307 ||| TO
those  ||| S:19307 E:19313 ||| DT
of  ||| S:19313 E:19326 ||| IN
wild-type  ||| S:19326 E:19336 ||| JJ
L1 ||| S:19336 E:19338 ||| NN
.  ||| S:19338 E:19340 ||| .
Large-scale  ||| S:19340 E:19352 ||| JJ
over-expression  ||| S:19352 E:19368 ||| JJ
and  ||| S:19368 E:19382 ||| CC
purification  ||| S:19382 E:19395 ||| NN
of  ||| S:19395 E:19398 ||| IN
the  ||| S:19398 E:19402 ||| DT
Y228A  ||| S:19402 E:19408 ||| NNP
and  ||| S:19408 E:19412 ||| CC
Y228F  ||| S:19412 E:19418 ||| CD
mutants  ||| S:19418 E:19426 ||| NNS
showed  ||| S:19426 E:19433 ||| VBD
that  ||| S:19433 E:19448 ||| IN
both  ||| S:19448 E:19453 ||| DT
mutants  ||| S:19453 E:19461 ||| NN
were  ||| S:19461 E:19466 ||| VBD
isolatable  ||| S:19466 E:19477 ||| VBN
at  ||| S:19477 E:19480 ||| IN
levels  ||| S:19480 E:19487 ||| NNS
comparable  ||| S:19487 E:19498 ||| JJ
to  ||| S:19498 E:19511 ||| TO
those  ||| S:19511 E:19517 ||| DT
of  ||| S:19517 E:19520 ||| IN
wild-type  ||| S:19520 E:19530 ||| JJ
L1 ||| S:19530 E:19532 ||| NN
.  ||| S:19532 E:19534 ||| .
Metal  ||| S:19534 E:19540 ||| NN
analyses  ||| S:19540 E:19549 ||| NNS
of  ||| S:19549 E:19552 ||| IN
the  ||| S:19552 E:19556 ||| DT
mutants  ||| S:19556 E:19574 ||| NN
showed  ||| S:19574 E:19581 ||| VBD
that  ||| S:19581 E:19586 ||| IN
both  ||| S:19586 E:19591 ||| DT
bind  ||| S:19591 E:19596 ||| NN
nearly  ||| S:19596 E:19603 ||| RB
two  ||| S:19603 E:19607 ||| CD
Zn ||| S:19607 E:19609 ||| NNP
( ||| S:19609 E:19610 ||| -LRB-
II ||| S:19610 E:19612 ||| NNP
)  ||| S:19612 E:19614 ||| -RRB-
ions  ||| S:19614 E:19619 ||| NNS
( ||| S:19619 E:19620 ||| -LRB-
Table  ||| S:19620 E:19626 ||| NNP
2 ||| S:19626 E:19627 ||| CD
) ||| S:19627 E:19628 ||| -RRB-
,  ||| S:19628 E:19640 ||| ,
like  ||| S:19640 E:19645 ||| IN
wild-type  ||| S:19645 E:19655 ||| NNP
L1  ||| S:19655 E:19658 ||| NNP
[  ||| S:19658 E:19660 ||| -LRB-
36  ||| S:19660 E:19663 ||| CD
]  ||| S:19663 E:19665 ||| -RRB-
,  ||| S:19665 E:19667 ||| ,
and  ||| S:19667 E:19671 ||| CC
CD  ||| S:19671 E:19674 ||| NNP
spectra  ||| S:19674 E:19682 ||| NN
of  ||| S:19682 E:19685 ||| IN
the  ||| S:19685 E:19689 ||| DT
mutants  ||| S:19689 E:19707 ||| NN
were  ||| S:19707 E:19712 ||| VBD
similar  ||| S:19712 E:19720 ||| JJ
to  ||| S:19720 E:19723 ||| TO
those  ||| S:19723 E:19729 ||| DT
of  ||| S:19729 E:19732 ||| IN
wild-type  ||| S:19732 E:19742 ||| JJ
L1 ||| S:19742 E:19744 ||| NN
.  ||| S:19744 E:19746 ||| .
Steady-state  ||| S:19746 E:19769 ||| JJ
kinetic  ||| S:19769 E:19777 ||| JJ
studies  ||| S:19777 E:19785 ||| NNS
were  ||| S:19785 E:19790 ||| VBD
conducted  ||| S:19790 E:19800 ||| VBN
with  ||| S:19800 E:19805 ||| IN
both  ||| S:19805 E:19810 ||| DT
mutants  ||| S:19810 E:19818 ||| NN
in  ||| S:19818 E:19831 ||| IN
buffer  ||| S:19831 E:19838 ||| NN
containing  ||| S:19838 E:19849 ||| VBG
100  ||| S:19849 E:19853 ||| CD
μM  ||| S:19853 E:19856 ||| JJ
ZnCl  ||| S:19856 E:19872 ||| JJ
2  ||| S:19872 E:19874 ||| CD
to  ||| S:19874 E:19877 ||| TO
ensure  ||| S:19877 E:19884 ||| VB
that  ||| S:19884 E:19889 ||| IN
both  ||| S:19889 E:19894 ||| DT
Zn ||| S:19894 E:19896 ||| NNP
( ||| S:19896 E:19897 ||| -LRB-
II ||| S:19897 E:19899 ||| NNP
)  ||| S:19899 E:19901 ||| -RRB-
binding  ||| S:19901 E:19919 ||| JJ
sites  ||| S:19919 E:19925 ||| NNS
were  ||| S:19925 E:19930 ||| VBD
saturated  ||| S:19930 E:19940 ||| VBN
in  ||| S:19940 E:19943 ||| IN
these  ||| S:19943 E:19949 ||| DT
studies ||| S:19949 E:19956 ||| NNS
.  ||| S:19956 E:19958 ||| .
Addition  ||| S:19958 E:19967 ||| NN
of  ||| S:19967 E:19970 ||| IN
higher  ||| S:19970 E:19987 ||| JJR
concentrations  ||| S:19987 E:20002 ||| NNS
of  ||| S:20002 E:20005 ||| IN
Zn ||| S:20005 E:20007 ||| NNP
( ||| S:20007 E:20008 ||| -LRB-
II ||| S:20008 E:20010 ||| NNP
)  ||| S:20010 E:20012 ||| -RRB-
did  ||| S:20012 E:20016 ||| VBD
not  ||| S:20016 E:20020 ||| RB
result  ||| S:20020 E:20027 ||| VB
in  ||| S:20027 E:20030 ||| IN
different  ||| S:20030 E:20050 ||| JJ
values  ||| S:20050 E:20057 ||| NNS
for  ||| S:20057 E:20061 ||| IN
the  ||| S:20061 E:20065 ||| DT
steady-state  ||| S:20065 E:20078 ||| JJ
kinetic  ||| S:20078 E:20086 ||| JJ
constants  ||| S:20086 E:20096 ||| NN
in  ||| S:20096 E:20099 ||| IN
Tables  ||| S:20099 E:20116 ||| NNP
3 ||| S:20116 E:20117 ||| CD
,  ||| S:20117 E:20119 ||| ,
4 ||| S:20119 E:20120 ||| CD
,  ||| S:20120 E:20122 ||| ,
5 ||| S:20122 E:20123 ||| CD
.  ||| S:20123 E:20135 ||| .
When  ||| S:20135 E:20140 ||| WRB
cephalosporins  ||| S:20140 E:20155 ||| NNS
were  ||| S:20155 E:20160 ||| VBD
used  ||| S:20160 E:20165 ||| VBN
as  ||| S:20165 E:20168 ||| IN
substrates ||| S:20168 E:20178 ||| NN
,  ||| S:20178 E:20180 ||| ,
the  ||| S:20180 E:20184 ||| DT
Y228A  ||| S:20184 E:20200 ||| NNP
and  ||| S:20200 E:20204 ||| CC
Y228F  ||| S:20204 E:20210 ||| FW
mutants  ||| S:20210 E:20218 ||| FW
exhibited  ||| S:20218 E:20228 ||| FW
K  ||| S:20228 E:20241 ||| NNP
m  ||| S:20241 E:20243 ||| NN
values  ||| S:20243 E:20250 ||| NNS
that  ||| S:20250 E:20255 ||| WDT
were  ||| S:20255 E:20260 ||| VBD
6-  ||| S:20260 E:20263 ||| CD
to  ||| S:20263 E:20266 ||| TO
45-fold  ||| S:20266 E:20284 ||| CD
higher  ||| S:20284 E:20291 ||| JJR
than  ||| S:20291 E:20296 ||| IN
those  ||| S:20296 E:20302 ||| DT
observed  ||| S:20302 E:20311 ||| NN
for  ||| S:20311 E:20315 ||| IN
wild-type  ||| S:20315 E:20325 ||| NNP
L1  ||| S:20325 E:20328 ||| NNP
( ||| S:20328 E:20329 ||| -LRB-
Table  ||| S:20329 E:20335 ||| NNP
3 ||| S:20335 E:20336 ||| CD
) ||| S:20336 E:20337 ||| -RRB-
.  ||| S:20337 E:20349 ||| .
The  ||| S:20349 E:20353 ||| DT
largest  ||| S:20353 E:20361 ||| JJS
change  ||| S:20361 E:20368 ||| NN
in  ||| S:20368 E:20371 ||| IN
K  ||| S:20371 E:20384 ||| NNP
m  ||| S:20384 E:20386 ||| NN
was  ||| S:20386 E:20390 ||| VBD
observed  ||| S:20390 E:20399 ||| VBN
when  ||| S:20399 E:20404 ||| WRB
cefaclor  ||| S:20404 E:20413 ||| NNS
was  ||| S:20413 E:20417 ||| VBD
used  ||| S:20417 E:20432 ||| VBN
as  ||| S:20432 E:20435 ||| IN
substrate ||| S:20435 E:20444 ||| NN
,  ||| S:20444 E:20446 ||| ,
and  ||| S:20446 E:20450 ||| CC
the  ||| S:20450 E:20454 ||| DT
smallest  ||| S:20454 E:20463 ||| JJS
change  ||| S:20463 E:20470 ||| NN
was  ||| S:20470 E:20474 ||| VBD
observed  ||| S:20474 E:20483 ||| VBN
when  ||| S:20483 E:20498 ||| WRB
nitrocefin  ||| S:20498 E:20509 ||| NNS
was  ||| S:20509 E:20513 ||| VBD
used  ||| S:20513 E:20518 ||| VBN
as  ||| S:20518 E:20521 ||| IN
substrate ||| S:20521 E:20530 ||| NN
.  ||| S:20530 E:20532 ||| .
The  ||| S:20532 E:20536 ||| DT
Tyr228  ||| S:20536 E:20543 ||| FW
mutants  ||| S:20543 E:20561 ||| FW
exhibited  ||| S:20561 E:20571 ||| FW
< ||| S:20571 E:20573 ||| SYM
4-fold  ||| S:20573 E:20580 ||| FW
change  ||| S:20580 E:20587 ||| NN
in  ||| S:20587 E:20601 ||| IN
k  ||| S:20601 E:20614 ||| JJ
cat  ||| S:20614 E:20618 ||| NN
values  ||| S:20618 E:20625 ||| NNS
for  ||| S:20625 E:20629 ||| IN
the  ||| S:20629 E:20633 ||| DT
cephalosporins  ||| S:20633 E:20658 ||| JJ
tested  ||| S:20658 E:20665 ||| NNS
( ||| S:20665 E:20666 ||| -LRB-
Table  ||| S:20666 E:20672 ||| NNP
3 ||| S:20672 E:20673 ||| CD
) ||| S:20673 E:20674 ||| -RRB-
,  ||| S:20674 E:20676 ||| ,
suggesting  ||| S:20676 E:20687 ||| VBG
that  ||| S:20687 E:20692 ||| IN
Tyr228  ||| S:20692 E:20699 ||| NNP
is  ||| S:20699 E:20702 ||| VBZ
not  ||| S:20702 E:20706 ||| RB
playing  ||| S:20706 E:20714 ||| VBG
a  ||| S:20714 E:20726 ||| DT
large  ||| S:20726 E:20732 ||| JJ
role  ||| S:20732 E:20737 ||| NN
in  ||| S:20737 E:20740 ||| IN
catalysis ||| S:20740 E:20749 ||| NN
.  ||| S:20749 E:20751 ||| .
When  ||| S:20751 E:20756 ||| WRB
penicillins  ||| S:20756 E:20768 ||| NNS
were  ||| S:20768 E:20773 ||| VBD
used  ||| S:20773 E:20778 ||| VBN
as  ||| S:20778 E:20791 ||| IN
substrates ||| S:20791 E:20801 ||| NN
,  ||| S:20801 E:20803 ||| ,
the  ||| S:20803 E:20807 ||| DT
Tyr228  ||| S:20807 E:20814 ||| FW
mutants  ||| S:20814 E:20822 ||| FW
exhibited  ||| S:20822 E:20832 ||| FW
3-  ||| S:20832 E:20835 ||| FW
to  ||| S:20835 E:20838 ||| TO
13-fold  ||| S:20838 E:20856 ||| NNP
increased  ||| S:20856 E:20866 ||| VBD
K  ||| S:20866 E:20879 ||| NNP
m  ||| S:20879 E:20881 ||| NN
values  ||| S:20881 E:20888 ||| NNS
and  ||| S:20888 E:20892 ||| CC
< ||| S:20892 E:20894 ||| SYM
2-fold  ||| S:20894 E:20901 ||| CD
changes  ||| S:20901 E:20909 ||| NNS
in  ||| S:20909 E:20923 ||| IN
k  ||| S:20923 E:20936 ||| JJ
cat  ||| S:20936 E:20940 ||| NN
,  ||| S:20940 E:20942 ||| ,
as  ||| S:20942 E:20945 ||| RB
compared  ||| S:20945 E:20954 ||| VBN
to  ||| S:20954 E:20957 ||| TO
the  ||| S:20957 E:20961 ||| DT
values  ||| S:20961 E:20978 ||| NNS
ascertained  ||| S:20978 E:20990 ||| VBP
using  ||| S:20990 E:20996 ||| VBG
wild-type  ||| S:20996 E:21006 ||| JJ
L1  ||| S:21006 E:21009 ||| NNP
( ||| S:21009 E:21010 ||| -LRB-
Table  ||| S:21010 E:21016 ||| NNP
4 ||| S:21016 E:21017 ||| CD
) ||| S:21017 E:21018 ||| -RRB-
.  ||| S:21018 E:21020 ||| .
On  ||| S:21020 E:21023 ||| IN
the  ||| S:21023 E:21027 ||| DT
other  ||| S:21027 E:21043 ||| JJ
hand  ||| S:21043 E:21048 ||| NN
when  ||| S:21048 E:21053 ||| WRB
carbapenems  ||| S:21053 E:21065 ||| NNS
were  ||| S:21065 E:21070 ||| VBD
used  ||| S:21070 E:21075 ||| VBN
as  ||| S:21075 E:21078 ||| IN
substrates ||| S:21078 E:21088 ||| NN
,  ||| S:21088 E:21090 ||| ,
the  ||| S:21090 E:21094 ||| DT
Tyr228  ||| S:21094 E:21111 ||| CD
mutants  ||| S:21111 E:21119 ||| CD
exhibited  ||| S:21119 E:21129 ||| CD
< ||| S:21129 E:21131 ||| SYM
6-fold  ||| S:21131 E:21138 ||| CD
increases  ||| S:21138 E:21148 ||| NNS
in  ||| S:21148 E:21151 ||| IN
K  ||| S:21151 E:21164 ||| NNP
m  ||| S:21164 E:21166 ||| NN
values  ||| S:21166 E:21173 ||| VBZ
as  ||| S:21173 E:21176 ||| RB
compared  ||| S:21176 E:21185 ||| VBN
to  ||| S:21185 E:21188 ||| TO
those  ||| S:21188 E:21194 ||| DT
values  ||| S:21194 E:21211 ||| NNS
for  ||| S:21211 E:21215 ||| IN
wild-type  ||| S:21215 E:21225 ||| NNP
L1  ||| S:21225 E:21228 ||| NNP
( ||| S:21228 E:21229 ||| -LRB-
Table  ||| S:21229 E:21235 ||| NNP
5 ||| S:21235 E:21236 ||| CD
) ||| S:21236 E:21237 ||| -RRB-
.  ||| S:21237 E:21239 ||| .
Interestingly ||| S:21239 E:21252 ||| RB
,  ||| S:21252 E:21254 ||| ,
there  ||| S:21254 E:21260 ||| EX
was  ||| S:21260 E:21264 ||| VBD
a  ||| S:21264 E:21266 ||| DT
2-  ||| S:21266 E:21279 ||| NN
to  ||| S:21279 E:21282 ||| TO
8-fold  ||| S:21282 E:21289 ||| CD
drop  ||| S:21289 E:21294 ||| NN
in  ||| S:21294 E:21308 ||| IN
k  ||| S:21308 E:21321 ||| JJ
cat  ||| S:21321 E:21325 ||| NN
values  ||| S:21325 E:21332 ||| NNS
for  ||| S:21332 E:21336 ||| IN
the  ||| S:21336 E:21340 ||| DT
Tyr228  ||| S:21340 E:21347 ||| JJ
mutants ||| S:21347 E:21354 ||| NN
,  ||| S:21354 E:21356 ||| ,
as  ||| S:21356 E:21369 ||| RB
compared  ||| S:21369 E:21378 ||| VBN
to  ||| S:21378 E:21381 ||| TO
values  ||| S:21381 E:21388 ||| NNS
observed  ||| S:21388 E:21397 ||| VBD
for  ||| S:21397 E:21401 ||| IN
wild-type  ||| S:21401 E:21411 ||| NNP
L1 ||| S:21411 E:21413 ||| NNP
,  ||| S:21413 E:21415 ||| ,
when  ||| S:21415 E:21420 ||| WRB
using  ||| S:21420 E:21436 ||| VBG
the  ||| S:21436 E:21440 ||| DT
carbapenems  ||| S:21440 E:21452 ||| NN
as  ||| S:21452 E:21455 ||| IN
substrates ||| S:21455 E:21465 ||| NN
.  ||| S:21465 E:21477 ||| .
Rapid-scanning  ||| S:21477 E:21492 ||| NNP
Vis  ||| S:21492 E:21496 ||| NNP
spectra  ||| S:21496 E:21504 ||| NN
of  ||| S:21504 E:21507 ||| IN
the  ||| S:21507 E:21511 ||| DT
reaction  ||| S:21511 E:21520 ||| NN
of  ||| S:21520 E:21523 ||| IN
the  ||| S:21523 E:21537 ||| DT
Y228A  ||| S:21537 E:21543 ||| NNP
and  ||| S:21543 E:21547 ||| CC
Y228F  ||| S:21547 E:21553 ||| CD
mutants  ||| S:21553 E:21561 ||| NN
with  ||| S:21561 E:21566 ||| IN
nitrocefin  ||| S:21566 E:21577 ||| NN
demonstrated  ||| S:21577 E:21590 ||| VBD
a  ||| S:21590 E:21602 ||| DT
marked  ||| S:21602 E:21609 ||| JJ
decrease  ||| S:21609 E:21618 ||| NN
in  ||| S:21618 E:21621 ||| IN
the  ||| S:21621 E:21625 ||| DT
amount  ||| S:21625 E:21632 ||| NN
of  ||| S:21632 E:21635 ||| IN
intermediate  ||| S:21635 E:21648 ||| JJ
formed  ||| S:21648 E:21655 ||| VBN
with  ||| S:21655 E:21670 ||| IN
these  ||| S:21670 E:21676 ||| DT
mutants  ||| S:21676 E:21684 ||| NN
( ||| S:21684 E:21685 ||| -LRB-
Figure  ||| S:21685 E:21692 ||| NNP
2 ||| S:21692 E:21693 ||| CD
) ||| S:21693 E:21694 ||| -RRB-
.  ||| S:21694 E:21696 ||| .
In  ||| S:21696 E:21699 ||| IN
reactions  ||| S:21699 E:21709 ||| NNS
with  ||| S:21709 E:21714 ||| IN
50  ||| S:21714 E:21717 ||| CD
μM  ||| S:21717 E:21720 ||| JJ
mutant  ||| S:21720 E:21737 ||| NN
and  ||| S:21737 E:21741 ||| CC
5  ||| S:21741 E:21743 ||| CD
μM  ||| S:21743 E:21746 ||| JJ
nitrocefin ||| S:21746 E:21756 ||| NN
,  ||| S:21756 E:21758 ||| ,
only  ||| S:21758 E:21763 ||| RB
0.75  ||| S:21763 E:21768 ||| CD
and  ||| S:21768 E:21772 ||| CC
< ||| S:21772 E:21774 ||| SYM
0.30  ||| S:21774 E:21779 ||| CD
μM  ||| S:21779 E:21792 ||| JJ
intermediate  ||| S:21792 E:21805 ||| NNS
formed  ||| S:21805 E:21812 ||| VBN
for  ||| S:21812 E:21816 ||| IN
the  ||| S:21816 E:21820 ||| DT
Y228F  ||| S:21820 E:21826 ||| NNP
and  ||| S:21826 E:21830 ||| CC
Y228A  ||| S:21830 E:21836 ||| CD
mutants ||| S:21836 E:21843 ||| NN
,  ||| S:21843 E:21855 ||| ,
respectively ||| S:21855 E:21867 ||| RB
.  ||| S:21867 E:21869 ||| .
The  ||| S:21869 E:21873 ||| DT
concentration  ||| S:21873 E:21887 ||| NN
of  ||| S:21887 E:21890 ||| IN
mutants  ||| S:21890 E:21898 ||| NN
were  ||| S:21898 E:21903 ||| VBD
varied  ||| S:21903 E:21920 ||| VBN
between  ||| S:21920 E:21928 ||| IN
25  ||| S:21928 E:21931 ||| CD
to  ||| S:21931 E:21934 ||| TO
150  ||| S:21934 E:21938 ||| CD
μM  ||| S:21938 E:21941 ||| JJ
to  ||| S:21941 E:21944 ||| TO
ensure  ||| S:21944 E:21951 ||| VB
that  ||| S:21951 E:21956 ||| IN
all  ||| S:21956 E:21960 ||| DT
of  ||| S:21960 E:21963 ||| IN
the  ||| S:21963 E:21967 ||| DT
substrate  ||| S:21967 E:21987 ||| NN
was  ||| S:21987 E:21991 ||| VBD
bound ||| S:21991 E:21996 ||| VBN
;  ||| S:21996 E:21998 ||| :
however ||| S:21998 E:22005 ||| RB
,  ||| S:22005 E:22007 ||| ,
none  ||| S:22007 E:22012 ||| NN
of  ||| S:22012 E:22015 ||| IN
the  ||| S:22015 E:22019 ||| DT
reactions  ||| S:22019 E:22029 ||| NNS
resulted  ||| S:22029 E:22038 ||| VBD
in  ||| S:22038 E:22041 ||| IN
the  ||| S:22041 E:22055 ||| DT
detection  ||| S:22055 E:22065 ||| NN
of  ||| S:22065 E:22068 ||| IN
intermediate  ||| S:22068 E:22081 ||| JJ
at  ||| S:22081 E:22084 ||| IN
levels  ||| S:22084 E:22091 ||| NNS
observed  ||| S:22091 E:22100 ||| VBD
for  ||| S:22100 E:22114 ||| IN
wild-type  ||| S:22114 E:22124 ||| NNP
L1  ||| S:22124 E:22127 ||| NNP
( ||| S:22127 E:22128 ||| -LRB-
data  ||| S:22128 E:22133 ||| NNS
not  ||| S:22133 E:22137 ||| RB
shown ||| S:22137 E:22142 ||| VBN
) ||| S:22142 E:22143 ||| -RRB-
.  ||| S:22143 E:22145 ||| .
Stopped-flow  ||| S:22145 E:22158 ||| JJ
fluorescence  ||| S:22158 E:22181 ||| JJ
studies  ||| S:22181 E:22189 ||| NNS
at  ||| S:22189 E:22192 ||| IN
10°C  ||| S:22192 E:22197 ||| CD
of  ||| S:22197 E:22200 ||| IN
nitrocefin  ||| S:22200 E:22211 ||| JJ
hydrolysis  ||| S:22211 E:22222 ||| NN
by  ||| S:22222 E:22225 ||| IN
Y191A  ||| S:22225 E:22231 ||| NNP
and  ||| S:22231 E:22245 ||| CC
Y191F  ||| S:22245 E:22251 ||| NNP
resulted  ||| S:22251 E:22260 ||| VBD
in  ||| S:22260 E:22263 ||| IN
K  ||| S:22263 E:22276 ||| NNP
S  ||| S:22276 E:22278 ||| NNP
values  ||| S:22278 E:22285 ||| NNS
of  ||| S:22285 E:22288 ||| IN
85  ||| S:22288 E:22291 ||| CD
±  ||| S:22291 E:22293 ||| CD
9  ||| S:22293 E:22295 ||| CD
and  ||| S:22295 E:22299 ||| CC
22  ||| S:22299 E:22302 ||| CD
±  ||| S:22302 E:22304 ||| CD
6  ||| S:22304 E:22306 ||| CD
μM ||| S:22306 E:22308 ||| NN
,  ||| S:22308 E:22320 ||| ,
respectively ||| S:22320 E:22332 ||| RB
.  ||| S:22332 E:22362 ||| .
Ile164  ||| S:22362 E:22369 ||| NNP
and  ||| S:22369 E:22373 ||| CC
Phe158  ||| S:22373 E:22380 ||| NNP
mutants  ||| S:22380 E:22398 ||| VBD
All  ||| S:22398 E:22402 ||| DT
crystallographically  ||| S:22402 E:22423 ||| JJ
characterized  ||| S:22423 E:22447 ||| JJ
metallo-β-lactamases  ||| S:22447 E:22468 ||| NNS
have  ||| S:22468 E:22473 ||| VBP
a  ||| S:22473 E:22475 ||| DT
flexible  ||| S:22475 E:22484 ||| JJ
amino  ||| S:22484 E:22490 ||| JJ
acid  ||| S:22490 E:22495 ||| NN
chain  ||| S:22495 E:22511 ||| NN
that  ||| S:22511 E:22516 ||| WDT
extends  ||| S:22516 E:22524 ||| VBZ
over  ||| S:22524 E:22529 ||| IN
the  ||| S:22529 E:22533 ||| DT
active  ||| S:22533 E:22540 ||| JJ
site  ||| S:22540 E:22545 ||| NN
[  ||| S:22545 E:22547 ||| -LRB-
37  ||| S:22547 E:22550 ||| CD
42  ||| S:22550 E:22553 ||| CD
44  ||| S:22553 E:22556 ||| CD
45  ||| S:22556 E:22559 ||| CD
46  ||| S:22559 E:22562 ||| CD
47  ||| S:22562 E:22565 ||| CD
48  ||| S:22565 E:22578 ||| CD
49  ||| S:22578 E:22581 ||| CD
]  ||| S:22581 E:22583 ||| -RRB-
.  ||| S:22583 E:22585 ||| .
Previous  ||| S:22585 E:22594 ||| JJ
NMR  ||| S:22594 E:22598 ||| NN
studies  ||| S:22598 E:22606 ||| NNS
on  ||| S:22606 E:22609 ||| IN
CcrA  ||| S:22609 E:22614 ||| NNS
have  ||| S:22614 E:22619 ||| VBP
shown  ||| S:22619 E:22625 ||| VBN
that  ||| S:22625 E:22630 ||| IN
this  ||| S:22630 E:22645 ||| DT
loop  ||| S:22645 E:22650 ||| JJ
"clamps  ||| S:22650 E:22658 ||| NN
down ||| S:22658 E:22662 ||| IN
"  ||| S:22662 E:22664 ||| ``
on  ||| S:22664 E:22667 ||| IN
substrate  ||| S:22667 E:22677 ||| NN
or  ||| S:22677 E:22680 ||| CC
inhibitor  ||| S:22680 E:22690 ||| NN
upon  ||| S:22690 E:22705 ||| IN
binding ||| S:22705 E:22712 ||| JJ
,  ||| S:22712 E:22714 ||| ,
and  ||| S:22714 E:22718 ||| CC
there  ||| S:22718 E:22724 ||| EX
is  ||| S:22724 E:22727 ||| VBZ
speculation  ||| S:22727 E:22739 ||| NN
that  ||| S:22739 E:22744 ||| IN
the  ||| S:22744 E:22748 ||| DT
distortion  ||| S:22748 E:22759 ||| NN
of  ||| S:22759 E:22772 ||| IN
substrate  ||| S:22772 E:22782 ||| NN
upon  ||| S:22782 E:22787 ||| IN
clamping  ||| S:22787 E:22796 ||| VBG
down  ||| S:22796 E:22801 ||| RP
of  ||| S:22801 E:22804 ||| IN
the  ||| S:22804 E:22808 ||| DT
loop  ||| S:22808 E:22813 ||| NN
may  ||| S:22813 E:22817 ||| MD
drive  ||| S:22817 E:22833 ||| VB
catalysis  ||| S:22833 E:22843 ||| NNS
[  ||| S:22843 E:22845 ||| -LRB-
50  ||| S:22845 E:22848 ||| CD
]  ||| S:22848 E:22850 ||| -RRB-
.  ||| S:22850 E:22852 ||| .
The  ||| S:22852 E:22856 ||| DT
crystal  ||| S:22856 E:22864 ||| NN
structure  ||| S:22864 E:22874 ||| NN
of  ||| S:22874 E:22877 ||| IN
L1  ||| S:22877 E:22880 ||| NNP
showed  ||| S:22880 E:22897 ||| VBD
that  ||| S:22897 E:22902 ||| IN
there  ||| S:22902 E:22908 ||| EX
is  ||| S:22908 E:22911 ||| VBZ
a  ||| S:22911 E:22913 ||| DT
large  ||| S:22913 E:22919 ||| JJ
loop  ||| S:22919 E:22924 ||| NN
that  ||| S:22924 E:22929 ||| WDT
extends  ||| S:22929 E:22937 ||| VBZ
over  ||| S:22937 E:22942 ||| IN
the  ||| S:22942 E:22946 ||| DT
active  ||| S:22946 E:22963 ||| JJ
site ||| S:22963 E:22967 ||| NN
,  ||| S:22967 E:22969 ||| ,
and  ||| S:22969 E:22973 ||| CC
modeling  ||| S:22973 E:22982 ||| JJ
studies  ||| S:22982 E:22990 ||| NNS
have  ||| S:22990 E:22995 ||| VBP
predicted  ||| S:22995 E:23005 ||| VBN
that  ||| S:23005 E:23010 ||| IN
two  ||| S:23010 E:23024 ||| CD
residues ||| S:23024 E:23032 ||| NNS
,  ||| S:23032 E:23034 ||| ,
Ile164  ||| S:23034 E:23041 ||| NNP
and  ||| S:23041 E:23045 ||| CC
Phe158 ||| S:23045 E:23051 ||| NNP
,  ||| S:23051 E:23053 ||| ,
make  ||| S:23053 E:23058 ||| VB
significant  ||| S:23058 E:23070 ||| JJ
contacts  ||| S:23070 E:23089 ||| NNS
with  ||| S:23089 E:23094 ||| IN
large ||| S:23094 E:23099 ||| JJ
,  ||| S:23099 E:23101 ||| ,
hydrophobic  ||| S:23101 E:23113 ||| JJ
substituents  ||| S:23113 E:23126 ||| NN
at  ||| S:23126 E:23129 ||| IN
the  ||| S:23129 E:23133 ||| DT
2 ||| S:23133 E:23134 ||| CD
'  ||| S:23134 E:23136 ||| ''
or  ||| S:23136 E:23139 ||| CC
6 ||| S:23139 E:23140 ||| CD
'  ||| S:23140 E:23152 ||| POS
positions  ||| S:23152 E:23162 ||| NNS
on  ||| S:23162 E:23165 ||| IN
penicillins ||| S:23165 E:23176 ||| NN
,  ||| S:23176 E:23178 ||| ,
cephalosporins ||| S:23178 E:23192 ||| NN
,  ||| S:23192 E:23194 ||| ,
or  ||| S:23194 E:23197 ||| CC
carbapenems  ||| S:23197 E:23219 ||| NNS
[  ||| S:23219 E:23221 ||| -LRB-
37  ||| S:23221 E:23224 ||| CD
]  ||| S:23224 E:23226 ||| -RRB-
.  ||| S:23226 E:23228 ||| .
To  ||| S:23228 E:23231 ||| TO
test  ||| S:23231 E:23236 ||| VB
this  ||| S:23236 E:23241 ||| DT
prediction ||| S:23241 E:23251 ||| NN
,  ||| S:23251 E:23253 ||| ,
Ile  ||| S:23253 E:23257 ||| NNP
164  ||| S:23257 E:23261 ||| CD
and  ||| S:23261 E:23265 ||| CC
Phe158  ||| S:23265 E:23272 ||| NNP
were  ||| S:23272 E:23287 ||| VBD
changed  ||| S:23287 E:23295 ||| VBN
from  ||| S:23295 E:23300 ||| IN
large ||| S:23300 E:23305 ||| JJ
,  ||| S:23305 E:23307 ||| ,
hydrophobic  ||| S:23307 E:23319 ||| JJ
residues  ||| S:23319 E:23328 ||| NNS
to  ||| S:23328 E:23331 ||| TO
alanines  ||| S:23331 E:23340 ||| VB
to  ||| S:23340 E:23353 ||| TO
afford  ||| S:23353 E:23360 ||| VB
the  ||| S:23360 E:23364 ||| DT
I164A  ||| S:23364 E:23370 ||| NNP
and  ||| S:23370 E:23374 ||| CC
F158A  ||| S:23374 E:23380 ||| CD
mutants ||| S:23380 E:23387 ||| NNS
.  ||| S:23387 E:23399 ||| .
Small-scale  ||| S:23399 E:23411 ||| JJ
growth  ||| S:23411 E:23418 ||| NN
cultures  ||| S:23418 E:23427 ||| NNS
demonstrated  ||| S:23427 E:23440 ||| VBD
the  ||| S:23440 E:23444 ||| DT
I164A  ||| S:23444 E:23450 ||| NNP
and  ||| S:23450 E:23464 ||| CC
F158A  ||| S:23464 E:23470 ||| CD
mutants  ||| S:23470 E:23478 ||| NNS
were  ||| S:23478 E:23483 ||| VBD
over-expressed  ||| S:23483 E:23498 ||| JJ
at  ||| S:23498 E:23501 ||| IN
levels  ||| S:23501 E:23508 ||| NNS
comparable  ||| S:23508 E:23519 ||| JJ
to  ||| S:23519 E:23532 ||| TO
that  ||| S:23532 E:23537 ||| DT
of  ||| S:23537 E:23540 ||| IN
wild-type  ||| S:23540 E:23550 ||| NNP
L1  ||| S:23550 E:23553 ||| NNP
( ||| S:23553 E:23554 ||| -LRB-
data  ||| S:23554 E:23559 ||| NNS
not  ||| S:23559 E:23563 ||| RB
shown ||| S:23563 E:23568 ||| VBN
) ||| S:23568 E:23569 ||| -RRB-
.  ||| S:23569 E:23571 ||| .
Large-scale  ||| S:23571 E:23593 ||| JJ
over-expression  ||| S:23593 E:23609 ||| JJ
and  ||| S:23609 E:23613 ||| CC
purification  ||| S:23613 E:23626 ||| NN
of  ||| S:23626 E:23629 ||| IN
the  ||| S:23629 E:23633 ||| DT
mutants  ||| S:23633 E:23641 ||| NN
resulted  ||| S:23641 E:23660 ||| VBD
in  ||| S:23660 E:23663 ||| IN
comparable  ||| S:23663 E:23674 ||| JJ
quantities  ||| S:23674 E:23685 ||| NNS
of  ||| S:23685 E:23688 ||| IN
isolatable  ||| S:23688 E:23699 ||| JJ
enzymes ||| S:23699 E:23706 ||| NN
,  ||| S:23706 E:23708 ||| ,
which  ||| S:23708 E:23714 ||| WDT
had  ||| S:23714 E:23728 ||| VBD
identical  ||| S:23728 E:23738 ||| JJ
CD  ||| S:23738 E:23741 ||| NN
spectra  ||| S:23741 E:23749 ||| NN
as  ||| S:23749 E:23752 ||| IN
wild-type  ||| S:23752 E:23762 ||| NNP
L1  ||| S:23762 E:23765 ||| NNP
and  ||| S:23765 E:23769 ||| CC
bound  ||| S:23769 E:23775 ||| VBN
slightly  ||| S:23775 E:23794 ||| RB
less  ||| S:23794 E:23799 ||| JJR
Zn ||| S:23799 E:23801 ||| NNP
( ||| S:23801 E:23802 ||| -LRB-
II ||| S:23802 E:23804 ||| NNP
)  ||| S:23804 E:23806 ||| -RRB-
than  ||| S:23806 E:23811 ||| IN
wild-type  ||| S:23811 E:23821 ||| NNP
L1  ||| S:23821 E:23824 ||| NNP
( ||| S:23824 E:23825 ||| -LRB-
Table  ||| S:23825 E:23831 ||| NNP
2 ||| S:23831 E:23832 ||| CD
) ||| S:23832 E:23833 ||| -RRB-
.  ||| S:23833 E:23835 ||| .
All  ||| S:23835 E:23839 ||| DT
steady-state  ||| S:23839 E:23862 ||| JJ
kinetic  ||| S:23862 E:23870 ||| JJ
studies  ||| S:23870 E:23878 ||| NNS
were  ||| S:23878 E:23883 ||| VBD
conducted  ||| S:23883 E:23893 ||| VBN
in  ||| S:23893 E:23896 ||| IN
buffers  ||| S:23896 E:23904 ||| NNS
containing  ||| S:23904 E:23915 ||| VBG
100  ||| S:23915 E:23929 ||| CD
μM  ||| S:23929 E:23932 ||| JJ
ZnCl  ||| S:23932 E:23948 ||| JJ
2  ||| S:23948 E:23950 ||| CD
to  ||| S:23950 E:23953 ||| TO
ensure  ||| S:23953 E:23960 ||| VB
that  ||| S:23960 E:23965 ||| IN
both  ||| S:23965 E:23970 ||| DT
metal  ||| S:23970 E:23976 ||| NN
binding  ||| S:23976 E:23994 ||| JJ
sites  ||| S:23994 E:24000 ||| NNS
were  ||| S:24000 E:24005 ||| VBD
saturated  ||| S:24005 E:24015 ||| VBN
during  ||| S:24015 E:24022 ||| IN
the  ||| S:24022 E:24026 ||| DT
studies ||| S:24026 E:24033 ||| NNS
.  ||| S:24033 E:24045 ||| .
When  ||| S:24045 E:24050 ||| WRB
using  ||| S:24050 E:24056 ||| VBG
the  ||| S:24056 E:24060 ||| DT
cephalosporins ||| S:24060 E:24074 ||| NN
,  ||| S:24074 E:24076 ||| ,
nitrocefin ||| S:24076 E:24086 ||| NN
,  ||| S:24086 E:24088 ||| ,
cefoxitin ||| S:24088 E:24097 ||| NN
,  ||| S:24097 E:24109 ||| ,
and  ||| S:24109 E:24113 ||| CC
cephalothin ||| S:24113 E:24124 ||| NN
,  ||| S:24124 E:24126 ||| ,
as  ||| S:24126 E:24129 ||| IN
substrates  ||| S:24129 E:24140 ||| NN
and  ||| S:24140 E:24144 ||| CC
the  ||| S:24144 E:24148 ||| DT
I164A  ||| S:24148 E:24154 ||| JJ
mutant ||| S:24154 E:24160 ||| NN
,  ||| S:24160 E:24172 ||| ,
there  ||| S:24172 E:24178 ||| EX
were  ||| S:24178 E:24183 ||| VBD
2-  ||| S:24183 E:24186 ||| CD
to  ||| S:24186 E:24189 ||| TO
10-fold  ||| S:24189 E:24197 ||| CD
( ||| S:24197 E:24198 ||| -LRB-
only  ||| S:24198 E:24203 ||| RB
for  ||| S:24203 E:24207 ||| IN
cefoxitin ||| S:24207 E:24216 ||| CD
)  ||| S:24216 E:24218 ||| -RRB-
increases  ||| S:24218 E:24238 ||| NNS
in  ||| S:24238 E:24241 ||| IN
K  ||| S:24241 E:24254 ||| NNP
m  ||| S:24254 E:24256 ||| NN
and  ||| S:24256 E:24260 ||| CC
2-  ||| S:24260 E:24263 ||| CD
to  ||| S:24263 E:24266 ||| TO
4-fold  ||| S:24266 E:24273 ||| CD
increases  ||| S:24273 E:24283 ||| NNS
in  ||| S:24283 E:24297 ||| IN
k  ||| S:24297 E:24310 ||| FW
cat  ||| S:24310 E:24314 ||| FW
observed  ||| S:24314 E:24323 ||| FW
( ||| S:24323 E:24324 ||| -LRB-
Table  ||| S:24324 E:24330 ||| NNP
3 ||| S:24330 E:24331 ||| CD
) ||| S:24331 E:24332 ||| -RRB-
.  ||| S:24332 E:24334 ||| .
However  ||| S:24334 E:24342 ||| RB
when  ||| S:24342 E:24357 ||| WRB
cefaclor  ||| S:24357 E:24366 ||| NNS
was  ||| S:24366 E:24370 ||| VBD
used  ||| S:24370 E:24375 ||| VBN
as  ||| S:24375 E:24378 ||| IN
substrate ||| S:24378 E:24387 ||| NN
,  ||| S:24387 E:24389 ||| ,
the  ||| S:24389 E:24393 ||| DT
I164A  ||| S:24393 E:24399 ||| FW
mutant  ||| S:24399 E:24416 ||| FW
exhibited  ||| S:24416 E:24426 ||| FW
a  ||| S:24426 E:24428 ||| FW
3-fold  ||| S:24428 E:24435 ||| FW
decrease  ||| S:24435 E:24444 ||| NN
in  ||| S:24444 E:24447 ||| IN
K  ||| S:24447 E:24460 ||| NNP
m  ||| S:24460 E:24462 ||| NN
and  ||| S:24462 E:24466 ||| CC
a  ||| S:24466 E:24468 ||| DT
1.5-fold  ||| S:24468 E:24477 ||| JJ
decrease  ||| S:24477 E:24486 ||| NN
in  ||| S:24486 E:24500 ||| IN
k  ||| S:24500 E:24513 ||| JJ
cat  ||| S:24513 E:24517 ||| NNS
( ||| S:24517 E:24518 ||| -LRB-
Table  ||| S:24518 E:24524 ||| NNP
3 ||| S:24524 E:24525 ||| CD
) ||| S:24525 E:24526 ||| -RRB-
.  ||| S:24526 E:24528 ||| .
On  ||| S:24528 E:24531 ||| IN
the  ||| S:24531 E:24535 ||| DT
other  ||| S:24535 E:24541 ||| JJ
hand ||| S:24541 E:24545 ||| NN
,  ||| S:24545 E:24547 ||| ,
the  ||| S:24547 E:24561 ||| DT
K  ||| S:24561 E:24574 ||| NNP
m  ||| S:24574 E:24576 ||| NN
and  ||| S:24576 E:24591 ||| CC
k  ||| S:24591 E:24604 ||| JJ
cat  ||| S:24604 E:24608 ||| NN
values  ||| S:24608 E:24615 ||| NNS
for  ||| S:24615 E:24619 ||| IN
the  ||| S:24619 E:24623 ||| DT
I164A  ||| S:24623 E:24629 ||| JJ
mutant  ||| S:24629 E:24636 ||| NN
when  ||| S:24636 E:24651 ||| WRB
the  ||| S:24651 E:24655 ||| DT
penicillins  ||| S:24655 E:24667 ||| NN
or  ||| S:24667 E:24670 ||| CC
carbapenems  ||| S:24670 E:24682 ||| NNS
were  ||| S:24682 E:24687 ||| VBD
used  ||| S:24687 E:24692 ||| VBN
as  ||| S:24692 E:24695 ||| IN
substrates  ||| S:24695 E:24716 ||| NN
were  ||| S:24716 E:24721 ||| VBD
very  ||| S:24721 E:24726 ||| RB
similar  ||| S:24726 E:24734 ||| JJ
to  ||| S:24734 E:24737 ||| TO
those  ||| S:24737 E:24743 ||| DT
numbers  ||| S:24743 E:24751 ||| NNS
exhibited  ||| S:24751 E:24761 ||| VBN
by  ||| S:24761 E:24764 ||| IN
wild-type  ||| S:24764 E:24784 ||| NNP
L1  ||| S:24784 E:24787 ||| NNP
( ||| S:24787 E:24788 ||| -LRB-
Tables  ||| S:24788 E:24795 ||| NNP
4and  ||| S:24795 E:24800 ||| CD
5 ||| S:24800 E:24801 ||| CD
) ||| S:24801 E:24802 ||| -RRB-
.  ||| S:24802 E:24814 ||| .
When  ||| S:24814 E:24819 ||| WRB
the  ||| S:24819 E:24823 ||| DT
cephalosporins  ||| S:24823 E:24838 ||| NN
were  ||| S:24838 E:24843 ||| VBD
used  ||| S:24843 E:24848 ||| VBN
as  ||| S:24848 E:24851 ||| IN
substrates  ||| S:24851 E:24862 ||| NN
for  ||| S:24862 E:24876 ||| IN
the  ||| S:24876 E:24880 ||| DT
F158A  ||| S:24880 E:24886 ||| JJ
mutant ||| S:24886 E:24892 ||| NN
,  ||| S:24892 E:24894 ||| ,
the  ||| S:24894 E:24898 ||| DT
K  ||| S:24898 E:24911 ||| NNP
m  ||| S:24911 E:24913 ||| NN
values  ||| S:24913 E:24920 ||| NNS
observed  ||| S:24920 E:24929 ||| VBD
were  ||| S:24929 E:24934 ||| VBD
7-  ||| S:24934 E:24937 ||| CD
to  ||| S:24937 E:24940 ||| TO
31-fold  ||| S:24940 E:24958 ||| CD
higher  ||| S:24958 E:24965 ||| JJR
than  ||| S:24965 E:24970 ||| IN
those  ||| S:24970 E:24976 ||| DT
determined  ||| S:24976 E:24987 ||| VBN
for  ||| S:24987 E:24991 ||| IN
wild-type  ||| S:24991 E:25001 ||| NNP
L1 ||| S:25001 E:25003 ||| NNP
,  ||| S:25003 E:25005 ||| ,
and  ||| S:25005 E:25019 ||| CC
surprisingly ||| S:25019 E:25031 ||| RB
,  ||| S:25031 E:25033 ||| ,
the  ||| S:25033 E:25048 ||| DT
k  ||| S:25048 E:25061 ||| JJ
cat  ||| S:25061 E:25065 ||| NN
values  ||| S:25065 E:25072 ||| NNS
were  ||| S:25072 E:25077 ||| VBD
2-  ||| S:25077 E:25080 ||| CD
to  ||| S:25080 E:25083 ||| TO
31-fold  ||| S:25083 E:25091 ||| CD
higher  ||| S:25091 E:25108 ||| JJR
than  ||| S:25108 E:25113 ||| IN
those  ||| S:25113 E:25119 ||| DT
exhibited  ||| S:25119 E:25129 ||| NN
by  ||| S:25129 E:25132 ||| IN
wild-type  ||| S:25132 E:25142 ||| NNP
L1  ||| S:25142 E:25145 ||| NNP
( ||| S:25145 E:25146 ||| -LRB-
Table  ||| S:25146 E:25152 ||| NNP
3 ||| S:25152 E:25153 ||| CD
) ||| S:25153 E:25154 ||| -RRB-
.  ||| S:25154 E:25156 ||| .
As  ||| S:25156 E:25159 ||| RB
with  ||| S:25159 E:25174 ||| IN
the  ||| S:25174 E:25178 ||| DT
I164A  ||| S:25178 E:25184 ||| JJ
mutant ||| S:25184 E:25190 ||| NN
,  ||| S:25190 E:25192 ||| ,
the  ||| S:25192 E:25196 ||| DT
changes  ||| S:25196 E:25204 ||| NNS
in  ||| S:25204 E:25207 ||| IN
K  ||| S:25207 E:25220 ||| NNP
m  ||| S:25220 E:25222 ||| NN
and  ||| S:25222 E:25237 ||| CC
k  ||| S:25237 E:25250 ||| JJ
cat  ||| S:25250 E:25254 ||| NN
for  ||| S:25254 E:25258 ||| IN
the  ||| S:25258 E:25262 ||| DT
penicillins  ||| S:25262 E:25274 ||| NN
and  ||| S:25274 E:25288 ||| CC
carbapenems  ||| S:25288 E:25300 ||| NNS
were  ||| S:25300 E:25305 ||| VBD
relatively  ||| S:25305 E:25316 ||| RB
small ||| S:25316 E:25321 ||| JJ
,  ||| S:25321 E:25323 ||| ,
as  ||| S:25323 E:25326 ||| RB
compared  ||| S:25326 E:25335 ||| VBN
with  ||| S:25335 E:25340 ||| IN
the  ||| S:25340 E:25354 ||| DT
values  ||| S:25354 E:25361 ||| NNS
obtained  ||| S:25361 E:25370 ||| VBN
with  ||| S:25370 E:25375 ||| IN
the  ||| S:25375 E:25379 ||| DT
cephalosporins  ||| S:25379 E:25394 ||| NN
( ||| S:25394 E:25395 ||| -LRB-
Table  ||| S:25395 E:25401 ||| NNP
4 ||| S:25401 E:25402 ||| CD
) ||| S:25402 E:25403 ||| -RRB-
.  ||| S:25403 E:25415 ||| .
Rapid-scanning  ||| S:25415 E:25430 ||| NNP
Vis  ||| S:25430 E:25434 ||| NNP
studies  ||| S:25434 E:25442 ||| NNS
on  ||| S:25442 E:25445 ||| IN
nitrocefin  ||| S:25445 E:25456 ||| JJ
hydrolysis  ||| S:25456 E:25467 ||| NN
by  ||| S:25467 E:25480 ||| IN
I164A  ||| S:25480 E:25486 ||| NNP
and  ||| S:25486 E:25490 ||| CC
F158A  ||| S:25490 E:25496 ||| NNP
showed  ||| S:25496 E:25503 ||| VBD
a  ||| S:25503 E:25505 ||| DT
marked  ||| S:25505 E:25512 ||| JJ
decrease  ||| S:25512 E:25521 ||| NN
in  ||| S:25521 E:25524 ||| IN
intermediate  ||| S:25524 E:25547 ||| JJ
accumulation ||| S:25547 E:25559 ||| NN
,  ||| S:25559 E:25561 ||| ,
with  ||| S:25561 E:25566 ||| IN
the  ||| S:25566 E:25570 ||| DT
I164A  ||| S:25570 E:25576 ||| FW
mutant  ||| S:25576 E:25583 ||| FW
generating  ||| S:25583 E:25594 ||| FW
< ||| S:25594 E:25596 ||| SYM
0.30  ||| S:25596 E:25611 ||| FW
μM  ||| S:25611 E:25614 ||| FW
intermediate  ||| S:25614 E:25627 ||| FW
and  ||| S:25627 E:25631 ||| CC
the  ||| S:25631 E:25635 ||| DT
F158A  ||| S:25635 E:25641 ||| NN
producing  ||| S:25641 E:25651 ||| VBG
no  ||| S:25651 E:25654 ||| DT
detectable  ||| S:25654 E:25675 ||| JJ
intermediate  ||| S:25675 E:25688 ||| NNS
( ||| S:25688 E:25689 ||| -LRB-
Figure  ||| S:25689 E:25696 ||| NNP
2 ||| S:25696 E:25697 ||| CD
) ||| S:25697 E:25698 ||| -RRB-
.  ||| S:25698 E:25700 ||| .
Stopped-flow  ||| S:25700 E:25713 ||| JJ
fluorescence  ||| S:25713 E:25736 ||| JJ
studies  ||| S:25736 E:25744 ||| NNS
at  ||| S:25744 E:25747 ||| IN
10°C  ||| S:25747 E:25752 ||| NNP
resulted  ||| S:25752 E:25761 ||| VBD
in  ||| S:25761 E:25764 ||| IN
a  ||| S:25764 E:25766 ||| DT
K  ||| S:25766 E:25779 ||| NNP
S  ||| S:25779 E:25781 ||| NNP
value  ||| S:25781 E:25787 ||| NN
of  ||| S:25787 E:25790 ||| IN
31  ||| S:25790 E:25793 ||| CD
±  ||| S:25793 E:25795 ||| CD
11  ||| S:25795 E:25798 ||| CD
μM  ||| S:25798 E:25801 ||| NN
for  ||| S:25801 E:25805 ||| IN
the  ||| S:25805 E:25809 ||| DT
I164A  ||| S:25809 E:25825 ||| JJ
mutant ||| S:25825 E:25831 ||| NN
.  ||| S:25831 E:25833 ||| .
The  ||| S:25833 E:25837 ||| DT
reaction  ||| S:25837 E:25846 ||| NN
of  ||| S:25846 E:25849 ||| IN
F158A  ||| S:25849 E:25855 ||| CD
with  ||| S:25855 E:25860 ||| IN
nitrocefin  ||| S:25860 E:25871 ||| NN
was  ||| S:25871 E:25875 ||| VBD
so  ||| S:25875 E:25888 ||| RB
rapid ||| S:25888 E:25893 ||| JJ
,  ||| S:25893 E:25895 ||| ,
we  ||| S:25895 E:25898 ||| PRP
could  ||| S:25898 E:25904 ||| MD
not  ||| S:25904 E:25908 ||| RB
determine  ||| S:25908 E:25918 ||| VB
a  ||| S:25918 E:25920 ||| DT
K  ||| S:25920 E:25933 ||| NNP
S  ||| S:25933 E:25935 ||| NNP
value  ||| S:25935 E:25941 ||| NN
for  ||| S:25941 E:25945 ||| IN
this  ||| S:25945 E:25950 ||| DT
mutant ||| S:25950 E:25956 ||| NN
.  ||| S:25956 E:25989 ||| .
Discussion  ||| S:25989 E:26008 ||| NN
β-Lactam  ||| S:26008 E:26017 ||| NN
containing  ||| S:26017 E:26028 ||| VBG
antibiotics  ||| S:26028 E:26040 ||| NNS
constitute  ||| S:26040 E:26051 ||| VBP
the  ||| S:26051 E:26055 ||| DT
largest  ||| S:26055 E:26071 ||| JJS
class  ||| S:26071 E:26077 ||| NN
of  ||| S:26077 E:26080 ||| IN
antibiotics ||| S:26080 E:26091 ||| NN
,  ||| S:26091 E:26093 ||| ,
and  ||| S:26093 E:26097 ||| CC
these  ||| S:26097 E:26103 ||| DT
compounds  ||| S:26103 E:26113 ||| NNS
are  ||| S:26113 E:26117 ||| VBP
relatively  ||| S:26117 E:26136 ||| RB
inexpensive  ||| S:26136 E:26148 ||| JJ
to  ||| S:26148 E:26151 ||| TO
produce ||| S:26151 E:26158 ||| VB
,  ||| S:26158 E:26160 ||| ,
cause  ||| S:26160 E:26166 ||| VB
minor  ||| S:26166 E:26172 ||| JJ
side  ||| S:26172 E:26177 ||| NN
effects ||| S:26177 E:26184 ||| NNS
,  ||| S:26184 E:26186 ||| ,
and  ||| S:26186 E:26190 ||| CC
are  ||| S:26190 E:26202 ||| VBP
effective  ||| S:26202 E:26212 ||| JJ
towards  ||| S:26212 E:26220 ||| IN
a  ||| S:26220 E:26222 ||| DT
number  ||| S:26222 E:26229 ||| NN
of  ||| S:26229 E:26232 ||| IN
bacterial  ||| S:26232 E:26242 ||| JJ
strains ||| S:26242 E:26249 ||| NNS
.  ||| S:26249 E:26259 ||| .
Nonetheless ||| S:26259 E:26270 ||| RB
,  ||| S:26270 E:26272 ||| ,
bacterial  ||| S:26272 E:26282 ||| JJ
resistance  ||| S:26282 E:26293 ||| NN
to  ||| S:26293 E:26296 ||| TO
these  ||| S:26296 E:26302 ||| DT
antibiotics  ||| S:26302 E:26314 ||| NN
is  ||| S:26314 E:26325 ||| VBZ
extensive ||| S:26325 E:26334 ||| JJ
,  ||| S:26334 E:26336 ||| ,
most  ||| S:26336 E:26341 ||| RBS
commonly  ||| S:26341 E:26350 ||| RB
due  ||| S:26350 E:26354 ||| JJ
to  ||| S:26354 E:26357 ||| TO
the  ||| S:26357 E:26361 ||| DT
bacterial  ||| S:26361 E:26371 ||| JJ
production  ||| S:26371 E:26382 ||| NN
of  ||| S:26382 E:26393 ||| IN
β-lactamases  ||| S:26393 E:26406 ||| NNP
[  ||| S:26406 E:26408 ||| -LRB-
10  ||| S:26408 E:26411 ||| CD
51  ||| S:26411 E:26414 ||| CD
]  ||| S:26414 E:26416 ||| -RRB-
.  ||| S:26416 E:26418 ||| .
In  ||| S:26418 E:26421 ||| IN
fact ||| S:26421 E:26425 ||| NN
,  ||| S:26425 E:26427 ||| ,
there  ||| S:26427 E:26433 ||| EX
have  ||| S:26433 E:26438 ||| VBP
been  ||| S:26438 E:26443 ||| VBN
over  ||| S:26443 E:26448 ||| IN
300  ||| S:26448 E:26460 ||| CD
distinct  ||| S:26460 E:26469 ||| JJ
β-lactamases  ||| S:26469 E:26482 ||| NN
reported ||| S:26482 E:26490 ||| VBD
,  ||| S:26490 E:26492 ||| ,
and  ||| S:26492 E:26496 ||| CC
most  ||| S:26496 E:26501 ||| JJS
of  ||| S:26501 E:26504 ||| IN
these  ||| S:26504 E:26510 ||| DT
enzymes  ||| S:26510 E:26526 ||| NN
utilize  ||| S:26526 E:26534 ||| VBD
an  ||| S:26534 E:26537 ||| DT
active  ||| S:26537 E:26544 ||| JJ
site  ||| S:26544 E:26549 ||| NN
serine  ||| S:26549 E:26556 ||| NN
group  ||| S:26556 E:26562 ||| NN
to  ||| S:26562 E:26565 ||| TO
nucleophilically  ||| S:26565 E:26590 ||| VB
attack  ||| S:26590 E:26597 ||| VB
the  ||| S:26597 E:26601 ||| DT
β-lactam  ||| S:26601 E:26610 ||| JJ
carbonyl ||| S:26610 E:26618 ||| NN
,  ||| S:26618 E:26620 ||| ,
resulting  ||| S:26620 E:26630 ||| VBG
in  ||| S:26630 E:26633 ||| IN
a  ||| S:26633 E:26635 ||| DT
hydrolyzed  ||| S:26635 E:26654 ||| JJ
product  ||| S:26654 E:26662 ||| NN
that  ||| S:26662 E:26667 ||| WDT
is  ||| S:26667 E:26670 ||| VBZ
covalently  ||| S:26670 E:26681 ||| VBN
attached  ||| S:26681 E:26690 ||| VBN
to  ||| S:26690 E:26693 ||| TO
the  ||| S:26693 E:26697 ||| DT
active  ||| S:26697 E:26704 ||| JJ
site ||| S:26704 E:26708 ||| NN
.  ||| S:26708 E:26710 ||| .
To  ||| S:26710 E:26721 ||| TO
combat  ||| S:26721 E:26728 ||| VB
these  ||| S:26728 E:26734 ||| DT
enzymes ||| S:26734 E:26741 ||| NN
,  ||| S:26741 E:26743 ||| ,
β-lactamase  ||| S:26743 E:26755 ||| JJ
inhibitors  ||| S:26755 E:26766 ||| JJ
such  ||| S:26766 E:26771 ||| JJ
as  ||| S:26771 E:26782 ||| IN
clavulanic  ||| S:26782 E:26793 ||| JJ
acid ||| S:26793 E:26797 ||| NN
,  ||| S:26797 E:26799 ||| ,
sulbactam ||| S:26799 E:26808 ||| NN
,  ||| S:26808 E:26810 ||| ,
and  ||| S:26810 E:26814 ||| CC
tazobactam  ||| S:26814 E:26825 ||| NNS
have  ||| S:26825 E:26830 ||| VBP
been  ||| S:26830 E:26835 ||| VBN
given  ||| S:26835 E:26849 ||| VBN
in  ||| S:26849 E:26852 ||| IN
combination  ||| S:26852 E:26864 ||| NN
with  ||| S:26864 E:26869 ||| IN
a  ||| S:26869 E:26871 ||| DT
β-lactam  ||| S:26871 E:26880 ||| JJ
containing  ||| S:26880 E:26891 ||| JJ
antibiotic  ||| S:26891 E:26902 ||| NN
to  ||| S:26902 E:26913 ||| TO
treat  ||| S:26913 E:26919 ||| VB
bacterial  ||| S:26919 E:26929 ||| JJ
infections  ||| S:26929 E:26940 ||| NNS
[  ||| S:26940 E:26942 ||| -LRB-
52  ||| S:26942 E:26945 ||| CD
]  ||| S:26945 E:26947 ||| -RRB-
.  ||| S:26947 E:26949 ||| .
One  ||| S:26949 E:26953 ||| CD
class  ||| S:26953 E:26959 ||| NN
of  ||| S:26959 E:26970 ||| IN
β-lactamases  ||| S:26970 E:26983 ||| NN
that  ||| S:26983 E:26988 ||| WDT
are  ||| S:26988 E:26992 ||| VBP
particularly  ||| S:26992 E:27005 ||| RB
unaffected  ||| S:27005 E:27016 ||| VBN
by  ||| S:27016 E:27019 ||| IN
the  ||| S:27019 E:27023 ||| DT
known  ||| S:27023 E:27037 ||| VBN
β-lactamase  ||| S:27037 E:27049 ||| JJ
inhibitors  ||| S:27049 E:27060 ||| NN
and  ||| S:27060 E:27064 ||| CC
have  ||| S:27064 E:27069 ||| VBP
been  ||| S:27069 E:27074 ||| VBN
shown  ||| S:27074 E:27080 ||| VBN
to  ||| S:27080 E:27083 ||| TO
hydrolyze  ||| S:27083 E:27101 ||| VB
almost  ||| S:27101 E:27108 ||| RB
all  ||| S:27108 E:27112 ||| RB
known  ||| S:27112 E:27118 ||| VBN
β-lactam  ||| S:27118 E:27127 ||| JJ
containing  ||| S:27127 E:27138 ||| NNS
antibiotics  ||| S:27138 E:27150 ||| VBP
including  ||| S:27150 E:27168 ||| VBG
late  ||| S:27168 E:27173 ||| JJ
generation  ||| S:27173 E:27184 ||| NN
carbapenems  ||| S:27184 E:27196 ||| NN
at  ||| S:27196 E:27199 ||| IN
high  ||| S:27199 E:27204 ||| JJ
rates  ||| S:27204 E:27210 ||| NNS
are  ||| S:27210 E:27214 ||| VBP
the  ||| S:27214 E:27226 ||| DT
metallo-β-lactamases  ||| S:27226 E:27247 ||| JJ
[  ||| S:27247 E:27249 ||| -LRB-
14  ||| S:27249 E:27252 ||| CD
15  ||| S:27252 E:27255 ||| CD
16  ||| S:27255 E:27258 ||| CD
17  ||| S:27258 E:27261 ||| CD
18  ||| S:27261 E:27264 ||| CD
19  ||| S:27264 E:27267 ||| CD
]  ||| S:27267 E:27269 ||| -RRB-
.  ||| S:27269 E:27271 ||| .
Although  ||| S:27271 E:27280 ||| IN
there  ||| S:27280 E:27294 ||| EX
are  ||| S:27294 E:27298 ||| VBP
no  ||| S:27298 E:27301 ||| DT
reports  ||| S:27301 E:27309 ||| NNS
of  ||| S:27309 E:27312 ||| IN
metallo-β-lactamases  ||| S:27312 E:27333 ||| JJ
isolated  ||| S:27333 E:27342 ||| NN
from  ||| S:27342 E:27347 ||| IN
major  ||| S:27347 E:27361 ||| JJ
pathogens  ||| S:27361 E:27371 ||| NNS
[  ||| S:27371 E:27373 ||| -LRB-
51  ||| S:27373 E:27376 ||| CD
53  ||| S:27376 E:27379 ||| CD
]  ||| S:27379 E:27381 ||| -RRB-
,  ||| S:27381 E:27383 ||| ,
these  ||| S:27383 E:27389 ||| DT
enzymes  ||| S:27389 E:27397 ||| NNS
are  ||| S:27397 E:27401 ||| VBP
produced  ||| S:27401 E:27410 ||| VBN
by  ||| S:27410 E:27421 ||| IN
pathogens  ||| S:27421 E:27431 ||| JJ
such  ||| S:27431 E:27436 ||| JJ
as  ||| S:27436 E:27448 ||| IN
B.  ||| S:27448 E:27451 ||| NNP
fragilis ||| S:27451 E:27459 ||| NN
,  ||| S:27459 E:27461 ||| ,
S.  ||| S:27461 E:27464 ||| NNP
maltophilia ||| S:27464 E:27475 ||| NN
,  ||| S:27475 E:27477 ||| ,
and  ||| S:27477 E:27490 ||| CC
P.  ||| S:27490 E:27493 ||| NNP
aeruginosa ||| S:27493 E:27503 ||| NN
.  ||| S:27503 E:27505 ||| .
It  ||| S:27505 E:27508 ||| PRP
is  ||| S:27508 E:27511 ||| VBZ
inevitable  ||| S:27511 E:27522 ||| JJ
that  ||| S:27522 E:27535 ||| IN
the  ||| S:27535 E:27539 ||| DT
continued  ||| S:27539 E:27549 ||| JJ
and  ||| S:27549 E:27553 ||| CC
extensive  ||| S:27553 E:27563 ||| JJ
use  ||| S:27563 E:27567 ||| NN
of  ||| S:27567 E:27570 ||| IN
β-lactam  ||| S:27570 E:27579 ||| JJ
antibiotics  ||| S:27579 E:27599 ||| NN
will  ||| S:27599 E:27604 ||| MD
result  ||| S:27604 E:27611 ||| VB
in  ||| S:27611 E:27614 ||| IN
a  ||| S:27614 E:27616 ||| DT
major  ||| S:27616 E:27622 ||| JJ
pathogen  ||| S:27622 E:27631 ||| NN
that  ||| S:27631 E:27636 ||| WDT
produces  ||| S:27636 E:27645 ||| VBZ
a  ||| S:27645 E:27655 ||| DT
metallo-β-lactamase ||| S:27655 E:27674 ||| JJ
.  ||| S:27674 E:27684 ||| .
Efforts  ||| S:27684 E:27692 ||| NNS
to  ||| S:27692 E:27695 ||| TO
solve  ||| S:27695 E:27701 ||| VB
the  ||| S:27701 E:27705 ||| DT
crystal  ||| S:27705 E:27713 ||| NN
structure  ||| S:27713 E:27723 ||| NN
of  ||| S:27723 E:27726 ||| IN
one  ||| S:27726 E:27730 ||| CD
of  ||| S:27730 E:27733 ||| IN
the  ||| S:27733 E:27745 ||| DT
metallo-β-lactamases  ||| S:27745 E:27766 ||| JJ
with  ||| S:27766 E:27771 ||| IN
a  ||| S:27771 E:27773 ||| DT
bound  ||| S:27773 E:27779 ||| JJ
substrate  ||| S:27779 E:27789 ||| JJ
molecule  ||| S:27789 E:27798 ||| NNS
have  ||| S:27798 E:27811 ||| VBP
failed ||| S:27811 E:27817 ||| VBN
,  ||| S:27817 E:27819 ||| ,
most  ||| S:27819 E:27824 ||| RBS
likely  ||| S:27824 E:27831 ||| JJ
due  ||| S:27831 E:27835 ||| JJ
to  ||| S:27835 E:27838 ||| TO
the  ||| S:27838 E:27842 ||| DT
high  ||| S:27842 E:27847 ||| JJ
activity  ||| S:27847 E:27856 ||| NN
of  ||| S:27856 E:27859 ||| IN
the  ||| S:27859 E:27863 ||| DT
enzymes  ||| S:27863 E:27879 ||| NN
towards  ||| S:27879 E:27887 ||| IN
all  ||| S:27887 E:27891 ||| DT
β-lactam  ||| S:27891 E:27900 ||| JJ
containing  ||| S:27900 E:27911 ||| VBG
antibiotics  ||| S:27911 E:27923 ||| NNS
[  ||| S:27923 E:27925 ||| -LRB-
37  ||| S:27925 E:27928 ||| CD
54  ||| S:27928 E:27931 ||| CD
]  ||| S:27931 E:27933 ||| -RRB-
.  ||| S:27933 E:27943 ||| .
Therefore ||| S:27943 E:27952 ||| RB
,  ||| S:27952 E:27954 ||| ,
computational  ||| S:27954 E:27968 ||| JJ
studies  ||| S:27968 E:27976 ||| NNS
have  ||| S:27976 E:27981 ||| VBP
been  ||| S:27981 E:27986 ||| VBN
used  ||| S:27986 E:27991 ||| VBN
extensively  ||| S:27991 E:28011 ||| RB
to  ||| S:28011 E:28014 ||| TO
study  ||| S:28014 E:28020 ||| VB
substrate  ||| S:28020 E:28030 ||| JJ
binding ||| S:28030 E:28037 ||| NN
,  ||| S:28037 E:28039 ||| ,
the  ||| S:28039 E:28043 ||| DT
role  ||| S:28043 E:28048 ||| NN
of  ||| S:28048 E:28051 ||| IN
the  ||| S:28051 E:28055 ||| DT
Zn ||| S:28055 E:28057 ||| NNP
( ||| S:28057 E:28058 ||| -LRB-
II ||| S:28058 E:28060 ||| NNP
)  ||| S:28060 E:28062 ||| -RRB-
ions  ||| S:28062 E:28067 ||| NN
in  ||| S:28067 E:28078 ||| IN
catalysis ||| S:28078 E:28087 ||| NN
,  ||| S:28087 E:28089 ||| ,
the  ||| S:28089 E:28093 ||| DT
protonation  ||| S:28093 E:28105 ||| JJ
state  ||| S:28105 E:28111 ||| NN
of  ||| S:28111 E:28114 ||| IN
the  ||| S:28114 E:28118 ||| DT
active  ||| S:28118 E:28125 ||| JJ
site ||| S:28125 E:28129 ||| NN
,  ||| S:28129 E:28131 ||| ,
and  ||| S:28131 E:28143 ||| CC
inhibitor  ||| S:28143 E:28153 ||| JJ
binding  ||| S:28153 E:28161 ||| NNS
[  ||| S:28161 E:28163 ||| -LRB-
37  ||| S:28163 E:28166 ||| CD
42  ||| S:28166 E:28169 ||| CD
55  ||| S:28169 E:28172 ||| CD
56  ||| S:28172 E:28175 ||| CD
57  ||| S:28175 E:28178 ||| CD
58  ||| S:28178 E:28181 ||| CD
59  ||| S:28181 E:28184 ||| CD
]  ||| S:28184 E:28186 ||| -RRB-
.  ||| S:28186 E:28188 ||| .
All  ||| S:28188 E:28192 ||| DT
of  ||| S:28192 E:28195 ||| IN
the  ||| S:28195 E:28207 ||| DT
substrate  ||| S:28207 E:28217 ||| JJ
binding  ||| S:28217 E:28225 ||| JJ
models  ||| S:28225 E:28232 ||| NNS
have  ||| S:28232 E:28237 ||| VBP
made  ||| S:28237 E:28242 ||| VBN
assumptions  ||| S:28242 E:28254 ||| NNS
before  ||| S:28254 E:28261 ||| IN
the  ||| S:28261 E:28273 ||| DT
substrate  ||| S:28273 E:28283 ||| NN
was  ||| S:28283 E:28287 ||| VBD
docked  ||| S:28287 E:28294 ||| VBN
into  ||| S:28294 E:28299 ||| IN
the  ||| S:28299 E:28303 ||| DT
active  ||| S:28303 E:28310 ||| JJ
site  ||| S:28310 E:28315 ||| NN
[  ||| S:28315 E:28317 ||| -LRB-
37  ||| S:28317 E:28320 ||| CD
42  ||| S:28320 E:28323 ||| CD
]  ||| S:28323 E:28325 ||| -RRB-
,  ||| S:28325 E:28327 ||| ,
and  ||| S:28327 E:28339 ||| CC
some  ||| S:28339 E:28344 ||| DT
of  ||| S:28344 E:28347 ||| IN
these  ||| S:28347 E:28353 ||| DT
assumptions  ||| S:28353 E:28365 ||| NNS
have  ||| S:28365 E:28370 ||| VBP
been  ||| S:28370 E:28375 ||| VBN
shown  ||| S:28375 E:28381 ||| VBN
to  ||| S:28381 E:28384 ||| TO
be  ||| S:28384 E:28387 ||| VB
invalid  ||| S:28387 E:28395 ||| VBN
for  ||| S:28395 E:28407 ||| IN
certain  ||| S:28407 E:28415 ||| JJ
substrates  ||| S:28415 E:28426 ||| NNS
[  ||| S:28426 E:28428 ||| -LRB-
43  ||| S:28428 E:28431 ||| CD
]  ||| S:28431 E:28433 ||| -RRB-
.  ||| S:28433 E:28435 ||| .
With  ||| S:28435 E:28440 ||| IN
L1 ||| S:28440 E:28442 ||| NNP
,  ||| S:28442 E:28444 ||| ,
two  ||| S:28444 E:28448 ||| CD
key  ||| S:28448 E:28452 ||| JJ
assumptions  ||| S:28452 E:28472 ||| NNS
were  ||| S:28472 E:28477 ||| VBD
made ||| S:28477 E:28481 ||| VBN
:  ||| S:28481 E:28483 ||| :
( ||| S:28483 E:28484 ||| -LRB-
1 ||| S:28484 E:28485 ||| LS
)  ||| S:28485 E:28487 ||| -RRB-
the  ||| S:28487 E:28491 ||| DT
bridging  ||| S:28491 E:28500 ||| JJ
hydroxide  ||| S:28500 E:28510 ||| JJ
functions  ||| S:28510 E:28520 ||| NNS
as  ||| S:28520 E:28523 ||| IN
the  ||| S:28523 E:28535 ||| DT
nucleophile  ||| S:28535 E:28547 ||| NN
during  ||| S:28547 E:28554 ||| IN
catalysis  ||| S:28554 E:28564 ||| NN
and  ||| S:28564 E:28568 ||| CC
( ||| S:28568 E:28569 ||| -LRB-
2 ||| S:28569 E:28570 ||| LS
)  ||| S:28570 E:28572 ||| -RRB-
Zn  ||| S:28572 E:28584 ||| NNP
1  ||| S:28584 E:28586 ||| CD
coordinates  ||| S:28586 E:28598 ||| VBZ
the  ||| S:28598 E:28602 ||| DT
β-lactam  ||| S:28602 E:28611 ||| JJ
carbonyl  ||| S:28611 E:28620 ||| NNS
[  ||| S:28620 E:28622 ||| -LRB-
37  ||| S:28622 E:28633 ||| CD
]  ||| S:28633 E:28635 ||| -RRB-
.  ||| S:28635 E:28637 ||| .
With  ||| S:28637 E:28642 ||| IN
these  ||| S:28642 E:28648 ||| DT
assumptions  ||| S:28648 E:28660 ||| NNS
and  ||| S:28660 E:28664 ||| CC
after  ||| S:28664 E:28670 ||| IN
energy  ||| S:28670 E:28677 ||| NN
minimizations ||| S:28677 E:28690 ||| NN
,  ||| S:28690 E:28700 ||| ,
Ser224  ||| S:28700 E:28707 ||| NNP
was  ||| S:28707 E:28711 ||| VBD
predicted  ||| S:28711 E:28721 ||| VBN
to  ||| S:28721 E:28724 ||| TO
hydrogen  ||| S:28724 E:28733 ||| VB
bond  ||| S:28733 E:28738 ||| NN
to  ||| S:28738 E:28741 ||| TO
the  ||| S:28741 E:28745 ||| DT
substrate  ||| S:28745 E:28763 ||| JJ
carboxylate  ||| S:28763 E:28775 ||| NNS
[  ||| S:28775 E:28777 ||| -LRB-
37  ||| S:28777 E:28780 ||| CD
]  ||| S:28780 E:28782 ||| -RRB-
,  ||| S:28782 E:28784 ||| ,
reminiscent  ||| S:28784 E:28796 ||| JJ
of  ||| S:28796 E:28799 ||| IN
the  ||| S:28799 E:28803 ||| DT
role  ||| S:28803 E:28808 ||| NN
predicted  ||| S:28808 E:28818 ||| VBD
for  ||| S:28818 E:28830 ||| IN
Lys224  ||| S:28830 E:28837 ||| CD
in  ||| S:28837 E:28840 ||| IN
CcrA  ||| S:28840 E:28845 ||| NNP
[  ||| S:28845 E:28847 ||| -LRB-
42  ||| S:28847 E:28850 ||| CD
]  ||| S:28850 E:28852 ||| -RRB-
.  ||| S:28852 E:28854 ||| .
Ullah  ||| S:28854 E:28869 ||| NNP
et  ||| S:28869 E:28872 ||| NNP
al.  ||| S:28872 E:28876 ||| NNP
predicted  ||| S:28876 E:28886 ||| VBD
that  ||| S:28886 E:28891 ||| IN
Phe158  ||| S:28891 E:28898 ||| NNP
and  ||| S:28898 E:28902 ||| CC
Ile  ||| S:28902 E:28914 ||| NNP
164  ||| S:28914 E:28918 ||| CD
form  ||| S:28918 E:28923 ||| NN
hydrophobic  ||| S:28923 E:28935 ||| NN
interactions  ||| S:28935 E:28948 ||| NNS
with  ||| S:28948 E:28953 ||| IN
bulky  ||| S:28953 E:28959 ||| JJ
substituents  ||| S:28959 E:28980 ||| NN
on  ||| S:28980 E:28983 ||| IN
the  ||| S:28983 E:28987 ||| DT
substrate ||| S:28987 E:28996 ||| NN
,  ||| S:28996 E:28998 ||| ,
suggesting  ||| S:28998 E:29009 ||| VBG
that  ||| S:29009 E:29014 ||| IN
the  ||| S:29014 E:29018 ||| DT
loss  ||| S:29018 E:29023 ||| NN
of  ||| S:29023 E:29026 ||| IN
these  ||| S:29026 E:29040 ||| DT
residues  ||| S:29040 E:29049 ||| NN
would  ||| S:29049 E:29055 ||| MD
only  ||| S:29055 E:29060 ||| RB
affect  ||| S:29060 E:29067 ||| VB
binding  ||| S:29067 E:29075 ||| VBN
of  ||| S:29075 E:29078 ||| IN
substrates  ||| S:29078 E:29089 ||| NN
with  ||| S:29089 E:29094 ||| IN
large  ||| S:29094 E:29108 ||| JJ
aromatic  ||| S:29108 E:29117 ||| JJ
substituents  ||| S:29117 E:29130 ||| NNS
[  ||| S:29130 E:29132 ||| -LRB-
37  ||| S:29132 E:29135 ||| CD
]  ||| S:29135 E:29137 ||| -RRB-
.  ||| S:29137 E:29139 ||| .
In  ||| S:29139 E:29142 ||| IN
the  ||| S:29142 E:29146 ||| DT
modeling  ||| S:29146 E:29155 ||| JJ
studies  ||| S:29155 E:29163 ||| NNS
on  ||| S:29163 E:29174 ||| IN
CcrA  ||| S:29174 E:29179 ||| NNP
[  ||| S:29179 E:29181 ||| -LRB-
42  ||| S:29181 E:29184 ||| CD
]  ||| S:29184 E:29186 ||| -RRB-
,  ||| S:29186 E:29188 ||| ,
Asn233  ||| S:29188 E:29195 ||| NNP
was  ||| S:29195 E:29199 ||| VBD
predicted  ||| S:29199 E:29209 ||| VBN
to  ||| S:29209 E:29212 ||| TO
interact  ||| S:29212 E:29221 ||| VB
with  ||| S:29221 E:29226 ||| IN
the  ||| S:29226 E:29238 ||| DT
β-lactam  ||| S:29238 E:29247 ||| JJ
carbonyl  ||| S:29247 E:29256 ||| NN
on  ||| S:29256 E:29259 ||| IN
substrate ||| S:29259 E:29268 ||| NN
,  ||| S:29268 E:29270 ||| ,
and  ||| S:29270 E:29274 ||| CC
mutagenesis  ||| S:29274 E:29286 ||| JJ
studies  ||| S:29286 E:29302 ||| NNS
have  ||| S:29302 E:29307 ||| VBP
supported  ||| S:29307 E:29317 ||| VBN
this  ||| S:29317 E:29322 ||| DT
prediction  ||| S:29322 E:29333 ||| NN
[  ||| S:29333 E:29335 ||| -LRB-
43  ||| S:29335 E:29338 ||| CD
]  ||| S:29338 E:29340 ||| -RRB-
.  ||| S:29340 E:29342 ||| .
Although  ||| S:29342 E:29351 ||| IN
Asn233  ||| S:29351 E:29358 ||| NNP
is  ||| S:29358 E:29369 ||| VBZ
sequence  ||| S:29369 E:29378 ||| JJ
conserved  ||| S:29378 E:29388 ||| NN
in  ||| S:29388 E:29391 ||| IN
L1  ||| S:29391 E:29394 ||| NNP
[  ||| S:29394 E:29396 ||| -LRB-
35  ||| S:29396 E:29399 ||| CD
]  ||| S:29399 E:29401 ||| -RRB-
,  ||| S:29401 E:29403 ||| ,
it  ||| S:29403 E:29406 ||| PRP
is  ||| S:29406 E:29409 ||| VBZ
located  ||| S:29409 E:29417 ||| VBN
14Å  ||| S:29417 E:29421 ||| RB
away  ||| S:29421 E:29434 ||| RB
from  ||| S:29434 E:29439 ||| IN
the  ||| S:29439 E:29443 ||| DT
modeled  ||| S:29443 E:29451 ||| JJ
position  ||| S:29451 E:29460 ||| NN
of  ||| S:29460 E:29463 ||| IN
the  ||| S:29463 E:29467 ||| DT
β-lactam  ||| S:29467 E:29476 ||| JJ
carbonyl  ||| S:29476 E:29485 ||| NN
and  ||| S:29485 E:29489 ||| CC
was  ||| S:29489 E:29501 ||| VBD
predicted  ||| S:29501 E:29511 ||| VBN
not  ||| S:29511 E:29515 ||| RB
to  ||| S:29515 E:29518 ||| TO
play  ||| S:29518 E:29523 ||| VB
a  ||| S:29523 E:29525 ||| DT
role  ||| S:29525 E:29530 ||| NN
in  ||| S:29530 E:29533 ||| IN
substrate  ||| S:29533 E:29543 ||| JJ
binding  ||| S:29543 E:29551 ||| NN
to  ||| S:29551 E:29554 ||| TO
L1  ||| S:29554 E:29557 ||| CD
[  ||| S:29557 E:29567 ||| -LRB-
37  ||| S:29567 E:29570 ||| CD
]  ||| S:29570 E:29572 ||| -RRB-
.  ||| S:29572 E:29574 ||| .
On  ||| S:29574 E:29577 ||| IN
the  ||| S:29577 E:29581 ||| DT
other  ||| S:29581 E:29587 ||| JJ
hand ||| S:29587 E:29591 ||| NN
,  ||| S:29591 E:29593 ||| ,
the  ||| S:29593 E:29597 ||| DT
substrate-binding  ||| S:29597 E:29615 ||| JJ
model  ||| S:29615 E:29629 ||| NN
predicted  ||| S:29629 E:29639 ||| VBD
that  ||| S:29639 E:29644 ||| IN
Tyr228  ||| S:29644 E:29651 ||| NNP
was  ||| S:29651 E:29655 ||| VBD
in  ||| S:29655 E:29658 ||| IN
position  ||| S:29658 E:29667 ||| NN
to  ||| S:29667 E:29670 ||| TO
offer  ||| S:29670 E:29676 ||| VB
a  ||| S:29676 E:29678 ||| DT
hydrogen  ||| S:29678 E:29695 ||| NN
bond  ||| S:29695 E:29700 ||| NN
to  ||| S:29700 E:29703 ||| TO
the  ||| S:29703 E:29707 ||| DT
β-lactam  ||| S:29707 E:29716 ||| JJ
carbonyl  ||| S:29716 E:29725 ||| NN
and  ||| S:29725 E:29729 ||| CC
participate  ||| S:29729 E:29741 ||| VB
in  ||| S:29741 E:29744 ||| IN
an  ||| S:29744 E:29755 ||| DT
oxyanion  ||| S:29755 E:29764 ||| JJ
hole  ||| S:29764 E:29769 ||| NN
that  ||| S:29769 E:29774 ||| WDT
was  ||| S:29774 E:29778 ||| VBD
proposed  ||| S:29778 E:29787 ||| VBN
to  ||| S:29787 E:29790 ||| TO
form  ||| S:29790 E:29795 ||| VB
as  ||| S:29795 E:29798 ||| IN
the  ||| S:29798 E:29802 ||| DT
substrate  ||| S:29802 E:29820 ||| NN
was  ||| S:29820 E:29824 ||| VBD
hydrolyzed  ||| S:29824 E:29835 ||| NNS
[  ||| S:29835 E:29837 ||| -LRB-
37  ||| S:29837 E:29840 ||| CD
]  ||| S:29840 E:29842 ||| -RRB-
.  ||| S:29842 E:29844 ||| .
By  ||| S:29844 E:29847 ||| IN
using  ||| S:29847 E:29853 ||| VBG
the  ||| S:29853 E:29857 ||| DT
crystal  ||| S:29857 E:29865 ||| NN
structure  ||| S:29865 E:29875 ||| NN
and  ||| S:29875 E:29887 ||| CC
modeling  ||| S:29887 E:29896 ||| JJ
studies  ||| S:29896 E:29904 ||| NNS
on  ||| S:29904 E:29907 ||| IN
L1 ||| S:29907 E:29909 ||| NNP
,  ||| S:29909 E:29911 ||| ,
Ullah  ||| S:29911 E:29926 ||| NNP
et  ||| S:29926 E:29929 ||| NNP
al.  ||| S:29929 E:29933 ||| NNP
proposed  ||| S:29933 E:29942 ||| VBD
a  ||| S:29942 E:29944 ||| DT
reaction  ||| S:29944 E:29953 ||| NN
mechanism  ||| S:29953 E:29971 ||| NN
for  ||| S:29971 E:29975 ||| IN
the  ||| S:29975 E:29979 ||| DT
enzyme  ||| S:29979 E:29986 ||| NN
[  ||| S:29986 E:29988 ||| -LRB-
37  ||| S:29988 E:29991 ||| CD
]  ||| S:29991 E:29993 ||| -RRB-
.  ||| S:29993 E:29995 ||| .
To  ||| S:29995 E:29998 ||| TO
test  ||| S:29998 E:30003 ||| VB
this  ||| S:30003 E:30008 ||| DT
proposed  ||| S:30008 E:30017 ||| JJ
mechanism  ||| S:30017 E:30027 ||| NN
and  ||| S:30027 E:30039 ||| CC
the  ||| S:30039 E:30043 ||| DT
proposed  ||| S:30043 E:30052 ||| JJ
roles  ||| S:30052 E:30058 ||| NNS
of  ||| S:30058 E:30061 ||| IN
the  ||| S:30061 E:30065 ||| DT
amino  ||| S:30065 E:30071 ||| JJ
acids  ||| S:30071 E:30077 ||| NNS
discussed  ||| S:30077 E:30087 ||| VBN
above ||| S:30087 E:30092 ||| IN
,  ||| S:30092 E:30102 ||| ,
site-directed  ||| S:30102 E:30116 ||| JJ
mutagenesis  ||| S:30116 E:30128 ||| JJ
studies  ||| S:30128 E:30136 ||| NNS
were  ||| S:30136 E:30141 ||| VBD
conducted  ||| S:30141 E:30151 ||| VBN
on  ||| S:30151 E:30162 ||| IN
metallo-β-lactamase  ||| S:30162 E:30182 ||| NNP
L1  ||| S:30182 E:30185 ||| NNP
and  ||| S:30185 E:30189 ||| CC
reported  ||| S:30189 E:30198 ||| VBD
herein ||| S:30198 E:30204 ||| VBN
.  ||| S:30204 E:30214 ||| .
The  ||| S:30214 E:30218 ||| DT
overlap  ||| S:30218 E:30226 ||| JJ
extension  ||| S:30226 E:30236 ||| NN
method  ||| S:30236 E:30243 ||| NN
[  ||| S:30243 E:30245 ||| -LRB-
60  ||| S:30245 E:30248 ||| CD
]  ||| S:30248 E:30250 ||| -RRB-
was  ||| S:30250 E:30254 ||| VBD
used  ||| S:30254 E:30259 ||| VBN
to  ||| S:30259 E:30262 ||| TO
prepare  ||| S:30262 E:30278 ||| VB
the  ||| S:30278 E:30282 ||| DT
site-directed  ||| S:30282 E:30296 ||| JJ
mutants ||| S:30296 E:30303 ||| NN
,  ||| S:30303 E:30305 ||| ,
and  ||| S:30305 E:30309 ||| CC
a  ||| S:30309 E:30311 ||| DT
variety  ||| S:30311 E:30319 ||| NN
of  ||| S:30319 E:30322 ||| IN
studies  ||| S:30322 E:30330 ||| NNS
were  ||| S:30330 E:30343 ||| VBD
used  ||| S:30343 E:30348 ||| VBN
to  ||| S:30348 E:30351 ||| TO
probe  ||| S:30351 E:30357 ||| VB
whether  ||| S:30357 E:30365 ||| IN
the  ||| S:30365 E:30369 ||| DT
single  ||| S:30369 E:30376 ||| JJ
point  ||| S:30376 E:30382 ||| NN
mutations  ||| S:30382 E:30392 ||| NNS
resulted  ||| S:30392 E:30409 ||| VBD
in  ||| S:30409 E:30412 ||| IN
large  ||| S:30412 E:30418 ||| JJ
structural  ||| S:30418 E:30429 ||| JJ
changes  ||| S:30429 E:30437 ||| NNS
in  ||| S:30437 E:30440 ||| IN
the  ||| S:30440 E:30444 ||| DT
mutant  ||| S:30444 E:30451 ||| JJ
enzymes.  ||| S:30451 E:30460 ||| NNP
( ||| S:30460 E:30461 ||| -LRB-
1 ||| S:30461 E:30462 ||| LS
)  ||| S:30462 E:30464 ||| -RRB-
The  ||| S:30464 E:30476 ||| DT
over-expression  ||| S:30476 E:30492 ||| JJ
levels  ||| S:30492 E:30499 ||| NNS
of  ||| S:30499 E:30502 ||| IN
mutants  ||| S:30502 E:30510 ||| NN
were  ||| S:30510 E:30515 ||| VBD
analyzed  ||| S:30515 E:30524 ||| VBN
with  ||| S:30524 E:30537 ||| IN
SDS-PAGE  ||| S:30537 E:30546 ||| JJ
to  ||| S:30546 E:30549 ||| TO
ensure  ||| S:30549 E:30556 ||| VB
that  ||| S:30556 E:30561 ||| IN
the  ||| S:30561 E:30565 ||| DT
mutations  ||| S:30565 E:30575 ||| NN
did  ||| S:30575 E:30579 ||| VBD
not  ||| S:30579 E:30583 ||| RB
result  ||| S:30583 E:30590 ||| VB
in  ||| S:30590 E:30601 ||| IN
changes  ||| S:30601 E:30609 ||| NNS
in  ||| S:30609 E:30612 ||| IN
the  ||| S:30612 E:30616 ||| DT
over-expression  ||| S:30616 E:30632 ||| JJ
levels  ||| S:30632 E:30639 ||| NNS
of  ||| S:30639 E:30642 ||| IN
the  ||| S:30642 E:30646 ||| DT
enzymes ||| S:30646 E:30653 ||| NN
.  ||| S:30653 E:30655 ||| .
With  ||| S:30655 E:30668 ||| IN
a  ||| S:30668 E:30670 ||| DT
few  ||| S:30670 E:30674 ||| JJ
L1  ||| S:30674 E:30677 ||| CD
mutants  ||| S:30677 E:30685 ||| NNS
and  ||| S:30685 E:30689 ||| CC
with  ||| S:30689 E:30694 ||| IN
other  ||| S:30694 E:30700 ||| JJ
enzyme  ||| S:30700 E:30707 ||| JJ
systems  ||| S:30707 E:30715 ||| NNS
in  ||| S:30715 E:30718 ||| IN
the  ||| S:30718 E:30722 ||| DT
lab ||| S:30722 E:30725 ||| NN
,  ||| S:30725 E:30735 ||| ,
single  ||| S:30735 E:30742 ||| JJ
point  ||| S:30742 E:30748 ||| NN
mutations  ||| S:30748 E:30758 ||| NNS
often  ||| S:30758 E:30764 ||| RB
result  ||| S:30764 E:30771 ||| VB
in  ||| S:30771 E:30774 ||| IN
depressed  ||| S:30774 E:30784 ||| JJ
levels  ||| S:30784 E:30791 ||| NNS
of  ||| S:30791 E:30802 ||| IN
over-expression  ||| S:30802 E:30818 ||| NNP
[  ||| S:30818 E:30820 ||| -LRB-
61  ||| S:30820 E:30823 ||| CD
]  ||| S:30823 E:30825 ||| -RRB-
.  ||| S:30825 E:30827 ||| .
In  ||| S:30827 E:30830 ||| IN
the  ||| S:30830 E:30834 ||| DT
case  ||| S:30834 E:30839 ||| NN
of  ||| S:30839 E:30842 ||| IN
the  ||| S:30842 E:30846 ||| DT
mutants  ||| S:30846 E:30862 ||| NN
described  ||| S:30862 E:30872 ||| VBD
here ||| S:30872 E:30876 ||| RB
,  ||| S:30876 E:30878 ||| ,
all  ||| S:30878 E:30882 ||| DT
of  ||| S:30882 E:30885 ||| IN
the  ||| S:30885 E:30889 ||| DT
mutants  ||| S:30889 E:30897 ||| JJ
over-expressed  ||| S:30897 E:30912 ||| NN
at  ||| S:30912 E:30915 ||| IN
levels  ||| S:30915 E:30930 ||| NNS
comparable  ||| S:30930 E:30941 ||| JJ
to  ||| S:30941 E:30944 ||| TO
wild-type  ||| S:30944 E:30954 ||| NNP
L1  ||| S:30954 E:30957 ||| NNP
( ||| S:30957 E:30958 ||| -LRB-
data  ||| S:30958 E:30963 ||| NNS
not  ||| S:30963 E:30967 ||| RB
shown ||| S:30967 E:30972 ||| VBN
) ||| S:30972 E:30973 ||| -RRB-
.  ||| S:30973 E:30975 ||| .
( ||| S:30975 E:30976 ||| -LRB-
2 ||| S:30976 E:30977 ||| LS
)  ||| S:30977 E:30979 ||| -RRB-
The  ||| S:30979 E:30983 ||| DT
total  ||| S:30983 E:30997 ||| JJ
amounts  ||| S:30997 E:31005 ||| NNS
of  ||| S:31005 E:31008 ||| IN
the  ||| S:31008 E:31012 ||| DT
mutants  ||| S:31012 E:31020 ||| JJ
isolatable  ||| S:31020 E:31031 ||| NN
after  ||| S:31031 E:31037 ||| IN
chromatography  ||| S:31037 E:31052 ||| NN
were  ||| S:31052 E:31065 ||| VBD
compared  ||| S:31065 E:31074 ||| VBN
with  ||| S:31074 E:31079 ||| IN
wild-type  ||| S:31079 E:31089 ||| JJ
L1  ||| S:31089 E:31092 ||| CD
levels ||| S:31092 E:31098 ||| NNS
.  ||| S:31098 E:31100 ||| .
We  ||| S:31100 E:31103 ||| PRP
have  ||| S:31103 E:31108 ||| VBP
found ||| S:31108 E:31113 ||| VBN
,  ||| S:31113 E:31115 ||| ,
in  ||| S:31115 E:31126 ||| IN
particular  ||| S:31126 E:31137 ||| JJ
with  ||| S:31137 E:31142 ||| IN
metal  ||| S:31142 E:31148 ||| NN
binding  ||| S:31148 E:31156 ||| JJ
mutants  ||| S:31156 E:31164 ||| NN
of  ||| S:31164 E:31167 ||| IN
L1  ||| S:31167 E:31170 ||| NNP
( ||| S:31170 E:31171 ||| -LRB-
G ||| S:31171 E:31172 ||| NNP
.  ||| S:31172 E:31174 ||| .
Periyannan ||| S:31174 E:31184 ||| NNP
,  ||| S:31184 E:31194 ||| ,
R.B.  ||| S:31194 E:31199 ||| NNP
Yates ||| S:31199 E:31204 ||| NNP
,  ||| S:31204 E:31206 ||| ,
and  ||| S:31206 E:31210 ||| CC
M.W.  ||| S:31210 E:31215 ||| NNP
Crowder ||| S:31215 E:31222 ||| NNP
,  ||| S:31222 E:31224 ||| ,
unpublished  ||| S:31224 E:31236 ||| JJ
results ||| S:31236 E:31243 ||| NNS
)  ||| S:31243 E:31245 ||| -RRB-
and  ||| S:31245 E:31257 ||| CC
glyoxalase  ||| S:31257 E:31268 ||| JJ
II  ||| S:31268 E:31271 ||| NNP
[  ||| S:31271 E:31273 ||| -LRB-
61  ||| S:31273 E:31276 ||| CD
]  ||| S:31276 E:31278 ||| -RRB-
,  ||| S:31278 E:31280 ||| ,
that  ||| S:31280 E:31285 ||| DT
single  ||| S:31285 E:31292 ||| JJ
point  ||| S:31292 E:31298 ||| NN
mutations  ||| S:31298 E:31308 ||| NNS
can  ||| S:31308 E:31320 ||| MD
result  ||| S:31320 E:31327 ||| VB
in  ||| S:31327 E:31330 ||| IN
over-expressed  ||| S:31330 E:31345 ||| JJ
mutants  ||| S:31345 E:31353 ||| NNS
being  ||| S:31353 E:31359 ||| VBG
processed  ||| S:31359 E:31369 ||| VBN
into  ||| S:31369 E:31382 ||| IN
inclusion  ||| S:31382 E:31392 ||| NN
bodies  ||| S:31392 E:31399 ||| NNS
and  ||| S:31399 E:31403 ||| CC
unisolatable  ||| S:31403 E:31416 ||| NN
as  ||| S:31416 E:31419 ||| IN
soluble  ||| S:31419 E:31427 ||| JJ
proteins ||| S:31427 E:31435 ||| NNS
.  ||| S:31435 E:31437 ||| .
In  ||| S:31437 E:31448 ||| IN
the  ||| S:31448 E:31452 ||| DT
case  ||| S:31452 E:31457 ||| NN
of  ||| S:31457 E:31460 ||| IN
the  ||| S:31460 E:31464 ||| DT
mutants  ||| S:31464 E:31472 ||| NN
described  ||| S:31472 E:31482 ||| VBD
here ||| S:31482 E:31486 ||| RB
,  ||| S:31486 E:31488 ||| ,
all  ||| S:31488 E:31492 ||| DT
of  ||| S:31492 E:31495 ||| IN
the  ||| S:31495 E:31499 ||| DT
mutants  ||| S:31499 E:31515 ||| NN
were  ||| S:31515 E:31520 ||| VBD
isolated  ||| S:31520 E:31529 ||| VBN
at  ||| S:31529 E:31532 ||| IN
levels  ||| S:31532 E:31539 ||| NNS
comparable  ||| S:31539 E:31550 ||| JJ
to  ||| S:31550 E:31553 ||| TO
wild-type  ||| S:31553 E:31563 ||| NNP
L1.  ||| S:31563 E:31567 ||| NNP
( ||| S:31567 E:31568 ||| -LRB-
3 ||| S:31568 E:31569 ||| LS
)  ||| S:31569 E:31571 ||| -RRB-
CD  ||| S:31571 E:31582 ||| NN
spectra  ||| S:31582 E:31590 ||| NNS
were  ||| S:31590 E:31595 ||| VBD
collected  ||| S:31595 E:31605 ||| VBN
for  ||| S:31605 E:31609 ||| IN
all  ||| S:31609 E:31613 ||| DT
mutants  ||| S:31613 E:31621 ||| NN
and  ||| S:31621 E:31625 ||| CC
compared  ||| S:31625 E:31634 ||| VBN
to  ||| S:31634 E:31637 ||| TO
the  ||| S:31637 E:31649 ||| DT
spectrum  ||| S:31649 E:31658 ||| NN
of  ||| S:31658 E:31661 ||| IN
wild-type  ||| S:31661 E:31671 ||| JJ
L1 ||| S:31671 E:31673 ||| NN
.  ||| S:31673 E:31675 ||| .
Although  ||| S:31675 E:31684 ||| IN
we  ||| S:31684 E:31687 ||| PRP
did  ||| S:31687 E:31691 ||| VBD
not  ||| S:31691 E:31695 ||| RB
expect  ||| S:31695 E:31702 ||| VB
a  ||| S:31702 E:31712 ||| DT
large  ||| S:31712 E:31718 ||| JJ
change  ||| S:31718 E:31725 ||| NN
in  ||| S:31725 E:31728 ||| IN
the  ||| S:31728 E:31732 ||| DT
secondary  ||| S:31732 E:31742 ||| JJ
structure  ||| S:31742 E:31752 ||| NN
of  ||| S:31752 E:31755 ||| IN
L1  ||| S:31755 E:31758 ||| CD
upon  ||| S:31758 E:31763 ||| IN
single  ||| S:31763 E:31778 ||| JJ
point  ||| S:31778 E:31784 ||| NN
mutations ||| S:31784 E:31793 ||| NNS
,  ||| S:31793 E:31795 ||| ,
CD  ||| S:31795 E:31798 ||| NNP
spectroscopy  ||| S:31798 E:31811 ||| NN
is  ||| S:31811 E:31814 ||| VBZ
the  ||| S:31814 E:31818 ||| DT
most  ||| S:31818 E:31823 ||| RBS
common  ||| S:31823 E:31838 ||| JJ
structural  ||| S:31838 E:31849 ||| JJ
technique  ||| S:31849 E:31859 ||| NN
to  ||| S:31859 E:31862 ||| TO
characterize  ||| S:31862 E:31875 ||| VB
site-directed  ||| S:31875 E:31889 ||| JJ
mutants ||| S:31889 E:31896 ||| NN
.  ||| S:31896 E:31906 ||| .
All  ||| S:31906 E:31910 ||| DT
of  ||| S:31910 E:31913 ||| IN
the  ||| S:31913 E:31917 ||| DT
mutants  ||| S:31917 E:31925 ||| NN
described  ||| S:31925 E:31935 ||| VBD
here  ||| S:31935 E:31940 ||| RB
exhibited  ||| S:31940 E:31950 ||| JJ
CD  ||| S:31950 E:31953 ||| NN
spectra  ||| S:31953 E:31961 ||| NNS
that  ||| S:31961 E:31974 ||| WDT
were  ||| S:31974 E:31979 ||| VBD
very  ||| S:31979 E:31984 ||| RB
similar ||| S:31984 E:31991 ||| JJ
,  ||| S:31991 E:31993 ||| ,
or  ||| S:31993 E:31996 ||| CC
identical ||| S:31996 E:32005 ||| JJ
,  ||| S:32005 E:32007 ||| ,
to  ||| S:32007 E:32010 ||| TO
that  ||| S:32010 E:32015 ||| DT
of  ||| S:32015 E:32018 ||| IN
wild-type  ||| S:32018 E:32028 ||| NNP
L1  ||| S:32028 E:32039 ||| NNP
( ||| S:32039 E:32040 ||| -LRB-
see  ||| S:32040 E:32044 ||| VB
Additional  ||| S:32044 E:32055 ||| JJ
file  ||| S:32055 E:32060 ||| NN
1 ||| S:32060 E:32061 ||| CD
:  ||| S:32061 E:32063 ||| :
CD  ||| S:32063 E:32066 ||| NNP
spectra ||| S:32066 E:32073 ||| CD
) ||| S:32073 E:32074 ||| -RRB-
.  ||| S:32074 E:32076 ||| .
( ||| S:32076 E:32077 ||| -LRB-
4 ||| S:32077 E:32078 ||| LS
)  ||| S:32078 E:32080 ||| -RRB-
Metal  ||| S:32080 E:32086 ||| NNP
analyses  ||| S:32086 E:32095 ||| NNS
on  ||| S:32095 E:32106 ||| IN
the  ||| S:32106 E:32110 ||| DT
mutants  ||| S:32110 E:32118 ||| NN
were  ||| S:32118 E:32123 ||| VBD
used  ||| S:32123 E:32128 ||| VBN
to  ||| S:32128 E:32131 ||| TO
probe  ||| S:32131 E:32137 ||| VB
whether  ||| S:32137 E:32145 ||| IN
point  ||| S:32145 E:32151 ||| NN
mutations  ||| S:32151 E:32169 ||| NNS
caused  ||| S:32169 E:32176 ||| VBD
a  ||| S:32176 E:32178 ||| DT
significant  ||| S:32178 E:32190 ||| JJ
change  ||| S:32190 E:32197 ||| NN
to  ||| S:32197 E:32200 ||| TO
the  ||| S:32200 E:32204 ||| DT
metal  ||| S:32204 E:32210 ||| NN
binding  ||| S:32210 E:32218 ||| JJ
site  ||| S:32218 E:32223 ||| NN
as  ||| S:32223 E:32226 ||| IN
to  ||| S:32226 E:32237 ||| TO
preclude  ||| S:32237 E:32246 ||| VB
metal  ||| S:32246 E:32252 ||| NN
binding ||| S:32252 E:32259 ||| NN
.  ||| S:32259 E:32261 ||| .
The  ||| S:32261 E:32265 ||| DT
crystal  ||| S:32265 E:32273 ||| NN
structures  ||| S:32273 E:32284 ||| NNS
of  ||| S:32284 E:32287 ||| IN
the  ||| S:32287 E:32299 ||| DT
metallo-β-lactamases  ||| S:32299 E:32320 ||| NNS
reveal  ||| S:32320 E:32327 ||| VBP
a  ||| S:32327 E:32329 ||| DT
complex  ||| S:32329 E:32337 ||| JJ
and  ||| S:32337 E:32341 ||| CC
far-reaching  ||| S:32341 E:32362 ||| JJ
hydrogen-bonding  ||| S:32362 E:32379 ||| JJ
network  ||| S:32379 E:32387 ||| NN
around  ||| S:32387 E:32394 ||| IN
the  ||| S:32394 E:32398 ||| DT
metal  ||| S:32398 E:32404 ||| NN
binding  ||| S:32404 E:32412 ||| JJ
sites ||| S:32412 E:32417 ||| NNS
,  ||| S:32417 E:32427 ||| ,
and  ||| S:32427 E:32431 ||| CC
disruption  ||| S:32431 E:32442 ||| NN
of  ||| S:32442 E:32445 ||| IN
this  ||| S:32445 E:32450 ||| DT
network  ||| S:32450 E:32458 ||| NN
is  ||| S:32458 E:32461 ||| VBZ
predicted  ||| S:32461 E:32471 ||| VBN
to  ||| S:32471 E:32474 ||| TO
affect  ||| S:32474 E:32481 ||| VB
metal  ||| S:32481 E:32495 ||| NN
binding  ||| S:32495 E:32503 ||| NNS
[  ||| S:32503 E:32505 ||| -LRB-
37  ||| S:32505 E:32508 ||| CD
42  ||| S:32508 E:32511 ||| CD
44  ||| S:32511 E:32514 ||| CD
45  ||| S:32514 E:32517 ||| CD
48  ||| S:32517 E:32520 ||| CD
49  ||| S:32520 E:32523 ||| CD
62  ||| S:32523 E:32526 ||| CD
63  ||| S:32526 E:32529 ||| CD
]  ||| S:32529 E:32531 ||| -RRB-
.  ||| S:32531 E:32533 ||| .
With  ||| S:32533 E:32538 ||| IN
all  ||| S:32538 E:32542 ||| DT
of  ||| S:32542 E:32545 ||| IN
the  ||| S:32545 E:32557 ||| DT
mutants  ||| S:32557 E:32565 ||| NN
described  ||| S:32565 E:32575 ||| VBD
here  ||| S:32575 E:32580 ||| RB
except  ||| S:32580 E:32587 ||| IN
the  ||| S:32587 E:32591 ||| DT
S224K  ||| S:32591 E:32597 ||| JJ
mutant ||| S:32597 E:32603 ||| NN
,  ||| S:32603 E:32605 ||| ,
each  ||| S:32605 E:32610 ||| DT
mutant  ||| S:32610 E:32625 ||| JJ
binds  ||| S:32625 E:32631 ||| JJ
wild-type  ||| S:32631 E:32641 ||| JJ
or  ||| S:32641 E:32644 ||| CC
near-wild-type  ||| S:32644 E:32659 ||| JJ
levels  ||| S:32659 E:32666 ||| NNS
of  ||| S:32666 E:32669 ||| IN
Zn ||| S:32669 E:32671 ||| NNP
( ||| S:32671 E:32672 ||| -LRB-
II ||| S:32672 E:32674 ||| NNP
)  ||| S:32674 E:32676 ||| -RRB-
after  ||| S:32676 E:32690 ||| IN
purification ||| S:32690 E:32702 ||| NN
.  ||| S:32702 E:32704 ||| .
The  ||| S:32704 E:32708 ||| DT
S224K  ||| S:32708 E:32714 ||| NNP
mutant  ||| S:32714 E:32721 ||| VBD
exhibited  ||| S:32721 E:32731 ||| VBN
a  ||| S:32731 E:32733 ||| DT
50 ||| S:32733 E:32735 ||| CD
%  ||| S:32735 E:32737 ||| NN
reduction  ||| S:32737 E:32747 ||| NN
in  ||| S:32747 E:32758 ||| IN
metal  ||| S:32758 E:32764 ||| NN
binding  ||| S:32764 E:32772 ||| NNS
( ||| S:32772 E:32773 ||| -LRB-
Table  ||| S:32773 E:32779 ||| NNP
2 ||| S:32779 E:32780 ||| CD
) ||| S:32780 E:32781 ||| -RRB-
,  ||| S:32781 E:32783 ||| ,
and  ||| S:32783 E:32787 ||| CC
we  ||| S:32787 E:32790 ||| PRP
postulate  ||| S:32790 E:32800 ||| VBD
this  ||| S:32800 E:32805 ||| DT
is  ||| S:32805 E:32808 ||| VBZ
due  ||| S:32808 E:32812 ||| JJ
to  ||| S:32812 E:32823 ||| TO
electrostatic  ||| S:32823 E:32837 ||| VB
repulsions  ||| S:32837 E:32848 ||| VBN
between  ||| S:32848 E:32856 ||| IN
the  ||| S:32856 E:32860 ||| DT
newly  ||| S:32860 E:32866 ||| RB
introduced  ||| S:32866 E:32877 ||| VBN
Lys  ||| S:32877 E:32889 ||| NNP
with  ||| S:32889 E:32894 ||| IN
Zn  ||| S:32894 E:32906 ||| NNP
2  ||| S:32906 E:32908 ||| CD
.  ||| S:32908 E:32910 ||| .
In  ||| S:32910 E:32913 ||| IN
spite  ||| S:32913 E:32919 ||| NN
of  ||| S:32919 E:32922 ||| IN
the  ||| S:32922 E:32926 ||| DT
mutants  ||| S:32926 E:32934 ||| JJ
binding  ||| S:32934 E:32950 ||| JJ
significant  ||| S:32950 E:32962 ||| JJ
amounts  ||| S:32962 E:32970 ||| NNS
of  ||| S:32970 E:32973 ||| IN
Zn ||| S:32973 E:32975 ||| NNP
( ||| S:32975 E:32976 ||| -LRB-
II ||| S:32976 E:32978 ||| NNP
) ||| S:32978 E:32979 ||| -RRB-
,  ||| S:32979 E:32981 ||| ,
we  ||| S:32981 E:32984 ||| PRP
included  ||| S:32984 E:32993 ||| VBD
100  ||| S:32993 E:32997 ||| CD
μM  ||| S:32997 E:33000 ||| JJ
ZnCl  ||| S:33000 E:33014 ||| JJ
2  ||| S:33014 E:33016 ||| CD
in  ||| S:33016 E:33019 ||| IN
all  ||| S:33019 E:33023 ||| DT
of  ||| S:33023 E:33026 ||| IN
the  ||| S:33026 E:33030 ||| DT
kinetic  ||| S:33030 E:33038 ||| JJ
buffers  ||| S:33038 E:33046 ||| NN
to  ||| S:33046 E:33057 ||| TO
ensure  ||| S:33057 E:33064 ||| VB
saturation  ||| S:33064 E:33075 ||| VBN
of  ||| S:33075 E:33078 ||| IN
the  ||| S:33078 E:33082 ||| DT
metal  ||| S:33082 E:33088 ||| NN
binding  ||| S:33088 E:33096 ||| JJ
sites  ||| S:33096 E:33102 ||| NNS
and  ||| S:33102 E:33106 ||| CC
to  ||| S:33106 E:33117 ||| TO
facilitate  ||| S:33117 E:33128 ||| VB
direct  ||| S:33128 E:33135 ||| JJ
comparison  ||| S:33135 E:33146 ||| NN
of  ||| S:33146 E:33149 ||| IN
the  ||| S:33149 E:33153 ||| DT
kinetic  ||| S:33153 E:33161 ||| JJ
data.  ||| S:33161 E:33167 ||| NNP
( ||| S:33167 E:33168 ||| -LRB-
5 ||| S:33168 E:33169 ||| LS
)  ||| S:33169 E:33171 ||| -RRB-
All  ||| S:33171 E:33183 ||| DT
mutants  ||| S:33183 E:33191 ||| NN
were  ||| S:33191 E:33196 ||| VBD
stable  ||| S:33196 E:33203 ||| JJ
to  ||| S:33203 E:33206 ||| TO
multiple  ||| S:33206 E:33215 ||| JJ
freeze ||| S:33215 E:33221 ||| NN
/ ||| S:33221 E:33222 ||| CD
thaw  ||| S:33222 E:33227 ||| CD
cycles  ||| S:33227 E:33234 ||| NNS
and  ||| S:33234 E:33238 ||| CC
to  ||| S:33238 E:33249 ||| TO
prolonged  ||| S:33249 E:33259 ||| JJ
storage  ||| S:33259 E:33267 ||| NN
( ||| S:33267 E:33268 ||| -LRB-
>  ||| S:33268 E:33270 ||| CD
3  ||| S:33270 E:33272 ||| CD
weeks ||| S:33272 E:33277 ||| NNS
)  ||| S:33277 E:33279 ||| -RRB-
at  ||| S:33279 E:33282 ||| IN
4°C ||| S:33282 E:33285 ||| NNP
,  ||| S:33285 E:33287 ||| ,
retaining  ||| S:33287 E:33297 ||| VBG
>  ||| S:33297 E:33299 ||| CD
95 ||| S:33299 E:33301 ||| CD
%  ||| S:33301 E:33311 ||| NN
of  ||| S:33311 E:33314 ||| IN
their  ||| S:33314 E:33320 ||| PRP$
activity ||| S:33320 E:33328 ||| NN
.  ||| S:33328 E:33330 ||| .
With  ||| S:33330 E:33335 ||| IN
these  ||| S:33335 E:33341 ||| DT
five  ||| S:33341 E:33346 ||| CD
lines  ||| S:33346 E:33352 ||| NNS
of  ||| S:33352 E:33355 ||| IN
evidence ||| S:33355 E:33363 ||| NN
,  ||| S:33363 E:33365 ||| ,
we  ||| S:33365 E:33376 ||| PRP
were  ||| S:33376 E:33381 ||| VBD
confident  ||| S:33381 E:33391 ||| JJ
that  ||| S:33391 E:33396 ||| IN
none  ||| S:33396 E:33401 ||| NN
of  ||| S:33401 E:33404 ||| IN
the  ||| S:33404 E:33408 ||| DT
point  ||| S:33408 E:33414 ||| NN
mutations  ||| S:33414 E:33424 ||| NNS
resulted  ||| S:33424 E:33433 ||| VBD
in  ||| S:33433 E:33444 ||| IN
large  ||| S:33444 E:33450 ||| JJ
structural  ||| S:33450 E:33461 ||| JJ
changes  ||| S:33461 E:33469 ||| NNS
in  ||| S:33469 E:33472 ||| IN
L1  ||| S:33472 E:33475 ||| NNP
and  ||| S:33475 E:33479 ||| CC
that  ||| S:33479 E:33484 ||| IN
any  ||| S:33484 E:33488 ||| DT
kinetic  ||| S:33488 E:33504 ||| JJ
differences  ||| S:33504 E:33516 ||| NNS
could  ||| S:33516 E:33522 ||| MD
be  ||| S:33522 E:33525 ||| VB
attributed  ||| S:33525 E:33536 ||| VBN
to  ||| S:33536 E:33539 ||| TO
the  ||| S:33539 E:33543 ||| DT
changed  ||| S:33543 E:33551 ||| JJ
amino  ||| S:33551 E:33565 ||| JJ
acid ||| S:33565 E:33569 ||| NN
.  ||| S:33569 E:33579 ||| .
As  ||| S:33579 E:33582 ||| IN
a  ||| S:33582 E:33584 ||| DT
first  ||| S:33584 E:33590 ||| JJ
approximation  ||| S:33590 E:33604 ||| NN
of  ||| S:33604 E:33607 ||| IN
substrate  ||| S:33607 E:33617 ||| JJ
binding ||| S:33617 E:33624 ||| NN
,  ||| S:33624 E:33626 ||| ,
we  ||| S:33626 E:33637 ||| PRP
examined  ||| S:33637 E:33646 ||| VBD
the  ||| S:33646 E:33650 ||| DT
steady-state  ||| S:33650 E:33663 ||| JJ
kinetics  ||| S:33663 E:33672 ||| NN
of  ||| S:33672 E:33675 ||| IN
4  ||| S:33675 E:33677 ||| CD
cephalosporins ||| S:33677 E:33691 ||| NN
,  ||| S:33691 E:33693 ||| ,
2  ||| S:33693 E:33703 ||| CD
penicillins ||| S:33703 E:33714 ||| NN
,  ||| S:33714 E:33716 ||| ,
and  ||| S:33716 E:33720 ||| CC
3  ||| S:33720 E:33722 ||| CD
carbapenems  ||| S:33722 E:33734 ||| NNS
( ||| S:33734 E:33735 ||| -LRB-
Tables  ||| S:33735 E:33742 ||| NNP
3 ||| S:33742 E:33743 ||| CD
,  ||| S:33743 E:33745 ||| ,
4 ||| S:33745 E:33746 ||| CD
,  ||| S:33746 E:33748 ||| ,
5 ||| S:33748 E:33749 ||| CD
)  ||| S:33749 E:33751 ||| -RRB-
and  ||| S:33751 E:33763 ||| CC
compared  ||| S:33763 E:33772 ||| VBN
the  ||| S:33772 E:33776 ||| DT
K  ||| S:33776 E:33787 ||| NNP
m  ||| S:33787 E:33789 ||| NN
values  ||| S:33789 E:33796 ||| NNS
of  ||| S:33796 E:33799 ||| IN
the  ||| S:33799 E:33803 ||| DT
mutants  ||| S:33803 E:33811 ||| NN
with  ||| S:33811 E:33816 ||| IN
those  ||| S:33816 E:33822 ||| DT
of  ||| S:33822 E:33833 ||| IN
wild-type  ||| S:33833 E:33843 ||| JJ
L1 ||| S:33843 E:33845 ||| NN
.  ||| S:33845 E:33847 ||| .
The  ||| S:33847 E:33851 ||| DT
substrates  ||| S:33851 E:33862 ||| JJ
tested  ||| S:33862 E:33869 ||| NN
were  ||| S:33869 E:33874 ||| VBD
chosen  ||| S:33874 E:33881 ||| VBN
because  ||| S:33881 E:33897 ||| IN
they  ||| S:33897 E:33902 ||| PRP
exhibited  ||| S:33902 E:33912 ||| VBP
low  ||| S:33912 E:33916 ||| JJ
K  ||| S:33916 E:33927 ||| NNP
m  ||| S:33927 E:33929 ||| NN
values  ||| S:33929 E:33936 ||| NNS
in  ||| S:33936 E:33939 ||| IN
previous  ||| S:33939 E:33948 ||| JJ
kinetic  ||| S:33948 E:33956 ||| JJ
studies  ||| S:33956 E:33964 ||| NNS
[  ||| S:33964 E:33974 ||| -LRB-
36  ||| S:33974 E:33977 ||| CD
]  ||| S:33977 E:33979 ||| -RRB-
,  ||| S:33979 E:33981 ||| ,
and  ||| S:33981 E:33985 ||| CC
we  ||| S:33985 E:33988 ||| PRP
believed  ||| S:33988 E:33997 ||| VBD
that  ||| S:33997 E:34002 ||| IN
we  ||| S:34002 E:34005 ||| PRP
could  ||| S:34005 E:34011 ||| MD
saturate  ||| S:34011 E:34020 ||| VB
the  ||| S:34020 E:34024 ||| DT
enzymes  ||| S:34024 E:34040 ||| NN
with  ||| S:34040 E:34045 ||| IN
substrate  ||| S:34045 E:34055 ||| VBG
even  ||| S:34055 E:34060 ||| RB
if  ||| S:34060 E:34063 ||| IN
there  ||| S:34063 E:34069 ||| EX
was  ||| S:34069 E:34073 ||| VBD
large  ||| S:34073 E:34079 ||| JJ
change  ||| S:34079 E:34086 ||| NN
in  ||| S:34086 E:34089 ||| IN
binding  ||| S:34089 E:34105 ||| VBG
with  ||| S:34105 E:34110 ||| IN
the  ||| S:34110 E:34114 ||| DT
point  ||| S:34114 E:34120 ||| NN
mutations ||| S:34120 E:34129 ||| NNS
.  ||| S:34129 E:34131 ||| .
The  ||| S:34131 E:34135 ||| DT
Tyr228  ||| S:34135 E:34142 ||| CD
mutants  ||| S:34142 E:34150 ||| NNS
exhibited  ||| S:34150 E:34168 ||| VBP
increased  ||| S:34168 E:34178 ||| VBN
K  ||| S:34178 E:34189 ||| NNP
m  ||| S:34189 E:34191 ||| NN
values  ||| S:34191 E:34198 ||| NNS
for  ||| S:34198 E:34202 ||| IN
8  ||| S:34202 E:34204 ||| CD
of  ||| S:34204 E:34207 ||| IN
the  ||| S:34207 E:34211 ||| DT
9  ||| S:34211 E:34213 ||| CD
substrates  ||| S:34213 E:34232 ||| NNS
tested ||| S:34232 E:34238 ||| VBN
,  ||| S:34238 E:34240 ||| ,
with  ||| S:34240 E:34245 ||| IN
the  ||| S:34245 E:34249 ||| DT
smallest  ||| S:34249 E:34258 ||| JJS
changes  ||| S:34258 E:34266 ||| NNS
in  ||| S:34266 E:34269 ||| IN
K  ||| S:34269 E:34280 ||| NNP
m  ||| S:34280 E:34282 ||| NN
observed  ||| S:34282 E:34291 ||| VBD
when  ||| S:34291 E:34296 ||| WRB
the  ||| S:34296 E:34300 ||| DT
carbapenems  ||| S:34300 E:34312 ||| NN
were  ||| S:34312 E:34325 ||| VBD
used  ||| S:34325 E:34330 ||| VBN
as  ||| S:34330 E:34333 ||| IN
the  ||| S:34333 E:34337 ||| DT
substrate ||| S:34337 E:34346 ||| NN
.  ||| S:34346 E:34348 ||| .
This  ||| S:34348 E:34353 ||| DT
result  ||| S:34353 E:34360 ||| NN
supports  ||| S:34360 E:34369 ||| VBZ
the  ||| S:34369 E:34373 ||| DT
proposed  ||| S:34373 E:34390 ||| JJ
role  ||| S:34390 E:34395 ||| NN
of  ||| S:34395 E:34398 ||| IN
Tyr228  ||| S:34398 E:34405 ||| CD
in  ||| S:34405 E:34408 ||| IN
substrate  ||| S:34408 E:34418 ||| JJ
binding ||| S:34418 E:34425 ||| NN
.  ||| S:34425 E:34427 ||| .
In  ||| S:34427 E:34430 ||| IN
contrast ||| S:34430 E:34438 ||| NN
,  ||| S:34438 E:34440 ||| ,
the  ||| S:34440 E:34452 ||| DT
results  ||| S:34452 E:34460 ||| NNS
on  ||| S:34460 E:34463 ||| IN
the  ||| S:34463 E:34467 ||| DT
Ser224  ||| S:34467 E:34474 ||| CD
mutants  ||| S:34474 E:34482 ||| NNS
suggest  ||| S:34482 E:34490 ||| VBP
that  ||| S:34490 E:34495 ||| IN
this  ||| S:34495 E:34500 ||| DT
residue  ||| S:34500 E:34508 ||| NN
is  ||| S:34508 E:34519 ||| VBZ
not  ||| S:34519 E:34523 ||| RB
important  ||| S:34523 E:34533 ||| JJ
in  ||| S:34533 E:34536 ||| IN
substrate  ||| S:34536 E:34546 ||| JJ
binding ||| S:34546 E:34553 ||| NN
,  ||| S:34553 E:34555 ||| ,
since  ||| S:34555 E:34561 ||| IN
the  ||| S:34561 E:34565 ||| DT
S224A  ||| S:34565 E:34571 ||| NNP
and  ||| S:34571 E:34583 ||| CC
S224K  ||| S:34583 E:34589 ||| CD
mutants  ||| S:34589 E:34597 ||| NNS
did  ||| S:34597 E:34601 ||| VBD
not  ||| S:34601 E:34605 ||| RB
exhibit  ||| S:34605 E:34613 ||| VB
any  ||| S:34613 E:34617 ||| DT
significant  ||| S:34617 E:34629 ||| JJ
increases  ||| S:34629 E:34639 ||| NNS
( ||| S:34639 E:34640 ||| -LRB-
by  ||| S:34640 E:34651 ||| IN
a  ||| S:34651 E:34653 ||| DT
factor  ||| S:34653 E:34660 ||| NN
of  ||| S:34660 E:34663 ||| IN
≥  ||| S:34663 E:34665 ||| CD
10 ||| S:34665 E:34667 ||| CD
)  ||| S:34667 E:34669 ||| -RRB-
in  ||| S:34669 E:34672 ||| IN
K  ||| S:34672 E:34683 ||| NNP
m  ||| S:34683 E:34685 ||| NN
for  ||| S:34685 E:34689 ||| IN
any  ||| S:34689 E:34693 ||| DT
of  ||| S:34693 E:34696 ||| IN
the  ||| S:34696 E:34700 ||| DT
substrates  ||| S:34700 E:34711 ||| NN
tested ||| S:34711 E:34717 ||| VBD
.  ||| S:34717 E:34719 ||| .
Only  ||| S:34719 E:34732 ||| RB
when  ||| S:34732 E:34737 ||| WRB
Ser224  ||| S:34737 E:34744 ||| NNP
was  ||| S:34744 E:34748 ||| VBD
replaced  ||| S:34748 E:34757 ||| VBN
with  ||| S:34757 E:34762 ||| IN
an  ||| S:34762 E:34765 ||| DT
Asp  ||| S:34765 E:34769 ||| JJ
residue  ||| S:34769 E:34777 ||| NN
was  ||| S:34777 E:34781 ||| VBD
there  ||| S:34781 E:34795 ||| RB
significant  ||| S:34795 E:34807 ||| JJ
increases  ||| S:34807 E:34817 ||| NNS
in  ||| S:34817 E:34820 ||| IN
the  ||| S:34820 E:34824 ||| DT
observed  ||| S:34824 E:34833 ||| JJ
K  ||| S:34833 E:34844 ||| NNP
m  ||| S:34844 E:34846 ||| JJ
value  ||| S:34846 E:34852 ||| NN
for  ||| S:34852 E:34856 ||| IN
6  ||| S:34856 E:34858 ||| CD
of  ||| S:34858 E:34861 ||| IN
the  ||| S:34861 E:34865 ||| DT
9  ||| S:34865 E:34867 ||| CD
substrates  ||| S:34867 E:34886 ||| NNS
tested ||| S:34886 E:34892 ||| VBN
,  ||| S:34892 E:34894 ||| ,
and  ||| S:34894 E:34898 ||| CC
the  ||| S:34898 E:34902 ||| DT
largest  ||| S:34902 E:34910 ||| JJS
changes  ||| S:34910 E:34918 ||| NNS
were  ||| S:34918 E:34923 ||| VBD
exhibited  ||| S:34923 E:34933 ||| VBN
when  ||| S:34933 E:34938 ||| WRB
the  ||| S:34938 E:34950 ||| DT
penicillins  ||| S:34950 E:34962 ||| NN
were  ||| S:34962 E:34967 ||| VBD
used  ||| S:34967 E:34972 ||| VBN
as  ||| S:34972 E:34975 ||| IN
substrates ||| S:34975 E:34985 ||| NN
.  ||| S:34985 E:34987 ||| .
This  ||| S:34987 E:34992 ||| DT
result  ||| S:34992 E:34999 ||| NN
supports  ||| S:34999 E:35016 ||| VBZ
the  ||| S:35016 E:35020 ||| DT
observation  ||| S:35020 E:35032 ||| NN
of  ||| S:35032 E:35035 ||| IN
differential  ||| S:35035 E:35048 ||| JJ
binding  ||| S:35048 E:35056 ||| JJ
modes  ||| S:35056 E:35062 ||| NNS
of  ||| S:35062 E:35065 ||| IN
substrates  ||| S:35065 E:35084 ||| VBG
to  ||| S:35084 E:35087 ||| TO
the  ||| S:35087 E:35091 ||| DT
β-lactamases ||| S:35091 E:35103 ||| JJ
,  ||| S:35103 E:35105 ||| ,
depending  ||| S:35105 E:35115 ||| VBG
on  ||| S:35115 E:35118 ||| IN
the  ||| S:35118 E:35122 ||| DT
structure  ||| S:35122 E:35132 ||| NN
of  ||| S:35132 E:35135 ||| IN
the  ||| S:35135 E:35147 ||| DT
substrate  ||| S:35147 E:35157 ||| NN
[  ||| S:35157 E:35159 ||| -LRB-
43  ||| S:35159 E:35162 ||| CD
64  ||| S:35162 E:35165 ||| CD
65  ||| S:35165 E:35168 ||| CD
]  ||| S:35168 E:35170 ||| -RRB-
.  ||| S:35170 E:35172 ||| .
The  ||| S:35172 E:35176 ||| DT
only  ||| S:35176 E:35181 ||| RB
remaining  ||| S:35181 E:35191 ||| VBG
mutants  ||| S:35191 E:35199 ||| NN
that  ||| S:35199 E:35212 ||| IN
exhibited  ||| S:35212 E:35222 ||| JJ
significant  ||| S:35222 E:35234 ||| JJ
changes  ||| S:35234 E:35242 ||| NNS
in  ||| S:35242 E:35245 ||| IN
the  ||| S:35245 E:35249 ||| DT
K  ||| S:35249 E:35260 ||| NNP
m  ||| S:35260 E:35262 ||| NN
values  ||| S:35262 E:35269 ||| NNS
were  ||| S:35269 E:35274 ||| VBD
the  ||| S:35274 E:35278 ||| DT
I164A  ||| S:35278 E:35284 ||| NNP
and  ||| S:35284 E:35288 ||| CC
F158A  ||| S:35288 E:35302 ||| CD
mutants ||| S:35302 E:35309 ||| NNS
.  ||| S:35309 E:35311 ||| .
The  ||| S:35311 E:35315 ||| DT
I164A  ||| S:35315 E:35321 ||| CD
mutant  ||| S:35321 E:35328 ||| NNS
exhibited  ||| S:35328 E:35338 ||| VBP
increased  ||| S:35338 E:35348 ||| VBN
K  ||| S:35348 E:35359 ||| NNP
m  ||| S:35359 E:35361 ||| NN
values  ||| S:35361 E:35368 ||| VBZ
only  ||| S:35368 E:35373 ||| RB
when  ||| S:35373 E:35378 ||| WRB
using  ||| S:35378 E:35384 ||| VBG
cefoxitin  ||| S:35384 E:35394 ||| NN
as  ||| S:35394 E:35405 ||| IN
the  ||| S:35405 E:35409 ||| DT
substrate ||| S:35409 E:35418 ||| NN
,  ||| S:35418 E:35420 ||| ,
suggesting  ||| S:35420 E:35431 ||| VBG
an  ||| S:35431 E:35434 ||| DT
interaction  ||| S:35434 E:35446 ||| NN
of  ||| S:35446 E:35449 ||| IN
the  ||| S:35449 E:35453 ||| DT
isoleucine  ||| S:35453 E:35472 ||| JJ
group  ||| S:35472 E:35478 ||| NN
with  ||| S:35478 E:35483 ||| IN
the  ||| S:35483 E:35487 ||| DT
methoxy  ||| S:35487 E:35495 ||| JJ
group  ||| S:35495 E:35501 ||| NN
on  ||| S:35501 E:35504 ||| IN
cefoxitin ||| S:35504 E:35513 ||| NN
.  ||| S:35513 E:35515 ||| .
The  ||| S:35515 E:35519 ||| DT
F158A  ||| S:35519 E:35525 ||| NNP
mutant  ||| S:35525 E:35540 ||| VBD
exhibited  ||| S:35540 E:35550 ||| VBN
higher  ||| S:35550 E:35557 ||| JJR
K  ||| S:35557 E:35568 ||| NNP
m  ||| S:35568 E:35570 ||| NN
values  ||| S:35570 E:35577 ||| NNS
when  ||| S:35577 E:35582 ||| WRB
using  ||| S:35582 E:35588 ||| VBG
the  ||| S:35588 E:35592 ||| DT
cephalosporins  ||| S:35592 E:35615 ||| NN
as  ||| S:35615 E:35618 ||| IN
substrates ||| S:35618 E:35628 ||| NN
,  ||| S:35628 E:35630 ||| ,
suggesting  ||| S:35630 E:35641 ||| VBG
an  ||| S:35641 E:35644 ||| DT
interaction  ||| S:35644 E:35656 ||| NN
of  ||| S:35656 E:35659 ||| IN
the  ||| S:35659 E:35671 ||| DT
cephalosporins ||| S:35671 E:35685 ||| NN
'  ||| S:35685 E:35687 ||| POS
substituents  ||| S:35687 E:35700 ||| NN
with  ||| S:35700 E:35705 ||| IN
the  ||| S:35705 E:35709 ||| DT
phenylalanine  ||| S:35709 E:35723 ||| NN
on  ||| S:35723 E:35726 ||| IN
the  ||| S:35726 E:35738 ||| DT
loop  ||| S:35738 E:35743 ||| NN
that  ||| S:35743 E:35748 ||| WDT
extends  ||| S:35748 E:35756 ||| VBZ
over  ||| S:35756 E:35761 ||| IN
the  ||| S:35761 E:35765 ||| DT
active  ||| S:35765 E:35772 ||| JJ
site ||| S:35772 E:35776 ||| NN
.  ||| S:35776 E:35778 ||| .
None  ||| S:35778 E:35783 ||| NN
of  ||| S:35783 E:35786 ||| IN
the  ||| S:35786 E:35790 ||| DT
other  ||| S:35790 E:35804 ||| JJ
mutants  ||| S:35804 E:35812 ||| NNS
exhibited  ||| S:35812 E:35822 ||| VBP
vastly  ||| S:35822 E:35829 ||| RB
different  ||| S:35829 E:35839 ||| JJ
values  ||| S:35839 E:35846 ||| NNS
for  ||| S:35846 E:35850 ||| IN
K  ||| S:35850 E:35861 ||| NNP
m  ||| S:35861 E:35863 ||| NN
with  ||| S:35863 E:35868 ||| IN
any  ||| S:35868 E:35872 ||| DT
of  ||| S:35872 E:35875 ||| IN
the  ||| S:35875 E:35879 ||| DT
substrates  ||| S:35879 E:35890 ||| NN
tested ||| S:35890 E:35896 ||| VBD
.  ||| S:35896 E:35906 ||| .
An  ||| S:35906 E:35909 ||| DT
examination  ||| S:35909 E:35921 ||| NN
of  ||| S:35921 E:35924 ||| IN
the  ||| S:35924 E:35937 ||| DT
k  ||| S:35937 E:35948 ||| JJ
cat  ||| S:35948 E:35952 ||| NN
values  ||| S:35952 E:35959 ||| NNS
of  ||| S:35959 E:35962 ||| IN
the  ||| S:35962 E:35966 ||| DT
mutants  ||| S:35966 E:35974 ||| NN
revealed  ||| S:35974 E:35983 ||| VBD
some  ||| S:35983 E:35996 ||| DT
surprising  ||| S:35996 E:36007 ||| JJ
results ||| S:36007 E:36014 ||| NNS
.  ||| S:36014 E:36016 ||| .
The  ||| S:36016 E:36020 ||| DT
S224D  ||| S:36020 E:36026 ||| FW
mutants  ||| S:36026 E:36034 ||| FW
displayed  ||| S:36034 E:36044 ||| FW
decreased  ||| S:36044 E:36063 ||| FW
k  ||| S:36063 E:36074 ||| FW
cat  ||| S:36074 E:36078 ||| FW
values  ||| S:36078 E:36085 ||| NNS
for  ||| S:36085 E:36089 ||| IN
7  ||| S:36089 E:36091 ||| CD
of  ||| S:36091 E:36094 ||| IN
the  ||| S:36094 E:36098 ||| DT
9  ||| S:36098 E:36100 ||| CD
substrates  ||| S:36100 E:36119 ||| NNS
tested ||| S:36119 E:36125 ||| VBD
.  ||| S:36125 E:36127 ||| .
Since  ||| S:36127 E:36133 ||| IN
similar  ||| S:36133 E:36141 ||| JJ
results  ||| S:36141 E:36149 ||| NNS
were  ||| S:36149 E:36154 ||| VBD
not  ||| S:36154 E:36158 ||| RB
observed  ||| S:36158 E:36167 ||| VBN
with  ||| S:36167 E:36172 ||| IN
the  ||| S:36172 E:36184 ||| DT
S224K  ||| S:36184 E:36190 ||| NNP
and  ||| S:36190 E:36194 ||| CC
S224A  ||| S:36194 E:36200 ||| CD
mutants ||| S:36200 E:36207 ||| NN
,  ||| S:36207 E:36209 ||| ,
we  ||| S:36209 E:36212 ||| PRP
do  ||| S:36212 E:36215 ||| VBP
not  ||| S:36215 E:36219 ||| RB
propose  ||| S:36219 E:36227 ||| VB
a  ||| S:36227 E:36229 ||| DT
catalytic  ||| S:36229 E:36239 ||| JJ
role  ||| S:36239 E:36252 ||| NN
for  ||| S:36252 E:36256 ||| IN
Ser224 ||| S:36256 E:36262 ||| CD
.  ||| S:36262 E:36264 ||| .
Instead ||| S:36264 E:36271 ||| RB
,  ||| S:36271 E:36273 ||| ,
we  ||| S:36273 E:36276 ||| PRP
predict  ||| S:36276 E:36284 ||| VBP
that  ||| S:36284 E:36289 ||| IN
the  ||| S:36289 E:36293 ||| DT
insertion  ||| S:36293 E:36303 ||| NN
of  ||| S:36303 E:36306 ||| IN
an  ||| S:36306 E:36317 ||| DT
aspartic  ||| S:36317 E:36326 ||| JJ
acid  ||| S:36326 E:36331 ||| NN
into  ||| S:36331 E:36336 ||| IN
the  ||| S:36336 E:36340 ||| DT
active  ||| S:36340 E:36347 ||| JJ
site  ||| S:36347 E:36352 ||| NN
at  ||| S:36352 E:36355 ||| IN
position  ||| S:36355 E:36364 ||| NN
224  ||| S:36364 E:36368 ||| CD
results  ||| S:36368 E:36384 ||| NNS
in  ||| S:36384 E:36387 ||| IN
a  ||| S:36387 E:36389 ||| DT
change  ||| S:36389 E:36396 ||| NN
in  ||| S:36396 E:36399 ||| IN
the  ||| S:36399 E:36403 ||| DT
hydrogen  ||| S:36403 E:36412 ||| NN
bonding  ||| S:36412 E:36420 ||| NN
network  ||| S:36420 E:36428 ||| NN
in  ||| S:36428 E:36431 ||| IN
L1 ||| S:36431 E:36433 ||| CD
;  ||| S:36433 E:36435 ||| :
this  ||| S:36435 E:36448 ||| DT
hydrogen  ||| S:36448 E:36457 ||| NN
bonding  ||| S:36457 E:36465 ||| NN
network  ||| S:36465 E:36473 ||| NN
is  ||| S:36473 E:36476 ||| VBZ
extensive  ||| S:36476 E:36486 ||| JJ
in  ||| S:36486 E:36489 ||| IN
all  ||| S:36489 E:36501 ||| DT
metallo-β-lactamases  ||| S:36501 E:36522 ||| NN
that  ||| S:36522 E:36527 ||| WDT
have  ||| S:36527 E:36532 ||| VBP
been  ||| S:36532 E:36537 ||| VBN
characterized  ||| S:36537 E:36559 ||| VBN
crystallographically  ||| S:36559 E:36580 ||| NNS
[  ||| S:36580 E:36582 ||| -LRB-
37  ||| S:36582 E:36585 ||| CD
42  ||| S:36585 E:36588 ||| CD
44  ||| S:36588 E:36591 ||| CD
45  ||| S:36591 E:36594 ||| CD
48  ||| S:36594 E:36597 ||| CD
49  ||| S:36597 E:36600 ||| CD
62  ||| S:36600 E:36603 ||| CD
63  ||| S:36603 E:36606 ||| CD
]  ||| S:36606 E:36608 ||| -RRB-
.  ||| S:36608 E:36610 ||| .
The  ||| S:36610 E:36622 ||| DT
N233D  ||| S:36622 E:36628 ||| NNP
mutant  ||| S:36628 E:36635 ||| VBD
also  ||| S:36635 E:36640 ||| RB
exhibited  ||| S:36640 E:36650 ||| VBN
greatly  ||| S:36650 E:36658 ||| RB
reduced  ||| S:36658 E:36675 ||| VBN
k  ||| S:36675 E:36686 ||| JJ
cat  ||| S:36686 E:36690 ||| NN
values  ||| S:36690 E:36697 ||| NNS
for  ||| S:36697 E:36701 ||| IN
biapenem  ||| S:36701 E:36710 ||| NN
and  ||| S:36710 E:36714 ||| CC
meropenem  ||| S:36714 E:36732 ||| NNS
but  ||| S:36732 E:36736 ||| CC
not  ||| S:36736 E:36740 ||| RB
for  ||| S:36740 E:36744 ||| IN
imipenem  ||| S:36744 E:36753 ||| NN
or  ||| S:36753 E:36756 ||| CC
any  ||| S:36756 E:36760 ||| DT
of  ||| S:36760 E:36763 ||| IN
the  ||| S:36763 E:36767 ||| DT
other  ||| S:36767 E:36773 ||| JJ
substrates  ||| S:36773 E:36784 ||| NN
tested ||| S:36784 E:36790 ||| VBD
.  ||| S:36790 E:36800 ||| .
This  ||| S:36800 E:36805 ||| DT
mutation  ||| S:36805 E:36814 ||| NN
is  ||| S:36814 E:36817 ||| VBZ
also  ||| S:36817 E:36822 ||| RB
predicted  ||| S:36822 E:36832 ||| VBN
to  ||| S:36832 E:36835 ||| TO
affect  ||| S:36835 E:36842 ||| VB
the  ||| S:36842 E:36846 ||| DT
hydrogen  ||| S:36846 E:36863 ||| NN
bonding  ||| S:36863 E:36871 ||| NN
network  ||| S:36871 E:36879 ||| NN
around  ||| S:36879 E:36886 ||| IN
the  ||| S:36886 E:36890 ||| DT
active  ||| S:36890 E:36897 ||| JJ
site ||| S:36897 E:36901 ||| NN
,  ||| S:36901 E:36903 ||| ,
and  ||| S:36903 E:36907 ||| CC
apparently ||| S:36907 E:36917 ||| RB
,  ||| S:36917 E:36927 ||| ,
interactions  ||| S:36927 E:36940 ||| NNS
of  ||| S:36940 E:36943 ||| IN
the  ||| S:36943 E:36947 ||| DT
enzyme  ||| S:36947 E:36954 ||| NN
with  ||| S:36954 E:36959 ||| IN
the  ||| S:36959 E:36963 ||| DT
4 ||| S:36963 E:36964 ||| CD
'  ||| S:36964 E:36966 ||| POS
substituent  ||| S:36966 E:36978 ||| NN
of  ||| S:36978 E:36981 ||| IN
the  ||| S:36981 E:36993 ||| DT
carbapenems  ||| S:36993 E:37005 ||| NN
has  ||| S:37005 E:37009 ||| VBZ
an  ||| S:37009 E:37012 ||| DT
effect  ||| S:37012 E:37019 ||| NN
on  ||| S:37019 E:37022 ||| IN
catalysis ||| S:37022 E:37031 ||| NN
.  ||| S:37031 E:37033 ||| .
More  ||| S:37033 E:37038 ||| RBR
surprisingly  ||| S:37038 E:37059 ||| RB
are  ||| S:37059 E:37063 ||| VBP
the  ||| S:37063 E:37067 ||| DT
increases  ||| S:37067 E:37077 ||| NNS
in  ||| S:37077 E:37089 ||| IN
k  ||| S:37089 E:37100 ||| JJ
cat  ||| S:37100 E:37104 ||| NN
of  ||| S:37104 E:37107 ||| IN
the  ||| S:37107 E:37111 ||| DT
F158A  ||| S:37111 E:37117 ||| JJ
mutants ||| S:37117 E:37124 ||| NN
.  ||| S:37124 E:37126 ||| .
We  ||| S:37126 E:37129 ||| PRP
are  ||| S:37129 E:37141 ||| VBP
uncertain  ||| S:37141 E:37151 ||| JJ
why  ||| S:37151 E:37155 ||| WRB
the  ||| S:37155 E:37159 ||| DT
mutation  ||| S:37159 E:37168 ||| NN
of  ||| S:37168 E:37171 ||| IN
residues  ||| S:37171 E:37180 ||| NNS
on  ||| S:37180 E:37183 ||| IN
the  ||| S:37183 E:37187 ||| DT
loop  ||| S:37187 E:37192 ||| NN
that  ||| S:37192 E:37205 ||| WDT
extends  ||| S:37205 E:37213 ||| VBZ
over  ||| S:37213 E:37218 ||| IN
the  ||| S:37218 E:37222 ||| DT
active  ||| S:37222 E:37229 ||| JJ
site  ||| S:37229 E:37234 ||| NN
would  ||| S:37234 E:37240 ||| MD
affect  ||| S:37240 E:37256 ||| VB
k  ||| S:37256 E:37267 ||| JJ
cat  ||| S:37267 E:37271 ||| NN
,  ||| S:37271 E:37273 ||| ,
since  ||| S:37273 E:37279 ||| IN
substrate  ||| S:37279 E:37289 ||| NN
and  ||| S:37289 E:37293 ||| CC
product  ||| S:37293 E:37309 ||| NN
binding  ||| S:37309 E:37317 ||| NNS
have  ||| S:37317 E:37322 ||| VBP
been  ||| S:37322 E:37327 ||| VBN
predicted  ||| S:37327 E:37337 ||| VBN
to  ||| S:37337 E:37340 ||| TO
be  ||| S:37340 E:37343 ||| VB
very  ||| S:37343 E:37348 ||| RB
fast  ||| S:37348 E:37353 ||| RB
in  ||| S:37353 E:37356 ||| IN
the  ||| S:37356 E:37360 ||| DT
reaction  ||| S:37360 E:37377 ||| NN
of  ||| S:37377 E:37380 ||| IN
nitrocefin  ||| S:37380 E:37391 ||| NN
with  ||| S:37391 E:37396 ||| IN
L1 ||| S:37396 E:37398 ||| CD
.  ||| S:37398 E:37400 ||| .
However ||| S:37400 E:37407 ||| RB
,  ||| S:37407 E:37409 ||| ,
we  ||| S:37409 E:37412 ||| PRP
do  ||| S:37412 E:37415 ||| VBP
note  ||| S:37415 E:37420 ||| NN
that  ||| S:37420 E:37425 ||| IN
the  ||| S:37425 E:37429 ||| DT
k  ||| S:37429 E:37440 ||| JJ
cat  ||| S:37440 E:37444 ||| JJ
/ ||| S:37444 E:37445 ||| NNP
K  ||| S:37445 E:37456 ||| NNP
m  ||| S:37456 E:37458 ||| NN
values  ||| S:37458 E:37465 ||| NNS
of  ||| S:37465 E:37468 ||| IN
wild-type  ||| S:37468 E:37478 ||| NNP
L1  ||| S:37478 E:37481 ||| NNP
and  ||| S:37481 E:37485 ||| CC
F158A  ||| S:37485 E:37499 ||| CD
differ  ||| S:37499 E:37506 ||| NN
by  ||| S:37506 E:37509 ||| IN
a  ||| S:37509 E:37511 ||| DT
factor  ||| S:37511 E:37518 ||| NN
less  ||| S:37518 E:37523 ||| RBR
than  ||| S:37523 E:37528 ||| IN
2 ||| S:37528 E:37529 ||| CD
.  ||| S:37529 E:37539 ||| .
The  ||| S:37539 E:37543 ||| DT
inability  ||| S:37543 E:37553 ||| NN
to  ||| S:37553 E:37556 ||| TO
propose  ||| S:37556 E:37564 ||| VB
a  ||| S:37564 E:37566 ||| DT
consistent  ||| S:37566 E:37577 ||| JJ
binding  ||| S:37577 E:37585 ||| JJ
model  ||| S:37585 E:37591 ||| NN
also  ||| S:37591 E:37604 ||| RB
supports  ||| S:37604 E:37613 ||| VBZ
the  ||| S:37613 E:37617 ||| DT
recent  ||| S:37617 E:37624 ||| JJ
proposal  ||| S:37624 E:37633 ||| NN
that  ||| S:37633 E:37638 ||| IN
different  ||| S:37638 E:37648 ||| JJ
substrates  ||| S:37648 E:37659 ||| NN
of  ||| S:37659 E:37670 ||| IN
L1  ||| S:37670 E:37673 ||| NNP
are  ||| S:37673 E:37677 ||| VBP
hydrolyzed  ||| S:37677 E:37688 ||| VBN
by  ||| S:37688 E:37691 ||| IN
different  ||| S:37691 E:37701 ||| JJ
mechanisms  ||| S:37701 E:37712 ||| NNS
and  ||| S:37712 E:37716 ||| CC
further  ||| S:37716 E:37732 ||| RB
suggests  ||| S:37732 E:37741 ||| VBZ
that  ||| S:37741 E:37746 ||| IN
using  ||| S:37746 E:37752 ||| VBG
steady-state  ||| S:37752 E:37765 ||| JJ
kinetic  ||| S:37765 E:37773 ||| JJ
constants  ||| S:37773 E:37783 ||| NN
may  ||| S:37783 E:37787 ||| MD
not  ||| S:37787 E:37799 ||| RB
be  ||| S:37799 E:37802 ||| VB
a  ||| S:37802 E:37804 ||| DT
valid  ||| S:37804 E:37810 ||| JJ
way  ||| S:37810 E:37814 ||| NN
to  ||| S:37814 E:37817 ||| TO
probe  ||| S:37817 E:37823 ||| VB
substrate  ||| S:37823 E:37833 ||| JJ
binding  ||| S:37833 E:37841 ||| NN
to  ||| S:37841 E:37844 ||| TO
L1 ||| S:37844 E:37846 ||| CD
.  ||| S:37846 E:37848 ||| .
In  ||| S:37848 E:37859 ||| IN
addition ||| S:37859 E:37867 ||| NN
,  ||| S:37867 E:37869 ||| ,
the  ||| S:37869 E:37873 ||| DT
minimal  ||| S:37873 E:37881 ||| JJ
kinetic  ||| S:37881 E:37889 ||| JJ
mechanism  ||| S:37889 E:37899 ||| NN
of  ||| S:37899 E:37902 ||| IN
nitrocefin  ||| S:37902 E:37921 ||| JJ
hydrolysis  ||| S:37921 E:37932 ||| NN
by  ||| S:37932 E:37935 ||| IN
L1  ||| S:37935 E:37938 ||| NNP
has  ||| S:37938 E:37942 ||| VBZ
been  ||| S:37942 E:37947 ||| VBN
reported ||| S:37947 E:37955 ||| VBN
,  ||| S:37955 E:37957 ||| ,
and  ||| S:37957 E:37961 ||| CC
this  ||| S:37961 E:37966 ||| DT
mechanism  ||| S:37966 E:37984 ||| NN
predicts  ||| S:37984 E:37993 ||| VBZ
that  ||| S:37993 E:37998 ||| IN
K  ||| S:37998 E:38009 ||| NNP
m  ||| S:38009 E:38011 ||| NN
does  ||| S:38011 E:38016 ||| VBZ
not  ||| S:38016 E:38020 ||| RB
accurately  ||| S:38020 E:38031 ||| RB
reflect  ||| S:38031 E:38039 ||| VB
substrate  ||| S:38039 E:38057 ||| JJ
binding ||| S:38057 E:38064 ||| NN
.  ||| S:38064 E:38066 ||| .
By  ||| S:38066 E:38069 ||| IN
using  ||| S:38069 E:38075 ||| VBG
this  ||| S:38075 E:38080 ||| DT
mechanism  ||| S:38080 E:38090 ||| NN
[  ||| S:38090 E:38092 ||| -LRB-
39  ||| S:38092 E:38095 ||| CD
]  ||| S:38095 E:38097 ||| -RRB-
,  ||| S:38097 E:38099 ||| ,
K  ||| S:38099 E:38110 ||| NNP
m  ||| S:38110 E:38112 ||| NN
is  ||| S:38112 E:38115 ||| VBZ
equal  ||| S:38115 E:38121 ||| JJ
to  ||| S:38121 E:38124 ||| TO
{ ||| S:38124 E:38125 ||| CD
( ||| S:38125 E:38126 ||| -LRB-
k  ||| S:38126 E:38137 ||| FW
-1  ||| S:38137 E:38140 ||| FW
+  ||| S:38140 E:38142 ||| FW
k  ||| S:38142 E:38153 ||| FW
2  ||| S:38153 E:38155 ||| LS
) ||| S:38155 E:38156 ||| -RRB-
k  ||| S:38156 E:38167 ||| VBD
3  ||| S:38167 E:38169 ||| CD
k  ||| S:38169 E:38180 ||| CD
4  ||| S:38180 E:38182 ||| CD
}  ||| S:38182 E:38184 ||| -RRB-
/  ||| S:38184 E:38186 ||| NNP
{ ||| S:38186 E:38187 ||| -LRB-
k  ||| S:38187 E:38198 ||| CD
1  ||| S:38198 E:38200 ||| CD
( ||| S:38200 E:38201 ||| -LRB-
k  ||| S:38201 E:38212 ||| CD
3  ||| S:38212 E:38214 ||| CD
k  ||| S:38214 E:38225 ||| CD
4  ||| S:38225 E:38227 ||| CD
+  ||| S:38227 E:38229 ||| CD
k  ||| S:38229 E:38240 ||| CD
2  ||| S:38240 E:38242 ||| CD
k  ||| S:38242 E:38253 ||| CD
4  ||| S:38253 E:38255 ||| CD
+  ||| S:38255 E:38257 ||| CD
k  ||| S:38257 E:38268 ||| CD
2  ||| S:38268 E:38270 ||| CD
k  ||| S:38270 E:38281 ||| CD
3  ||| S:38281 E:38283 ||| CD
} ||| S:38283 E:38284 ||| -RRB-
.  ||| S:38284 E:38286 ||| .
To  ||| S:38286 E:38289 ||| TO
probe  ||| S:38289 E:38295 ||| VB
more  ||| S:38295 E:38300 ||| RBR
directly  ||| S:38300 E:38309 ||| RB
the  ||| S:38309 E:38321 ||| DT
reaction ||| S:38321 E:38329 ||| NN
,  ||| S:38329 E:38331 ||| ,
stopped-flow  ||| S:38331 E:38344 ||| JJ
absorbance  ||| S:38344 E:38355 ||| JJ
studies  ||| S:38355 E:38363 ||| NNS
were  ||| S:38363 E:38368 ||| VBD
conducted ||| S:38368 E:38377 ||| VBN
,  ||| S:38377 E:38387 ||| ,
and  ||| S:38387 E:38391 ||| CC
the  ||| S:38391 E:38395 ||| DT
substrate  ||| S:38395 E:38405 ||| JJ
decay  ||| S:38405 E:38411 ||| NN
rates  ||| S:38411 E:38417 ||| NNS
( ||| S:38417 E:38418 ||| -LRB-
390  ||| S:38418 E:38422 ||| CD
nm ||| S:38422 E:38424 ||| CD
)  ||| S:38424 E:38426 ||| -RRB-
were  ||| S:38426 E:38431 ||| VBD
studied  ||| S:38431 E:38439 ||| VBN
as  ||| S:38439 E:38442 ||| IN
a  ||| S:38442 E:38452 ||| DT
function  ||| S:38452 E:38461 ||| NN
of  ||| S:38461 E:38464 ||| IN
nitrocefin  ||| S:38464 E:38475 ||| JJ
concentration ||| S:38475 E:38488 ||| NN
.  ||| S:38488 E:38490 ||| .
While  ||| S:38490 E:38496 ||| IN
nitrocefin  ||| S:38496 E:38507 ||| NN
is  ||| S:38507 E:38510 ||| VBZ
a  ||| S:38510 E:38520 ||| DT
nontypical  ||| S:38520 E:38531 ||| JJ
substrate ||| S:38531 E:38540 ||| NN
,  ||| S:38540 E:38542 ||| ,
as  ||| S:38542 E:38545 ||| IN
a  ||| S:38545 E:38547 ||| DT
result  ||| S:38547 E:38554 ||| NN
of  ||| S:38554 E:38557 ||| IN
the  ||| S:38557 E:38569 ||| DT
dinitro-substituted  ||| S:38569 E:38589 ||| JJ
styryl  ||| S:38589 E:38596 ||| JJ
substituent  ||| S:38596 E:38608 ||| NNS
[  ||| S:38608 E:38610 ||| -LRB-
40  ||| S:38610 E:38613 ||| CD
]  ||| S:38613 E:38615 ||| -RRB-
,  ||| S:38615 E:38617 ||| ,
it  ||| S:38617 E:38620 ||| PRP
is  ||| S:38620 E:38623 ||| VBZ
the  ||| S:38623 E:38635 ||| DT
substrate  ||| S:38635 E:38645 ||| NN
about  ||| S:38645 E:38651 ||| IN
which  ||| S:38651 E:38657 ||| WDT
the  ||| S:38657 E:38661 ||| DT
most  ||| S:38661 E:38666 ||| JJS
is  ||| S:38666 E:38669 ||| VBZ
known  ||| S:38669 E:38675 ||| VBN
about  ||| S:38675 E:38681 ||| IN
its  ||| S:38681 E:38693 ||| PRP$
hydrolysis  ||| S:38693 E:38704 ||| JJ
mechanism ||| S:38704 E:38713 ||| NN
.  ||| S:38713 E:38715 ||| .
Therefore ||| S:38715 E:38724 ||| RB
,  ||| S:38724 E:38726 ||| ,
kinetic  ||| S:38726 E:38734 ||| JJ
studies  ||| S:38734 E:38742 ||| NNS
with  ||| S:38742 E:38755 ||| IN
nitrocefin  ||| S:38755 E:38766 ||| NN
as  ||| S:38766 E:38769 ||| IN
substrate  ||| S:38769 E:38779 ||| VBG
allowed  ||| S:38779 E:38787 ||| VBN
for  ||| S:38787 E:38791 ||| IN
us  ||| S:38791 E:38794 ||| PRP
to  ||| S:38794 E:38797 ||| TO
evaluate  ||| S:38797 E:38806 ||| VB
the  ||| S:38806 E:38818 ||| DT
effect  ||| S:38818 E:38825 ||| NN
of  ||| S:38825 E:38828 ||| IN
point  ||| S:38828 E:38834 ||| NN
mutations  ||| S:38834 E:38844 ||| NNS
on  ||| S:38844 E:38847 ||| IN
the  ||| S:38847 E:38851 ||| DT
reaction  ||| S:38851 E:38860 ||| NN
mechanism  ||| S:38860 E:38870 ||| NN
of  ||| S:38870 E:38873 ||| IN
L1 ||| S:38873 E:38875 ||| CD
.  ||| S:38875 E:38885 ||| .
There  ||| S:38885 E:38891 ||| EX
was  ||| S:38891 E:38895 ||| VBD
no  ||| S:38895 E:38898 ||| DT
clear  ||| S:38898 E:38904 ||| JJ
dependence  ||| S:38904 E:38915 ||| NN
on  ||| S:38915 E:38918 ||| IN
substrate  ||| S:38918 E:38928 ||| JJ
decay  ||| S:38928 E:38934 ||| NN
rates  ||| S:38934 E:38940 ||| NNS
with  ||| S:38940 E:38953 ||| IN
nitrocefin  ||| S:38953 E:38964 ||| JJ
concentration  ||| S:38964 E:38978 ||| NN
( ||| S:38978 E:38979 ||| -LRB-
data  ||| S:38979 E:38984 ||| NNS
not  ||| S:38984 E:38988 ||| RB
shown ||| S:38988 E:38993 ||| VBN
) ||| S:38993 E:38994 ||| -RRB-
.  ||| S:38994 E:38996 ||| .
We  ||| S:38996 E:38999 ||| PRP
did  ||| S:38999 E:39003 ||| VBD
note  ||| S:39003 E:39016 ||| NN
though  ||| S:39016 E:39023 ||| IN
that  ||| S:39023 E:39028 ||| IN
the  ||| S:39028 E:39032 ||| DT
amount  ||| S:39032 E:39039 ||| NN
of  ||| S:39039 E:39042 ||| IN
intermediate  ||| S:39042 E:39055 ||| JJ
formed  ||| S:39055 E:39062 ||| VBN
during  ||| S:39062 E:39069 ||| IN
the  ||| S:39069 E:39081 ||| DT
reactions  ||| S:39081 E:39091 ||| NNS
varied  ||| S:39091 E:39098 ||| VBD
considerably  ||| S:39098 E:39111 ||| RB
depending  ||| S:39111 E:39121 ||| VBG
upon  ||| S:39121 E:39126 ||| IN
which  ||| S:39126 E:39132 ||| WDT
mutant  ||| S:39132 E:39147 ||| VBZ
of  ||| S:39147 E:39150 ||| IN
L1  ||| S:39150 E:39153 ||| NNP
was  ||| S:39153 E:39157 ||| VBD
used  ||| S:39157 E:39162 ||| VBN
in  ||| S:39162 E:39165 ||| IN
the  ||| S:39165 E:39169 ||| DT
study ||| S:39169 E:39174 ||| NN
.  ||| S:39174 E:39176 ||| .
All  ||| S:39176 E:39180 ||| DT
of  ||| S:39180 E:39183 ||| IN
the  ||| S:39183 E:39187 ||| DT
mutants  ||| S:39187 E:39195 ||| JJ
exhibited  ||| S:39195 E:39213 ||| JJ
decreases  ||| S:39213 E:39223 ||| NNS
in  ||| S:39223 E:39226 ||| IN
intermediate  ||| S:39226 E:39239 ||| JJ
formation ||| S:39239 E:39248 ||| NN
,  ||| S:39248 E:39250 ||| ,
and  ||| S:39250 E:39254 ||| CC
the  ||| S:39254 E:39258 ||| DT
S224D ||| S:39258 E:39263 ||| NNP
,  ||| S:39263 E:39265 ||| ,
S224K ||| S:39265 E:39270 ||| NNP
,  ||| S:39270 E:39280 ||| ,
F158A ||| S:39280 E:39285 ||| NNP
,  ||| S:39285 E:39287 ||| ,
N233D ||| S:39287 E:39292 ||| NNP
,  ||| S:39292 E:39294 ||| ,
and  ||| S:39294 E:39298 ||| CC
N233L  ||| S:39298 E:39304 ||| CD
mutants  ||| S:39304 E:39312 ||| NNS
yielded  ||| S:39312 E:39320 ||| VBD
rapid-scanning  ||| S:39320 E:39335 ||| JJ
data  ||| S:39335 E:39348 ||| NNS
consistent  ||| S:39348 E:39359 ||| JJ
with  ||| S:39359 E:39364 ||| IN
no  ||| S:39364 E:39367 ||| DT
detectable  ||| S:39367 E:39378 ||| JJ
intermediate ||| S:39378 E:39390 ||| NN
.  ||| S:39390 E:39392 ||| .
These  ||| S:39392 E:39398 ||| DT
same  ||| S:39398 E:39411 ||| JJ
mutants  ||| S:39411 E:39419 ||| NNS
exhibited  ||| S:39419 E:39429 ||| VBP
vastly  ||| S:39429 E:39436 ||| RB
differing  ||| S:39436 E:39446 ||| VBG
K  ||| S:39446 E:39457 ||| NNP
m  ||| S:39457 E:39459 ||| NN
values ||| S:39459 E:39465 ||| NNS
.  ||| S:39465 E:39467 ||| .
Clearly  ||| S:39467 E:39475 ||| RB
there  ||| S:39475 E:39481 ||| EX
is  ||| S:39481 E:39484 ||| VBZ
no  ||| S:39484 E:39495 ||| DT
correlation  ||| S:39495 E:39507 ||| NN
of  ||| S:39507 E:39510 ||| IN
K  ||| S:39510 E:39521 ||| NNP
m  ||| S:39521 E:39523 ||| NN
with  ||| S:39523 E:39528 ||| IN
the  ||| S:39528 E:39532 ||| DT
presence  ||| S:39532 E:39541 ||| NN
of  ||| S:39541 E:39544 ||| IN
the  ||| S:39544 E:39548 ||| DT
reaction  ||| S:39548 E:39565 ||| NN
intermediate ||| S:39565 E:39577 ||| NN
.  ||| S:39577 E:39579 ||| .
Apparently ||| S:39579 E:39589 ||| RB
,  ||| S:39589 E:39591 ||| ,
the  ||| S:39591 E:39595 ||| DT
ability  ||| S:39595 E:39603 ||| NN
to  ||| S:39603 E:39606 ||| TO
observe  ||| S:39606 E:39614 ||| VB
the  ||| S:39614 E:39626 ||| DT
intermediate  ||| S:39626 E:39639 ||| NN
is  ||| S:39639 E:39642 ||| VBZ
not  ||| S:39642 E:39646 ||| RB
governed  ||| S:39646 E:39655 ||| VBN
entirely  ||| S:39655 E:39664 ||| RB
by  ||| S:39664 E:39667 ||| IN
the  ||| S:39667 E:39671 ||| DT
choice  ||| S:39671 E:39678 ||| NN
of  ||| S:39678 E:39689 ||| IN
substrate  ||| S:39689 E:39699 ||| NNS
[  ||| S:39699 E:39701 ||| -LRB-
40  ||| S:39701 E:39704 ||| CD
]  ||| S:39704 E:39706 ||| -RRB-
,  ||| S:39706 E:39708 ||| ,
and  ||| S:39708 E:39712 ||| CC
it  ||| S:39712 E:39715 ||| PRP
also  ||| S:39715 E:39720 ||| RB
depends  ||| S:39720 E:39728 ||| VBZ
on  ||| S:39728 E:39731 ||| IN
precise  ||| S:39731 E:39747 ||| JJ
arrangement  ||| S:39747 E:39759 ||| NN
of  ||| S:39759 E:39762 ||| IN
active  ||| S:39762 E:39769 ||| JJ
site  ||| S:39769 E:39774 ||| NN
residues ||| S:39774 E:39782 ||| NNS
.  ||| S:39782 E:39784 ||| .
It  ||| S:39784 E:39787 ||| PRP
is  ||| S:39787 E:39790 ||| VBZ
also  ||| S:39790 E:39795 ||| RB
possible  ||| S:39795 E:39812 ||| JJ
that  ||| S:39812 E:39817 ||| IN
the  ||| S:39817 E:39821 ||| DT
site-directed  ||| S:39821 E:39835 ||| JJ
mutants  ||| S:39835 E:39843 ||| NN
could  ||| S:39843 E:39849 ||| MD
be  ||| S:39849 E:39852 ||| VB
utilizing  ||| S:39852 E:39862 ||| VBN
a  ||| S:39862 E:39872 ||| DT
different  ||| S:39872 E:39882 ||| JJ
mechanism  ||| S:39882 E:39892 ||| NN
to  ||| S:39892 E:39895 ||| TO
hydrolyze  ||| S:39895 E:39905 ||| VB
nitrocefin  ||| S:39905 E:39916 ||| NNS
[  ||| S:39916 E:39918 ||| -LRB-
66  ||| S:39918 E:39921 ||| CD
]  ||| S:39921 E:39923 ||| -RRB-
.  ||| S:39923 E:39933 ||| .
Recently ||| S:39933 E:39941 ||| RB
,  ||| S:39941 E:39943 ||| ,
Spencer  ||| S:39943 E:39951 ||| NNP
and  ||| S:39951 E:39955 ||| CC
co-workers  ||| S:39955 E:39966 ||| NNS
reported  ||| S:39966 E:39975 ||| VBD
that  ||| S:39975 E:39988 ||| DT
stopped-flow  ||| S:39988 E:40001 ||| JJ
fluorescence  ||| S:40001 E:40014 ||| JJ
studies  ||| S:40014 E:40022 ||| NNS
can  ||| S:40022 E:40026 ||| MD
be  ||| S:40026 E:40029 ||| VB
used  ||| S:40029 E:40034 ||| VBN
to  ||| S:40034 E:40037 ||| TO
monitor  ||| S:40037 E:40053 ||| VB
the  ||| S:40053 E:40057 ||| DT
reaction  ||| S:40057 E:40066 ||| NN
of  ||| S:40066 E:40069 ||| IN
L1  ||| S:40069 E:40072 ||| CD
with  ||| S:40072 E:40077 ||| IN
nitrocefin  ||| S:40077 E:40088 ||| NN
and  ||| S:40088 E:40092 ||| CC
that  ||| S:40092 E:40097 ||| IN
an  ||| S:40097 E:40100 ||| DT
initial  ||| S:40100 E:40116 ||| JJ
binding  ||| S:40116 E:40124 ||| JJ
step  ||| S:40124 E:40129 ||| NN
can  ||| S:40129 E:40133 ||| MD
be  ||| S:40133 E:40136 ||| VB
directly  ||| S:40136 E:40145 ||| RB
monitored  ||| S:40145 E:40155 ||| VBN
[  ||| S:40155 E:40157 ||| -LRB-
40  ||| S:40157 E:40160 ||| CD
]  ||| S:40160 E:40162 ||| -RRB-
.  ||| S:40162 E:40164 ||| .
By  ||| S:40164 E:40175 ||| IN
increasing  ||| S:40175 E:40186 ||| VBG
the  ||| S:40186 E:40190 ||| DT
concentration  ||| S:40190 E:40204 ||| NN
of  ||| S:40204 E:40207 ||| IN
nitrocefin ||| S:40207 E:40217 ||| NN
,  ||| S:40217 E:40219 ||| ,
the  ||| S:40219 E:40223 ||| DT
rate  ||| S:40223 E:40228 ||| NN
of  ||| S:40228 E:40231 ||| IN
the  ||| S:40231 E:40243 ||| DT
initial  ||| S:40243 E:40251 ||| JJ
binding  ||| S:40251 E:40259 ||| JJ
step  ||| S:40259 E:40264 ||| NN
increased  ||| S:40264 E:40274 ||| VBD
to  ||| S:40274 E:40277 ||| TO
a  ||| S:40277 E:40279 ||| DT
maximum ||| S:40279 E:40286 ||| NN
,  ||| S:40286 E:40288 ||| ,
and  ||| S:40288 E:40292 ||| CC
fitting  ||| S:40292 E:40300 ||| JJ
of  ||| S:40300 E:40311 ||| IN
these  ||| S:40311 E:40317 ||| DT
data  ||| S:40317 E:40322 ||| NNS
yielded  ||| S:40322 E:40330 ||| VBD
a  ||| S:40330 E:40332 ||| DT
binding  ||| S:40332 E:40340 ||| JJ
constant  ||| S:40340 E:40349 ||| JJ
( ||| S:40349 E:40350 ||| -LRB-
called  ||| S:40350 E:40357 ||| VBN
K  ||| S:40357 E:40368 ||| NNP
S  ||| S:40368 E:40370 ||| NNP
herein ||| S:40370 E:40376 ||| CD
)  ||| S:40376 E:40378 ||| -RRB-
for  ||| S:40378 E:40382 ||| IN
nitrocefin ||| S:40382 E:40392 ||| NN
.  ||| S:40392 E:40394 ||| .
Each  ||| S:40394 E:40399 ||| DT
of  ||| S:40399 E:40402 ||| IN
the  ||| S:40402 E:40406 ||| DT
L1  ||| S:40406 E:40417 ||| CD
mutants  ||| S:40417 E:40425 ||| NNS
were  ||| S:40425 E:40430 ||| VBD
studied  ||| S:40430 E:40438 ||| VBN
using  ||| S:40438 E:40444 ||| VBG
the  ||| S:40444 E:40448 ||| DT
stopped-flow  ||| S:40448 E:40461 ||| JJ
fluorescence  ||| S:40461 E:40482 ||| JJ
studies ||| S:40482 E:40489 ||| NNS
,  ||| S:40489 E:40491 ||| ,
and  ||| S:40491 E:40495 ||| CC
the  ||| S:40495 E:40499 ||| DT
resulting  ||| S:40499 E:40509 ||| VBG
data  ||| S:40509 E:40514 ||| NNS
were  ||| S:40514 E:40519 ||| VBD
fitted  ||| S:40519 E:40526 ||| VBN
as  ||| S:40526 E:40529 ||| RB
reported  ||| S:40529 E:40538 ||| VBN
by  ||| S:40538 E:40549 ||| IN
Spencer  ||| S:40549 E:40566 ||| NNP
et  ||| S:40566 E:40569 ||| FW
al.  ||| S:40569 E:40573 ||| FW
[  ||| S:40573 E:40575 ||| -LRB-
40  ||| S:40575 E:40578 ||| CD
]  ||| S:40578 E:40580 ||| -RRB-
( ||| S:40580 E:40581 ||| -LRB-
Table  ||| S:40581 E:40587 ||| NNP
6 ||| S:40587 E:40588 ||| CD
) ||| S:40588 E:40589 ||| -RRB-
.  ||| S:40589 E:40591 ||| .
All  ||| S:40591 E:40595 ||| DT
of  ||| S:40595 E:40598 ||| IN
the  ||| S:40598 E:40610 ||| DT
mutants  ||| S:40610 E:40618 ||| JJ
exhibited  ||| S:40618 E:40628 ||| JJ
K  ||| S:40628 E:40639 ||| NNP
S  ||| S:40639 E:40641 ||| NNP
values  ||| S:40641 E:40648 ||| VBZ
identical ||| S:40648 E:40657 ||| JJ
,  ||| S:40657 E:40659 ||| ,
within  ||| S:40659 E:40666 ||| IN
error ||| S:40666 E:40671 ||| NN
,  ||| S:40671 E:40673 ||| ,
to  ||| S:40673 E:40684 ||| TO
wild-type  ||| S:40684 E:40694 ||| NNP
L1 ||| S:40694 E:40696 ||| NNP
,  ||| S:40696 E:40698 ||| ,
except  ||| S:40698 E:40705 ||| IN
the  ||| S:40705 E:40709 ||| DT
S224D  ||| S:40709 E:40715 ||| NNP
and  ||| S:40715 E:40719 ||| CC
the  ||| S:40719 E:40723 ||| DT
Y228A  ||| S:40723 E:40729 ||| JJ
mutants ||| S:40729 E:40736 ||| NN
.  ||| S:40736 E:40738 ||| .
The  ||| S:40738 E:40750 ||| DT
placement  ||| S:40750 E:40760 ||| NN
of  ||| S:40760 E:40763 ||| IN
a  ||| S:40763 E:40765 ||| DT
negative  ||| S:40765 E:40774 ||| JJ
charge  ||| S:40774 E:40781 ||| NN
at  ||| S:40781 E:40784 ||| IN
position  ||| S:40784 E:40793 ||| NN
224  ||| S:40793 E:40797 ||| CD
drastically  ||| S:40797 E:40817 ||| NN
affects  ||| S:40817 E:40825 ||| VBZ
nitrocefin  ||| S:40825 E:40836 ||| JJ
binding  ||| S:40836 E:40844 ||| NN
and  ||| S:40844 E:40848 ||| CC
results  ||| S:40848 E:40856 ||| NNS
in  ||| S:40856 E:40859 ||| IN
a  ||| S:40859 E:40861 ||| DT
6-fold  ||| S:40861 E:40868 ||| JJ
decrease  ||| S:40868 E:40885 ||| NN
in  ||| S:40885 E:40888 ||| IN
binding  ||| S:40888 E:40896 ||| JJ
affinity  ||| S:40896 E:40905 ||| NNS
( ||| S:40905 E:40906 ||| -LRB-
Table  ||| S:40906 E:40912 ||| NNP
6 ||| S:40912 E:40913 ||| CD
) ||| S:40913 E:40914 ||| -RRB-
.  ||| S:40914 E:40916 ||| .
To  ||| S:40916 E:40919 ||| TO
a  ||| S:40919 E:40921 ||| DT
lesser  ||| S:40921 E:40928 ||| JJR
degree ||| S:40928 E:40934 ||| NN
,  ||| S:40934 E:40936 ||| ,
the  ||| S:40936 E:40948 ||| DT
aromatic  ||| S:40948 E:40957 ||| JJ
portion  ||| S:40957 E:40965 ||| NN
of  ||| S:40965 E:40968 ||| IN
Tyr228  ||| S:40968 E:40975 ||| NNP
must  ||| S:40975 E:40980 ||| MD
have  ||| S:40980 E:40985 ||| VB
an  ||| S:40985 E:40988 ||| DT
effect  ||| S:40988 E:40995 ||| NN
on  ||| S:40995 E:40998 ||| IN
the  ||| S:40998 E:41010 ||| DT
binding  ||| S:41010 E:41018 ||| JJ
site  ||| S:41018 E:41023 ||| NN
as  ||| S:41023 E:41026 ||| IN
the  ||| S:41026 E:41030 ||| DT
K  ||| S:41030 E:41041 ||| NNP
S  ||| S:41041 E:41043 ||| NNP
value  ||| S:41043 E:41049 ||| NN
for  ||| S:41049 E:41053 ||| IN
nitrocefin  ||| S:41053 E:41064 ||| JJ
binding  ||| S:41064 E:41072 ||| NN
to  ||| S:41072 E:41075 ||| TO
this  ||| S:41075 E:41088 ||| DT
mutant  ||| S:41088 E:41095 ||| NN
is  ||| S:41095 E:41098 ||| VBZ
decreased  ||| S:41098 E:41108 ||| VBN
by  ||| S:41108 E:41111 ||| IN
a  ||| S:41111 E:41113 ||| DT
factor  ||| S:41113 E:41120 ||| NN
of  ||| S:41120 E:41123 ||| IN
2 ||| S:41123 E:41124 ||| CD
;  ||| S:41124 E:41126 ||| :
however ||| S:41126 E:41133 ||| RB
,  ||| S:41133 E:41135 ||| ,
the  ||| S:41135 E:41139 ||| DT
hydroxyl  ||| S:41139 E:41156 ||| JJ
group  ||| S:41156 E:41162 ||| NN
probably  ||| S:41162 E:41171 ||| RB
does  ||| S:41171 E:41176 ||| VBZ
not  ||| S:41176 E:41180 ||| RB
form  ||| S:41180 E:41185 ||| VB
a  ||| S:41185 E:41187 ||| DT
hydrogen  ||| S:41187 E:41196 ||| NN
bond  ||| S:41196 E:41201 ||| NN
to  ||| S:41201 E:41204 ||| TO
the  ||| S:41204 E:41216 ||| DT
substrate  ||| S:41216 E:41226 ||| NN
as  ||| S:41226 E:41229 ||| IN
proposed ||| S:41229 E:41237 ||| VBN
.  ||| S:41237 E:41239 ||| .
By  ||| S:41239 E:41242 ||| IN
using  ||| S:41242 E:41248 ||| VBG
nitrocefin  ||| S:41248 E:41259 ||| NN
as  ||| S:41259 E:41262 ||| IN
substrate  ||| S:41262 E:41272 ||| NN
and  ||| S:41272 E:41284 ||| CC
K  ||| S:41284 E:41295 ||| NNP
m  ||| S:41295 E:41297 ||| NN
values  ||| S:41297 E:41304 ||| VBZ
alone ||| S:41304 E:41309 ||| RB
,  ||| S:41309 E:41311 ||| ,
a  ||| S:41311 E:41313 ||| DT
completely  ||| S:41313 E:41324 ||| RB
different  ||| S:41324 E:41342 ||| JJ
conclusion  ||| S:41342 E:41353 ||| NN
is  ||| S:41353 E:41356 ||| VBZ
reached  ||| S:41356 E:41364 ||| VBN
regarding  ||| S:41364 E:41374 ||| VBG
important  ||| S:41374 E:41384 ||| JJ
substrate  ||| S:41384 E:41394 ||| JJ
binding  ||| S:41394 E:41410 ||| JJ
residues ||| S:41410 E:41418 ||| NNS
.  ||| S:41418 E:41420 ||| .
The  ||| S:41420 E:41424 ||| DT
results  ||| S:41424 E:41432 ||| NNS
presented  ||| S:41432 E:41442 ||| VBD
here  ||| S:41442 E:41447 ||| RB
suggests  ||| S:41447 E:41456 ||| VBZ
that  ||| S:41456 E:41461 ||| DT
none  ||| S:41461 E:41466 ||| NN
of  ||| S:41466 E:41477 ||| IN
the  ||| S:41477 E:41481 ||| DT
residues  ||| S:41481 E:41490 ||| NN
in  ||| S:41490 E:41493 ||| IN
this  ||| S:41493 E:41498 ||| DT
study  ||| S:41498 E:41504 ||| NN
are  ||| S:41504 E:41508 ||| VBP
essential  ||| S:41508 E:41518 ||| JJ
for  ||| S:41518 E:41522 ||| IN
tight  ||| S:41522 E:41536 ||| JJ
nitrocefin  ||| S:41536 E:41547 ||| JJ
binding ||| S:41547 E:41554 ||| NN
,  ||| S:41554 E:41556 ||| ,
possibly  ||| S:41556 E:41565 ||| RB
because  ||| S:41565 E:41573 ||| IN
other  ||| S:41573 E:41579 ||| JJ
parts  ||| S:41579 E:41585 ||| NNS
of  ||| S:41585 E:41588 ||| IN
the  ||| S:41588 E:41600 ||| DT
active  ||| S:41600 E:41607 ||| JJ
site  ||| S:41607 E:41612 ||| NN
accommodate  ||| S:41612 E:41624 ||| VB
the  ||| S:41624 E:41628 ||| DT
loss  ||| S:41628 E:41633 ||| NN
of  ||| S:41633 E:41636 ||| IN
certain  ||| S:41636 E:41644 ||| JJ
binding  ||| S:41644 E:41660 ||| JJ
contacts ||| S:41660 E:41668 ||| NNS
.  ||| S:41668 E:41678 ||| .
Spencer  ||| S:41678 E:41695 ||| NNP
et  ||| S:41695 E:41698 ||| NNP
al.  ||| S:41698 E:41702 ||| NNP
also  ||| S:41702 E:41707 ||| RB
reported  ||| S:41707 E:41716 ||| VBD
stopped-flow  ||| S:41716 E:41737 ||| JJ
fluorescence  ||| S:41737 E:41750 ||| JJ
studies  ||| S:41750 E:41758 ||| NNS
when  ||| S:41758 E:41763 ||| WRB
using  ||| S:41763 E:41769 ||| VBG
cefaclor  ||| S:41769 E:41778 ||| NNS
and  ||| S:41778 E:41782 ||| CC
meropenem  ||| S:41782 E:41792 ||| NN
as  ||| S:41792 E:41803 ||| IN
substrates ||| S:41803 E:41813 ||| NN
,  ||| S:41813 E:41815 ||| ,
and  ||| S:41815 E:41819 ||| CC
K  ||| S:41819 E:41830 ||| NNP
S  ||| S:41830 E:41832 ||| NNP
values  ||| S:41832 E:41839 ||| NNS
for  ||| S:41839 E:41843 ||| IN
these  ||| S:41843 E:41849 ||| DT
substrates  ||| S:41849 E:41860 ||| NN
were  ||| S:41860 E:41873 ||| VBD
reported  ||| S:41873 E:41882 ||| VBN
to  ||| S:41882 E:41885 ||| TO
be  ||| S:41885 E:41888 ||| VB
710  ||| S:41888 E:41892 ||| CD
±  ||| S:41892 E:41894 ||| CD
180  ||| S:41894 E:41898 ||| CD
and  ||| S:41898 E:41902 ||| CC
272  ||| S:41902 E:41906 ||| CD
±  ||| S:41906 E:41908 ||| CD
112  ||| S:41908 E:41912 ||| CD
μM ||| S:41912 E:41914 ||| NN
,  ||| S:41914 E:41916 ||| ,
respectively  ||| S:41916 E:41929 ||| RB
[  ||| S:41929 E:41939 ||| -LRB-
40  ||| S:41939 E:41942 ||| CD
]  ||| S:41942 E:41944 ||| -RRB-
.  ||| S:41944 E:41946 ||| .
However  ||| S:41946 E:41954 ||| RB
in  ||| S:41954 E:41957 ||| IN
our  ||| S:41957 E:41961 ||| PRP$
hands ||| S:41961 E:41966 ||| NNS
,  ||| S:41966 E:41968 ||| ,
the  ||| S:41968 E:41972 ||| DT
rates  ||| S:41972 E:41978 ||| NNS
of  ||| S:41978 E:41981 ||| IN
substrate  ||| S:41981 E:41999 ||| JJ
hydrolysis  ||| S:41999 E:42010 ||| NN
were  ||| S:42010 E:42015 ||| VBD
so  ||| S:42015 E:42018 ||| RB
fast  ||| S:42018 E:42023 ||| RB
when  ||| S:42023 E:42028 ||| WRB
using  ||| S:42028 E:42034 ||| VBG
wild-type  ||| S:42034 E:42044 ||| JJ
L1  ||| S:42044 E:42047 ||| NN
that  ||| S:42047 E:42052 ||| IN
we  ||| S:42052 E:42063 ||| PRP
could  ||| S:42063 E:42069 ||| MD
not  ||| S:42069 E:42073 ||| RB
use  ||| S:42073 E:42077 ||| VB
substrate  ||| S:42077 E:42087 ||| JJ
concentrations  ||| S:42087 E:42102 ||| NNS
high  ||| S:42102 E:42107 ||| JJ
enough  ||| S:42107 E:42114 ||| JJ
to  ||| S:42114 E:42125 ||| TO
saturate  ||| S:42125 E:42134 ||| VB
the  ||| S:42134 E:42138 ||| DT
enzyme ||| S:42138 E:42144 ||| NN
.  ||| S:42144 E:42146 ||| .
Similarly ||| S:42146 E:42155 ||| RB
,  ||| S:42155 E:42157 ||| ,
we  ||| S:42157 E:42160 ||| PRP
could  ||| S:42160 E:42166 ||| MD
not  ||| S:42166 E:42170 ||| RB
determine  ||| S:42170 E:42180 ||| VB
K  ||| S:42180 E:42191 ||| NNP
S  ||| S:42191 E:42193 ||| NNP
values  ||| S:42193 E:42200 ||| NNS
for  ||| S:42200 E:42204 ||| IN
penicillin  ||| S:42204 E:42215 ||| JJ
G  ||| S:42215 E:42217 ||| NNP
or  ||| S:42217 E:42220 ||| CC
ampicillin  ||| S:42220 E:42239 ||| NN
because  ||| S:42239 E:42247 ||| IN
the  ||| S:42247 E:42251 ||| DT
observed  ||| S:42251 E:42260 ||| JJ
rates  ||| S:42260 E:42266 ||| NNS
of  ||| S:42266 E:42269 ||| IN
hydrolysis  ||| S:42269 E:42280 ||| NN
at  ||| S:42280 E:42283 ||| IN
low  ||| S:42283 E:42287 ||| JJ
substrate  ||| S:42287 E:42305 ||| JJ
concentrations  ||| S:42305 E:42320 ||| NNS
were  ||| S:42320 E:42325 ||| VBD
too  ||| S:42325 E:42329 ||| RB
fast  ||| S:42329 E:42334 ||| RB
to  ||| S:42334 E:42337 ||| TO
observe  ||| S:42337 E:42345 ||| VB
data ||| S:42345 E:42349 ||| NNS
,  ||| S:42349 E:42351 ||| ,
even  ||| S:42351 E:42356 ||| RB
at  ||| S:42356 E:42367 ||| IN
10°C ||| S:42367 E:42371 ||| CD
.  ||| S:42371 E:42395 ||| .
Conclusions  ||| S:42395 E:42415 ||| NNS
The  ||| S:42415 E:42419 ||| DT
results  ||| S:42419 E:42427 ||| NNS
presented  ||| S:42427 E:42437 ||| VBD
herein  ||| S:42437 E:42444 ||| RB
indicate  ||| S:42444 E:42453 ||| VB
that  ||| S:42453 E:42458 ||| DT
none  ||| S:42458 E:42463 ||| NN
of  ||| S:42463 E:42466 ||| IN
the  ||| S:42466 E:42478 ||| DT
active  ||| S:42478 E:42485 ||| JJ
site  ||| S:42485 E:42490 ||| NN
residues  ||| S:42490 E:42499 ||| VBZ
identified  ||| S:42499 E:42510 ||| VBN
with  ||| S:42510 E:42515 ||| IN
computational  ||| S:42515 E:42529 ||| JJ
studies  ||| S:42529 E:42545 ||| NNS
are  ||| S:42545 E:42549 ||| VBP
essential  ||| S:42549 E:42559 ||| JJ
for  ||| S:42559 E:42563 ||| IN
tight  ||| S:42563 E:42569 ||| JJ
substrate  ||| S:42569 E:42579 ||| JJ
binding ||| S:42579 E:42586 ||| NN
.  ||| S:42586 E:42588 ||| .
These  ||| S:42588 E:42594 ||| DT
data  ||| S:42594 E:42599 ||| NNS
also  ||| S:42599 E:42612 ||| RB
indicate  ||| S:42612 E:42621 ||| VB
that  ||| S:42621 E:42626 ||| IN
the  ||| S:42626 E:42630 ||| DT
use  ||| S:42630 E:42634 ||| NN
of  ||| S:42634 E:42637 ||| IN
K  ||| S:42637 E:42648 ||| NNP
m  ||| S:42648 E:42650 ||| NN
values  ||| S:42650 E:42657 ||| NNS
to  ||| S:42657 E:42660 ||| TO
describe  ||| S:42660 E:42669 ||| VB
substrate  ||| S:42669 E:42679 ||| JJ
binding  ||| S:42679 E:42695 ||| NN
to  ||| S:42695 E:42698 ||| TO
L1  ||| S:42698 E:42701 ||| NNP
is  ||| S:42701 E:42704 ||| VBZ
unreliable  ||| S:42704 E:42715 ||| JJ
and  ||| S:42715 E:42719 ||| CC
that  ||| S:42719 E:42724 ||| IN
there  ||| S:42724 E:42730 ||| EX
is  ||| S:42730 E:42733 ||| VBZ
no  ||| S:42733 E:42736 ||| DT
correlation  ||| S:42736 E:42756 ||| NN
between  ||| S:42756 E:42764 ||| IN
intermediate  ||| S:42764 E:42777 ||| JJ
accumulation  ||| S:42777 E:42790 ||| NN
and  ||| S:42790 E:42794 ||| CC
substrate  ||| S:42794 E:42804 ||| JJ
binding  ||| S:42804 E:42820 ||| JJ
affinity ||| S:42820 E:42828 ||| NN
.  ||| S:42828 E:42830 ||| .
These  ||| S:42830 E:42836 ||| DT
results  ||| S:42836 E:42844 ||| NNS
demonstrate  ||| S:42844 E:42856 ||| VBP
that  ||| S:42856 E:42861 ||| IN
new  ||| S:42861 E:42865 ||| JJ
computational  ||| S:42865 E:42887 ||| JJ
studies  ||| S:42887 E:42895 ||| NNS
are  ||| S:42895 E:42899 ||| VBP
now  ||| S:42899 E:42903 ||| RB
needed  ||| S:42903 E:42910 ||| VBN
to  ||| S:42910 E:42913 ||| TO
probe  ||| S:42913 E:42919 ||| VB
substrate  ||| S:42919 E:42929 ||| JJ
binding  ||| S:42929 E:42937 ||| NN
to  ||| S:42937 E:42940 ||| TO
L1 ||| S:42940 E:42942 ||| CD
,  ||| S:42942 E:42952 ||| ,
and  ||| S:42952 E:42956 ||| CC
these  ||| S:42956 E:42962 ||| DT
studies  ||| S:42962 E:42970 ||| NNS
are  ||| S:42970 E:42974 ||| VBP
currently  ||| S:42974 E:42984 ||| RB
underway ||| S:42984 E:42992 ||| VBN
.  ||| S:42992 E:42994 ||| .
The  ||| S:42994 E:42998 ||| DT
results  ||| S:42998 E:43014 ||| NNS
presented  ||| S:43014 E:43024 ||| VBN
herein  ||| S:43024 E:43031 ||| NNS
can  ||| S:43031 E:43035 ||| MD
be  ||| S:43035 E:43038 ||| VB
used  ||| S:43038 E:43043 ||| VBN
to  ||| S:43043 E:43046 ||| TO
guide  ||| S:43046 E:43052 ||| VB
these  ||| S:43052 E:43058 ||| DT
new  ||| S:43058 E:43070 ||| JJ
computational  ||| S:43070 E:43084 ||| JJ
studies ||| S:43084 E:43091 ||| NNS
,  ||| S:43091 E:43093 ||| ,
which  ||| S:43093 E:43099 ||| WDT
will  ||| S:43099 E:43104 ||| MD
lead  ||| S:43104 E:43109 ||| VB
to  ||| S:43109 E:43112 ||| TO
the  ||| S:43112 E:43116 ||| DT
design  ||| S:43116 E:43123 ||| NN
of  ||| S:43123 E:43134 ||| IN
potential  ||| S:43134 E:43144 ||| JJ
inhibitors  ||| S:43144 E:43155 ||| NN
and  ||| S:43155 E:43159 ||| CC
hopefully  ||| S:43159 E:43169 ||| RB
a  ||| S:43169 E:43171 ||| DT
way  ||| S:43171 E:43175 ||| NN
to  ||| S:43175 E:43178 ||| TO
combat  ||| S:43178 E:43193 ||| VB
penicillin  ||| S:43193 E:43204 ||| JJ
resistance  ||| S:43204 E:43215 ||| NN
in  ||| S:43215 E:43218 ||| IN
bacteria ||| S:43218 E:43226 ||| NNS
.  ||| S:43226 E:43250 ||| .
Materials  ||| S:43250 E:43260 ||| NNS
and  ||| S:43260 E:43264 ||| CC
Methods  ||| S:43264 E:43291 ||| NNP
Materials  ||| S:43291 E:43322 ||| NNPS
E.  ||| S:43322 E:43325 ||| NNP
coli  ||| S:43325 E:43330 ||| FW
strains  ||| S:43330 E:43338 ||| FW
DH5α  ||| S:43338 E:43343 ||| FW
and  ||| S:43343 E:43347 ||| CC
BL21 ||| S:43347 E:43351 ||| NNP
( ||| S:43351 E:43352 ||| -LRB-
DE3 ||| S:43352 E:43355 ||| NNP
)  ||| S:43355 E:43367 ||| -RRB-
pLysS  ||| S:43367 E:43373 ||| NNP
were  ||| S:43373 E:43378 ||| VBD
obtained  ||| S:43378 E:43387 ||| VBN
from  ||| S:43387 E:43392 ||| IN
Gibco  ||| S:43392 E:43398 ||| NNP
BRL  ||| S:43398 E:43402 ||| NNP
and  ||| S:43402 E:43406 ||| CC
Novagen ||| S:43406 E:43413 ||| NNP
,  ||| S:43413 E:43425 ||| ,
respectively ||| S:43425 E:43437 ||| RB
.  ||| S:43437 E:43439 ||| .
Plasmids  ||| S:43439 E:43448 ||| NNP
pET26b  ||| S:43448 E:43455 ||| NNP
and  ||| S:43455 E:43459 ||| CC
pUC19  ||| S:43459 E:43465 ||| NNP
were  ||| S:43465 E:43470 ||| VBD
purchased  ||| S:43470 E:43490 ||| VBN
from  ||| S:43490 E:43495 ||| IN
Novagen ||| S:43495 E:43502 ||| NNP
.  ||| S:43502 E:43504 ||| .
Primers  ||| S:43504 E:43512 ||| NNP
for  ||| S:43512 E:43516 ||| IN
sequencing  ||| S:43516 E:43527 ||| NN
and  ||| S:43527 E:43531 ||| CC
mutagenesis  ||| S:43531 E:43553 ||| JJ
studies  ||| S:43553 E:43561 ||| NNS
were  ||| S:43561 E:43566 ||| VBD
purchased  ||| S:43566 E:43576 ||| VBN
from  ||| S:43576 E:43581 ||| IN
Integrated  ||| S:43581 E:43592 ||| NNP
DNA  ||| S:43592 E:43596 ||| NNP
Technologies ||| S:43596 E:43608 ||| NNPS
.  ||| S:43608 E:43620 ||| .
Deoxynucleotide  ||| S:43620 E:43636 ||| JJ
triphosphates  ||| S:43636 E:43650 ||| NNS
( ||| S:43650 E:43651 ||| -LRB-
dNTP ||| S:43651 E:43655 ||| NNP
's ||| S:43655 E:43657 ||| POS
) ||| S:43657 E:43658 ||| -RRB-
,  ||| S:43658 E:43660 ||| ,
MgSO  ||| S:43660 E:43676 ||| JJ
4  ||| S:43676 E:43678 ||| CD
,  ||| S:43678 E:43680 ||| ,
thermopol  ||| S:43680 E:43690 ||| JJ
buffer ||| S:43690 E:43696 ||| NN
,  ||| S:43696 E:43698 ||| ,
Deep  ||| S:43698 E:43703 ||| NNP
Vent  ||| S:43703 E:43708 ||| NNP
DNA  ||| S:43708 E:43722 ||| NNP
polymerase ||| S:43722 E:43732 ||| NN
,  ||| S:43732 E:43734 ||| ,
and  ||| S:43734 E:43738 ||| CC
restrictions  ||| S:43738 E:43751 ||| NNS
enzymes  ||| S:43751 E:43759 ||| NN
were  ||| S:43759 E:43764 ||| VBD
purchased  ||| S:43764 E:43774 ||| VBN
from  ||| S:43774 E:43789 ||| IN
Promega  ||| S:43789 E:43797 ||| NNP
or  ||| S:43797 E:43800 ||| CC
New  ||| S:43800 E:43804 ||| NNP
England  ||| S:43804 E:43812 ||| NNP
Biolabs ||| S:43812 E:43819 ||| NNP
.  ||| S:43819 E:43821 ||| .
Polymerase  ||| S:43821 E:43832 ||| JJ
chain  ||| S:43832 E:43838 ||| NN
reaction  ||| S:43838 E:43857 ||| NN
was  ||| S:43857 E:43861 ||| VBD
conducted  ||| S:43861 E:43871 ||| VBN
using  ||| S:43871 E:43877 ||| VBG
a  ||| S:43877 E:43879 ||| DT
Thermolyne  ||| S:43879 E:43890 ||| NNP
Amplitron  ||| S:43890 E:43900 ||| NNP
II  ||| S:43900 E:43903 ||| NNP
unit ||| S:43903 E:43907 ||| NN
.  ||| S:43907 E:43909 ||| .
DNA  ||| S:43909 E:43923 ||| NNP
was  ||| S:43923 E:43927 ||| VBD
purified  ||| S:43927 E:43936 ||| VBN
using  ||| S:43936 E:43942 ||| VBG
the  ||| S:43942 E:43946 ||| DT
Qiagen  ||| S:43946 E:43953 ||| JJ
QIAQuick  ||| S:43953 E:43962 ||| JJ
gel  ||| S:43962 E:43966 ||| JJ
extraction  ||| S:43966 E:43977 ||| JJ
kit  ||| S:43977 E:43991 ||| NN
or  ||| S:43991 E:43994 ||| CC
Plasmid  ||| S:43994 E:44002 ||| NNP
Purification  ||| S:44002 E:44015 ||| NNP
kit  ||| S:44015 E:44019 ||| NN
with  ||| S:44019 E:44024 ||| IN
QIAGEN-tip  ||| S:44024 E:44035 ||| JJ
100  ||| S:44035 E:44039 ||| CD
( ||| S:44039 E:44040 ||| -LRB-
Midi ||| S:44040 E:44044 ||| NNP
)  ||| S:44044 E:44056 ||| -RRB-
columns ||| S:44056 E:44063 ||| NNS
.  ||| S:44063 E:44065 ||| .
Wizard  ||| S:44065 E:44072 ||| NNP
Plus  ||| S:44072 E:44077 ||| NNP
Minipreps  ||| S:44077 E:44087 ||| NNP
were  ||| S:44087 E:44092 ||| VBD
acquired  ||| S:44092 E:44101 ||| VBN
from  ||| S:44101 E:44116 ||| IN
Promega ||| S:44116 E:44123 ||| NNP
.  ||| S:44123 E:44125 ||| .
Luria-Bertani  ||| S:44125 E:44139 ||| NNP
( ||| S:44139 E:44140 ||| -LRB-
LB ||| S:44140 E:44142 ||| NNP
)  ||| S:44142 E:44144 ||| -RRB-
media  ||| S:44144 E:44150 ||| NNS
was  ||| S:44150 E:44154 ||| VBD
made  ||| S:44154 E:44159 ||| VBN
following  ||| S:44159 E:44179 ||| VBG
published  ||| S:44179 E:44189 ||| VBN
procedures  ||| S:44189 E:44200 ||| NNS
[  ||| S:44200 E:44202 ||| -LRB-
67  ||| S:44202 E:44205 ||| CD
]  ||| S:44205 E:44207 ||| -RRB-
.  ||| S:44207 E:44209 ||| .
Isopropyl-β-thiogalactoside  ||| S:44209 E:44247 ||| NNP
( ||| S:44247 E:44248 ||| -LRB-
IPTG ||| S:44248 E:44252 ||| NNP
) ||| S:44252 E:44253 ||| -RRB-
,  ||| S:44253 E:44255 ||| ,
Biotech  ||| S:44255 E:44263 ||| NNP
grade ||| S:44263 E:44268 ||| NN
,  ||| S:44268 E:44270 ||| ,
was  ||| S:44270 E:44274 ||| VBD
procured  ||| S:44274 E:44283 ||| VBN
from  ||| S:44283 E:44288 ||| IN
Anatrace ||| S:44288 E:44296 ||| NNP
.  ||| S:44296 E:44308 ||| .
Phenylmethylsulfonylfluoride  ||| S:44308 E:44337 ||| NNP
( ||| S:44337 E:44338 ||| -LRB-
PMSF ||| S:44338 E:44342 ||| NNP
)  ||| S:44342 E:44344 ||| -RRB-
was  ||| S:44344 E:44348 ||| VBD
purchased  ||| S:44348 E:44358 ||| VBN
from  ||| S:44358 E:44373 ||| IN
Sigma ||| S:44373 E:44378 ||| NNP
.  ||| S:44378 E:44380 ||| .
Protein  ||| S:44380 E:44388 ||| NN
solutions  ||| S:44388 E:44398 ||| NNS
were  ||| S:44398 E:44403 ||| VBD
concentrated  ||| S:44403 E:44416 ||| VBN
with  ||| S:44416 E:44421 ||| IN
an  ||| S:44421 E:44424 ||| DT
Amicon  ||| S:44424 E:44441 ||| JJ
ultrafiltration  ||| S:44441 E:44457 ||| JJ
cell  ||| S:44457 E:44462 ||| NN
equipped  ||| S:44462 E:44471 ||| VBN
with  ||| S:44471 E:44476 ||| IN
YM-10  ||| S:44476 E:44482 ||| NNP
DIAFLO  ||| S:44482 E:44489 ||| NNP
membranes  ||| S:44489 E:44509 ||| NN
from  ||| S:44509 E:44514 ||| IN
Amicon ||| S:44514 E:44520 ||| NNP
,  ||| S:44520 E:44522 ||| ,
Inc ||| S:44522 E:44525 ||| NNP
.  ||| S:44525 E:44527 ||| .
Dialysis  ||| S:44527 E:44536 ||| JJ
tubing  ||| S:44536 E:44543 ||| NN
was  ||| S:44543 E:44547 ||| VBD
prepared  ||| S:44547 E:44556 ||| VBN
using  ||| S:44556 E:44572 ||| VBG
Spectra ||| S:44572 E:44579 ||| NNP
/ ||| S:44579 E:44580 ||| FW
Por  ||| S:44580 E:44584 ||| FW
regenerated  ||| S:44584 E:44596 ||| FW
cellulose  ||| S:44596 E:44606 ||| FW
molecular  ||| S:44606 E:44616 ||| FW
porous  ||| S:44616 E:44633 ||| FW
membranes  ||| S:44633 E:44643 ||| FW
with  ||| S:44643 E:44648 ||| IN
a  ||| S:44648 E:44650 ||| DT
molecular  ||| S:44650 E:44660 ||| JJ
weight  ||| S:44660 E:44667 ||| NN
cut-off  ||| S:44667 E:44675 ||| NN
of  ||| S:44675 E:44678 ||| IN
6-8,000  ||| S:44678 E:44696 ||| FW
g ||| S:44696 E:44697 ||| FW
/ ||| S:44697 E:44698 ||| FW
mol ||| S:44698 E:44701 ||| FW
.  ||| S:44701 E:44703 ||| .
Q-Sepharose  ||| S:44703 E:44715 ||| NNP
Fast  ||| S:44715 E:44720 ||| NNP
Flow  ||| S:44720 E:44725 ||| NNP
was  ||| S:44725 E:44729 ||| VBD
purchased  ||| S:44729 E:44739 ||| VBN
from  ||| S:44739 E:44744 ||| IN
Amersham  ||| S:44744 E:44763 ||| NNP
Pharmacia  ||| S:44763 E:44773 ||| NNP
Biotech ||| S:44773 E:44780 ||| NNP
.  ||| S:44780 E:44782 ||| .
Nitrocefin  ||| S:44782 E:44793 ||| NNP
was  ||| S:44793 E:44797 ||| VBD
purchased  ||| S:44797 E:44807 ||| VBN
from  ||| S:44807 E:44812 ||| IN
Becton  ||| S:44812 E:44829 ||| NNP
Dickinson ||| S:44829 E:44838 ||| NNP
,  ||| S:44838 E:44840 ||| ,
and  ||| S:44840 E:44844 ||| CC
solutions  ||| S:44844 E:44854 ||| NNS
of  ||| S:44854 E:44857 ||| IN
nitrocefin  ||| S:44857 E:44868 ||| NN
were  ||| S:44868 E:44873 ||| VBD
filtered  ||| S:44873 E:44892 ||| VBN
through  ||| S:44892 E:44900 ||| IN
a  ||| S:44900 E:44902 ||| DT
Fisherbrand  ||| S:44902 E:44914 ||| NNP
0.45  ||| S:44914 E:44919 ||| FW
micron  ||| S:44919 E:44926 ||| FW
syringe  ||| S:44926 E:44934 ||| FW
filter ||| S:44934 E:44940 ||| FW
.  ||| S:44940 E:44952 ||| .
Cefaclor ||| S:44952 E:44960 ||| NNP
,  ||| S:44960 E:44962 ||| ,
cefoxitin ||| S:44962 E:44971 ||| NN
,  ||| S:44971 E:44973 ||| ,
and  ||| S:44973 E:44977 ||| CC
cephalothin  ||| S:44977 E:44989 ||| NNS
were  ||| S:44989 E:44994 ||| VBD
purchased  ||| S:44994 E:45004 ||| VBN
from  ||| S:45004 E:45019 ||| IN
Sigma ||| S:45019 E:45024 ||| NNP
;  ||| S:45024 E:45026 ||| :
penicillin  ||| S:45026 E:45037 ||| JJ
G  ||| S:45037 E:45039 ||| NNP
and  ||| S:45039 E:45043 ||| CC
ampicillin  ||| S:45043 E:45054 ||| NNS
were  ||| S:45054 E:45059 ||| VBD
purchased  ||| S:45059 E:45069 ||| VBN
from  ||| S:45069 E:45084 ||| IN
Fisher ||| S:45084 E:45090 ||| NNP
.  ||| S:45090 E:45092 ||| .
Imipenem ||| S:45092 E:45100 ||| NNP
,  ||| S:45100 E:45102 ||| ,
meropenem ||| S:45102 E:45111 ||| NN
,  ||| S:45111 E:45113 ||| ,
and  ||| S:45113 E:45117 ||| CC
biapenem  ||| S:45117 E:45126 ||| NNS
were  ||| S:45126 E:45131 ||| VBD
generously  ||| S:45131 E:45152 ||| RB
supplied  ||| S:45152 E:45161 ||| VBN
by  ||| S:45161 E:45164 ||| IN
Merck ||| S:45164 E:45169 ||| NNP
,  ||| S:45169 E:45171 ||| ,
Zeneca  ||| S:45171 E:45178 ||| NNP
Pharmaceuticals ||| S:45178 E:45193 ||| NNP
,  ||| S:45193 E:45195 ||| ,
and  ||| S:45195 E:45199 ||| CC
Lederle  ||| S:45199 E:45217 ||| NNP
( ||| S:45217 E:45218 ||| -LRB-
Japan ||| S:45218 E:45223 ||| NNP
) ||| S:45223 E:45224 ||| -RRB-
,  ||| S:45224 E:45226 ||| ,
respectively ||| S:45226 E:45238 ||| RB
.  ||| S:45238 E:45240 ||| .
All  ||| S:45240 E:45244 ||| DT
buffers  ||| S:45244 E:45252 ||| NN
and  ||| S:45252 E:45256 ||| CC
media  ||| S:45256 E:45262 ||| NNS
were  ||| S:45262 E:45277 ||| VBD
prepared  ||| S:45277 E:45286 ||| VBN
using  ||| S:45286 E:45292 ||| VBG
Barnstead  ||| S:45292 E:45302 ||| JJ
NANOpure  ||| S:45302 E:45311 ||| JJ
ultrapure  ||| S:45311 E:45321 ||| JJ
water ||| S:45321 E:45326 ||| NN
.  ||| S:45326 E:45356 ||| .
Generation  ||| S:45356 E:45367 ||| NN
of  ||| S:45367 E:45370 ||| IN
site-directed  ||| S:45370 E:45384 ||| JJ
mutants  ||| S:45384 E:45392 ||| NN
of  ||| S:45392 E:45395 ||| IN
L1  ||| S:45395 E:45408 ||| CD
The  ||| S:45408 E:45412 ||| DT
over-expression  ||| S:45412 E:45428 ||| JJ
plasmid  ||| S:45428 E:45436 ||| NN
for  ||| S:45436 E:45440 ||| IN
L1 ||| S:45440 E:45442 ||| NNP
,  ||| S:45442 E:45444 ||| ,
pUB5832 ||| S:45444 E:45451 ||| NNP
,  ||| S:45451 E:45453 ||| ,
was  ||| S:45453 E:45467 ||| VBD
digested  ||| S:45467 E:45476 ||| VBN
with  ||| S:45476 E:45492 ||| IN
Nde  ||| S:45492 E:45496 ||| NNP
I  ||| S:45496 E:45498 ||| NNP
and  ||| S:45498 E:45513 ||| CC
Hind  ||| S:45513 E:45518 ||| NNP
III ||| S:45518 E:45521 ||| NNP
,  ||| S:45521 E:45523 ||| ,
and  ||| S:45523 E:45527 ||| CC
the  ||| S:45527 E:45531 ||| DT
resulting  ||| S:45531 E:45552 ||| VBG
ca.  ||| S:45552 E:45556 ||| CD
900  ||| S:45556 E:45560 ||| CD
bp  ||| S:45560 E:45563 ||| JJ
piece  ||| S:45563 E:45569 ||| NN
was  ||| S:45569 E:45573 ||| VBD
gel  ||| S:45573 E:45577 ||| JJ
purified  ||| S:45577 E:45596 ||| NN
and  ||| S:45596 E:45600 ||| CC
ligated  ||| S:45600 E:45608 ||| VBP
using  ||| S:45608 E:45614 ||| VBG
T4  ||| S:45614 E:45617 ||| CD
ligase  ||| S:45617 E:45624 ||| NN
into  ||| S:45624 E:45629 ||| IN
pUC19 ||| S:45629 E:45634 ||| NNP
,  ||| S:45634 E:45636 ||| ,
which  ||| S:45636 E:45642 ||| WDT
was  ||| S:45642 E:45646 ||| VBD
also  ||| S:45646 E:45661 ||| RB
digested  ||| S:45661 E:45670 ||| VBN
with  ||| S:45670 E:45686 ||| IN
Nde  ||| S:45686 E:45690 ||| NNP
I  ||| S:45690 E:45692 ||| NNP
and  ||| S:45692 E:45707 ||| CC
Hind  ||| S:45707 E:45712 ||| NNP
III ||| S:45712 E:45715 ||| NNP
,  ||| S:45715 E:45717 ||| ,
to  ||| S:45717 E:45720 ||| TO
yield  ||| S:45720 E:45726 ||| VB
the  ||| S:45726 E:45730 ||| DT
cloning  ||| S:45730 E:45748 ||| JJ
plasmid  ||| S:45748 E:45756 ||| JJ
pL1PUC19 ||| S:45756 E:45764 ||| NN
.  ||| S:45764 E:45766 ||| .
Mutations  ||| S:45766 E:45776 ||| NNP
were  ||| S:45776 E:45781 ||| VBD
introduced  ||| S:45781 E:45792 ||| VBN
into  ||| S:45792 E:45797 ||| IN
the  ||| S:45797 E:45801 ||| DT
L1  ||| S:45801 E:45814 ||| JJ
gene  ||| S:45814 E:45819 ||| NN
by  ||| S:45819 E:45822 ||| IN
using  ||| S:45822 E:45828 ||| VBG
the  ||| S:45828 E:45832 ||| DT
overlap  ||| S:45832 E:45840 ||| JJ
extension  ||| S:45840 E:45850 ||| NN
method  ||| S:45850 E:45857 ||| NN
of  ||| S:45857 E:45860 ||| IN
Ho  ||| S:45860 E:45874 ||| NNP
et  ||| S:45874 E:45877 ||| FW
al.  ||| S:45877 E:45881 ||| FW
[  ||| S:45881 E:45883 ||| -LRB-
60  ||| S:45883 E:45886 ||| CD
]  ||| S:45886 E:45888 ||| -RRB-
,  ||| S:45888 E:45890 ||| ,
as  ||| S:45890 E:45893 ||| RB
described  ||| S:45893 E:45913 ||| VBN
previously  ||| S:45913 E:45924 ||| RB
[  ||| S:45924 E:45926 ||| -LRB-
68  ||| S:45926 E:45929 ||| CD
]  ||| S:45929 E:45931 ||| -RRB-
.  ||| S:45931 E:45933 ||| .
The  ||| S:45933 E:45937 ||| DT
oligonucleotides  ||| S:45937 E:45954 ||| NN
used  ||| S:45954 E:45959 ||| VBN
for  ||| S:45959 E:45963 ||| IN
the  ||| S:45963 E:45977 ||| DT
preparation  ||| S:45977 E:45989 ||| NN
of  ||| S:45989 E:45992 ||| IN
the  ||| S:45992 E:45996 ||| DT
mutants  ||| S:45996 E:46004 ||| NNS
are  ||| S:46004 E:46008 ||| VBP
shown  ||| S:46008 E:46014 ||| VBN
in  ||| S:46014 E:46017 ||| IN
Table  ||| S:46017 E:46023 ||| NNP
1 ||| S:46023 E:46024 ||| CD
.  ||| S:46024 E:46026 ||| .
The  ||| S:46026 E:46041 ||| DT
ca.  ||| S:46041 E:46045 ||| CD
900  ||| S:46045 E:46049 ||| CD
bp  ||| S:46049 E:46052 ||| JJ
PCR  ||| S:46052 E:46056 ||| NN
products  ||| S:46056 E:46065 ||| NNS
were  ||| S:46065 E:46080 ||| VBD
digested  ||| S:46080 E:46089 ||| VBN
with  ||| S:46089 E:46105 ||| IN
Nde  ||| S:46105 E:46109 ||| NNP
I  ||| S:46109 E:46111 ||| NNP
and  ||| S:46111 E:46126 ||| CC
Hind  ||| S:46126 E:46131 ||| NNP
III  ||| S:46131 E:46135 ||| NNP
and  ||| S:46135 E:46139 ||| CC
ligated  ||| S:46139 E:46147 ||| NN
into  ||| S:46147 E:46152 ||| IN
pUC19 ||| S:46152 E:46157 ||| CD
.  ||| S:46157 E:46169 ||| .
The  ||| S:46169 E:46173 ||| DT
DNA  ||| S:46173 E:46177 ||| NN
sequences  ||| S:46177 E:46187 ||| NNS
were  ||| S:46187 E:46192 ||| VBD
analyzed  ||| S:46192 E:46201 ||| VBN
by  ||| S:46201 E:46204 ||| IN
the  ||| S:46204 E:46208 ||| DT
Biosynthesis  ||| S:46208 E:46221 ||| NNP
and  ||| S:46221 E:46235 ||| CC
Sequencing  ||| S:46235 E:46246 ||| NNP
Facility  ||| S:46246 E:46255 ||| NNP
in  ||| S:46255 E:46258 ||| IN
the  ||| S:46258 E:46262 ||| DT
Department  ||| S:46262 E:46273 ||| NNP
of  ||| S:46273 E:46276 ||| IN
Biological  ||| S:46276 E:46297 ||| NNP
Chemistry  ||| S:46297 E:46307 ||| NNP
at  ||| S:46307 E:46310 ||| IN
Johns  ||| S:46310 E:46316 ||| NNP
Hopkins  ||| S:46316 E:46324 ||| NNP
University ||| S:46324 E:46334 ||| NNP
.  ||| S:46334 E:46336 ||| .
After  ||| S:46336 E:46342 ||| IN
confirmation  ||| S:46342 E:46365 ||| NN
of  ||| S:46365 E:46368 ||| IN
the  ||| S:46368 E:46372 ||| DT
sequence ||| S:46372 E:46380 ||| NN
,  ||| S:46380 E:46382 ||| ,
the  ||| S:46382 E:46386 ||| DT
mutated  ||| S:46386 E:46394 ||| JJ
pL1PUC19  ||| S:46394 E:46403 ||| CD
plasmid  ||| S:46403 E:46411 ||| NNS
was  ||| S:46411 E:46425 ||| VBD
digested  ||| S:46425 E:46434 ||| VBN
with  ||| S:46434 E:46450 ||| IN
Nde  ||| S:46450 E:46454 ||| NNP
I  ||| S:46454 E:46456 ||| NNP
and  ||| S:46456 E:46471 ||| CC
Hind  ||| S:46471 E:46476 ||| NNP
III ||| S:46476 E:46479 ||| NNP
,  ||| S:46479 E:46481 ||| ,
and  ||| S:46481 E:46485 ||| CC
the  ||| S:46485 E:46489 ||| DT
900  ||| S:46489 E:46493 ||| CD
bp ||| S:46493 E:46495 ||| NN
,  ||| S:46495 E:46497 ||| ,
mutated  ||| S:46497 E:46515 ||| CD
L1  ||| S:46515 E:46518 ||| CD
gene  ||| S:46518 E:46523 ||| NN
was  ||| S:46523 E:46527 ||| VBD
gel  ||| S:46527 E:46531 ||| JJ
purified  ||| S:46531 E:46540 ||| NN
and  ||| S:46540 E:46544 ||| CC
ligated  ||| S:46544 E:46552 ||| NN
into  ||| S:46552 E:46557 ||| IN
pET26b  ||| S:46557 E:46564 ||| CD
to  ||| S:46564 E:46577 ||| TO
create  ||| S:46577 E:46584 ||| VB
the  ||| S:46584 E:46588 ||| DT
mutant  ||| S:46588 E:46595 ||| JJ
overexpression  ||| S:46595 E:46610 ||| JJ
plasmids ||| S:46610 E:46618 ||| NN
.  ||| S:46618 E:46620 ||| .
To  ||| S:46620 E:46623 ||| TO
test  ||| S:46623 E:46628 ||| VB
for  ||| S:46628 E:46642 ||| IN
overexpression  ||| S:46642 E:46657 ||| NN
of  ||| S:46657 E:46660 ||| IN
the  ||| S:46660 E:46664 ||| DT
mutant  ||| S:46664 E:46671 ||| JJ
enzymes ||| S:46671 E:46678 ||| NN
,  ||| S:46678 E:46691 ||| ,
E.  ||| S:46691 E:46694 ||| NNP
coli  ||| S:46694 E:46699 ||| FW
BL21 ||| S:46699 E:46703 ||| FW
( ||| S:46703 E:46704 ||| -LRB-
DE3 ||| S:46704 E:46707 ||| NNP
) ||| S:46707 E:46708 ||| -RRB-
pLysS  ||| S:46708 E:46714 ||| JJ
cells  ||| S:46714 E:46720 ||| NNS
were  ||| S:46720 E:46735 ||| VBD
transformed  ||| S:46735 E:46747 ||| VBN
with  ||| S:46747 E:46752 ||| IN
the  ||| S:46752 E:46756 ||| DT
mutated  ||| S:46756 E:46764 ||| JJ
over-expression  ||| S:46764 E:46780 ||| JJ
plasmids ||| S:46780 E:46788 ||| NN
,  ||| S:46788 E:46800 ||| ,
and  ||| S:46800 E:46804 ||| CC
small  ||| S:46804 E:46810 ||| JJ
scale  ||| S:46810 E:46816 ||| NN
growth  ||| S:46816 E:46823 ||| NN
cultures  ||| S:46823 E:46832 ||| NNS
were  ||| S:46832 E:46837 ||| VBD
used  ||| S:46837 E:46842 ||| VBN
[  ||| S:46842 E:46844 ||| -LRB-
68  ||| S:46844 E:46847 ||| CD
]  ||| S:46847 E:46849 ||| -RRB-
.  ||| S:46849 E:46861 ||| .
Large-scale  ||| S:46861 E:46873 ||| JJ
( ||| S:46873 E:46874 ||| -LRB-
4  ||| S:46874 E:46876 ||| CD
L ||| S:46876 E:46877 ||| NNP
)  ||| S:46877 E:46879 ||| -RRB-
preparations  ||| S:46879 E:46892 ||| NN
of  ||| S:46892 E:46895 ||| IN
the  ||| S:46895 E:46899 ||| DT
L1  ||| S:46899 E:46902 ||| CD
mutants  ||| S:46902 E:46910 ||| NNS
were  ||| S:46910 E:46925 ||| VBD
performed  ||| S:46925 E:46935 ||| VBN
as  ||| S:46935 E:46938 ||| RB
described  ||| S:46938 E:46948 ||| VBN
previously  ||| S:46948 E:46959 ||| RB
[  ||| S:46959 E:46961 ||| -LRB-
36  ||| S:46961 E:46964 ||| CD
]  ||| S:46964 E:46966 ||| -RRB-
.  ||| S:46966 E:46968 ||| .
Protein  ||| S:46968 E:46976 ||| NN
purity  ||| S:46976 E:46993 ||| NNS
was  ||| S:46993 E:46997 ||| VBD
ascertained  ||| S:46997 E:47009 ||| VBN
by  ||| S:47009 E:47012 ||| IN
SDS-PAGE ||| S:47012 E:47020 ||| JJ
.  ||| S:47020 E:47050 ||| .
Metal  ||| S:47050 E:47056 ||| NNP
content  ||| S:47056 E:47074 ||| VBD
The  ||| S:47074 E:47078 ||| DT
concentrations  ||| S:47078 E:47093 ||| NNS
of  ||| S:47093 E:47096 ||| IN
L1  ||| S:47096 E:47099 ||| NNP
and  ||| S:47099 E:47103 ||| CC
the  ||| S:47103 E:47107 ||| DT
mutants  ||| S:47107 E:47115 ||| NN
were  ||| S:47115 E:47130 ||| VBD
determined  ||| S:47130 E:47141 ||| VBN
by  ||| S:47141 E:47144 ||| IN
measuring  ||| S:47144 E:47154 ||| VBG
the  ||| S:47154 E:47158 ||| DT
proteins ||| S:47158 E:47166 ||| NNS
'  ||| S:47166 E:47168 ||| POS
absorbance  ||| S:47168 E:47179 ||| NN
at  ||| S:47179 E:47182 ||| IN
280  ||| S:47182 E:47196 ||| CD
nm  ||| S:47196 E:47199 ||| NNS
and  ||| S:47199 E:47203 ||| CC
using  ||| S:47203 E:47209 ||| VBG
the  ||| S:47209 E:47213 ||| DT
published  ||| S:47213 E:47223 ||| JJ
extinction  ||| S:47223 E:47234 ||| NN
coefficient  ||| S:47234 E:47246 ||| NN
of  ||| S:47246 E:47249 ||| IN
ε  ||| S:47249 E:47262 ||| CD
280  ||| S:47262 E:47266 ||| CD
nm  ||| S:47266 E:47269 ||| CD
=  ||| S:47269 E:47271 ||| SYM
54,804  ||| S:47271 E:47278 ||| NNP
M  ||| S:47278 E:47280 ||| NNP
-1•cm  ||| S:47280 E:47286 ||| NNP
-1  ||| S:47286 E:47289 ||| NNP
[  ||| S:47289 E:47291 ||| -LRB-
36  ||| S:47291 E:47294 ||| CD
]  ||| S:47294 E:47296 ||| -RRB-
or  ||| S:47296 E:47309 ||| CC
by  ||| S:47309 E:47312 ||| IN
using  ||| S:47312 E:47318 ||| VBG
the  ||| S:47318 E:47322 ||| DT
method  ||| S:47322 E:47329 ||| NN
of  ||| S:47329 E:47332 ||| IN
Pace  ||| S:47332 E:47337 ||| NNP
[  ||| S:47337 E:47339 ||| -LRB-
69  ||| S:47339 E:47342 ||| CD
]  ||| S:47342 E:47344 ||| -RRB-
.  ||| S:47344 E:47346 ||| .
Before  ||| S:47346 E:47353 ||| IN
metal  ||| S:47353 E:47369 ||| NN
analyses ||| S:47369 E:47377 ||| NNS
,  ||| S:47377 E:47379 ||| ,
the  ||| S:47379 E:47383 ||| DT
protein  ||| S:47383 E:47391 ||| NN
samples  ||| S:47391 E:47399 ||| NNS
were  ||| S:47399 E:47404 ||| VBD
dialyzed  ||| S:47404 E:47413 ||| VBN
versus  ||| S:47413 E:47420 ||| IN
3  ||| S:47420 E:47422 ||| CD
×  ||| S:47422 E:47424 ||| CD
1  ||| S:47424 E:47436 ||| CD
L  ||| S:47436 E:47438 ||| NNP
of  ||| S:47438 E:47441 ||| IN
metal-free ||| S:47441 E:47451 ||| NNP
,  ||| S:47451 E:47453 ||| ,
50  ||| S:47453 E:47456 ||| CD
mM  ||| S:47456 E:47459 ||| JJ
HEPES ||| S:47459 E:47464 ||| NNP
,  ||| S:47464 E:47466 ||| ,
pH  ||| S:47466 E:47469 ||| JJ
7.5  ||| S:47469 E:47473 ||| CD
over  ||| S:47473 E:47478 ||| IN
96  ||| S:47478 E:47481 ||| CD
hours  ||| S:47481 E:47487 ||| NNS
at  ||| S:47487 E:47500 ||| IN
4°C ||| S:47500 E:47503 ||| CD
.  ||| S:47503 E:47505 ||| .
A  ||| S:47505 E:47507 ||| DT
Varian  ||| S:47507 E:47514 ||| NNP
Inductively  ||| S:47514 E:47526 ||| NNP
Coupled  ||| S:47526 E:47534 ||| NNP
Plasma  ||| S:47534 E:47541 ||| NNP
Spectrometer  ||| S:47541 E:47564 ||| NNP
with  ||| S:47564 E:47569 ||| IN
atomic  ||| S:47569 E:47576 ||| FW
emission  ||| S:47576 E:47585 ||| FW
spectroscopy  ||| S:47585 E:47598 ||| FW
detection  ||| S:47598 E:47608 ||| FW
( ||| S:47608 E:47609 ||| -LRB-
ICP-AES ||| S:47609 E:47616 ||| NNP
)  ||| S:47616 E:47618 ||| -RRB-
was  ||| S:47618 E:47632 ||| VBD
used  ||| S:47632 E:47637 ||| VBN
to  ||| S:47637 E:47640 ||| TO
determine  ||| S:47640 E:47650 ||| VB
metal  ||| S:47650 E:47656 ||| NN
content  ||| S:47656 E:47664 ||| NN
of  ||| S:47664 E:47667 ||| IN
multiple  ||| S:47667 E:47676 ||| JJ
preparations  ||| S:47676 E:47699 ||| NNS
of  ||| S:47699 E:47702 ||| IN
wild  ||| S:47702 E:47707 ||| JJ
type  ||| S:47707 E:47712 ||| NN
L1  ||| S:47712 E:47715 ||| NN
and  ||| S:47715 E:47719 ||| CC
L1  ||| S:47719 E:47722 ||| CD
mutants ||| S:47722 E:47729 ||| NNS
.  ||| S:47729 E:47731 ||| .
Calibration  ||| S:47731 E:47743 ||| JJ
curves  ||| S:47743 E:47750 ||| NN
were  ||| S:47750 E:47765 ||| VBD
based  ||| S:47765 E:47771 ||| VBN
on  ||| S:47771 E:47774 ||| IN
three  ||| S:47774 E:47780 ||| CD
standards  ||| S:47780 E:47790 ||| NNS
and  ||| S:47790 E:47794 ||| CC
had  ||| S:47794 E:47798 ||| VBD
correlation  ||| S:47798 E:47810 ||| JJ
coefficient  ||| S:47810 E:47832 ||| JJ
limits  ||| S:47832 E:47839 ||| NNS
of  ||| S:47839 E:47842 ||| IN
at  ||| S:47842 E:47845 ||| IN
least  ||| S:47845 E:47851 ||| JJS
0.9950 ||| S:47851 E:47857 ||| CD
.  ||| S:47857 E:47859 ||| .
The  ||| S:47859 E:47863 ||| DT
final  ||| S:47863 E:47869 ||| JJ
dialysis  ||| S:47869 E:47878 ||| NN
buffer  ||| S:47878 E:47885 ||| NN
was  ||| S:47885 E:47899 ||| VBD
used  ||| S:47899 E:47904 ||| VBN
as  ||| S:47904 E:47907 ||| IN
a  ||| S:47907 E:47909 ||| DT
blank ||| S:47909 E:47914 ||| JJ
,  ||| S:47914 E:47916 ||| ,
and  ||| S:47916 E:47920 ||| CC
the  ||| S:47920 E:47924 ||| DT
Zn ||| S:47924 E:47926 ||| NNP
( ||| S:47926 E:47927 ||| -LRB-
II ||| S:47927 E:47929 ||| NNP
)  ||| S:47929 E:47931 ||| -RRB-
content  ||| S:47931 E:47939 ||| NN
in  ||| S:47939 E:47942 ||| IN
the  ||| S:47942 E:47946 ||| DT
final  ||| S:47946 E:47962 ||| JJ
dialysis  ||| S:47962 E:47971 ||| NN
buffers  ||| S:47971 E:47979 ||| NNS
was  ||| S:47979 E:47983 ||| VBD
shown  ||| S:47983 E:47989 ||| VBN
to  ||| S:47989 E:47992 ||| TO
be  ||| S:47992 E:47995 ||| VB
< ||| S:47995 E:47997 ||| SYM
0.5  ||| S:47997 E:48001 ||| CD
μM  ||| S:48001 E:48004 ||| NNS
( ||| S:48004 E:48005 ||| -LRB-
detection  ||| S:48005 E:48025 ||| JJ
limit  ||| S:48025 E:48031 ||| NN
of  ||| S:48031 E:48034 ||| IN
ICP ||| S:48034 E:48037 ||| NNP
)  ||| S:48037 E:48039 ||| -RRB-
in  ||| S:48039 E:48042 ||| IN
separate  ||| S:48042 E:48051 ||| JJ
ICP  ||| S:48051 E:48055 ||| NN
measurements ||| S:48055 E:48067 ||| NNS
.  ||| S:48067 E:48069 ||| .
The  ||| S:48069 E:48073 ||| DT
emission  ||| S:48073 E:48092 ||| JJ
line  ||| S:48092 E:48097 ||| NN
of  ||| S:48097 E:48100 ||| IN
213.856  ||| S:48100 E:48108 ||| CD
nm  ||| S:48108 E:48111 ||| NN
is  ||| S:48111 E:48114 ||| VBZ
the  ||| S:48114 E:48118 ||| DT
most  ||| S:48118 E:48123 ||| RBS
intense  ||| S:48123 E:48131 ||| JJ
for  ||| S:48131 E:48135 ||| IN
zinc  ||| S:48135 E:48140 ||| NN
and  ||| S:48140 E:48144 ||| CC
was  ||| S:48144 E:48158 ||| VBD
used  ||| S:48158 E:48163 ||| VBN
to  ||| S:48163 E:48166 ||| TO
determine  ||| S:48166 E:48176 ||| VB
the  ||| S:48176 E:48180 ||| DT
Zn  ||| S:48180 E:48183 ||| JJ
content  ||| S:48183 E:48191 ||| NN
in  ||| S:48191 E:48194 ||| IN
the  ||| S:48194 E:48198 ||| DT
samples ||| S:48198 E:48205 ||| NNS
.  ||| S:48205 E:48207 ||| .
The  ||| S:48207 E:48221 ||| DT
errors  ||| S:48221 E:48228 ||| NNS
in  ||| S:48228 E:48231 ||| IN
metal  ||| S:48231 E:48237 ||| NN
content  ||| S:48237 E:48245 ||| NN
data  ||| S:48245 E:48250 ||| NNS
reflect  ||| S:48250 E:48258 ||| VBP
the  ||| S:48258 E:48262 ||| DT
standard  ||| S:48262 E:48281 ||| JJ
deviation  ||| S:48281 E:48291 ||| NN
( ||| S:48291 E:48292 ||| -LRB-
σ  ||| S:48292 E:48305 ||| FW
n-1  ||| S:48305 E:48309 ||| FW
)  ||| S:48309 E:48311 ||| -RRB-
of  ||| S:48311 E:48314 ||| IN
multiple  ||| S:48314 E:48323 ||| JJ
enzyme  ||| S:48323 E:48340 ||| JJ
preparations ||| S:48340 E:48352 ||| NNS
.  ||| S:48352 E:48382 ||| .
Steady-state  ||| S:48382 E:48395 ||| JJ
kinetic  ||| S:48395 E:48403 ||| JJ
studies  ||| S:48403 E:48421 ||| NNS
Steady-state  ||| S:48421 E:48434 ||| JJ
kinetic  ||| S:48434 E:48442 ||| JJ
assays  ||| S:48442 E:48449 ||| NN
were  ||| S:48449 E:48454 ||| VBD
conducted  ||| S:48454 E:48464 ||| VBN
at  ||| S:48464 E:48467 ||| IN
25°C  ||| S:48467 E:48472 ||| CD
in  ||| S:48472 E:48485 ||| IN
50  ||| S:48485 E:48488 ||| CD
mM  ||| S:48488 E:48491 ||| JJ
cacodylate  ||| S:48491 E:48502 ||| JJ
buffer ||| S:48502 E:48508 ||| NN
,  ||| S:48508 E:48510 ||| ,
pH  ||| S:48510 E:48513 ||| JJ
7.0 ||| S:48513 E:48516 ||| CD
,  ||| S:48516 E:48518 ||| ,
containing  ||| S:48518 E:48529 ||| VBG
100  ||| S:48529 E:48533 ||| CD
μM  ||| S:48533 E:48536 ||| JJ
ZnCl  ||| S:48536 E:48552 ||| JJ
2  ||| S:48552 E:48554 ||| CD
on  ||| S:48554 E:48557 ||| IN
a  ||| S:48557 E:48559 ||| DT
HP  ||| S:48559 E:48562 ||| NNP
5480A  ||| S:48562 E:48568 ||| NNP
diode  ||| S:48568 E:48574 ||| JJ
array  ||| S:48574 E:48580 ||| NN
UV-Vis  ||| S:48580 E:48597 ||| JJ
spectrophotometer  ||| S:48597 E:48615 ||| NN
at  ||| S:48615 E:48618 ||| IN
25°C ||| S:48618 E:48622 ||| CD
.  ||| S:48622 E:48624 ||| .
The  ||| S:48624 E:48628 ||| DT
changes  ||| S:48628 E:48636 ||| NNS
in  ||| S:48636 E:48639 ||| IN
molar  ||| S:48639 E:48655 ||| JJ
absorptivities  ||| S:48655 E:48670 ||| NNS
( ||| S:48670 E:48671 ||| -LRB-
Δε ||| S:48671 E:48673 ||| NNP
)  ||| S:48673 E:48675 ||| -RRB-
used  ||| S:48675 E:48680 ||| VBN
to  ||| S:48680 E:48683 ||| TO
quantitate  ||| S:48683 E:48694 ||| VB
products  ||| S:48694 E:48703 ||| NNS
were  ||| S:48703 E:48708 ||| VBD
( ||| S:48708 E:48709 ||| -LRB-
in  ||| S:48709 E:48722 ||| IN
M  ||| S:48722 E:48724 ||| NNP
-1cm  ||| S:48724 E:48729 ||| NNP
-1 ||| S:48729 E:48731 ||| NNP
) ||| S:48731 E:48732 ||| -RRB-
:  ||| S:48732 E:48734 ||| :
nitrocefin ||| S:48734 E:48744 ||| CD
,  ||| S:48744 E:48746 ||| ,
Δε  ||| S:48746 E:48760 ||| NNP
485  ||| S:48760 E:48764 ||| CD
=  ||| S:48764 E:48766 ||| SYM
17,420 ||| S:48766 E:48772 ||| CD
;  ||| S:48772 E:48774 ||| :
cephalothin ||| S:48774 E:48785 ||| CD
,  ||| S:48785 E:48787 ||| ,
Δε  ||| S:48787 E:48801 ||| NNP
265  ||| S:48801 E:48805 ||| CD
=  ||| S:48805 E:48807 ||| SYM
-8,790 ||| S:48807 E:48813 ||| CD
;  ||| S:48813 E:48815 ||| :
cefoxitin ||| S:48815 E:48824 ||| CD
,  ||| S:48824 E:48826 ||| ,
Δε  ||| S:48826 E:48840 ||| NNP
265  ||| S:48840 E:48844 ||| CD
=  ||| S:48844 E:48846 ||| SYM
-7,000 ||| S:48846 E:48852 ||| CD
;  ||| S:48852 E:48854 ||| :
cefaclor ||| S:48854 E:48862 ||| CD
,  ||| S:48862 E:48864 ||| ,
Δε  ||| S:48864 E:48878 ||| NNP
280  ||| S:48878 E:48882 ||| CD
=  ||| S:48882 E:48884 ||| SYM
-6,410 ||| S:48884 E:48890 ||| CD
;  ||| S:48890 E:48892 ||| :
imipenem ||| S:48892 E:48900 ||| CD
,  ||| S:48900 E:48902 ||| ,
Δε  ||| S:48902 E:48916 ||| NNP
300  ||| S:48916 E:48920 ||| CD
=  ||| S:48920 E:48922 ||| SYM
-9,000 ||| S:48922 E:48928 ||| CD
;  ||| S:48928 E:48930 ||| :
meropenem ||| S:48930 E:48939 ||| CD
,  ||| S:48939 E:48941 ||| ,
Δε  ||| S:48941 E:48955 ||| NNP
293  ||| S:48955 E:48959 ||| CD
=  ||| S:48959 E:48961 ||| SYM
-7,600 ||| S:48961 E:48967 ||| CD
;  ||| S:48967 E:48969 ||| :
biapenem ||| S:48969 E:48977 ||| CD
,  ||| S:48977 E:48979 ||| ,
Δε  ||| S:48979 E:48993 ||| NNP
293  ||| S:48993 E:48997 ||| CD
=  ||| S:48997 E:48999 ||| SYM
-8,630 ||| S:48999 E:49005 ||| CD
;  ||| S:49005 E:49007 ||| :
ampicillin ||| S:49007 E:49017 ||| CD
,  ||| S:49017 E:49019 ||| ,
Δε  ||| S:49019 E:49033 ||| NNP
235  ||| S:49033 E:49037 ||| CD
=  ||| S:49037 E:49039 ||| SYM
-809 ||| S:49039 E:49043 ||| CD
;  ||| S:49043 E:49045 ||| :
and  ||| S:49045 E:49049 ||| CC
penicillin  ||| S:49049 E:49060 ||| JJ
G ||| S:49060 E:49061 ||| NNP
,  ||| S:49061 E:49063 ||| ,
Δε  ||| S:49063 E:49077 ||| NNP
235  ||| S:49077 E:49081 ||| CD
=  ||| S:49081 E:49083 ||| SYM
-936 ||| S:49083 E:49087 ||| CD
.  ||| S:49087 E:49089 ||| .
When  ||| S:49089 E:49094 ||| WRB
possible ||| S:49094 E:49102 ||| JJ
,  ||| S:49102 E:49104 ||| ,
substrate  ||| S:49104 E:49124 ||| JJ
concentrations  ||| S:49124 E:49139 ||| NNS
were  ||| S:49139 E:49144 ||| VBD
varied  ||| S:49144 E:49151 ||| VBN
between  ||| S:49151 E:49159 ||| IN
0.1  ||| S:49159 E:49163 ||| CD
to  ||| S:49163 E:49166 ||| TO
10  ||| S:49166 E:49169 ||| CD
times  ||| S:49169 E:49175 ||| NNS
the  ||| S:49175 E:49179 ||| DT
K  ||| S:49179 E:49192 ||| NNP
m  ||| S:49192 E:49194 ||| JJ
value ||| S:49194 E:49199 ||| NN
.  ||| S:49199 E:49201 ||| .
In  ||| S:49201 E:49204 ||| IN
kinetic  ||| S:49204 E:49212 ||| JJ
studies  ||| S:49212 E:49220 ||| NNS
using  ||| S:49220 E:49236 ||| VBG
substrates  ||| S:49236 E:49247 ||| NN
with  ||| S:49247 E:49252 ||| IN
low  ||| S:49252 E:49256 ||| JJ
K  ||| S:49256 E:49269 ||| NNP
m  ||| S:49269 E:49271 ||| NN
values  ||| S:49271 E:49278 ||| NNS
( ||| S:49278 E:49279 ||| -LRB-
cefoxitin ||| S:49279 E:49288 ||| UH
,  ||| S:49288 E:49290 ||| ,
nitrocefin ||| S:49290 E:49300 ||| NN
,  ||| S:49300 E:49302 ||| ,
and  ||| S:49302 E:49316 ||| CC
cephalothin ||| S:49316 E:49327 ||| CD
)  ||| S:49327 E:49329 ||| -RRB-
or  ||| S:49329 E:49332 ||| CC
with  ||| S:49332 E:49337 ||| IN
small  ||| S:49337 E:49343 ||| JJ
Δε  ||| S:49343 E:49346 ||| JJ
values  ||| S:49346 E:49353 ||| NNS
( ||| S:49353 E:49354 ||| -LRB-
penicillin  ||| S:49354 E:49365 ||| NN
and  ||| S:49365 E:49379 ||| CC
ampicillin ||| S:49379 E:49389 ||| CD
) ||| S:49389 E:49390 ||| -RRB-
,  ||| S:49390 E:49392 ||| ,
we  ||| S:49392 E:49395 ||| PRP
typically  ||| S:49395 E:49405 ||| RB
used  ||| S:49405 E:49410 ||| VBN
substrate  ||| S:49410 E:49420 ||| JJ
concentrations  ||| S:49420 E:49445 ||| NNS
varied  ||| S:49445 E:49452 ||| VBN
between  ||| S:49452 E:49460 ||| IN
~  ||| S:49460 E:49462 ||| NNP
K  ||| S:49462 E:49475 ||| NNP
m  ||| S:49475 E:49477 ||| NN
and  ||| S:49477 E:49481 ||| CC
10  ||| S:49481 E:49484 ||| CD
×  ||| S:49484 E:49486 ||| CD
K  ||| S:49486 E:49499 ||| NNP
m  ||| S:49499 E:49501 ||| NN
and  ||| S:49501 E:49505 ||| CC
used  ||| S:49505 E:49510 ||| VBN
as  ||| S:49510 E:49513 ||| IN
much  ||| S:49513 E:49518 ||| JJ
of  ||| S:49518 E:49521 ||| IN
the  ||| S:49521 E:49525 ||| DT
ΔA  ||| S:49525 E:49528 ||| NNP
versus  ||| S:49528 E:49545 ||| CC
time  ||| S:49545 E:49550 ||| NN
data  ||| S:49550 E:49555 ||| NNS
( ||| S:49555 E:49556 ||| -LRB-
that  ||| S:49556 E:49561 ||| WDT
was  ||| S:49561 E:49565 ||| VBD
linear ||| S:49565 E:49571 ||| CD
)  ||| S:49571 E:49573 ||| -RRB-
as  ||| S:49573 E:49576 ||| IN
possible  ||| S:49576 E:49585 ||| JJ
to  ||| S:49585 E:49588 ||| TO
determine  ||| S:49588 E:49598 ||| VB
the  ||| S:49598 E:49612 ||| DT
velocity ||| S:49612 E:49620 ||| NN
.  ||| S:49620 E:49622 ||| .
Steady-state  ||| S:49622 E:49635 ||| JJ
kinetics  ||| S:49635 E:49644 ||| JJ
constants ||| S:49644 E:49653 ||| NN
,  ||| S:49653 E:49655 ||| ,
K  ||| S:49655 E:49668 ||| NNP
m  ||| S:49668 E:49670 ||| NN
and  ||| S:49670 E:49685 ||| CC
k  ||| S:49685 E:49698 ||| JJ
cat  ||| S:49698 E:49702 ||| NN
,  ||| S:49702 E:49704 ||| ,
were  ||| S:49704 E:49709 ||| VBD
determined  ||| S:49709 E:49720 ||| VBN
by  ||| S:49720 E:49723 ||| IN
fitting  ||| S:49723 E:49741 ||| JJ
initial  ||| S:49741 E:49749 ||| JJ
velocity  ||| S:49749 E:49758 ||| NN
versus  ||| S:49758 E:49765 ||| IN
substrate  ||| S:49765 E:49775 ||| JJ
concentration  ||| S:49775 E:49789 ||| NN
data  ||| S:49789 E:49804 ||| NNS
directly  ||| S:49804 E:49813 ||| RB
to  ||| S:49813 E:49816 ||| TO
the  ||| S:49816 E:49820 ||| DT
Michaelis  ||| S:49820 E:49830 ||| JJ
equation  ||| S:49830 E:49839 ||| NN
using  ||| S:49839 E:49845 ||| VBG
CurveFit  ||| S:49845 E:49854 ||| JJ
[  ||| S:49854 E:49856 ||| -LRB-
36  ||| S:49856 E:49859 ||| CD
]  ||| S:49859 E:49871 ||| -RRB-
.  ||| S:49871 E:49873 ||| .
The  ||| S:49873 E:49877 ||| DT
reported  ||| S:49877 E:49886 ||| JJ
errors  ||| S:49886 E:49893 ||| NNS
reflect  ||| S:49893 E:49901 ||| VBP
fitting  ||| S:49901 E:49909 ||| JJ
uncertainties ||| S:49909 E:49922 ||| NNS
.  ||| S:49922 E:49924 ||| .
All  ||| S:49924 E:49938 ||| DT
steady-state  ||| S:49938 E:49951 ||| JJ
kinetic  ||| S:49951 E:49959 ||| JJ
studies  ||| S:49959 E:49967 ||| NNS
were  ||| S:49967 E:49972 ||| VBD
performed  ||| S:49972 E:49982 ||| VBN
in  ||| S:49982 E:49985 ||| IN
triplicate  ||| S:49985 E:50006 ||| NN
with  ||| S:50006 E:50011 ||| IN
recombinant  ||| S:50011 E:50023 ||| JJ
L1  ||| S:50023 E:50026 ||| NN
from  ||| S:50026 E:50031 ||| IN
at  ||| S:50031 E:50034 ||| IN
least  ||| S:50034 E:50040 ||| JJS
three  ||| S:50040 E:50046 ||| CD
different  ||| S:50046 E:50056 ||| JJ
enzyme  ||| S:50056 E:50073 ||| JJ
preparations ||| S:50073 E:50085 ||| NNS
.  ||| S:50085 E:50115 ||| .
Circular  ||| S:50115 E:50124 ||| FW
dichroism  ||| S:50124 E:50144 ||| FW
Circular  ||| S:50144 E:50153 ||| FW
dichroism  ||| S:50153 E:50163 ||| FW
samples  ||| S:50163 E:50171 ||| NNS
were  ||| S:50171 E:50176 ||| VBD
prepared  ||| S:50176 E:50185 ||| VBN
by  ||| S:50185 E:50188 ||| IN
dialyzing  ||| S:50188 E:50208 ||| VBG
the  ||| S:50208 E:50212 ||| DT
purified  ||| S:50212 E:50221 ||| JJ
enzyme  ||| S:50221 E:50228 ||| JJ
samples  ||| S:50228 E:50236 ||| NNS
versus  ||| S:50236 E:50243 ||| IN
3  ||| S:50243 E:50245 ||| CD
×  ||| S:50245 E:50247 ||| CD
2  ||| S:50247 E:50249 ||| CD
L  ||| S:50249 E:50251 ||| NNP
of  ||| S:50251 E:50254 ||| IN
5  ||| S:50254 E:50256 ||| CD
mM  ||| S:50256 E:50269 ||| JJ
phosphate  ||| S:50269 E:50279 ||| JJ
buffer ||| S:50279 E:50285 ||| NN
,  ||| S:50285 E:50287 ||| ,
pH  ||| S:50287 E:50290 ||| JJ
7.0  ||| S:50290 E:50294 ||| CD
over  ||| S:50294 E:50299 ||| IN
six  ||| S:50299 E:50303 ||| CD
hours ||| S:50303 E:50308 ||| NNS
.  ||| S:50308 E:50310 ||| .
The  ||| S:50310 E:50314 ||| DT
samples  ||| S:50314 E:50322 ||| NNS
were  ||| S:50322 E:50337 ||| VBD
diluted  ||| S:50337 E:50345 ||| VBN
with  ||| S:50345 E:50350 ||| IN
final  ||| S:50350 E:50356 ||| JJ
dialysis  ||| S:50356 E:50365 ||| NN
buffer  ||| S:50365 E:50372 ||| NN
to  ||| S:50372 E:50375 ||| TO
~75  ||| S:50375 E:50379 ||| CD
μg ||| S:50379 E:50381 ||| CD
/ ||| S:50381 E:50382 ||| CD
mL ||| S:50382 E:50384 ||| NN
.  ||| S:50384 E:50386 ||| .
A  ||| S:50386 E:50388 ||| DT
JASCO  ||| S:50388 E:50404 ||| NNP
J-810  ||| S:50404 E:50410 ||| NNP
CD  ||| S:50410 E:50413 ||| NNP
spectropolarimeter  ||| S:50413 E:50432 ||| VBZ
operating  ||| S:50432 E:50442 ||| VBG
at  ||| S:50442 E:50445 ||| IN
25°C  ||| S:50445 E:50450 ||| NNP
was  ||| S:50450 E:50454 ||| VBD
used  ||| S:50454 E:50459 ||| VBN
to  ||| S:50459 E:50472 ||| TO
collect  ||| S:50472 E:50480 ||| VB
CD  ||| S:50480 E:50483 ||| NN
spectra ||| S:50483 E:50490 ||| NN
.  ||| S:50490 E:50520 ||| .
Stopped  ||| S:50520 E:50528 ||| VBN
-  ||| S:50528 E:50530 ||| :
flow ||| S:50530 E:50534 ||| NN
/ ||| S:50534 E:50535 ||| NNP
Rapid-Scanning  ||| S:50535 E:50550 ||| NNP
UV-Visible  ||| S:50550 E:50571 ||| NNP
Spectrophotometry  ||| S:50571 E:50599 ||| NNP
Rapid-scanning  ||| S:50599 E:50614 ||| NNP
Vis  ||| S:50614 E:50618 ||| NNP
spectra  ||| S:50618 E:50626 ||| NN
of  ||| S:50626 E:50629 ||| IN
nitrocefin  ||| S:50629 E:50640 ||| JJ
hydrolysis  ||| S:50640 E:50651 ||| NN
by  ||| S:50651 E:50664 ||| IN
L1  ||| S:50664 E:50667 ||| NNP
and  ||| S:50667 E:50671 ||| CC
the  ||| S:50671 E:50675 ||| DT
L1  ||| S:50675 E:50678 ||| CD
mutants  ||| S:50678 E:50686 ||| NNS
were  ||| S:50686 E:50691 ||| VBD
collected  ||| S:50691 E:50701 ||| VBN
on  ||| S:50701 E:50704 ||| IN
a  ||| S:50704 E:50706 ||| DT
Applied  ||| S:50706 E:50724 ||| NNP
Photophysics  ||| S:50724 E:50737 ||| NNP
SX.18MV  ||| S:50737 E:50745 ||| NNP
stopped-flow  ||| S:50745 E:50758 ||| NNP
spectrophotometer  ||| S:50758 E:50786 ||| VBD
equipped  ||| S:50786 E:50795 ||| VBN
with  ||| S:50795 E:50800 ||| IN
an  ||| S:50800 E:50803 ||| DT
Applied  ||| S:50803 E:50811 ||| NNP
Photophysics  ||| S:50811 E:50824 ||| NNP
PD.l  ||| S:50824 E:50829 ||| NNP
photodiode  ||| S:50829 E:50850 ||| JJ
array  ||| S:50850 E:50856 ||| NN
detector  ||| S:50856 E:50865 ||| NN
and  ||| S:50865 E:50869 ||| CC
a  ||| S:50869 E:50871 ||| DT
1  ||| S:50871 E:50873 ||| CD
cm  ||| S:50873 E:50876 ||| NNS
pathlength  ||| S:50876 E:50887 ||| VBP
optical  ||| S:50887 E:50895 ||| JJ
cell ||| S:50895 E:50899 ||| NN
.  ||| S:50899 E:50901 ||| .
A  ||| S:50901 E:50913 ||| DT
typical  ||| S:50913 E:50921 ||| JJ
experiment  ||| S:50921 E:50932 ||| NN
consisted  ||| S:50932 E:50942 ||| VBD
of  ||| S:50942 E:50945 ||| IN
25  ||| S:50945 E:50948 ||| CD
μM  ||| S:50948 E:50951 ||| JJ
enzyme  ||| S:50951 E:50958 ||| NN
and  ||| S:50958 E:50962 ||| CC
5  ||| S:50962 E:50964 ||| CD
μM  ||| S:50964 E:50977 ||| JJ
nitrocefin  ||| S:50977 E:50988 ||| NN
in  ||| S:50988 E:50991 ||| IN
50  ||| S:50991 E:50994 ||| CD
mM  ||| S:50994 E:50997 ||| JJ
cacodylate  ||| S:50997 E:51008 ||| JJ
buffer ||| S:51008 E:51014 ||| NN
,  ||| S:51014 E:51016 ||| ,
pH  ||| S:51016 E:51019 ||| JJ
7.0  ||| S:51019 E:51023 ||| CD
containing  ||| S:51023 E:51044 ||| CD
100  ||| S:51044 E:51048 ||| CD
μM  ||| S:51048 E:51051 ||| JJ
ZnCl  ||| S:51051 E:51067 ||| JJ
2  ||| S:51067 E:51069 ||| CD
,  ||| S:51069 E:51071 ||| ,
the  ||| S:51071 E:51075 ||| DT
reaction  ||| S:51075 E:51084 ||| NN
temperature  ||| S:51084 E:51096 ||| NN
was  ||| S:51096 E:51110 ||| VBD
thermostated  ||| S:51110 E:51123 ||| VBN
at  ||| S:51123 E:51126 ||| IN
25°C ||| S:51126 E:51130 ||| NNP
,  ||| S:51130 E:51132 ||| ,
and  ||| S:51132 E:51136 ||| CC
the  ||| S:51136 E:51140 ||| DT
spectra  ||| S:51140 E:51148 ||| NN
were  ||| S:51148 E:51153 ||| VBD
collected  ||| S:51153 E:51173 ||| VBN
between  ||| S:51173 E:51181 ||| IN
300  ||| S:51181 E:51185 ||| CD
and  ||| S:51185 E:51189 ||| CC
725  ||| S:51189 E:51193 ||| CD
nm ||| S:51193 E:51195 ||| NNS
.  ||| S:51195 E:51197 ||| .
Data  ||| S:51197 E:51202 ||| NNS
from  ||| S:51202 E:51207 ||| IN
at  ||| S:51207 E:51210 ||| IN
least  ||| S:51210 E:51216 ||| JJS
three  ||| S:51216 E:51232 ||| CD
experiments  ||| S:51232 E:51244 ||| NNS
were  ||| S:51244 E:51249 ||| VBD
collected  ||| S:51249 E:51259 ||| VBN
and  ||| S:51259 E:51263 ||| CC
averaged ||| S:51263 E:51271 ||| VBD
.  ||| S:51271 E:51273 ||| .
Absorbance  ||| S:51273 E:51284 ||| JJ
data  ||| S:51284 E:51299 ||| NNS
were  ||| S:51299 E:51304 ||| VBD
converted  ||| S:51304 E:51314 ||| VBN
to  ||| S:51314 E:51317 ||| TO
concentration  ||| S:51317 E:51331 ||| VB
data  ||| S:51331 E:51336 ||| NNS
as  ||| S:51336 E:51339 ||| RB
described  ||| S:51339 E:51359 ||| VBN
previously  ||| S:51359 E:51370 ||| RB
by  ||| S:51370 E:51373 ||| IN
McMannus  ||| S:51373 E:51382 ||| JJ
and  ||| S:51382 E:51386 ||| CC
Crowder  ||| S:51386 E:51394 ||| NNP
[  ||| S:51394 E:51396 ||| -LRB-
39  ||| S:51396 E:51399 ||| CD
]  ||| S:51399 E:51401 ||| -RRB-
.  ||| S:51401 E:51403 ||| .
Stopped-flow  ||| S:51403 E:51426 ||| JJ
fluorescence  ||| S:51426 E:51439 ||| JJ
studies  ||| S:51439 E:51447 ||| NNS
of  ||| S:51447 E:51450 ||| IN
nitrocefin  ||| S:51450 E:51461 ||| JJ
hydrolysis  ||| S:51461 E:51472 ||| NN
by  ||| S:51472 E:51475 ||| IN
L1  ||| S:51475 E:51478 ||| NNP
were  ||| S:51478 E:51493 ||| VBD
performed  ||| S:51493 E:51503 ||| VBN
on  ||| S:51503 E:51506 ||| IN
an  ||| S:51506 E:51509 ||| DT
Applied  ||| S:51509 E:51517 ||| NNP
Photophysics  ||| S:51517 E:51530 ||| NNP
SX.18MV  ||| S:51530 E:51548 ||| NNP
spectrophotometer ||| S:51548 E:51565 ||| NN
,  ||| S:51565 E:51567 ||| ,
using  ||| S:51567 E:51573 ||| VBG
an  ||| S:51573 E:51576 ||| DT
excitation  ||| S:51576 E:51587 ||| JJ
wavelength  ||| S:51587 E:51598 ||| NN
of  ||| S:51598 E:51601 ||| IN
295  ||| S:51601 E:51615 ||| CD
nm  ||| S:51615 E:51618 ||| NNS
and  ||| S:51618 E:51622 ||| CC
a  ||| S:51622 E:51624 ||| DT
WG320  ||| S:51624 E:51630 ||| JJ
nm  ||| S:51630 E:51633 ||| JJ
cut-off  ||| S:51633 E:51641 ||| JJ
filter  ||| S:51641 E:51648 ||| NN
on  ||| S:51648 E:51651 ||| IN
the  ||| S:51651 E:51655 ||| DT
photomultiplier ||| S:51655 E:51670 ||| NN
.  ||| S:51670 E:51682 ||| .
These  ||| S:51682 E:51688 ||| DT
experiments  ||| S:51688 E:51700 ||| NNS
were  ||| S:51700 E:51705 ||| VBD
conducted  ||| S:51705 E:51715 ||| VBN
at  ||| S:51715 E:51718 ||| IN
10°C  ||| S:51718 E:51723 ||| CD
using  ||| S:51723 E:51729 ||| VBG
the  ||| S:51729 E:51733 ||| DT
same  ||| S:51733 E:51748 ||| JJ
buffer  ||| S:51748 E:51755 ||| NN
in  ||| S:51755 E:51758 ||| IN
the  ||| S:51758 E:51762 ||| DT
rapid-scanning  ||| S:51762 E:51777 ||| JJ
Vis  ||| S:51777 E:51781 ||| JJ
studies ||| S:51781 E:51788 ||| NNS
.  ||| S:51788 E:51790 ||| .
Fluorescence  ||| S:51790 E:51813 ||| JJ
data  ||| S:51813 E:51818 ||| NNS
were  ||| S:51818 E:51823 ||| VBD
fitted  ||| S:51823 E:51830 ||| VBN
to  ||| S:51830 E:51844 ||| TO
k  ||| S:51844 E:51857 ||| VB
obs  ||| S:51857 E:51861 ||| NNS
=  ||| S:51861 E:51863 ||| SYM
{ ||| S:51863 E:51864 ||| FW
(  ||| S:51864 E:51877 ||| -LRB-
k  ||| S:51877 E:51890 ||| FW
f  ||| S:51890 E:51892 ||| FW
[ ||| S:51892 E:51893 ||| -LRB-
S ||| S:51893 E:51894 ||| NNP
] ||| S:51894 E:51895 ||| -RRB-
)  ||| S:51895 E:51897 ||| -RRB-
/  ||| S:51897 E:51899 ||| NNP
K  ||| S:51899 E:51912 ||| NNP
S  ||| S:51912 E:51914 ||| NNP
+  ||| S:51914 E:51916 ||| NNP
[ ||| S:51916 E:51917 ||| -LRB-
S ||| S:51917 E:51918 ||| NNP
] ||| S:51918 E:51919 ||| -RRB-
) ||| S:51919 E:51920 ||| CD
}  ||| S:51920 E:51922 ||| -RRB-
+  ||| S:51922 E:51935 ||| CD
k  ||| S:51935 E:51948 ||| NNS
r  ||| S:51948 E:51950 ||| VBP
as  ||| S:51950 E:51953 ||| RB
described  ||| S:51953 E:51963 ||| VBN
previously  ||| S:51963 E:51974 ||| RB
[  ||| S:51974 E:51976 ||| -LRB-
40  ||| S:51976 E:51979 ||| CD
]  ||| S:51979 E:51981 ||| -RRB-
or  ||| S:51981 E:51984 ||| CC
to  ||| S:51984 E:52008 ||| TO
k  ||| S:52008 E:52021 ||| VB
obs  ||| S:52021 E:52025 ||| NNS
=  ||| S:52025 E:52038 ||| SYM
k  ||| S:52038 E:52051 ||| FW
f  ||| S:52051 E:52053 ||| FW
[ ||| S:52053 E:52054 ||| -LRB-
S ||| S:52054 E:52055 ||| NNP
]  ||| S:52055 E:52057 ||| -RRB-
+  ||| S:52057 E:52070 ||| FW
k  ||| S:52070 E:52083 ||| FW
r  ||| S:52083 E:52085 ||| FW
by  ||| S:52085 E:52088 ||| IN
using  ||| S:52088 E:52094 ||| VBG
CurveFit  ||| S:52094 E:52103 ||| JJ
v.  ||| S:52103 E:52106 ||| CC
1.0 ||| S:52106 E:52109 ||| CD
.  ||| S:52109 E:52142 ||| .
Abbreviations  ||| S:52142 E:52164 ||| NNP
AES ||| S:52164 E:52167 ||| NNP
,  ||| S:52167 E:52169 ||| ,
atomic  ||| S:52169 E:52176 ||| JJ
emission  ||| S:52176 E:52185 ||| NN
spectroscopy ||| S:52185 E:52197 ||| NNS
;  ||| S:52197 E:52199 ||| :
bp ||| S:52199 E:52201 ||| CD
,  ||| S:52201 E:52203 ||| ,
base  ||| S:52203 E:52208 ||| NN
pairs ||| S:52208 E:52213 ||| NNS
;  ||| S:52213 E:52215 ||| :
CD ||| S:52215 E:52217 ||| NNP
,  ||| S:52217 E:52227 ||| ,
circular  ||| S:52227 E:52236 ||| JJ
dichroism ||| S:52236 E:52245 ||| NN
;  ||| S:52245 E:52247 ||| :
ε ||| S:52247 E:52248 ||| CD
,  ||| S:52248 E:52250 ||| ,
extinction  ||| S:52250 E:52261 ||| JJ
coefficient ||| S:52261 E:52272 ||| NN
;  ||| S:52272 E:52274 ||| :
ICP ||| S:52274 E:52277 ||| NNP
,  ||| S:52277 E:52287 ||| ,
inductively  ||| S:52287 E:52299 ||| VBD
coupled  ||| S:52299 E:52307 ||| VBN
plasma ||| S:52307 E:52313 ||| NN
;  ||| S:52313 E:52324 ||| :
k  ||| S:52324 E:52335 ||| JJ
cat  ||| S:52335 E:52339 ||| NN
,  ||| S:52339 E:52341 ||| ,
turnover  ||| S:52341 E:52350 ||| NN
number ||| S:52350 E:52356 ||| NN
;  ||| S:52356 E:52358 ||| :
kDa ||| S:52358 E:52361 ||| NNP
,  ||| S:52361 E:52363 ||| ,
kilodaltons ||| S:52363 E:52374 ||| NNS
;  ||| S:52374 E:52384 ||| :
K  ||| S:52384 E:52395 ||| NNP
m  ||| S:52395 E:52397 ||| NN
,  ||| S:52397 E:52399 ||| ,
Michaelis  ||| S:52399 E:52409 ||| NNP
constant ||| S:52409 E:52417 ||| JJ
;  ||| S:52417 E:52419 ||| :
K  ||| S:52419 E:52430 ||| NNP
S  ||| S:52430 E:52432 ||| NNP
,  ||| S:52432 E:52434 ||| ,
substrate  ||| S:52434 E:52444 ||| JJ
binding  ||| S:52444 E:52452 ||| JJ
constant ||| S:52452 E:52460 ||| JJ
;  ||| S:52460 E:52462 ||| :
LB ||| S:52462 E:52464 ||| NNP
,  ||| S:52464 E:52474 ||| ,
Luria-Bertani  ||| S:52474 E:52488 ||| JJ
media ||| S:52488 E:52493 ||| NNS
.  ||| S:52493 E:52510 ||| .
